0001477932-22-007013.txt : 20220919 0001477932-22-007013.hdr.sgml : 20220919 20220919062327 ACCESSION NUMBER: 0001477932-22-007013 CONFORMED SUBMISSION TYPE: 6-K/A PUBLIC DOCUMENT COUNT: 98 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220919 DATE AS OF CHANGE: 20220919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Flora Growth Corp. CENTRAL INDEX KEY: 0001790169 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40397 FILM NUMBER: 221249328 BUSINESS ADDRESS: STREET 1: 365 BAY STREET, SUITE 800 CITY: TORONTO STATE: A6 ZIP: M5H 2V1 BUSINESS PHONE: 416-861-2267 MAIL ADDRESS: STREET 1: 365 BAY STREET, SUITE 800 CITY: TORONTO STATE: A6 ZIP: M5H 2V1 6-K/A 1 flora_6k.htm FORM 6-K/A flora_6k.htm

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K/A

Amendment No. 1

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2022

 

Commission File Number 001-40397

 

FLORA GROWTH CORP.

(Exact name of registrant as specified in its charter)

 

365 Bay Street, Suite 800

TorontoONtario M5H 2V1

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ◻ Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ◻

 

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ◻

 

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

Explanatory Note

 

This Report on Form 6-K/A (the “Amendment”) amends the Report on Form 6-K filed on August 15, 2022 (the “Original 6-K”) containing the Unaudited Interim Condensed Consolidated Financial Statements of Flora Growth Corp. (the “Company”) as of and for the six months ended June 30, 2022. The purpose of this Amendment is solely to provide the Company’s Unaudited Interim Condensed Consolidated Financial Statements as of and for the six months ended June 30, 2022 formatted in Inline eXtensible Business Reporting Language (“iXBRL”) in accordance with Rule 405 of Regulation S-T and paragraph C.(6)(a)(ii) of the General Instructions to Form 6-K, attached hereto as Exhibit 99.1. Such Unaudited Interim Condensed Consolidated Financial Statements were previously filed without iXBRL as exhibit 99.2 to the Original 6-K.

 

Except as described above, this Amendment speaks as of the original filing date of the Original 6-K and does not amend, update or restate any information set forth in the Original 6-K or reflect any events that occurred subsequent to the original filing date of the Original 6-K.

 

The information contained in this Form 6-K, including Exhibits 99.1 and 101, is hereby incorporated by reference into the Company’s Registration Statements on Form S-8 (Registration Nos. 333-259198, 333-262660 and 333-266400).

 

Exhibit Index

Exhibit

 

99.1

 

Unaudited Interim Condensed Consolidated Financial Statements as of and for the six month periods ended June 30, 2022 and 2021.

 

 

 

101.NS

 

The following materials from this Report on Form 6-K are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Unaudited Interim Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021; (ii) Unaudited Interim Condensed Consolidated Statements of Loss and Comprehensive Loss for the six-month periods ended June 30, 2022 and 2021; (iii) Unaudited Interim Condensed Consolidated Statements of Shareholders’ Equity for the six-month periods ended June 30, 2022 and 2021; (iv) Unaudited Interim Condensed Consolidated Statements of Cash Flows for the six-month periods ended June 30, 2022 and 2021; and (v) Unaudited Notes to the Interim Condensed Consolidated Financial Statements for the six-month period ended June 30, 2022.

 

 
2

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

FLORA GROWTH CORP.

 

 

 

Date: September 19, 2022

By:

/s/ Luis Merchan

 

 

Name: Luis Merchan

 

 

Title: Chief Executive Officer

 

 

 

 
3

 

EX-99.1 2 flora_ex991.htm UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS flora_ex991.htm

 EXHIBIT 99.1

 

Flora Growth Corp.

 

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

For the six months ended June 30, 2022 and 2021

 

(Unaudited)

 

(Expressed in United States Dollars)

 

 

 

 

Flora Growth Corp.

 

 

 

 

Interim Condensed Consolidated Statements of Financial Position

(Unaudited - Prepared by Management)

(in thousands of United States dollars)

 

 

 

 

 

 

 

As at:

 

June 30, 2022

 

 

December 31, 2021

 

ASSETS

 

 

 

 

 

 

Current

 

 

 

 

 

 

Cash

 

$10,268

 

 

$37,614

 

Restricted cash

 

 

1

 

 

 

2

 

Trade and amounts receivable (Note 3)

 

 

5,092

 

 

 

5,324

 

Loans receivable and advances

 

 

262

 

 

 

273

 

Prepaid expenses

 

 

2,224

 

 

 

1,700

 

Biological assets (Note 4)

 

 

14

 

 

 

37

 

Inventory (Note 5)

 

 

9,295

 

 

 

2,993

 

Total current assets

 

 

27,156

 

 

 

47,943

 

Non-current

 

 

 

 

 

 

 

 

Property, plant and equipment (Note 6)

 

 

4,565

 

 

 

3,750

 

Right of use assets (Note 11)

 

 

3,639

 

 

 

1,229

 

Intangible assets (Note 9)

 

 

13,432

 

 

 

9,736

 

Goodwill (Note 9)

 

 

28,666

 

 

 

20,054

 

Investments (Note 7)

 

 

1,337

 

 

 

2,670

 

Other Assets

 

 

273

 

 

 

97

 

Total assets

 

$79,068

 

 

$85,479

 

LIABILITIES

 

 

 

 

 

 

 

 

Current

 

 

 

 

 

 

 

 

Trade payables and accrued liabilities

 

$7,401

 

 

$5,628

 

Current portion of long term debt

 

 

10

 

 

 

18

 

Current portion of lease liability (Note 11)

 

 

1,120

 

 

 

412

 

Other accrued liabilities

 

 

20

 

 

 

61

 

Total current liabilities

 

 

8,551

 

 

 

6,119

 

Non-current

 

 

 

 

 

 

 

 

Non-current debt

 

 

138

 

 

 

-

 

Non-current lease liability (Note 11)

 

 

2,411

 

 

 

908

 

Deferred tax (Note 16)

 

 

1,511

 

 

 

1,511

 

Other long term liabilities (Note 8)

 

 

3,958

 

 

 

-

 

Total liabilities

 

 

16,599

 

 

 

8,538

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Share capital (Note 12)

 

 

119,300

 

 

 

102,428

 

Options (Note 13)

 

 

6,611

 

 

 

3,712

 

Warrants (Note 14)

 

 

10,047

 

 

 

10,670

 

Accumulated other comprehensive loss

 

 

(1,675)

 

 

(1,108)

Deficit

 

 

(71,512)

 

 

(38,536)

Non-controlling interest

 

 

(302)

 

 

(225)

Total shareholders’ equity

 

 

62,469

 

 

 

76,941

 

Total liabilities and shareholders’ equity

 

$79,068

 

 

$85,479

 

 

Nature of operations (Note 1); Provisions, commitments and contingencies (Note 15); Subsequent events (Note 22)

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

 
Page 2

 

 

Flora Growth Corp.

 

 

 

 

 

 

Interim Condensed Consolidated Statements of Loss and Comprehensive Loss

 

 

 

 

(Unaudited - Prepared by Management)

 

 

 

 

(in thousands of United States dollars, except per share amounts which are in thousands of shares)

 

 

 

 

 

 

 

 

 

For the six months ended June 30, 2022

 

 

For the six months ended June 30, 2021

 

Revenue (Note 21)

 

$14,917

 

 

$2,118

 

Cost of sales

 

 

8,415

 

 

 

1,106

 

Gross profit before fair value adjustments

 

 

6,502

 

 

 

1,012

 

Unrealized gain on changes in fair value of biological assets (Note 4)

 

 

46

 

 

 

-

 

Realized fair value amounts included in inventory sold (Note 4)

 

 

(2)

 

 

-

 

Gross Profit

 

 

6,546

 

 

 

1,012

 

Operating Expenses

 

 

 

 

 

 

 

 

Consulting and management fees

 

 

5,243

 

 

 

2,262

 

Professional fees

 

 

2,096

 

 

 

766

 

General and administrative

 

 

2,429

 

 

 

1,481

 

Promotion and communication

 

 

4,719

 

 

 

1,180

 

Travel expenses

 

 

601

 

 

 

143

 

Share based compensation (Note 13)

 

 

2,855

 

 

 

95

 

Research and development

 

 

422

 

 

 

85

 

Depreciation and amortization (Notes 6 and 9)

 

 

1,712

 

 

 

119

 

Bad debt expense (Note 3)

 

 

405

 

 

 

100

 

Goodwill impairment (Notes 9 and 10)

 

 

16,000

 

 

 

-

 

Other expenses (income), net

 

 

1,178

 

 

 

(67)

Total operating expenses

 

 

37,660

 

 

 

6,164

 

Operating Loss

 

 

(31,114)

 

 

(5,152)

Interest expense

 

 

69

 

 

 

64

 

Foreign exchange loss (gain)

 

 

200

 

 

 

(78)

Unrealized loss on fair value of investments (Note 7)

 

 

1,333

 

 

 

-

 

Net loss before income taxes

 

 

(32,716)

 

 

(5,138)

Income tax benefit (Note 16)

 

 

-

 

 

 

-

 

Net loss for the period

 

$(32,716)

 

$(5,138)

Other comprehensive loss

 

 

 

 

 

 

 

 

Exchange differences on foreign operations

 

567

 

 

200

 

Total comprehensive loss for the period

 

$(33,283)

 

$(5,338)

 

 

 

 

 

 

 

 

 

Net loss attributable to:

 

 

 

 

 

 

 

 

Flora Growth Corp.

 

$(32,611)

 

$(5,097)

Non-controlling interests

 

 

(105)

 

 

(41)

Comprehensive loss attributable to:

 

 

 

 

 

 

 

 

Flora Growth Corp.

 

$(33,178)

 

$(5,297)

Non-controlling interests

 

 

(105)

 

 

(41)

Basic and diluted loss per share attributable to Flora Growth Corp.

 

$(0.42)

 

$(0.13)

Weighted average number of common shares outstanding - basic and diluted (Note 17)

 

 

76,944

 

 

 

39,604

 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

 
Page 3

 

 

Flora Growth Corp.

Interim Condensed Consolidated Statement of Shareholders’ Equity (Deficiency)

(Unaudited - Prepared by Management)

(in thousands of United States dollars, except for share amounts which are in thousands of shares)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Options

 

 

Warrants

 

 

Accumulated other comprehensive (loss) income

 

 

Accumulated Deficit

 

 

Non-Controlling interest (Deficiency)

 

 

 

Shareholders’ Equity 

(Deficiency)

 

 

 

#

 

 

$

 

 

 $

 

 

 $

 

 

$ 

 

 

$

 

 

 $

 

 

$

 

Balance, December 31, 2020

 

 

38,355

 

 

 

27,254

 

 

 

2,396

 

 

 

3,961

 

 

 

39

 

 

 

(17,287)

 

 

(113)

 

 

16,250

 

Initial public offering

 

 

3,333

 

 

 

16,667

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

16,667

 

Regulation A and Other Offerings

 

 

(1)

 

 

(3)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3)

Share issuance costs

 

 

-

 

 

 

(5,040)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,040)

Warrants issued

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,349

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,349

 

Warrants exercised

 

 

337

 

 

 

65

 

 

 

-

 

 

 

(5)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

60

 

Options issued

 

 

-

 

 

 

-

 

 

 

95

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

95

 

Other comprehensive loss –

 exchange differences on foreign

 operations

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(201)

 

 

-

 

 

 

-

 

 

 

(201)

Current year net loss attributable to Flora

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,097)

 

 

(41)

 

 

(5,138)

Balance, June 30, 2021

 

 

42,024

 

 

 

38,943

 

 

 

2,491

 

 

 

5,305

 

 

 

(162)

 

 

(22,384)

 

 

(154)

 

 

24,039

 

Balance, December 31, 2021

 

 

65,517

 

 

 

102,428

 

 

 

3,712

 

 

 

10,670

 

 

 

(1,108)

 

 

(38,536)

 

 

(225)

 

 

76,941

 

Share repurchase (Note 12)

 

 

-

 

 

 

(250)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(250)

Common shares issued for business combinations (Notes 8 and 12)

 

 

9,500

 

 

 

14,697

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

14,697

 

Common shares issued for other agreements (Note 12)

 

 

811

 

 

 

1,470

 

 

 

84

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,554

 

Acquisition of noncontrolling interest (Note 8)

 

 

131

 

 

 

220

 

 

 

63

 

 

 

-

 

 

 

-

 

 

 

(365)

 

 

28

 

 

 

(54)

Options issued (Note 13)

 

 

-

 

 

 

-

 

 

 

2,771

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,771

 

Options exercised (Note 13)

 

 

512

 

 

 

96

 

 

 

(19)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

77

 

Warrants exercised (Note 14)

 

 

473

 

 

 

132

 

 

 

-

 

 

 

(41)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

91

 

Warrants expired/cancelled (Note 14)

 

 

-

 

 

 

582

 

 

 

-

 

 

 

(582)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Share issuance costs

 

 

-

 

 

 

(75)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(75)

Other comprehensive loss –

 exchange differences on foreign operations

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(567)

 

 

-

 

 

 

-

 

 

 

(567)

Current year net loss attributable to Flora

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(32,611)

 

 

(105)

 

 

(32,716)

Balance, June 30, 2022

 

 

76,944

 

 

119,300

 

 

6,611

 

 

10,047

 

 

(1,675)

 

(71,512)

 

(302)

 

62,469

 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

 
Page 4

 

 

Flora Growth Corp.

Interim Condensed Consolidated Statement of Cash Flows

(Unaudited - Prepared by Management)

(in thousands of United States dollars)

 

 

 

 

 

 

 

 

 

For the six months ended June 30, 2022

 

 

For the six months ended June 30, 2021

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$(32,716)

 

$(5,138)

Adjustments to net loss:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

1,712

 

 

 

119

 

Stock-based compensation

 

 

3,044

 

 

 

95

 

Impairments

 

 

16,000

 

 

 

-

 

Changes in fair value of investments and biological assets

 

 

1,287

 

 

 

-

 

Bad debt expense

 

 

405

 

 

 

100

 

Interest expense

 

 

56

 

 

 

15

 

Income tax benefit

 

 

-

 

 

 

-

 

Income tax (paid) received

 

 

-

 

 

 

-

 

 

 

 

(10,212)

 

 

(4,809)

Net change in non-cash working capital:

 

 

 

 

 

 

 

 

Trade and other receivables

 

 

802

 

 

 

(772)

Inventory

 

 

(699)

 

 

(421)

Prepaid expenses and other assets

 

 

(33)

 

 

(1,415)

Trade payables and accrued liabilities

 

 

(341)

 

 

1,647

 

Net cash used in operating activities

 

 

(10,483)

 

 

(5,770)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Common shares issued

 

 

-

 

 

 

16,664

 

Equity issue costs

 

 

(75)

 

 

(2,024)

Exercise of warrants and options

 

 

168

 

 

 

60

 

Repayments of lease liability

 

 

(420)

 

 

(61)

Common shares repurchased

 

 

(250)

 

 

-

 

Interest paid

 

 

(69)

 

 

-

 

Loan borrowing (repayments)

 

 

130

 

 

 

(220)

Net cash (used) provided by financing activities

 

 

(516)

 

 

14,419

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Loans provided

 

 

-

 

 

 

(275)

Loan repayments received

 

 

-

 

 

 

224

 

Purchases of property, plant and equipment and other assets

 

 

(722)

 

 

(1,384)

Purchase of investments

 

 

-

 

 

 

(2,430)

Business and asset acquisitions, net of cash acquired

 

 

(15,457)

 

 

(1,306)

Net cash used in investing activities

 

 

(16,179)

 

 

(5,171)

 

 

 

 

 

 

 

 

 

Effect of exchange rate on changes on cash

 

 

(168)

 

 

(195)

 

 

 

 

 

 

 

 

 

Change in cash during the period

 

 

(27,346)

 

 

3,283

 

Cash and cash equivalents at beginning of period

 

 

37,614

 

 

 

15,523

 

Cash and cash equivalents at end of period

 

$10,268

 

 

$18,806

 

Supplemental disclosure of non-cash activities

 

 

 

 

 

 

 

 

Right of use assets and lease liabilities acquired (Note 11)

 

$2,053

 

 

$-

 

Common shares issued for business combinations (Notes 8)

 

 

14,917

 

 

 

-

 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

 
Page 5

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

1. NATURE OF OPERATIONS

 

Flora Growth Corp. (the “Company” or “Flora”) was incorporated under the laws of the Province of Ontario, Canada on March 13, 2019. The Company is a manufacturer of global cannabis products and brands, building a connected, design-led collective of plant-based wellness and lifestyle brands. The Company’s registered office is located at 365 Bay Street, Suite 800, Toronto, Ontario, M5H 2V1, Canada and our principal place of business in the United States is located at 3406 SW 26th Terrace, Suite C-1, Fort Lauderdale, Florida 33312.

 

These interim condensed consolidated financial statements have been prepared on a going concern basis, meaning that the Company will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations.

 

2. BASIS OF PRESENTATION

 

Statement of compliance

These interim condensed consolidated financial statements have been prepared by management in accordance with International Financial Reporting Standards (“IFRS”) and International Accounting Standards 34, Interim Financial Reporting (“IAS 34”), issued by the International Accounting Standards Board (“IASB”). These interim condensed consolidated financial statements do not include all notes of the type normally included within the annual financial statements and should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December 31, 2021 included in our Annual Report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”), which have been prepared in accordance with IFRS issued by the IASB and interpretations issued by the IFRS Interpretations Committee (“IFRIC”).

 

These consolidated financial statements were approved and authorized for issuance by the Board of Directors of the Company on August 11, 2022.

 

Basis of consolidation

These interim condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions were eliminated on consolidation. Subsidiaries are entities the Company controls when it is exposed, or has rights, to variable returns from its involvement in the entity and can affect those returns through its power to direct the relevant activities of the entity. Subsidiaries are included in the consolidated financial results of the Company from the date of acquisition up to the date of disposition or loss of control. As at June 30, 2022, the Company had the following subsidiaries:

 

Subsidiaries

Country of incorporation

Ownership

Functional currency

Cosechemos YA S.A.S.

Colombia

90%

Colombia Peso (COP)

Flora Growth Corp. Sucursal Colombia

Colombia

100%

Colombia Peso (COP)

Hemp Textiles & Co. LLC

United States

100%

United States Dollar (USD)

Hemp Textiles & Co. S.A.S.

Colombia

100%

Colombia Peso (COP)

Flora Beauty LLC

United States

100%

United States Dollar (USD)

Flora Beauty LLC Sucursal Colombia

Colombia

100%

Colombia Peso (COP)

Kasa Wholefoods Company S.A.S.

Colombia

90%

Colombia Peso (COP)

Kasa Wholefoods Company LLC

United States

100%

United States Dollar (USD)

Grupo Farmaceutico Cronomed S.A.S.

Colombia

100%

Colombia Peso (COP)

Labcofarm Laboratorios S.A.S.

Colombia

100%

Colombia Peso (COP)

Breeze Laboratory S.A.S.

Colombia

100%

Colombia Peso (COP)

Vessel Brand Inc.

United States

100%

United States Dollar (USD)

Just Brands LLC

United States

100%

United States Dollar (USD)

Just Brands International LTD

United Kingdom

100%

British Pound (GBP)

High Roller Private Label LLC

United States

100%

United States Dollar (USD)

Flora Growth US Holdings Corp.

United States

100%

United States Dollar (USD)

Flora Growth Management Corp.

United States

100%

United States Dollar (USD)

Cardiff Brand Corp.

United States

100%

United States Dollar (USD)

Keel Brand Corp.

United States

100%

United States Dollar (USD)

Flora Growth F&B Corp.

United States

100%

United States Dollar (USD)

 

 
Page 6

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

Basis of measurement

The interim condensed consolidated financial statements have been prepared on the historical cost basis, except for certain financial instruments that are measured at fair value and biological assets as explained in the accounting policies included in the audited consolidated financial statements of the Company for the year ended December 31, 2021. Historical cost is generally based on the fair value of the consideration given in exchange for goods and services.

 

The unaudited interim condensed consolidated financial statements are presented in United States dollars (“$”) unless otherwise noted.

 

Significant Accounting Policies and Critical Judgments and Estimation Uncertainties

The interim condensed consolidated financial statements were prepared using the same accounting policies, judgments, estimates and assumptions as those used in the Company’s consolidated financial statements for the year ended December 31, 2021, except as noted below for the following new significant transactions that occurred in 2022.

 

Contingent Purchase Consideration

Contingent consideration is measured at its acquisition date fair value and is included as part of the consideration transferred in a business combination, subject to the applicable terms and conditions. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration that is classified as a liability is remeasured at subsequent reporting dates with the corresponding gain or loss recognized in profit or loss. Management exercises judgment to determine the classification of contingent consideration as equity or liability based on the terms of the agreement and potential for the consideration to result in a cash outflow by the Company. Fair value estimates are determined using appropriate valuation techniques based on the nature of the terms in the purchase agreement.

 

3. TRADE AND AMOUNTS RECEIVABLE

 

The Company’s trade and amounts receivable are recorded at amortized cost. The trade and other receivables balance as at June 30, 2022 and December 31, 2021 consists of trade accounts receivable, amounts recoverable from the Government of Canada for Harmonized Sales Taxes (“HST”) and other receivables.

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Thousands of United States dollars

 

 

 

 

 

 

Trade accounts receivable

 

$5,428

 

 

$5,565

 

Allowance for expected credit losses

 

 

(1,679)

 

 

(1,252)

HST receivable

 

 

411

 

 

 

259

 

Other receivables

 

 

932

 

 

 

752

 

Total

 

5,092

 

 

5,324

 

 

Changes in the trade accounts receivable allowance in the six months ended June 30, 2022 primarily relate to establishing an allowance for expected credit losses from the acquisition of JustCBD balances. There were no write-offs of trade receivables during the six months ended June 30, 2022. The Company has no amounts written-off that are still subject to collection enforcement activity as at June 30, 2022. There was an additional $0.3 million of expected credit losses recorded in other receivables as at June 30, 2022. The Company’s aging of trade accounts receivable is as follows:

 

 

 

June 30, 2022

 

Thousands of United States dollars

 

 

 

Current

 

$1,641

 

1-30 Days

 

 

614

 

31-60 Days

 

 

259

 

61-90 Days

 

 

383

 

91-180 Days

 

 

1,383

 

180+ Days

 

 

1,148

 

Total trade receivables

 

$5,428

 

 

 
Page 7

 

  

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

4. BIOLOGICAL ASSETS

 

The Company’s biological assets consist of cannabis plants throughout the growth cycle including propagation, vegetative and flowering stages. Cannabis plants cease being biological assets upon harvest when the fair value at time of harvest is transferred to harvested cannabis inventory. The Company has no biological assets with title restricted or pledged as collateral, and no significant commitments for development or acquisition of biological assets as at June 30, 2022.

 

The changes in the carrying value of biological assets are as follows:

 

Thousands of United States Dollars

 

 

 

Opening balance at December 31, 2021

 

$37

 

Changes in fair value less cost to sell due to biological transformation

 

 

46

 

Transferred to harvested cannabis inventory upon harvest

 

 

(69)

Ending balance at June 30, 2022

 

14

 

 

The valuation of biological assets is based on an income approach (Level 3) in which the fair value at the point of harvesting is estimated based on selling prices less the costs to sell. For in-process biological assets (growing plants), the fair value at the point of harvest is adjusted based on the stage of growth at period-end. Harvested cannabis is transferred from biological assets at their fair value at harvest to harvested cannabis within inventory.

 

Significant inputs and assumptions used in determining the fair value of cannabis plants are as follows as at June 30, 2022:

 

Average selling price per gram of $0.10 – Represents estimated selling price of dried cannabis end products net of excise taxes, where applicable, for the period for all strains of cannabis, which is expected to approximate future selling prices. Increasing this amount results in an increase in fair value.

 

Weighted average yield of 21 gram per plant – Represents the weighted average number of grams of dried cannabis inventory expected to be harvested from each cannabis plant. Increasing this amount results in an increase in fair value.

 

Post-harvest cost per gram to complete production of $0.04 – Based on estimated future production costs incurred divided by estimated grams produced in the period. Increasing this amount results in a decrease in fair value.

 

Changes in the assumptions above of 10% would not have a significant impact on the fair value of biological assets as at June 30, 2022.

 

As at June 30, 2022, the weighted average fair value less cost to complete and cost to sell a gram of dried cannabis was $0.06 per gram. The Company’s biological assets produced 746 kilograms of dried cannabis in the six months ended June 30, 2022 and the Company expects the biological assets will yield 190 kilograms of cannabis when harvested. The weighted average stage of growth for the biological assets was 41%.

 

5. INVENTORY

 

Inventory is comprised of the following as at June 30, 2022 and December 31, 2021:

 

 

 

 

 

 

 

 

Thousands of United States dollars

 

June 30, 2022 

 

 

December 31,

2021 

 

Raw materials and supplies

 

$2,161

 

 

$899

 

Harvested cannabis

 

 

92

 

 

 

35

 

Work in progress

 

 

465

 

 

 

97

 

Finished goods

 

 

6,577

 

 

 

1,962

 

Total

 

$9,295

 

 

$2,993

 

 

 
Page 8

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

6. PROPERTY, PLANT AND EQUIPMENT

 

In Thousands of United States dollars

 

Construction in progress

 

 

 Machinery and Office equipment

 

 

Buildings

 

 

Vehicles

 

 

 Land

 

 

Subtotal

 

 

 Right of use assets

 

 

Total

 

Cost at December 31, 2021

 

$905

 

 

$1,991

 

 

$928

 

 

$37

 

 

$112

 

 

$3,973

 

 

$1,532

 

 

$5,505

 

Additions

 

 

321

 

 

 

53

 

 

 

23

 

 

 

-

 

 

 

305

 

 

 

702

 

 

 

2,053

 

 

 

2,755

 

Business combinations (Note 8)

 

 

-

 

 

 

506

 

 

 

-

 

 

 

30

 

 

 

-

 

 

 

536

 

 

 

772

 

 

 

1,308

 

Foreign exchange translation

 

 

(52)

 

 

(71)

 

 

(38)

 

 

(1)

 

 

(22)

 

 

(184)

 

 

(49)

 

 

(233)

Cost as at June 30, 2022

 

 

1,174

 

 

 

2,479

 

 

 

913

 

 

 

66

 

 

 

395

 

 

 

5,027

 

 

 

4,308

 

 

 

9,335

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at December 31, 2021

 

 

-

 

 

 

(169)

 

 

(44)

 

 

(10)

 

 

-

 

 

 

(223)

 

 

(303)

 

 

(526)

Depreciation

 

 

-

 

 

 

(229)

 

 

(44)

 

 

(2)

 

 

-

 

 

 

(275)

 

 

(383)

 

 

(658)

Disposals

 

 

-

 

 

 

20

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

20

 

 

 

-

 

 

 

20

 

Foreign exchange translation

 

 

-

 

 

 

12

 

 

 

4

 

 

 

-

 

 

 

-

 

 

 

16

 

 

 

17

 

 

 

33

 

Accumulated depreciation as at June 30, 2022

 

 

-

 

 

 

(366)

 

 

(84)

 

 

(12)

 

 

-

 

 

 

(462)

 

 

(669)

 

 

(1,131)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at December 31, 2020

 

 

905

 

 

 

1,822

 

 

 

884

 

 

 

27

 

 

 

112

 

 

 

3,750

 

 

 

1,229

 

 

 

4,979

 

As at June 30, 2022

 

$1,174

 

 

$2,113

 

 

$829

 

 

$54

 

 

$395

 

 

$4,565

 

 

$3,639

 

 

$8,204

 

 

7. LONG-TERM INVESTMENTS

 

As at June 30, 2022, the Company’s long-term investments consist of common shares and warrants to purchase additional common shares in an early stage European cannabis company. In 2021, the Company purchased common shares from the investee for Euro 2.0 million ($2.4 million), purchased its first tranche of warrants from existing investors in exchange for 225,000 common shares of the Company, and obtained a second tranche of warrants from the investee as an inducement to exercise some of the first tranche of warrants. As at June 30, 2022, the Company owns approximately 9.6% of the investee, or approximately 8.6% on a diluted basis including exercisable warrants of the Company and other investors.

 

The warrants allow the holder to purchase one common share of the investee for CAD 0.30 ($0.23) for the first tranche, and CAD 1.00 ($0.78) for the second tranche. The warrants were immediately exercisable and expire February 1, 2023.

 

The Company’s cost of the investments was recorded based on the fair value of the consideration exchanged as at the respective transaction dates. The investee is not a publicly listed entity and has no active quoted prices for its common shares or warrants. Subsequent remeasurements are recorded as FVPL as indicated on the unrealized investments loss caption on the statement of loss and comprehensive loss. The Company estimated the fair value of the investments as at June 30, 2022 using Level 3 inputs of the fair value hierarchy with the fair value of the investee common shares at $0.32, the first tranche warrants at $0.13, and the second tranche warrants at $0.02.

 

The investee common shares were valued considering price to book value and price to tangible book value of the investee (3.6 and 4.8, respectively) as well as comparable guideline publicly traded companies at the time of initial investment. These initial investment multiples were compared to the guideline public company multiples observed as at June 30, 2022 (2.2 price to book value and 3.0 price to tangible value), with these updated valuation multiples applied to the investee’s estimated book value. The Company also considered the status of the investee’s milestones between the purchase date and year-end for indicators of change in value.

 

The fair value of the warrants was developed using a Black-Scholes model for each tranche with the following assumptions:

 

 

 

Warrants CAD 0.30 exercise price

 

 

Warrants CAD 1.00 exercise price

 

Share price

 

$0.32

 

 

$0.32

 

Exercise price

 

$0.23

 

 

$0.78

 

Volatility

 

 

100%

 

 

100%

Risk-free interest rate

 

 

3.1%

 

 

3.1%

Dividend yield

 

 

0.0%

 

 

0.0%

Expected term in years

 

 

0.6

 

 

 

0.6

 

Fair value

 

$0.13

 

 

$0.02

 

Quantity owned

 

 

1,666,667

 

 

 

333,333

 

Fair value

 

$222,000

 

 

$8,000

 

 

 
Page 9

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

The share price is based on the calculated value of the investee’s common shares as discussed above. The volatility considers actual volatility of comparable guideline public companies.

 

A schedule of the Company’s long-term investments activity is as follows:

 

 

 

Investee common shares

 

 

Warrants CAD 0.30 exercise price

 

 

Warrants CAD 1.00 exercise price

 

 

 

Financial asset hierarchy level

 

Level 3

 

 

Level 3

 

 

Level 3

 

 

 Total

 

Thousands of United States dollars

 

 $

 

 

 $

 

 

 $

 

 

 $

 

Balance at December 31, 2021

 

 

1,987

 

 

 

625

 

 

 

58

 

 

 

2,670

 

Loss on changes in fair value

 

 

(880)

 

 

(403)

 

 

(50)

 

 

(1,333)

Balance at June 30, 2022

 

 

1,107

 

 

 

222

 

 

 

8

 

 

 

1,337

 

 

The loss on changes in fair value appear in the unrealized loss on fair value of investments caption in the statement of loss and comprehensive loss.

 

As a sensitivity assessment to the fair value calculations, a 10% change in the valuation multiples applied to the investee common shares results in a 10% change in the fair value as at June 30, 2022 of $111,000. Applying a 10% change in share price to the warrants results in an approximately $44,000 change in fair value, and a 10% change in volatility of approximately $14,000.

 

8. ASSET ACQUISITIONS AND BUSINESS COMBINATIONS

 

Just Brands LLC and High Roller Private Label LLC (collectively “JustCBD”) business combination

 

On February 24, 2022, Flora Growth U.S. Holdings Corp., a wholly-owned subsidiary of the Company, completed the acquisition of 100% of the outstanding equity interests in each of (i) Just Brands LLC and (ii) High Roller Private Label LLC for total purchase consideration of $34.6 million. JustCBD is a manufacturer and distributor of consumable cannabinoid products, including gummies, tinctures, vape cartridges, and creams. JustCBD is based in Florida in the United States and was formed in 2017. The Company acquired JustCBD to expand its product offerings, accelerate its revenue growth, expand its customer and distribution footprints in the United States and for the acquisition of human capital through JustCBD’s management team.

 

The purchase consideration was comprised of $16.0 million of cash, 9.5 million common shares of the Company valued at $14.7 million, inclusive of a 15% fair value discount for the required six-month holding period of the shares, and $4.0 million of contingent purchase consideration. The contingent purchase consideration is based on a clause in the purchase agreement that provides that if at any time during the 24 months following the acquisition date, the five-day volume weighted average price (“VWAP”) per share of the Company’s common shares as quoted on the Nasdaq Capital Market fails to equal or exceed $5.00, then the Company shall issue a number of additional common shares to the sellers equal to the difference between (x) a fraction, the numerator of which is $47.5 million and the denominator of which is the highest five day VWAP at any point during the 24 months following the closing and (y) the 9.5 million common shares delivered to the sellers at the closing. In no event shall the Company be required to issue more than 3.65 million common shares unless it shall have obtained the consent of the Company’s shareholders to do so. In the event the Company is required to deliver in excess of 3.65 million shares to the sellers (“Excess Shares”) and the Company shall not have obtained shareholder consent, the Company may deliver cash to the sellers in lieu of such Excess Shares determined by a formula set forth in the purchase agreement. The contingent purchase consideration is classified as a financial liability within other long-term liabilities on the statement of financial position as the Company may be required to settle any amounts due in cash instead of common shares if the Company’s common shareholders do not provide requisite shareholder approval to issue additional common shares.

 

The fair value of the contingent purchase consideration was determined using a Monte Carlo simulation incorporating Brownian motion with 100,000 trials through a binomial lattice model. The significant inputs to the valuation include the two year time period, the Company’s closing share price at February 24, 2022 ($1.82), estimated Company common share volatility (100%), and risk free rate of 1.5% to discount the ending result to present value.

 

 
Page 10

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

The amounts recognized as at the acquisition date for each major class of assets acquired and liabilities assumed are as follows:

 

(Thousands of United States dollars)

 

 

 

Current assets

 

 

 

Cash

 

$535

 

Trade receivables

 

 

975

 

Inventory

 

 

5,534

 

Other current assets

 

 

540

 

 

 

 

 

 

Non-current assets

 

 

 

 

Property, plant, and equipment

 

 

537

 

Right of use assets

 

 

772

 

Other non-current assets

 

 

127

 

Intangible asset

 

 

4,757

 

Goodwill

 

 

24,869

 

Total assets

 

$38,646

 

 

 

 

 

 

Current liabilities

 

 

 

 

Trade payables and accrued liabilities

 

$(2,273)

Current lease liabilities

 

 

(644)

Provision for sales tax

 

 

(982)

Other current liabilities

 

 

(99)

Total liabilities

 

$(3,998)

Total net assets acquired

 

$34,648

 

 

The fair value of the trade receivables reflects a $291,000 discount to the gross contractual amounts as allowance for potentially uncollectible amounts. Since the acquisition date through June 30, 2022, JustCBD revenue was $10.0 million with net loss and comprehensive loss of $0.4 million.

 

The intangible assets of $4.8 million are comprised of the following categories and estimated useful lives: tradenames of $3.4 million for eight to nine years, customer relationships of $1.2 million for five to seven years, and know-how of $0.2 million for three years. The Company expects the goodwill and intangible asset values to be deductible for Unites States income tax purposes.

 

If JustCBD was acquired at January 1, 2022, the combined revenue and net loss of JustCBD and the Company would have increased approximately $5.2 million and $1.6 million, respectively.

 

Acquisition of Minority interests

On January 18, 2022, the Company acquired the remaining 10% of the outstanding equity interests in Flora Beauty LLC from its minority shareholder in exchange for 100,000 common shares of the Company and a stock option exercisable for up to 50,000 common shares of the Company at an exercise price of $1.70 per share that expire five years from the date of the grant.

 

On January 31, 2022, the Company completed its acquisition of Breeze by acquiring the remaining 10% of the equity interests in Breeze from its minority shareholders in exchange for 30,282 common shares of the Company.

 

 
Page 11

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

9. INTANGIBLE ASSETS AND GOODWILL

 

A continuity of intangible assets for the six months ended June 30, 2022 is as follows:

 

 In Thousands of United States dollars

 

License

 

 

Customer Relationships

 

 

Trademarks and Brands

 

 

Patents

 

 

Non-Compete Agreements

 

 

Goodwill

 

 

Total

 

Cost

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2021

 

$610

 

 

$1,759

 

 

$2,211

 

 

$4,300

 

 

$1,190

 

 

$20,054

 

 

$30,124

 

Acquired through business combinations (Note 8)

 

 

-

 

 

 

1,160

 

 

 

3,357

 

 

 

240

 

 

 

-

 

 

 

24,869

 

 

 

29,626

 

Impairment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(16,000)

 

 

(16,000)

At June 30, 2022

 

$610

 

 

$2,919

 

 

$5,568

 

 

$4,540

 

 

$1,190

 

 

$28,923

 

 

$43,750

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2021

 

$129

 

 

$26

 

 

$35

 

 

$48

 

 

$66

 

 

$-

 

 

$304

 

Additions

 

 

82

 

 

 

169

 

 

 

306

 

 

 

297

 

 

 

198

 

 

 

-

 

 

 

1,052

 

At June 30, 2022

 

$211

 

 

$195

 

 

$341

 

 

$345

 

 

$264

 

 

$-

 

 

$1,356

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Currency translation

 

 

(18)

 

 

-

 

 

 

(21)

 

 

-

 

 

 

-

 

 

 

(257)

 

 

(296)

Net book value at June 30, 2022

 

$381

 

 

$2,724

 

 

$5,206

 

 

$4,195

 

 

$926

 

 

$28,666

 

 

$42,098

 

 

The Company’s intangible asset additions in 2022 primarily consist of assets acquired as part of the February 2022 purchase of JustCBD (Note 8). Information regarding the significant JustCBD intangible assets within the indicated categories of the table above is as follows as at June 30, 2022:

 

 

·

Tradenames: carrying amount $3.2 million with 92 to 104 months of remaining amortization periods

 

·

Customer relationships: carrying amount $1.1 million with 56 to 80 months of remaining amortization periods

 

·

Know-how: carrying amount $0.2 million with 32 months of remaining amortization period

 

The Company’s goodwill is assigned to the following cash generating units (“CGU’s”) as at June 30, 2022:

 

In Thousands of United States dollars

 

 Pharmaceuticals and nutraceuticals

 

 

 Vessel

 

 

 JustCBD

 

 

 Total

 

As at December 31, 2021

 

$379

 

 

$19,675

 

 

$-

 

 

$20,054

 

Acquired through business combinations (Note 8)

 

 

-

 

 

 

-

 

 

 

24,612

 

 

 

24,612

 

Impairment

 

 

-

 

 

 

(16,000)

 

 

-

 

 

 

(16,000)

As at June 30, 2022

 

$379

 

 

$3,675

 

 

$24,612

 

 

$28,666

 

 

10. IMPAIRMENT OF ASSETS

 

The carrying amounts of the Company’s non-financial assets are reviewed for impairment each reporting period or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. At June 30, 2022, the Company’s Vessel CGU had external indicators of impairment primarily due to a 2022 decline in comparable public company share prices which would negatively impact the implied valuation of Vessel. As such, the Company tested the Vessel CGU non-financial assets for impairment as at June 30, 2022. The Vessel CGU was acquired in November 2021 and is part of the Company’s consumer products reportable segment.

 

Vessel’s June 30, 2022 carrying value of $28.0 million is comprised primarily of goodwill and identified intangible assets of $28.0 million and other long-lived assets of $1.4 million. The carrying value is reduced by inseparable market participant liabilities associated with the November 2021 acquisition of Vessel which includes $1.4 million of deferred tax liability and $1.2 million of lease liability. The estimated recoverable amount of Vessel at June 30, 2022 was $11.9 million, resulting in impairment of $16.0 million as the carrying value of the CGU’s assets exceeds the recoverable amount. The impairment is recorded in goodwill impairment caption on the statement of loss and comprehensive loss.

 

The recoverable amount is based on fair value less costs of disposal. The fair value was determined based on guideline public companies similar to Vessel considering financial metrics such as historical revenue growth, gross margin and EBITDA profitability and with operations focused on consumer brands and similar sales channels. An enterprise value to latest twelve months revenue multiple of 1.75 was selected based on consideration of the enterprise value to latest twelve months multiples of the guideline companies. The multiple was applied to Vessel’s revenue for the twelve months ended June 30, 2022. Estimated costs of disposal of 3% were subtracted to arrive at the recoverable amount. The impairment test valuation is considered a Level 3 method within the IFRS 13 fair value hierarchy.

 

After the impairment, Vessel’s carrying value is equal to its recoverable amount. Any change in the significant assumptions could result in additional impairment of its goodwill and long-lived assets as at June 30, 2022. As a sensitivity assessment to the recoverable amount calculations, reducing the selected revenue multiple by 0.5 from 1.75 above down to 1.25 (approximately 29% decrease) would result in additional goodwill impairment of approximately $3.0 million.

 

 
Page 12

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

11. LEASES

 

The Company’s leases primarily consist of administrative real estate leases in Colombia and the United States, and the Company’s cultivation property in Santander, Colombia. Information regarding the Company’s leases is as follows:

 

Thousands of United States dollars

 

 Six months ended June 30, 2022

 

 

 Six months ended June 30, 2021

 

Lease expense

 

 

 

 

 

 

Amortization expense by class of underlying asset

 

 

 

 

 

 

Office Space

 

$351

 

 

$40

 

Building

 

 

5

 

 

 

5

 

Land

 

 

27

 

 

 

-

 

Total amortization expense

 

 

383

 

 

 

45

 

Interest on lease liabilities

 

 

83

 

 

 

14

 

Short-term and low value assets lease expense

 

 

510

 

 

 

-

 

Total lease expense

 

$976

 

 

$59

 

 

 

 

 

 

 

 

 

 

Other Information

 

 

 

 

 

 

 

 

Additions to right of use assets

 

$2,053

 

 

$-

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

 

 

 

 

 

 

Financing cash flows from leases (interest)

 

 

69

 

 

 

16

 

Financing cash flows from leases (principal)

 

 

420

 

 

 

70

 

Operating cash flows for short term and low value asset leases

 

 

510

 

 

 

-

 

Total cash outflows from leases

 

$999

 

 

$86

 

 

 

 

 

 

 

 

 

 

Carrying amount of right of use asset by class of underlying asset

 

 

 

 

 

 

 

 

Office Space

 

$2,492

 

 

$231

 

Building

 

 

1,036

 

 

 

16

 

Land

 

 

111

 

 

 

-

 

Total carrying amount of right of use assets

 

$3,639

 

 

$247

 

 

The maturity analysis of the undiscounted contractual balances of the lease liability is as follows:

 

Thousands of United States dollars

 

 As at June 30, 2022

 

2023

 

$1,366

 

2024

 

 

1,251

 

2025

 

 

447

 

2026

 

 

440

 

2027

 

 

373

 

Thereafter

 

 

290

 

Total undiscounted cash flows

 

$4,167

 

Less: present value discount

 

 

(606)

Total lease liabilities

 

$3,561

 

 

 
Page 13

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

Most of the Company’s leases contain renewal options to continue the leases for another term equivalent to the original term, which are generally up to two years. The lease liabilities above include renewal terms that management has executed or is reasonably certain of renewing, which only included leases that would have expired in 2022. The Company’s land lease for 361 hectares of property in Santander, Colombia expires August 31, 2024 and is recorded as a right of use asset in property, plant and equipment. There is an option to extend the lease for an additional five years, unless either the Company or lessor provide notice to terminate the lease at the end of the original term with six months’ notice.

 

12. CAPITAL STOCK

 

Authorized and issued

 

The Company has an unlimited number of common shares, no par value, authorized.

 

The Company had the following significant common share transactions:

 

Six months ended June 30, 2022

 

FEBRUARY 2022 PAYMENT TO JUSTCBD OWNERS

As discussed in Note 8, the Company issued 9,500,000 common shares of the Company valued at $14.7 million, inclusive of a 15% fair value discount for the required six-month holding period of the shares, to the prior owners of JustCBD as part of the Company’s acquisition of JustCBD in February 2022.

 

ACQUISITION OF NONCONTROLLING INTERESTS

On January 18, 2022, the Company issued 100,000 common shares of the Company valued at $0.2 million to acquire the remaining 10% of the outstanding equity interests in Flora Beauty LLC from its minority shareholders. In addition to the common shares, the Company granted a stock option, exercisable for up to 50,000 common shares of the Company at an exercise price of $1.70 per share that expire five years from the date of the grant.

 

On January 31, 2022, the Company issued 30,282 common shares of the Company valued at $0.1 million to complete its acquisition of Breeze by acquiring the remaining 10% of the equity interests in Breeze from its minority shareholders.

 

OTHER OFFERINGS

In January 2022, the Company amended an agreement with a consultant pursuant to which the Company issued 111,112 common shares of the Company valued at $0.2 million and a stock option, exercisable for up to 83,333 common shares of the Company at an exercise price of $2.25 per share that expire five years from the date of the grant.

 

On April 5, 2022, the Company issued 700,000 common shares of the Company valued at $1.3 million as part of a settlement agreement with Boustead Securities, LLC (“Boustead”) to resolve certain disputes arising under a prior underwriting agreement and engagement letter. In addition to the common shares, the Company paid Boustead $0.4 million.

 

SHARE REPURCHASE

On June 16, 2022, the Company announced that its Board of Directors had approved the repurchase of up to $5 million of its common shares. For the six months ended June 30, 2022, no shares were repurchased.

 

Any future repurchases will depend on factors such as market conditions, share price and other opportunities to invest capital for growth. From time to time when management does not possess material nonpublic information about the Company or its securities, the Company may enter a pre-defined plan with a broker to allow for the repurchase of shares at times when the Company ordinarily would not be active in the market due to internal trading blackout periods, insider trading rules or otherwise. Any such plans entered with our broker will be adopted in accordance with applicable securities laws such as the requirements of Rule 10b5-1 under the U.S. Securities Exchange Act of 1934, as amended.

 

13. OPTIONS

 

In March of 2019, the Company adopted a stock option plan whereby it may grant options for the purchase of common shares to any director, consultant, employee or officer of the Company or its subsidiaries. The aggregate number of shares that may be issuable pursuant to options granted under the Company’s stock option plan will not exceed 10% of the common shares of the Company outstanding (the “Shares”) at the date of grant. The options are non-transferable and non-assignable and may be granted for a term not exceeding five years. The exercise price of the options will be determined by the Board of Directors of the Company at the time of grant, but if the Shares are traded on any stock exchange (the “Exchange”), the exercise price may not be less than the closing price of the Shares on the Exchange on the trading date immediately preceding the date of grant, subject to all applicable regulatory requirements. Stock option vesting terms are subject to the discretion of the Company’s Board of Directors.

 

 
Page 14

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

Information relating to share options outstanding and exercisable as at June 30, 2022 and December 31, 2021:

 

 

 

Number of options

 

 

Weighted average exercise price

 

 

 

Thousands

 

 

$

 

Balance, December 31, 2021

 

 

5,448

 

 

 

1.96

 

Granted

 

 

471

 

 

 

1.62

 

Exercised

 

 

(512)

 

 

0.15

 

Balance, June 30, 2022

 

 

5,407

 

 

 

2.09

 

 

Date of expiry

Options outstanding

Options exercisable

Exercise price

Grant date fair value vested

Remaining life in years

 

Thousands

Thousands

$

Thousands of Dollars

 

June 28, 2024

949

949

 0.15

35

 2.0

April 23, 2025

117

117

 2.25

344

 2.8

July 6, 2025

317

317

 2.25

252

 3.0

July 15, 2025

84

-

 2.25

84

 3.0

July 31, 2025

17

17

 2.25

23

 3.1

September 8, 2025

66

66

 2.25

92

 3.2

November 4, 2025

666

666

 2.25

918

 3.4

December 23, 2025

500

500

 2.25

689

 3.5

June 3, 2026

241

241

 3.87

686

 3.9

June 10, 2026

167

167

 3.68

455

 3.9

September 21, 2026

16

-

 5.20

54

 4.2

September 25, 2026

240

-

 6.90

1,026

 4.2

December 16, 2026

1,640

175

 2.04

1,590

 4.5

January 17, 2027

 50

50

 1.70

63

 4.6

January 26, 2027

287

217

 1.48

296

 4.6

May 16, 2027

50

-

 1.30

4

 4.9

 

5,407

3,482

 2.09

6,611

 3.6

 

The fair value of stock options issued during the six months ended June 30, 2022 was determined at the time of issuance using the Black-Scholes option pricing model with the following weighted average inputs, assumptions and results:

 

Risk-free annual interest rate

 

 

1.75%

Current stock price

 

$1.58

 

Expected annualized volatility

 

 

100%

Expected life (years)

 

 

4.65

 

Expected annual dividend yield

 

 

0%

Exercise price

 

$1.62

 

 

The total expense related to the options granted in the period ended June 30, 2022 was $2.9 million (2021 - $0.1 million). The options issued in 2022 vest one year following the date of grant if the award holder is still employed or engaged by the Company.

 

No stock options expired or were forfeited in the six months ended June 30, 2022.

 

 
Page 15

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

14.WARRANTS

 

The following tables show warrants outstanding as at June 30, 2022:

 

 

 

 

Number of warrants

 

 

Weighted average exercise price

 

 

 

Thousands

 

 

 

Balance, December 31, 2021

 

 

8,746

 

 

$3.37

 

Exercised

 

 

(473)

 

 

0.49

 

Cancelled/Expired

 

 

(885)

 

 

3.00

 

Balance, June 30, 2022

 

 

7,388

 

 

$3.60

 

 

Date of expiry

 

Warrants outstanding

 

 

Exercise price

 

 

Grant date

fair value

 

 

Remaining life

 in years

 

 

 

 

 

 

Thousands

 

 

$

 

 

Thousands of Dollars

 

 

 

 

July 23, 2021 - September 20, 2022

 

 

1,178

 

 

 

3.00

 

 

 

776

 

 

 

0.12

 

November 18, 2026

 

 

5,750

 

 

 

3.75

 

 

 

8,706

 

 

 

4.39

 

November 18, 2027

 

 

460

 

 

 

3.30

 

 

 

1,055

 

 

 

5.39

 

 

 

 

7,388

 

 

3.60

 

 

10,537

 

 

 

3.77

 

 

15. PROVISIONS, COMMITMENTS AND CONTINGENCIES

 

Provisions

The Company’s current known provisions and contingent liabilities consist of termination benefits and legal disputes.

 

Thousands of United States dollars

 

Termination benefits

 

 

Legal disputes

 

 

Sales tax

 

Balance as at December 31, 2021

 

$352

 

 

$1,681

 

 

$-

 

Acquired through business combinations

 

 

-

 

 

 

-

 

 

 

982

 

Payments/settlements

 

 

(352)

 

 

(1,681)

 

 

-

 

Additional provisions

 

 

-

 

 

 

-

 

 

 

407

 

Balance as at June 30, 2022

 

$-

 

 

$-

 

 

$1,389

 

 

The Sales tax provision relates to estimated amounts owed to certain jurisdictions in the Unites States for sales from the Company’s JustCBD operations. The opening balance was acquired during the February 24, 2022 acquisition of JustCBD, with additional provision for estimated amounts due on sales subsequent to the acquisition. The ending balance is recorded within trade payables and accrued liabilities with current liabilities on the statement of financial position, and as a reduction of revenue on the statement of loss and comprehensive loss.

 

The Company records liabilities for legal proceedings in those instances where it can reasonably estimate the amount of the loss and where liability is probable. The Company is engaged from time-to-time in various legal proceedings and claims that have arisen in the ordinary course of business. The outcome of all the proceedings and claims against the Company is subject to future resolution, including the uncertainties of litigation. Based on information currently known to the Company and after consultation with outside legal counsel, management believes that the probable ultimate resolution of any such proceedings and claims, individually or in the aggregate, will not have a material adverse effect on the financial condition of the Company, taken as a whole as at June 30, 2022.

 

On March 18, 2022, the Company received a letter from a law firm representing an undisclosed group of former pre-acquisition shareholders of VBI (the “VBI Shareholders”) seeking to engage in settlement discussions on the basis that the Company was purportedly misleading in its intentions to engage in a capital raising transaction shortly after the completion of the VBI acquisition. We promptly responded in writing and denied the VBI Shareholders presentation of the facts and denied all allegations against the Company. We believe that any potential claims as alleged in the letter are without merit and we intend to defend vigorously against them in connection with any future potential legal proceedings. The VBI Shareholders have not commenced litigation against the Company and it is unknown whether the VBI Shareholders will do so and what their claims may be. The Company believes that an unfavorable settlement in this matter is remote, and, as such, has not accrued a liability as of June 30, 2022.

 

 
Page 16

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

On June 21, 2022, an action was brought against the Company in the Ontario Superior Court of Justice by Gerardo Andres Garcia Mendez claiming that the Company is obligated to issue 3.0 million (pre-one-for three reverse stock split) common shares to him for a purchase price of $0.05 per share. Mr. Mendez claims he is entitled to such shares as a result of alleged consulting services he performed in 2019. The Company disputes his claims and intends to vigorously defend against this action. The Company believes that an unfavorable settlement in this matter is remote, and, as such, has not accrued a liability as of June 30, 2022.

 

In connection with the Company’s acquisition of JustCBD, the former owners of JustCBD agreed to fully indemnify the Company against any losses which may arise out of certain pre-existing litigation against JustCBD (including all matters disclosed below) as well as litigation which may be brought in the future against JustCBD and pertaining to the period prior to the acquisition. Since these matters are fully indemnified, the Company has not accrued any liability with respect to these claims. As of the date hereof, the following actions are pending against JustCBD:

 

Erin Gilbert et al. vs. Just CBD LLC, et al., Case No. 062019CA020275AXXXCE. This matter involves allegations that JustCBD sold a defective Just CBD mango Vape Cartridge which is alleged to have caused Plaintiff, Erin Gilbert, to suffer personal injuries. The claims asserted against JustCBD include: (1) strict liability design defect; (2) negligent design; (3) strict liability manufacturing defect; (4) negligent manufacturing; (5) warning defects; and (6) loss of consortium. The same allegations were asserted against seven (7) other defendants, including two (2) manufacturers of the actual vape cartridge. To date, JustCBD has vigorously defended the case and the case is in the discovery phase. Currently, this matter is scheduled for trial to commence on September 19, 2022 but it is likely the trial will be continued pending further discovery.

 

William Braley vs. Just Brands USA, Inc., Just Brands FL, LLC, and SSGI Financial Services, Inc., Case No. 21-cv-06812, Northern District of Illinois. This matter involves allegations that the Defendants falsely and deceptively marketed cannabidiol infused gummies as not containing Tetrahydrocannabinol (“THC”). Plaintiff asserts he has suffered damages because after ingesting the gummies he failed an employment related drug test. JustCBD disputes these claims. At this time, JustCBD has filed a motion to dismiss the RICO portion of the complaint and answered and asserted affirmative defenses to the Consumer Protection claims.

 

Management contracts

The Company is party to certain management contracts. As at June 30, 2022, these contracts require payments totaling approximately $2.3 million to be made upon the occurrence of a change in control to the officers of the Company. The Company is also committed to payments to certain individuals upon termination of approximately $1.9 million pursuant to the terms of these contracts. As a triggering event has not taken place, these amounts have not been recorded in these consolidated financial statements.

 

16. INCOME TAXES

 

Income tax expense is recognized at an amount determined by multiplying the income (loss) before income taxes for the interim period for each significant jurisdiction by management’s best estimate of the annual income tax rate expected for the full fiscal year for each significant jurisdiction.

 

There was no current or deferred income tax expense recorded for the six months ended June 30, 2022. The Company’s effective income tax rate of nil% for the six months ended June 30, 2022 is different than the statutory rate primarily due to the nonrecognition of deferred tax assets related to net operating losses.

 

17. LOSS PER SHARE

 

The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive as the Company has a net loss for each period presented:

 

Thousands of securities

 

June 30, 2022

 

 

June 30, 2021

 

Stock options (Note 13)

 

 

5,407

 

 

 

4,202

 

Warrants (Note 14)

 

 

7,388

 

 

 

9,295

 

JustCBD potential additional shares to settle contingent consideration (Note 8)

 

 

13,141

 

 

 

-

 

Total anti-dilutive

 

 

25,936

 

 

 

13,497

 

 

 
Page 17

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

18. RELATED PARTY DISCLOSURES

 

Key management personnel compensation

 

In addition to their contracted fees, directors and officers also participate in the Company’s stock option program. Certain executive officers are subject to termination notices of 24 to 36 months and change of control payments (Note 15). Key management personnel compensation is comprised of the following:

 

Thousands of United States dollars

 

Six months ended June 30, 2022

 

 

Six months ended June 30, 2021

 

Directors’ and officers’ compensation

 

$816

 

 

$736

 

Share-based payments

 

 

197

 

 

 

1,748

 

 

 

$1,013

 

 

$2,484

 

 

The Company defines key management personnel as those persons having authority and responsibility for planning, directing, and controlling the activities of the Company directly or indirectly, and was determined to be executive officers and directors (executive and non-executive) of the Company. The remuneration of directors and key executives is determined by the Board of Directors of the Company having regard to the performance of individuals and market trends.

 

As at June 30, 2022, $0.0 million of the above directors’ and officers’ compensation was included in the trade payables and accrued liabilities (December 31, 2021 – $0.1 million). These amounts are unsecured, non-interest bearing and due on demand.  The share-based payments amount above for the six months ended June 30, 2021 includes 333,333 common shares to the Chief Executive Officer of the Company, valued at $1.7 million, that were recorded to equity as share issuance costs as payment related to services provided during the Company’s initial public offering process.

  

Related party transactions

During the six months ended June 30, 2022, the Company incurred expenses for consulting, rent and promotion services totaling less than $0.1 million (June 30, 2021 - $0.1 million) from 2227929 Ontario Inc., an entity affiliated with a former director, and expenses for consulting in the amount of $0.3 million (June 30, 2021 - $0.1 million) total from Forbes and Manhattan Inc and 2051580 Ontario Corp., two entities affiliated with a former director. As at June 30, 2022, $0 (December 31, 2021 - $6,000) was owed to 2227929 Ontario Inc., $11,000 (December 31, 2021 - $11,000) was owed to Forbes and Manhattan Inc. and $0 was owed to 2051580 Ontario Corp. These amounts were included in trade payables and accrued liabilities, and are unsecured, non-interest bearing and due on demand. Fred Leigh is a former director of the Company and is also a director and officer of 2227929 Ontario Inc. Stan Bharti is a former director and former Chairman of the Company and is also a director of Forbes and Manhattan Inc.

 

19. FINANCIAL INSTRUMENTS AND RISK MANAGMENT

 

Environmental

The Company’s growth and development activities are subject to laws and regulations governing the protection of the environment. These laws and regulations are continually changing and generally becoming more restrictive. The Company believes its operations are materially in compliance with all applicable laws and regulations. The Company has made, and expects to make in the future, expenditures to comply with such laws and regulations.

 

Fair value

The Company’s financial instruments measured at amortized cost as at June 30, 2022 and December 31, 2021 consist of cash, restricted cash, trade and amounts receivable, loans receivable, trade payables and accrued liabilities, lease liabilities, and debt and loans payable. The amounts reflected in the consolidated statements of financial position approximate fair value due to the short-term maturity of these instruments.

 

Financial instruments recorded at the reporting date at fair value are classified into one of three levels based upon the fair value hierarchy. Items are categorized based on inputs used to derive fair value based on:

 

Level 1 - quoted prices that are unadjusted in active markets for identical assets or liabilities

Level 2 - inputs other than quoted prices included in level 1 that are observable for the asset/liability either directly or indirectly; and

Level 3 - inputs for the instruments are not based on any observable market data.

 

The Company’s long-term investments require significant unobservable inputs and as discussed at Note 7, are measured at FVPL and as a Level 3 fair value financial instrument within the fair value hierarchy as at June 30, 2022. As discussed in Note 8, the Company’s other long-term liabilities consist of the estimated fair value of contingent purchase consideration from the acquisition of JustCBD in February 2022. The amount is measured at FVPL as a Level 2 fair value financial instrument within the fair value hierarchy as at June 30, 2022. As valuations of the investments and other long-term liabilities for which market quotations are not readily available are inherently uncertain, may fluctuate within short periods of time and are based on estimates, determination of fair value may differ materially from the values that would have resulted if a ready market existed for the investments. Such changes may have a significant impact on the Company’s financial condition or operating results.

  

 
Page 18

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

Risk management overview

The Company has exposure to credit, liquidity and market risks from its use of financial instruments. This note provides information about the Company’s exposure to each of these risks, the Company’s objectives, policies and processes for measuring and managing risk. Further quantitative disclosures are included throughout these condensed interim consolidated financial statements.

 

Credit risk

Credit risk is the risk of financial loss to the Company if a counterparty to a financial instrument fails to meet its contractual obligations and arises principally from the Company’s trade and other receivables, loans receivable and cash held with banks and other financial intermediaries.

 

The carrying amount of the cash, restricted cash, trade and amounts receivables and loan receivable represents the maximum credit exposure as presented in the statement of financial position.

 

The Company has assessed that there has been no significant increase in credit risk of the loans receivable from initial recognition based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. As a result, the loss allowance recognized during the period was limited to twelve months expected credit losses. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an insignificant loss allowance on the loans’ receivable and advances as at June 30, 2022 and December 31, 2021.

 

The Company provides credit to certain customers in the normal course of business and has established credit evaluation and monitoring processes to mitigate credit risk. Credit risk for customers is assessed on a case-by-case basis and an allowance for specific expected credit losses is recorded where required, in addition to an estimate of lifetime expected credit losses for the portfolio of accounts receivable. See credit risk analysis for trade receivables at Note 3.

 

The Company held cash and restricted cash of $10.3 million and $37.6 million as at June 30, 2022 and December 31, 2021, respectively, of which, $10.1 million and $37.4 million, respectively, was held with large financial institutions and national central banks. The remaining $0.2 million cash amounts for both periods are held with financial intermediaries in Colombia and the United States. The Company has assessed no significant increase in credit risk from initial recognition based on the availability of funds, and the regulatory and economic environment of the financial intermediary. As a result, the loss allowance recognized during the period was limited to twelve months of expected credit losses. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an insignificant loss allowance on these cash and restricted cash balances as at June 30, 2022 and December 31, 2021.

 

Market risk

Market risk is the risk that changes in market conditions, such as commodity prices, foreign exchange rates, and interest rates, will affect the Company’s net income or the value of financial instruments. The objective of market risk management is to manage and control market risk exposures within acceptable limits, while maximizing the Company’s returns.

 

Foreign currency exchange rate risk is the risk that the fair value of future cash flows will fluctuate due to changes in foreign exchange rates. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk as management has determined that this risk is not significant. As such, the Company’s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates.

 

As at June 30, 2022, the Company had the following monetary assets and liabilities denominated in foreign currencies:

 

 

 

CAD

 

 

COP

 

 

GBP

 

 

EUR

 

 

CHF

 

Thousands of foreign currencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

862

 

 

 

1,673,360

 

 

 

22

 

 

 

1,605

 

 

 

-

 

Amounts receivable

 

 

-

 

 

 

12,946,301

 

 

 

174

 

 

 

-

 

 

 

-

 

Loans receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

250

 

Trade payables

 

 

(152)

 

 

(8,285,897)

 

 

(23)

 

 

(5)

 

 

-

 

Accrued liabilities

 

 

(175)

 

 

(960,040)

 

 

(16)

 

 

-

 

 

 

-

 

Lease liability

 

 

-

 

 

 

(2,166,163)

 

 

(27)

 

 

-

 

 

 

-

 

Long term debt

 

 

-

 

 

 

(40,405)

 

 

-

 

 

 

-

 

 

 

-

 

Net carrying value

 

 

535

 

 

 

3,167,156

 

 

 

130

 

 

 

1,600

 

 

 

250

 

 

 
Page 19

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

As at December 31, 2021, the Company had the following monetary assets and liabilities denominated in foreign currencies:

 

 

 

CAD

 

 

COP

 

 

EUR

 

 

CHF

 

Thousands of foreign currencies

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

1,393

 

 

 

4,451,775

 

 

 

896

 

 

 

-

 

Amounts receivable

 

 

72

 

 

 

15,775,755

 

 

 

-

 

 

 

-

 

Loans receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

250

 

Trade payables

 

 

(40)

 

 

(5,398,068)

 

 

-

 

 

 

-

 

Accrued liabilities

 

 

(589)

 

 

(2,120,869)

 

 

-

 

 

 

-

 

Lease liability

 

 

-

 

 

 

(1,690,797)

 

 

-

 

 

 

-

 

Long term debt

 

 

-

 

 

 

(72,963)

 

 

-

 

 

 

-

 

Net carrying value

 

 

836

 

 

 

10,944,833

 

 

 

896

 

 

 

250

 

 

Monetary assets and liabilities denominated in Canadian dollars, Colombian pesos, British pounds, Euros and Swiss Francs are subject to foreign currency risk. The Company has estimated that as at June 30, 2022, the effect of a 10% increase or decrease in Canadian dollars, Colombian pesos, British pounds, Euros and Swiss Francs (“CHF”) against the Unites States dollar on financial assets and liabilities would result in an increase or decrease of approximately $0.3 million (December 31, 2021 – $0.5 million) to net loss and comprehensive loss.

 

The Company calculates this sensitivity analysis based on the net financial assets denominated in each currency using the June 30, 2022 exchange rate, then changing the rate by 10%. Management determined 10% is a ‘reasonably possible’ change in foreign currency rates by considering the approximate change in rates in the prior twelve months.

 

It is management’s opinion that the Company is not subject to significant commodity or interest rate risk.

 

Management considers concentration risk with counterparties considering the level of purchases and sales of its business segments (Note 21). Several of the Company’s business units purchase substantially all their inventory or materials from a single supplier.

 

Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting obligations associated with its financial liabilities. The Company’s financial liabilities consist of trade payables and accrued liabilities, loans payable and debt, and lease liabilities as presented on the statement of financial position. The Company had cash and restricted cash as presented on the statement of financial position. The Company has no available credit lines of facilities to draw borrowings from should additional liquidity be needed. The Company’s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company’s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise.

 

Trade payables and accrued liabilities consist of invoices payable to trade suppliers for administration and professional expenditures. The Company processes invoices within a normal payment period. Trade payables have contractual maturities of less than 90 days. Some suppliers of materials and inventory require full prepayment from the Company prior to providing such goods to the Company. See schedule of future lease commitments at Note 11.

 

The Company’s long-term investments in equity of other entities are not publicly traded and there is not an active market to sell the investments for cash.

 

Novel Coronavirus (“COVID-19”)

The Company’s operations could be significantly adversely affected by the effects of a widespread global outbreak of a contagious disease, including the recent outbreak of respiratory illness caused by COVID-19. The Company cannot accurately predict the impact COVID-19 will have on its operations and the ability of others to meet their obligations with the Company, including uncertainties relating to the ultimate geographic spread of the virus, the severity of the disease, the duration of the outbreak, and the length of travel and quarantine restrictions imposed by governments of affected countries. In addition, a significant outbreak of contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could further affect the Company’s operations and ability to finance its operations.

 

 
Page 20

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

20. CAPITAL MANAGEMENT

 

The Company considers the aggregate of its common shares, options, warrants and borrowings as capital. The Company’s capital management objective is to ensure sufficient resources are available to meet day to day operating requirements and to safeguard its ability to continue as a going concern to provide returns for shareholders and benefits for other shareholders.

 

For the six months ended June 30, 2022, the Company had negative cash from operations and the main source of cash flow was generated from 2021 and prior financing activities. Potential business activities are appropriately evaluated by senior management and a formal review and approval process has been established by the Board of Directors. The Company may enter new financing arrangements to meet its objectives for managing capital until the Company’s operating cash flows are sufficient to cover its operational requirements. The Company’s capital management objectives were being met in 2022 primarily from the use of existing cash balances from 2021 and prior issuances of common shares and warrants and generating increasing revenue in 2022 from the Company’s reportable segments as presented in Note 21.

 

The Company’s officers and senior management take full responsibility for managing the Company’s capital and do so through quarterly meetings and regular review of financial information. The Company’s Board of Directors is responsible for overseeing this process.

 

The Company is not subject to any external capital requirements. As discussed in Note 12, on June 16, 2022, the Company announced that it plans to repurchase up to $5 million of its common shares.

 

21. SEGMENTED INFORMATION

 

The Company is engaged in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products through its Colombia Cosechemos subsidiary. The Company’s other businesses are run through its other Colombia and United States subsidiaries. Management has defined the reportable segments of the Company based on this internal business unit reporting, which is by major product line, and aggregates similar businesses into the Consumer Products segment below. The Corporate segment reflects balances and expenses that do not directly influence business unit operations and includes the Company’s long-term investments. The Corporate segment revenue includes the license of intellectual property.

 

The following tables show information regarding the Company’s segments for the six months ended June 30, 2022 and June 30, 2021. The 2022 segments were updated to reflect the acquisition of JustCBD (Note 8) with High Roller Private Label LLC operations assigned to the Pharmaceuticals and Nutraceuticals segment, and Just Brands LLC assigned to the Consumer Products segment.

  

Thousands of United States dollars

 

Cannabis growth and derivative production

 

 

Consumer products

 

 

Pharmaceuticals and nutraceuticals

 

 

Beverage and food

 

 

Corporate and Eliminations

 

 

Total

 

For the six months ended June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$3

 

 

$13,603

 

 

$3,708

 

 

$252

 

 

$(2,649)

 

$14,917

 

Gross profit

 

 

47

 

 

 

4,304

 

 

 

2,096

 

 

 

99

 

 

 

-

 

 

 

6,546

 

Net (loss) income

 

 

(715)

 

 

(19,420)

 

 

317

 

 

 

(462)

 

 

(12,436)

 

 

(32,716)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the six months ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$-

 

 

$286

 

 

$1,629

 

 

$310

 

 

$(107)

 

$2,118

 

Gross profit

 

 

-

 

 

 

173

 

 

 

752

 

 

 

87

 

 

 

-

 

 

 

1,012

 

Net (loss) income

 

 

(428)

 

 

(857)

 

 

50

 

 

 

(64)

 

 

(3,839)

 

 

(5,138)

 

 

Page 21

 

 

Flora Growth Corp.

Notes to the interim condensed consolidated financial statements (unaudited)

For the six months ended June 30, 2022 and June 30, 2021

(United States dollars, except shares and per share amounts)

 

Geographical information:

 

Thousands of United States dollars

 

Colombia

 

 

United States

 

 

Canada

 

 

United Kingdom

 

 

Total

 

Non-current assets at June 30, 2022

 

$5,320

 

 

$42,351

 

 

$1,533

 

 

$2,708

 

 

$51,912

 

Total liabilities at June 30, 2022

 

 

2,732

 

 

 

9,290

 

 

 

4,496

 

 

 

81

 

 

 

16,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets at December 31, 2021

 

$4,042

 

 

$29,650

 

 

$3,844

 

 

$-

 

 

$37,536

 

Total liabilities at December 31, 2021

 

 

2,359

 

 

 

3,106

 

 

 

3,073

 

 

 

-

 

 

 

8,538

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$1,631

 

 

$12,887

 

 

$-

 

 

$399

 

 

$14,917

 

Gross profit

 

 

999

 

 

 

5,471

 

 

 

-

 

 

 

76

 

 

 

6,546

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$2,069

 

 

$49

 

 

$-

 

 

$-

 

 

$2,118

 

Gross profit

 

 

1,009

 

 

 

3

 

 

 

-

 

 

 

-

 

 

 

1,012

 

 

In 2022, the Company did not have sales to a single customer exceeding 10% of its consolidated revenue.

 

22. SUBSEQUENT EVENTS

 

OTHER

 

Subsequent to June 30, 2022, a total of 266 warrants were exercised in exchange 266 common shares and a total of 798,602 warrants expired. Since June 30, 2022, the Company repurchased 366,645 of its common shares under its previously announced share repurchase plan for $250,000.

 

On July 5, 2022, the Company’s shareholders approved the 2022 Flora Growth Incentive Compensation Plan. Pursuant to this plan, the Company has reserved 6 million of its common shares for potential issuance to officers, directors, employees and consultants of the Company. Effective July 5, 2022, no further stock options may be issued under the Company’s 2019 stock option plan.

 

 

 

Page 22

 

 

 

EX-101.SCH 3 flora-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - Interim Condensed Consolidated Statements of Financial Position link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - Interim Condensed Consolidated Statements of Loss on Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - Interim Condensed Consolidated Statement of Shareholders' Equity (Deficiency) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - Interim Condensed Consolidated Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 000006 - Disclosure - NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - TRADE AND AMOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - BIOLOGICAL ASSETS link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - PROPERTY PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - LONGTERM INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - INTANGIBLE ASSETS AND GOODWILL link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - IMPAIRMENT OF ASSETS link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - OPTIONS link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - RELATED PARTY DISCLOSURES link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - CAPITAL MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - SEGMENTED INFORMATION link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - BASIS OF PRESENTATION (Tables) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - BIOLOGICAL ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - PROPERTY PLANT AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - LONGTERM INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - OPTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 000040 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 000041 - Disclosure - LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 000042 - Disclosure - RELATED PARTY DISCLOSURES (Tables) link:presentationLink link:calculationLink link:definitionLink 000043 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 000044 - Disclosure - SEGMENT DISCLOSURES (Tables) link:presentationLink link:calculationLink link:definitionLink 000045 - Disclosure - NATURE OF OPERATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000046 - Disclosure - BASIS OF PRESENTATION (Details) link:presentationLink link:calculationLink link:definitionLink 000047 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 000048 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details 1) link:presentationLink link:calculationLink link:definitionLink 000049 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000050 - Disclosure - BIOLOGICAL ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 000051 - Disclosure - BIOLOGICAL ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000052 - Disclosure - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 000053 - Disclosure - PROPERTY PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 000054 - Disclosure - LONGTERM INVESTMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 000055 - Disclosure - LONGTERM INVESTMENTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 000056 - Disclosure - LONGTERM INVESTMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000057 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 000058 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000059 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details) link:presentationLink link:calculationLink link:definitionLink 000060 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 1) link:presentationLink link:calculationLink link:definitionLink 000061 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000062 - Disclosure - IMPAIRMENT OF ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000063 - Disclosure - LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 000064 - Disclosure - LEASES (Details 1) link:presentationLink link:calculationLink link:definitionLink 000065 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000066 - Disclosure - CAPITAL STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000067 - Disclosure - OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 000068 - Disclosure - OPTIONS (Details 1) link:presentationLink link:calculationLink link:definitionLink 000069 - Disclosure - OPTIONS (Details 2) link:presentationLink link:calculationLink link:definitionLink 000070 - Disclosure - OPTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000071 - Disclosure - WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 000072 - Disclosure - WARRANTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 000073 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 000074 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000075 - Disclosure - LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 000076 - Disclosure - RELATED PARTY DISCLOSURES (Details) link:presentationLink link:calculationLink link:definitionLink 000077 - Disclosure - RELATED PARTY DISCLOSURES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000078 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details ) link:presentationLink link:calculationLink link:definitionLink 000079 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000080 - Disclosure - CAPITAL MANAGEMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000081 - Disclosure - SEGMENTED INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 000082 - Disclosure - SEGMENTED INFORMATION (Details 1) link:presentationLink link:calculationLink link:definitionLink 000083 - Disclosure - SEGMENTED INFORMATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000084 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 flora-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity File Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code Amendment Description Interim Condensed Consolidated Statements of Financial Position ASSETS Current Cash Restricted cash Trade and amounts receivable (Note 3) Loans receivable and advances Prepaid expenses Biological assets (Note 4) Inventory (Note 5) Total current assets [Current assets] Non-current Property, plant and equipment (Note 6) Right of use assets (Note 11) Intangible assets (Note 9) Goodwill (Note 9) Investments (Note 7) Other Assets Total assets [Assets] LIABILITIES Current Current liabilities [abstract] Trade payables and accrued liabilities Current portion of long term debt Current portion of lease liability (Note 11) Other accrued liabilities Total current liabilities [Current liabilities] Non-current Non-current liabilities [abstract] Non-current debt Non-current lease liability (Note 11) Deferred tax (Note 16) Other long term liabilities (Note 8) Total liabilities [Liabilities] SHAREHOLDERS' EQUITY Share capital (Note 12) Options (Note 13) Warrants (Note 14) Accumulated other comprehensive loss Deficit Non-controlling interest Total shareholders' equity [Equity] Total liabilities and shareholders' equity [Equity and liabilities] Interim Condensed Consolidated Statements of Loss on Comprehensive Loss Revenue (Note 21) [Revenue] Cost of sales [Cost of sales] Gross profit before fair value adjustments [Gains (losses) on fair value adjustment, investment property] Unrealized gain on changes in fair value of biological assets (Note 4) Realized fair value amounts included in inventory sold (Note 4) Gross Profit [Gross profit] Operating Expenses Consulting and management fees Professional fees General and administrative Promotion and communication Travel expenses Share based compensation (Note 13) Research and development Depreciation and amortization (Notes 6 and 9) Bad debt expense (Note 3) Goodwill impairment (Notes 9 and 10) Other expenses (income), net Total operating expenses [Total operating expenses] Operating Loss [Operating Loss] Interest expense Foreign exchange loss (gain) Unrealized loss on fair value of investments (Note 7) Net loss before income taxes Income tax benefit (Note 16) Net loss for the period Other comprehensive loss Exchange differences on foreign operations Total comprehensive loss for the period Net loss attributable to: Flora Growth Corp. Non-controlling interests Comprehensive loss attributable to: Flora Growth Corp. Comprehensive loss attributable to: Non-controlling interests Basic and diluted loss per share attributable to Flora Growth Corp. Weighted average number of common shares outstanding - basic and diluted (Note 17) Interim Condensed Consolidated Statement of Shareholders' Equity (Deficiency) Statement [Table] Statement [Line Items] Components of equity [axis] Number of Common Shares Options Warrants [Member] Accumulated other comprehensive (loss) Accumulated Deficit Noncontrolling Interest Balance, shares [Number of shares issued] Balance, amount Initial public offering, shares Initial public offering, amount Regulation A and Other Offerings, shares Regulation A and Other Offerings, amount Share issuance costs Warrants issued Warrants exercised, shares Warrants exercised, amount Options issued Other comprehensive loss - exchange differences on foreign operations Current year net loss attributable to Flora Share repurchase (Note 12) Common shares issued for business combinations (Notes 8 and 12), shares Common shares issued for business combinations (Notes 8 and 12), amount Common shares issued for other agreements (Note 12), shares Common shares issued for other agreements (Note 12), amount Acquisition of noncontrolling interest (Note 8), shares Acquisition of noncontrolling interest (Note 8), amount Options Issued (Note 13) Options exercised (Note 13), shares Options exercised (Note 13), amount Warrants expired/cancelled (Note 14) Share issuance costs [Share issue related cost] Balance, shares Balance, amount Interim Condensed Consolidated Statement of Cash Flows Cash flows from operating activities: Net loss Adjustments to net loss: Depreciation and amortization Stock-based compensation Impairments Changes in fair value of investments and biological assets Bad debt expense Interest expense [Interest expense] Income tax benefit Income tax (paid) received Total [Cash flows from (used in) operations before changes in working capital] Net change in non-cash working capital: Trade and other receivables Inventory Prepaid expenses and other assets Trade payables and accrued liabilities [Adjustments for increase (decrease) in trade accounts payable] Net cash used in operating activities [Cash flows from (used in) operating activities] Cash flows from financing activities: Common shares issued Equity issue costs Exercise of warrants and options Repayments of lease liability Common shares repurchased Interest paid Loan borrowing (repayments) Net cash (used) provided by financing activities [Cash flows from (used in) financing activities] Cash flows from investing activities: Loans provided Loan repayments received Purchases of property, plant and equipment and other assets Purchase of investments Business and asset acquisitions, net of cash acquired Net cash used in investing activities [Cash flows from (used in) investing activities] Effect of exchange rate on changes on cash Change in cash during the period [Increase (decrease) in cash and cash equivalents after effect of exchange rate changes] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental disclosure of non-cash activities Right of use assets and lease liabilities acquired (Note 11) Common shares issued for business combinations (Notes 8) NATURE OF OPERATIONS Nature Of Operations BASIS OF PRESENTATION Basis Of Presentation TRADE AND AMOUNTS RECEIVABLE Trade And Amounts Receivable BIOLOGICAL ASSETS Biological Assets INVENTORY Inventory Disclosure of inventories [text block] PROPERTY PLANT AND EQUIPMENT Property, Plant And Equipment LONGTERM INVESTMENTS Long-term Investments ASSET ACQUISITIONS AND BUSINESS COMBINATIONS Asset Acquisitions And Business Combinations INTANGIBLE ASSETS AND GOODWILL Intangible Assets And Goodwill IMPAIRMENT OF ASSETS Impairment Of Assets LEASES Leases CAPITAL STOCK Capital Stock OPTIONS Options [Options] WARRANTS Warrants PROVISIONS COMMITMENTS AND CONTINGENCIES Provisions, Commitments And Contingencies INCOME TAXES Income Taxes LOSS PER SHARE Loss Per Share RELATED PARTY DISCLOSURES Related Party Disclosures FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Financial Instruments And Risk Management Capital Management SEGMENTED INFORMATION Segmented Information SUBSEQUENT EVENTS Subsequent Events Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies) Contingent Purchase Consideration Subsidiaries Trade And Other Paybles Schedule Of Trade Accounts Receivable Allowance Table Text Block Schedule Of Carrying Value Of Biological Assets Table Text Block Schedule Of Inventory Schedule Of Property Plant And Equipment Schedule Of Long-term Investments Activity Schedule Of Fair Value Of The Warrants Schedule Of Major Class Of Assets Acquired And Liabilities Schedule Of Intangible Assets Schedule Of Goodwill Schedule Of Leases Schedule Of Balances Of Lease Liability Schedule Of Share Options Outstanding And Exercisable Schedule Of Fair Value Of Stock Options Schedule Of Warrants Outstanding Schedule Of Provisions And Contingent Liabilities Schedule Of Computation Of Diluted Shares Outstanding Schedule Of Key Management Personnel Compensation Schedule Of Assets And Liabilities Denominated In Foreign Currencies Schedule Of Geographical Information Of Company's Non-current Assets NATURE OF OPERATIONS (Details Narrative) Country of incorporation Year of incorporation Principal Activity Company's Registered Office Principal Place Of Business Subsidiaries [axis] Subsidiary 20 [member] Subsidiary 1 [member] Subsidiary 2 [member] Subsidiary 3 [member] Subsidiary 4 [member] Subsidiary 5 [member] Subsidiary 6 [member] Subsidiary 7 [member] Subsidiary 8 [member] Subsidiary 9 [member] Subsidiary 10 [member] Subsidiary 11 [member] Subsidiary 12 [member] Subsidiary 13 [member] Subsidiary 14 [member] Subsidiary 15 [member] Subsidiary 16 [member] Subsidiary 17 [member] Subsidiary 18 [member] Subsidiary 19 [member] Name Of Subsidiary Country Of Incorporation Ownership Of Subsidiary Functional Currency Of Subsidiary TRADE AND AMOUNTS RECEIVABLE (Details) Trade Accounts Receivable Allowance For Expected Credit Losses Hst Receivable Other Receivables Total [Trade and other receivables] Current [Current trade receivables] 1-30 Days 31-60 Days 61-90 Days 91-180 Days 180+ Days Total Trade Receivables Additional Expected Credit Losses BIOLOGICAL ASSETS (Details) Balance, Beginning Changes In Fair Value Less Cost To Sell Due To Biological Transformation Transferred To Harvested Cannabis Inventory Upon Harvest Balance, Ending Weighted Average Yield Post Harvest Cost Per Gram Impact On The Fair Value Dried Cannabis Per Gram Weighted Average Stage of Growth INVENTORY (Details) Raw Materials And Supplies Harvested Cannabis Work In Progress Finished Goods Total Classes of property, plant and equipment [axis] Classes of financial instruments [axis] Accounting estimates [axis] Buildings Land Total [Member] Machinery and Office Equipment [Member] Vehicles [Member] Subtotal [Member] Right Of Use Assets [Member] Construction in Progress [Member] Balance, Beginning [Property, plant and equipment, gross carrying amount of fully depreciated assets still in use] Additions Business Combinations (note 8) Foreign Exchange Translation Balance, Ending Accumulated Depreciation, Balance Beginning [Accumulated Depreciation, Balance Beginning] Accumulated Depreciation, Depreciation Accumulated Depreciation, Disposals Accumulated Depreciation, Foreign Exchange Translation Property, plant and equipment, Carrying Value Accumulated Depreciation, Balance Ending Property Plant And Equipment LONGTERM INVESTMENTS (Details) Classes of assets [axis] WarrantsCAD Thirty [member] WarrantsCAD One [member] Share Price Exercise Price Volatility Risk Free Interest Rate Dividend Yield Expected term in years Fair Value Quantity Owned Fair Value Warrant Investee common share [member] Loss On Changes In Fair Value Balance, Ending [Non-current financial assets] Balance, Beginning LONGTERM INVESTMENTS (Details Narrative) Purchased Common Shares Exchange Common Shares Ownership Ownership Of Diluted Basis Purchased Common Share Of The Investee Purchased Common Share Of The Investee Second Tranche Fair Value Common Share Fair Value Common Shares Fair Value Common Shares Second Tranch Common Shares Price Common Shares Value Fair Value Calculations Common Shares Results Change In Share Price Fair Value [Plan assets, at fair value] Change in Fair Value, warrants Volatality change, fair value ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details) Cash [Cash transferred] Trade Receivables Inventory [Inventory recognised as of acquisition date] Other Current Assets Property, Plant And Equipment [Property, plant and equipment recognised as of acquisition date] Right Of Use Assets Other Noncurrent Assets Intangible Assets Goodwill Total Assets Trade Payables And Accrued Liabilities Current lease liabilities Provision for sales tax Other current liabilities Total Liabilities Total Net Assets Acquired ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative) Classes of intangible assets other than goodwill [axis] Geographical areas [axis] Range [axis] Business combinations [axis] Tradename [member] JustCBD [Member] Monte Carlo simulation Flora Beauty LLC Noncompete Agreement [member] Bottom [Member] Top [Member] Tradenames [member] Revenue Purchase Consideration Comprised Share [Purchase Consideration Comprised Share] Intangible Assets [Intangible Assets] Useful Lives Non-controlling Interest Total purchase consideration Consideration Additional common shares Trade receivables Increase in net loss [Increase in net loss] Increase in combined Revenue Comprehensive Loss Shares Issued Common shares delivered to the sellers Purchase Consideration Comprised Purchase Consideration Comprised Share Company Valued Fair Value Discount Intangible Assets Volatility [Volatility] Net Assets Acquired Exercise price Interest In Flora Beauty Llc Company Granted Common Shares Company Granted Common Shares To Flora Beauty LLC Company Granted Common Shares To Mr Breeze Equity Interests Own Useful Lives [Useful life measured as period of time, property, plant and equipment] Licences [member] Customer Relationships [Member] Trademarks and brands [Member] Patents [Member] Non-compete agreements [Member] Goodwill [Member] Balance, Beginning [Balance, Beginning] Additions [Additions other than through business combinations, intangible assets other than goodwill] Acquired Through Business Combinations (note 8) [Acquisitions through business combinations, intangible assets and goodwill] Impairment Accumulated Amortization, Balance Beginning [Accumulated Amortization, Balance Beginning] Accumulated Amortization, Additions Accumulated Amortization, Balance Ending Intangible Assets And Goodwill [Intangible assets and goodwill] Foreign Currency Translation Balance, Ending Balance, Beginning [Balance, Beginning 1] Balance, Ending Acquired Through Business Combinations (note 8) Products and services [axis] Pharmaceuticals and Nutraceuticals Just CBD [Member] Vessel [Member] Goodwill, Balance Beginning Acquired Through Business Combinations (note 8) Impairment Goodwill, Balance ending Intangible Assets And Goodwill [Intangible Assets And Goodwill] Intangible Assets And Goodwill [Intangible Assets And Goodwill 1] Description Of Amortization Description Of Amortization [Description Of Amortization] Redesignation [axis] Vessels One [Member] Vessel [Member] [Vessel [Member]] Deferred Tax Lease Liability Estimated Recoverable Amount Description Of Valuation Impairment Of CGU Total Carrying Value Goodwill And Identified Intangible Assets Other Long-lived Assets Description to sensitivity assessment to recoverable amount LEASES (Details) Office Space Amortization Expense By Class Of Underlying Asset Total Amortization Expense Interest On Lease Liabilities Short-term And Low Value Assets Lease Expense Total Lease Expense Other Information Additions To Right Of Use Assets Cash Paid For Amounts Included In The Measurement Of Lease Liabilities Financing Cash Flows From Leases (interest) Financing Cash Flows From Leases (principal) Operating Cash Flows For Short Term And Low Value Asset Leases Total Cash Outflows From Leases Carrying Amount Of Right Of Use Asset By Class Of Underlying Asset Total Carrying Amount Of Right Of Use Assets Maturity [axis] 2023 2024 2025 2027 Thereafter 2026 Total Undiscounted Cash Flows Less: Present Value Discount Total Lease Liabilities Description of lease CAPITAL STOCK (Details Narrative) Funding arrangements of defined benefit plans [axis] Acquisition Of Noncontrolling Interests Flora Beauty LLC Acquisition Of Noncontrolling Interests Breeze Other Offering Share Repurchased Stock Issued For Consulting Services Performed, Shares Stock Issued For Consulting Services Performed, Amount Cash Paid Common Shares Business Acquisition, Common Stock, Value of Shares Issued Fair Value Discount [Fair Value Discount] Common Share Exercisable Exercise price [Exercise price, share options granted] Gross Proceeds Share Acquired From Minority Interest OPTIONS (Details) Continuing involvement in derecognised financial assets by type of instrument [axis] Stock options Outstanding Balance, Beginning [Number of shares outstanding] Granted Exercised Outstanding Balance, Ending Weighted Average Exercise Price Outstanding Balance, Beginning [Weighted average exercise price of share options outstanding in share-based payment arrangement] Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Exercised Weighted Average Exercise Price Outstanding Balance, Ending Ranges of exercise prices for outstanding share options [axis] Exercise Price Four Exercise Price Five Exercise Price Six Exercise Price Seven Exercise Price Eight Exercise Price Nine Exercise Price Ten Exercise Price Eleven Exercise Price Twelve Exercise Price Thirteen Exercise Price Fourteen Exercise Price Fifteen Exercise Price Sixteen Exercise Price One Exercise Price Two Exercise Price Three Options Outstanding Options Exercisable Exercise Price [Exercise price of outstanding share options] Grant Date Fair Value Vested Amount Options Outstanding, Weighted Average Remaining Contractual Life Options Outstanding Risk-free Annual Interest Rate Current Stock Price Expected Annualized Volatility Expected Life (years) Expected Annual Dividend Yield Exercise Price Expense Related To Options Granted WARRANTS (Details) Number Of Warrants, Exercised Number Of Warrants, Cancelled/expired Number Of Warrants Balance, ending [Number Of Warrants Balance, ending] Number Of Warrants Balance, Beginning Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Cancelled/expired Grant date fair value vested amount Warrants, weighted average remaining contractual life Exercise Price Warrants Outstanding Date of expiry PROVISIONS COMMITMENTS AND CONTINGENCIES (Details) Attribution of expenses by nature to their function [axis] Termination Benefits Legal Disputes Sales Tax Member Beginning Balance, Amount [Expected reimbursement, contingent liabilities in business combination] Additional Provisions Acquired through business combinations Payment settlements Balance Ending as at June 30, 2022 Balance End as at June 30, 2022 Balance ending as at June 30, 2022 Additional Provisions15 Issued Common Shares Issued Common Shares [Par value per share] Total Contracts Payment Payment For Termination Total Anti-dilutive Directors' And Officers' Compensation Share-based Payments Total [Key management personnel compensation] Categories of related parties [axis] Ontario Inc. Forbes and Manhattan Inc. Ontario Corp. Rent And Promotion Services Expenses Termination description Expenses For Consulting Initial public offering Share Based Payments Trade And Other Payables Amount Owed To Related Parties FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details ) Transferred financial assets that are not derecognised in their entirety [axis] CAD COP EUR CHF GBP Cash [Cash] Amounts Receivable Loans Receivable Trade Payables Accrued Liabilities Lease Liabilities Long Term Debt Net Carrying Value Amounts Receivable [Amounts Receivable] Concentrations of risk [axis] Credit risk Financial Assets And Liabilities Description Of Exchange Rate Restricted Cash Cash Cash Held Amount CAPITAL MANAGEMENT (Details Narrative) Maximum number of shares repurchase, amount Cannabis Growth and Derivative Production Member Consumer Products Pharmaceuticals and Nutraceuticals [Pharmaceuticals and Nutraceuticals] Beverage and food Corporate and Eliminations Revenue Gross Profit Segment consolidation items [axis] United States Canada Colombia United Kingdom [Member] Non-current Assets Total Liabilities Gross Profit consolidated revenue SUBSEQUENT EVENTS (Details Narrative) Segments [axis] Subsegments Axis Exchange For Base Fees Stock Options Exercised During Period, Shares Warrants Exercised During Period, Shares Common Stock, Shares Issued During Period In Exchange Of Stock Options And Warrants Exercised EX-101.CAL 5 flora-20220630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 flora-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 flora-20220630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover
6 Months Ended
Jun. 30, 2022
Cover [Abstract]  
Entity Registrant Name FLORA GROWTH CORP.
Entity Central Index Key 0001790169
Document Type 6-K/A
Amendment Flag true
Current Fiscal Year End Date --12-31
Document Period End Date Jun. 30, 2022
Document Fiscal Period Focus Q2
Document Fiscal Year Focus 2022
Entity File Number 001-40397
Entity Address Address Line 1 365 Bay Street
Entity Address Address Line 2 Suite 800
Entity Address City Or Town Toronto
Entity Address State Or Province ON
Entity Address Postal Zip Code M5H 2V1
Amendment Description This Report on Form 6-K/A (the “Amendment”) amends the Report on Form 6-K filed on August 15, 2022 (the “Original 6-K”) containing the Unaudited Interim Condensed Consolidated Financial Statements of Flora Growth Corp. (the “Company”) as of and for the six months ended June 30, 2022. The purpose of this Amendment is solely to provide the Company’s Unaudited Interim Condensed Consolidated Financial Statements as of and for the six months ended June 30, 2022 formatted in Inline eXtensible Business Reporting Language (“iXBRL”) in accordance with Rule 405 of Regulation S-T and paragraph C.(6)(a)(ii) of the General Instructions to Form 6-K, attached hereto as Exhibit 99.1. Such Unaudited Interim Condensed Consolidated Financial Statements were previously filed without iXBRL as exhibit 99.2 to the Original 6-K. Except as described above, this Amendment speaks as of the original filing date of the Original 6-K and does not amend, update or restate any information set forth in the Original 6-K or reflect any events that occurred subsequent to the original filing date of the Original 6-K.
XML 9 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Interim Condensed Consolidated Statements of Financial Position - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current    
Cash $ 10,268,000 $ 37,614,000
Restricted cash 1,000 2,000
Trade and amounts receivable (Note 3) 5,092,000 5,324,000
Loans receivable and advances 262,000 273,000
Prepaid expenses 2,224,000 1,700,000
Biological assets (Note 4) 14,000 37,000
Inventory (Note 5) 9,295,000 2,993,000
Total current assets 27,156,000 47,943,000
Non-current    
Property, plant and equipment (Note 6) 4,565,000 3,750,000
Right of use assets (Note 11) 3,639,000 1,229,000
Intangible assets (Note 9) 13,432,000 9,736,000
Goodwill (Note 9) 28,666,000 20,054,000
Investments (Note 7) 1,337,000 2,670,000
Other Assets 273,000 97,000
Total assets 79,068,000 85,479,000
Current    
Trade payables and accrued liabilities 7,401,000 5,628,000
Current portion of long term debt 10,000 18,000
Current portion of lease liability (Note 11) 1,120,000 412,000
Other accrued liabilities 20,000 61,000
Total current liabilities 8,551,000 6,119,000
Non-current    
Non-current debt 138,000 0
Non-current lease liability (Note 11) 2,411,000 908,000
Deferred tax (Note 16) 1,511,000 1,511,000
Other long term liabilities (Note 8) 3,958,000 0
Total liabilities 16,599,000 8,538,000
SHAREHOLDERS' EQUITY    
Share capital (Note 12) 119,300,000 102,428,000
Options (Note 13) 6,611,000 3,712,000
Warrants (Note 14) 10,047,000 10,670,000
Accumulated other comprehensive loss (1,675,000) (1,108,000)
Deficit (71,512,000) (38,536,000)
Non-controlling interest (302,000) (225,000)
Total shareholders' equity 62,469,000 76,941,000
Total liabilities and shareholders' equity $ 79,068,000 $ 85,479,000
XML 10 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Interim Condensed Consolidated Statements of Loss on Comprehensive Loss - USD ($)
shares in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Interim Condensed Consolidated Statements of Loss on Comprehensive Loss    
Revenue (Note 21) $ 14,917,000 $ 2,118,000
Cost of sales 8,415,000 1,106,000
Gross profit before fair value adjustments 6,502,000 1,012,000
Unrealized gain on changes in fair value of biological assets (Note 4) 46,000 0
Realized fair value amounts included in inventory sold (Note 4) (2,000) 0
Gross Profit 6,546,000 1,012,000
Operating Expenses    
Consulting and management fees 5,243,000 2,262,000
Professional fees 2,096,000 766,000
General and administrative 2,429,000 1,481,000
Promotion and communication 4,719,000 1,180,000
Travel expenses 601,000 143,000
Share based compensation (Note 13) 2,855,000 95,000
Research and development 422,000 85,000
Depreciation and amortization (Notes 6 and 9) 1,712,000 119,000
Bad debt expense (Note 3) 405,000 100,000
Goodwill impairment (Notes 9 and 10) 16,000,000 0
Other expenses (income), net 1,178,000 (67,000)
Total operating expenses 37,660,000 6,164,000
Operating Loss (31,114,000) (5,152,000)
Interest expense 69,000 64,000
Foreign exchange loss (gain) 200,000 (78,000)
Unrealized loss on fair value of investments (Note 7) 1,333,000 0
Net loss before income taxes (32,716,000) (5,138,000)
Income tax benefit (Note 16) 0 0
Net loss for the period (32,716,000) (5,138,000)
Other comprehensive loss    
Exchange differences on foreign operations 567,000 200,000
Total comprehensive loss for the period (33,283,000) (5,338,000)
Net loss attributable to:    
Flora Growth Corp. (32,611,000) (5,097,000)
Non-controlling interests (105,000) (41,000)
Comprehensive loss attributable to: Flora Growth Corp. (33,178,000) (5,297,000)
Comprehensive loss attributable to: Non-controlling interests $ (105,000) $ (41,000)
Basic and diluted loss per share attributable to Flora Growth Corp. $ (0.42) $ (0.13)
Weighted average number of common shares outstanding - basic and diluted (Note 17) 76,944 39,604
XML 11 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Interim Condensed Consolidated Statement of Shareholders' Equity (Deficiency) - USD ($)
shares in Thousands, $ in Thousands
Total
Number of Common Shares
Options
Warrants [Member]
Accumulated other comprehensive (loss)
Accumulated Deficit
Noncontrolling Interest
Balance, shares at Dec. 31, 2020   38,355          
Balance, amount at Dec. 31, 2020 $ 16,250 $ 27,254 $ 2,396 $ 3,961 $ 39 $ (17,287) $ (113)
Statement [Line Items]              
Initial public offering, shares   3,333          
Initial public offering, amount 16,667 $ 16,667 0 0 0 0 0
Regulation A and Other Offerings, shares   (1)          
Regulation A and Other Offerings, amount (3) $ (3) 0 0 0 0 0
Share issuance costs (5,040) (5,040) 0 0 0 0 0
Warrants issued 1,349 $ 0 0 1,349 0 0 0
Warrants exercised, shares   337          
Warrants exercised, amount 60 $ 65 0 (5) 0 0 0
Options issued 95 0 95 0 0 0 0
Other comprehensive loss - exchange differences on foreign operations (201) 0 0 0 (201) 0 0
Current year net loss attributable to Flora (5,138) $ 0 0 0 0 (5,097) (41)
Balance, shares at Jun. 30, 2021   42,024          
Balance, amount at Jun. 30, 2021 24,039 $ 38,943 2,491 5,305 (162) (22,384) (154)
Balance, shares at Dec. 31, 2021   65,517          
Balance, amount at Dec. 31, 2021 76,941 $ 102,428 3,712 10,670 (1,108) (38,536) (225)
Statement [Line Items]              
Warrants exercised, shares   473          
Warrants exercised, amount 91 $ 132   (41)      
Other comprehensive loss - exchange differences on foreign operations (567)       (567)    
Current year net loss attributable to Flora (32,716)         (32,611) (105)
Share repurchase (Note 12) (250) $ 0 (250) 0      
Common shares issued for business combinations (Notes 8 and 12), shares   9,500          
Common shares issued for business combinations (Notes 8 and 12), amount 14,697 $ 14,697          
Common shares issued for other agreements (Note 12), shares   811          
Common shares issued for other agreements (Note 12), amount 1,554 $ 1,470 84        
Acquisition of noncontrolling interest (Note 8), shares   131          
Acquisition of noncontrolling interest (Note 8), amount (54) $ 220 63     (365) 28
Options Issued (Note 13) 2,771     2,771      
Options exercised (Note 13), shares   512          
Options exercised (Note 13), amount 77 $ 96 (19)        
Warrants expired/cancelled (Note 14)     582   (582)    
Share issuance costs (75)   (75)        
Balance, shares at Jun. 30, 2022   76,944          
Balance, amount at Jun. 30, 2022 $ 62,469 $ 119,300 $ 6,611 $ 10,047 $ (1,675) $ (71,512) $ (302)
XML 12 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Interim Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (32,716) $ (5,138)
Adjustments to net loss:    
Depreciation and amortization 1,712 119
Stock-based compensation 3,044 95
Impairments 16,000 0
Changes in fair value of investments and biological assets 1,287 0
Bad debt expense 405 100
Interest expense 56 15
Income tax benefit 0 0
Income tax (paid) received 0 0
Total (10,212) (4,809)
Net change in non-cash working capital:    
Trade and other receivables 802 (772)
Inventory (699) (421)
Prepaid expenses and other assets (33) (1,415)
Trade payables and accrued liabilities (341) 1,647
Net cash used in operating activities (10,483) (5,770)
Cash flows from financing activities:    
Common shares issued 0 16,664
Equity issue costs (75) (2,024)
Exercise of warrants and options 168 60
Repayments of lease liability (420) (61)
Common shares repurchased (250) 0
Interest paid (69) 0
Loan borrowing (repayments) 130 (220)
Net cash (used) provided by financing activities (516) 14,419
Cash flows from investing activities:    
Loans provided 0 (275)
Loan repayments received 0 224
Purchases of property, plant and equipment and other assets (722) (1,384)
Purchase of investments 0 (2,430)
Business and asset acquisitions, net of cash acquired (15,457) (1,306)
Net cash used in investing activities (16,179) (5,171)
Effect of exchange rate on changes on cash (168) (195)
Change in cash during the period (27,346) 3,283
Cash and cash equivalents at beginning of period 37,614 15,523
Cash and cash equivalents at end of period 10,268 18,806
Supplemental disclosure of non-cash activities    
Right of use assets and lease liabilities acquired (Note 11) 2,053 0
Common shares issued for business combinations (Notes 8) $ 14,917 $ 0
XML 13 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
NATURE OF OPERATIONS
6 Months Ended
Jun. 30, 2022
NATURE OF OPERATIONS  
Nature Of Operations

1. NATURE OF OPERATIONS

 

Flora Growth Corp. (the “Company” or “Flora”) was incorporated under the laws of the Province of Ontario, Canada on March 13, 2019. The Company is a manufacturer of global cannabis products and brands, building a connected, design-led collective of plant-based wellness and lifestyle brands. The Company’s registered office is located at 365 Bay Street, Suite 800, Toronto, Ontario, M5H 2V1, Canada and our principal place of business in the United States is located at 3406 SW 26th Terrace, Suite C-1, Fort Lauderdale, Florida 33312.

 

These interim condensed consolidated financial statements have been prepared on a going concern basis, meaning that the Company will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations.

XML 14 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
BASIS OF PRESENTATION
6 Months Ended
Jun. 30, 2022
Basis Of Presentation

2. BASIS OF PRESENTATION

 

Statement of compliance

These interim condensed consolidated financial statements have been prepared by management in accordance with International Financial Reporting Standards (“IFRS”) and International Accounting Standards 34, Interim Financial Reporting (“IAS 34”), issued by the International Accounting Standards Board (“IASB”). These interim condensed consolidated financial statements do not include all notes of the type normally included within the annual financial statements and should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December 31, 2021 included in our Annual Report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”), which have been prepared in accordance with IFRS issued by the IASB and interpretations issued by the IFRS Interpretations Committee (“IFRIC”).

 

These consolidated financial statements were approved and authorized for issuance by the Board of Directors of the Company on August 11, 2022.

 

Basis of consolidation

These interim condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions were eliminated on consolidation. Subsidiaries are entities the Company controls when it is exposed, or has rights, to variable returns from its involvement in the entity and can affect those returns through its power to direct the relevant activities of the entity. Subsidiaries are included in the consolidated financial results of the Company from the date of acquisition up to the date of disposition or loss of control. As at June 30, 2022, the Company had the following subsidiaries:

 

Subsidiaries

Country of incorporation

Ownership

Functional currency

Cosechemos YA S.A.S.

Colombia

90%

Colombia Peso (COP)

Flora Growth Corp. Sucursal Colombia

Colombia

100%

Colombia Peso (COP)

Hemp Textiles & Co. LLC

United States

100%

United States Dollar (USD)

Hemp Textiles & Co. S.A.S.

Colombia

100%

Colombia Peso (COP)

Flora Beauty LLC

United States

100%

United States Dollar (USD)

Flora Beauty LLC Sucursal Colombia

Colombia

100%

Colombia Peso (COP)

Kasa Wholefoods Company S.A.S.

Colombia

90%

Colombia Peso (COP)

Kasa Wholefoods Company LLC

United States

100%

United States Dollar (USD)

Grupo Farmaceutico Cronomed S.A.S.

Colombia

100%

Colombia Peso (COP)

Labcofarm Laboratorios S.A.S.

Colombia

100%

Colombia Peso (COP)

Breeze Laboratory S.A.S.

Colombia

100%

Colombia Peso (COP)

Vessel Brand Inc.

United States

100%

United States Dollar (USD)

Just Brands LLC

United States

100%

United States Dollar (USD)

Just Brands International LTD

United Kingdom

100%

British Pound (GBP)

High Roller Private Label LLC

United States

100%

United States Dollar (USD)

Flora Growth US Holdings Corp.

United States

100%

United States Dollar (USD)

Flora Growth Management Corp.

United States

100%

United States Dollar (USD)

Cardiff Brand Corp.

United States

100%

United States Dollar (USD)

Keel Brand Corp.

United States

100%

United States Dollar (USD)

Flora Growth F&B Corp.

United States

100%

United States Dollar (USD)

Basis of measurement

The interim condensed consolidated financial statements have been prepared on the historical cost basis, except for certain financial instruments that are measured at fair value and biological assets as explained in the accounting policies included in the audited consolidated financial statements of the Company for the year ended December 31, 2021. Historical cost is generally based on the fair value of the consideration given in exchange for goods and services.

 

The unaudited interim condensed consolidated financial statements are presented in United States dollars (“$”) unless otherwise noted.

 

Significant Accounting Policies and Critical Judgments and Estimation Uncertainties

The interim condensed consolidated financial statements were prepared using the same accounting policies, judgments, estimates and assumptions as those used in the Company’s consolidated financial statements for the year ended December 31, 2021, except as noted below for the following new significant transactions that occurred in 2022.

 

Contingent Purchase Consideration

Contingent consideration is measured at its acquisition date fair value and is included as part of the consideration transferred in a business combination, subject to the applicable terms and conditions. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration that is classified as a liability is remeasured at subsequent reporting dates with the corresponding gain or loss recognized in profit or loss. Management exercises judgment to determine the classification of contingent consideration as equity or liability based on the terms of the agreement and potential for the consideration to result in a cash outflow by the Company. Fair value estimates are determined using appropriate valuation techniques based on the nature of the terms in the purchase agreement.

XML 15 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
TRADE AND AMOUNTS RECEIVABLE
6 Months Ended
Jun. 30, 2022
TRADE AND AMOUNTS RECEIVABLE  
Trade And Amounts Receivable

3. TRADE AND AMOUNTS RECEIVABLE

 

The Company’s trade and amounts receivable are recorded at amortized cost. The trade and other receivables balance as at June 30, 2022 and December 31, 2021 consists of trade accounts receivable, amounts recoverable from the Government of Canada for Harmonized Sales Taxes (“HST”) and other receivables.

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Thousands of United States dollars

 

 

 

 

 

 

Trade accounts receivable

 

$5,428

 

 

$5,565

 

Allowance for expected credit losses

 

 

(1,679)

 

 

(1,252)

HST receivable

 

 

411

 

 

 

259

 

Other receivables

 

 

932

 

 

 

752

 

Total

 

5,092

 

 

5,324

 

 

Changes in the trade accounts receivable allowance in the six months ended June 30, 2022 primarily relate to establishing an allowance for expected credit losses from the acquisition of JustCBD balances. There were no write-offs of trade receivables during the six months ended June 30, 2022. The Company has no amounts written-off that are still subject to collection enforcement activity as at June 30, 2022. There was an additional $0.3 million of expected credit losses recorded in other receivables as at June 30, 2022. The Company’s aging of trade accounts receivable is as follows:

 

 

 

June 30, 2022

 

Thousands of United States dollars

 

 

 

Current

 

$1,641

 

1-30 Days

 

 

614

 

31-60 Days

 

 

259

 

61-90 Days

 

 

383

 

91-180 Days

 

 

1,383

 

180+ Days

 

 

1,148

 

Total trade receivables

 

$5,428

 

XML 16 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
BIOLOGICAL ASSETS
6 Months Ended
Jun. 30, 2022
BIOLOGICAL ASSETS  
Biological Assets

4. BIOLOGICAL ASSETS

 

The Company’s biological assets consist of cannabis plants throughout the growth cycle including propagation, vegetative and flowering stages. Cannabis plants cease being biological assets upon harvest when the fair value at time of harvest is transferred to harvested cannabis inventory. The Company has no biological assets with title restricted or pledged as collateral, and no significant commitments for development or acquisition of biological assets as at June 30, 2022.

 

The changes in the carrying value of biological assets are as follows:

 

Thousands of United States Dollars

 

 

 

Opening balance at December 31, 2021

 

$37

 

Changes in fair value less cost to sell due to biological transformation

 

 

46

 

Transferred to harvested cannabis inventory upon harvest

 

 

(69)

Ending balance at June 30, 2022

 

14

 

 

The valuation of biological assets is based on an income approach (Level 3) in which the fair value at the point of harvesting is estimated based on selling prices less the costs to sell. For in-process biological assets (growing plants), the fair value at the point of harvest is adjusted based on the stage of growth at period-end. Harvested cannabis is transferred from biological assets at their fair value at harvest to harvested cannabis within inventory.

 

Significant inputs and assumptions used in determining the fair value of cannabis plants are as follows as at June 30, 2022:

 

Average selling price per gram of $0.10 – Represents estimated selling price of dried cannabis end products net of excise taxes, where applicable, for the period for all strains of cannabis, which is expected to approximate future selling prices. Increasing this amount results in an increase in fair value.

 

Weighted average yield of 21 gram per plant – Represents the weighted average number of grams of dried cannabis inventory expected to be harvested from each cannabis plant. Increasing this amount results in an increase in fair value.

 

Post-harvest cost per gram to complete production of $0.04 – Based on estimated future production costs incurred divided by estimated grams produced in the period. Increasing this amount results in a decrease in fair value.

 

Changes in the assumptions above of 10% would not have a significant impact on the fair value of biological assets as at June 30, 2022.

 

As at June 30, 2022, the weighted average fair value less cost to complete and cost to sell a gram of dried cannabis was $0.06 per gram. The Company’s biological assets produced 746 kilograms of dried cannabis in the six months ended June 30, 2022 and the Company expects the biological assets will yield 190 kilograms of cannabis when harvested. The weighted average stage of growth for the biological assets was 41%.

XML 17 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVENTORY
6 Months Ended
Jun. 30, 2022
INVENTORY  
Inventory

5. INVENTORY

 

Inventory is comprised of the following as at June 30, 2022 and December 31, 2021:

 

 

 

 

 

 

 

 

Thousands of United States dollars

 

June 30, 2022 

 

 

December 31,

2021 

 

Raw materials and supplies

 

$2,161

 

 

$899

 

Harvested cannabis

 

 

92

 

 

 

35

 

Work in progress

 

 

465

 

 

 

97

 

Finished goods

 

 

6,577

 

 

 

1,962

 

Total

 

$9,295

 

 

$2,993

 

XML 18 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROPERTY PLANT AND EQUIPMENT
6 Months Ended
Jun. 30, 2022
PROPERTY PLANT AND EQUIPMENT  
Property, Plant And Equipment

6. PROPERTY, PLANT AND EQUIPMENT

 

In Thousands of United States dollars

 

Construction in progress

 

 

 Machinery and Office equipment

 

 

Buildings

 

 

Vehicles

 

 

 Land

 

 

Subtotal

 

 

 Right of use assets

 

 

Total

 

Cost at December 31, 2021

 

$905

 

 

$1,991

 

 

$928

 

 

$37

 

 

$112

 

 

$3,973

 

 

$1,532

 

 

$5,505

 

Additions

 

 

321

 

 

 

53

 

 

 

23

 

 

 

-

 

 

 

305

 

 

 

702

 

 

 

2,053

 

 

 

2,755

 

Business combinations (Note 8)

 

 

-

 

 

 

506

 

 

 

-

 

 

 

30

 

 

 

-

 

 

 

536

 

 

 

772

 

 

 

1,308

 

Foreign exchange translation

 

 

(52)

 

 

(71)

 

 

(38)

 

 

(1)

 

 

(22)

 

 

(184)

 

 

(49)

 

 

(233)

Cost as at June 30, 2022

 

 

1,174

 

 

 

2,479

 

 

 

913

 

 

 

66

 

 

 

395

 

 

 

5,027

 

 

 

4,308

 

 

 

9,335

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at December 31, 2021

 

 

-

 

 

 

(169)

 

 

(44)

 

 

(10)

 

 

-

 

 

 

(223)

 

 

(303)

 

 

(526)

Depreciation

 

 

-

 

 

 

(229)

 

 

(44)

 

 

(2)

 

 

-

 

 

 

(275)

 

 

(383)

 

 

(658)

Disposals

 

 

-

 

 

 

20

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

20

 

 

 

-

 

 

 

20

 

Foreign exchange translation

 

 

-

 

 

 

12

 

 

 

4

 

 

 

-

 

 

 

-

 

 

 

16

 

 

 

17

 

 

 

33

 

Accumulated depreciation as at June 30, 2022

 

 

-

 

 

 

(366)

 

 

(84)

 

 

(12)

 

 

-

 

 

 

(462)

 

 

(669)

 

 

(1,131)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at December 31, 2020

 

 

905

 

 

 

1,822

 

 

 

884

 

 

 

27

 

 

 

112

 

 

 

3,750

 

 

 

1,229

 

 

 

4,979

 

As at June 30, 2022

 

$1,174

 

 

$2,113

 

 

$829

 

 

$54

 

 

$395

 

 

$4,565

 

 

$3,639

 

 

$8,204

 

XML 19 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
LONGTERM INVESTMENTS
6 Months Ended
Jun. 30, 2022
LONGTERM INVESTMENTS  
Long-term Investments

7. LONG-TERM INVESTMENTS

 

As at June 30, 2022, the Company’s long-term investments consist of common shares and warrants to purchase additional common shares in an early stage European cannabis company. In 2021, the Company purchased common shares from the investee for Euro 2.0 million ($2.4 million), purchased its first tranche of warrants from existing investors in exchange for 225,000 common shares of the Company, and obtained a second tranche of warrants from the investee as an inducement to exercise some of the first tranche of warrants. As at June 30, 2022, the Company owns approximately 9.6% of the investee, or approximately 8.6% on a diluted basis including exercisable warrants of the Company and other investors.

 

The warrants allow the holder to purchase one common share of the investee for CAD 0.30 ($0.23) for the first tranche, and CAD 1.00 ($0.78) for the second tranche. The warrants were immediately exercisable and expire February 1, 2023.

 

The Company’s cost of the investments was recorded based on the fair value of the consideration exchanged as at the respective transaction dates. The investee is not a publicly listed entity and has no active quoted prices for its common shares or warrants. Subsequent remeasurements are recorded as FVPL as indicated on the unrealized investments loss caption on the statement of loss and comprehensive loss. The Company estimated the fair value of the investments as at June 30, 2022 using Level 3 inputs of the fair value hierarchy with the fair value of the investee common shares at $0.32, the first tranche warrants at $0.13, and the second tranche warrants at $0.02.

 

The investee common shares were valued considering price to book value and price to tangible book value of the investee (3.6 and 4.8, respectively) as well as comparable guideline publicly traded companies at the time of initial investment. These initial investment multiples were compared to the guideline public company multiples observed as at June 30, 2022 (2.2 price to book value and 3.0 price to tangible value), with these updated valuation multiples applied to the investee’s estimated book value. The Company also considered the status of the investee’s milestones between the purchase date and year-end for indicators of change in value.

 

The fair value of the warrants was developed using a Black-Scholes model for each tranche with the following assumptions:

 

 

 

Warrants CAD 0.30 exercise price

 

 

Warrants CAD 1.00 exercise price

 

Share price

 

$0.32

 

 

$0.32

 

Exercise price

 

$0.23

 

 

$0.78

 

Volatility

 

 

100%

 

 

100%

Risk-free interest rate

 

 

3.1%

 

 

3.1%

Dividend yield

 

 

0.0%

 

 

0.0%

Expected term in years

 

 

0.6

 

 

 

0.6

 

Fair value

 

$0.13

 

 

$0.02

 

Quantity owned

 

 

1,666,667

 

 

 

333,333

 

Fair value

 

$222,000

 

 

$8,000

 

The share price is based on the calculated value of the investee’s common shares as discussed above. The volatility considers actual volatility of comparable guideline public companies.

 

A schedule of the Company’s long-term investments activity is as follows:

 

 

 

Investee common shares

 

 

Warrants CAD 0.30 exercise price

 

 

Warrants CAD 1.00 exercise price

 

 

 

Financial asset hierarchy level

 

Level 3

 

 

Level 3

 

 

Level 3

 

 

 Total

 

Thousands of United States dollars

 

 $

 

 

 $

 

 

 $

 

 

 $

 

Balance at December 31, 2021

 

 

1,987

 

 

 

625

 

 

 

58

 

 

 

2,670

 

Loss on changes in fair value

 

 

(880)

 

 

(403)

 

 

(50)

 

 

(1,333)

Balance at June 30, 2022

 

 

1,107

 

 

 

222

 

 

 

8

 

 

 

1,337

 

 

The loss on changes in fair value appear in the unrealized loss on fair value of investments caption in the statement of loss and comprehensive loss.

 

As a sensitivity assessment to the fair value calculations, a 10% change in the valuation multiples applied to the investee common shares results in a 10% change in the fair value as at June 30, 2022 of $111,000. Applying a 10% change in share price to the warrants results in an approximately $44,000 change in fair value, and a 10% change in volatility of approximately $14,000.

XML 20 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
ASSET ACQUISITIONS AND BUSINESS COMBINATIONS
6 Months Ended
Jun. 30, 2022
ASSET ACQUISITIONS AND BUSINESS COMBINATIONS  
Asset Acquisitions And Business Combinations

8. ASSET ACQUISITIONS AND BUSINESS COMBINATIONS

 

Just Brands LLC and High Roller Private Label LLC (collectively “JustCBD”) business combination

 

On February 24, 2022, Flora Growth U.S. Holdings Corp., a wholly-owned subsidiary of the Company, completed the acquisition of 100% of the outstanding equity interests in each of (i) Just Brands LLC and (ii) High Roller Private Label LLC for total purchase consideration of $34.6 million. JustCBD is a manufacturer and distributor of consumable cannabinoid products, including gummies, tinctures, vape cartridges, and creams. JustCBD is based in Florida in the United States and was formed in 2017. The Company acquired JustCBD to expand its product offerings, accelerate its revenue growth, expand its customer and distribution footprints in the United States and for the acquisition of human capital through JustCBD’s management team.

 

The purchase consideration was comprised of $16.0 million of cash, 9.5 million common shares of the Company valued at $14.7 million, inclusive of a 15% fair value discount for the required six-month holding period of the shares, and $4.0 million of contingent purchase consideration. The contingent purchase consideration is based on a clause in the purchase agreement that provides that if at any time during the 24 months following the acquisition date, the five-day volume weighted average price (“VWAP”) per share of the Company’s common shares as quoted on the Nasdaq Capital Market fails to equal or exceed $5.00, then the Company shall issue a number of additional common shares to the sellers equal to the difference between (x) a fraction, the numerator of which is $47.5 million and the denominator of which is the highest five day VWAP at any point during the 24 months following the closing and (y) the 9.5 million common shares delivered to the sellers at the closing. In no event shall the Company be required to issue more than 3.65 million common shares unless it shall have obtained the consent of the Company’s shareholders to do so. In the event the Company is required to deliver in excess of 3.65 million shares to the sellers (“Excess Shares”) and the Company shall not have obtained shareholder consent, the Company may deliver cash to the sellers in lieu of such Excess Shares determined by a formula set forth in the purchase agreement. The contingent purchase consideration is classified as a financial liability within other long-term liabilities on the statement of financial position as the Company may be required to settle any amounts due in cash instead of common shares if the Company’s common shareholders do not provide requisite shareholder approval to issue additional common shares.

 

The fair value of the contingent purchase consideration was determined using a Monte Carlo simulation incorporating Brownian motion with 100,000 trials through a binomial lattice model. The significant inputs to the valuation include the two year time period, the Company’s closing share price at February 24, 2022 ($1.82), estimated Company common share volatility (100%), and risk free rate of 1.5% to discount the ending result to present value.

The amounts recognized as at the acquisition date for each major class of assets acquired and liabilities assumed are as follows:

 

(Thousands of United States dollars)

 

 

 

Current assets

 

 

 

Cash

 

$535

 

Trade receivables

 

 

975

 

Inventory

 

 

5,534

 

Other current assets

 

 

540

 

 

 

 

 

 

Non-current assets

 

 

 

 

Property, plant, and equipment

 

 

537

 

Right of use assets

 

 

772

 

Other non-current assets

 

 

127

 

Intangible asset

 

 

4,757

 

Goodwill

 

 

24,869

 

Total assets

 

$38,646

 

 

 

 

 

 

Current liabilities

 

 

 

 

Trade payables and accrued liabilities

 

$(2,273)

Current lease liabilities

 

 

(644)

Provision for sales tax

 

 

(982)

Other current liabilities

 

 

(99)

Total liabilities

 

$(3,998)

Total net assets acquired

 

$34,648

 

 

The fair value of the trade receivables reflects a $291,000 discount to the gross contractual amounts as allowance for potentially uncollectible amounts. Since the acquisition date through June 30, 2022, JustCBD revenue was $10.0 million with net loss and comprehensive loss of $0.4 million.

 

The intangible assets of $4.8 million are comprised of the following categories and estimated useful lives: tradenames of $3.4 million for eight to nine years, customer relationships of $1.2 million for five to seven years, and know-how of $0.2 million for three years. The Company expects the goodwill and intangible asset values to be deductible for Unites States income tax purposes.

 

If JustCBD was acquired at January 1, 2022, the combined revenue and net loss of JustCBD and the Company would have increased approximately $5.2 million and $1.6 million, respectively.

 

Acquisition of Minority interests

On January 18, 2022, the Company acquired the remaining 10% of the outstanding equity interests in Flora Beauty LLC from its minority shareholder in exchange for 100,000 common shares of the Company and a stock option exercisable for up to 50,000 common shares of the Company at an exercise price of $1.70 per share that expire five years from the date of the grant.

 

On January 31, 2022, the Company completed its acquisition of Breeze by acquiring the remaining 10% of the equity interests in Breeze from its minority shareholders in exchange for 30,282 common shares of the Company.

XML 21 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLE ASSETS AND GOODWILL
6 Months Ended
Jun. 30, 2022
INTANGIBLE ASSETS AND GOODWILL  
Intangible Assets And Goodwill

9. INTANGIBLE ASSETS AND GOODWILL

 

A continuity of intangible assets for the six months ended June 30, 2022 is as follows:

 

 In Thousands of United States dollars

 

License

 

 

Customer Relationships

 

 

Trademarks and Brands

 

 

Patents

 

 

Non-Compete Agreements

 

 

Goodwill

 

 

Total

 

Cost

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2021

 

$610

 

 

$1,759

 

 

$2,211

 

 

$4,300

 

 

$1,190

 

 

$20,054

 

 

$30,124

 

Acquired through business combinations (Note 8)

 

 

-

 

 

 

1,160

 

 

 

3,357

 

 

 

240

 

 

 

-

 

 

 

24,869

 

 

 

29,626

 

Impairment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(16,000)

 

 

(16,000)

At June 30, 2022

 

$610

 

 

$2,919

 

 

$5,568

 

 

$4,540

 

 

$1,190

 

 

$28,923

 

 

$43,750

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2021

 

$129

 

 

$26

 

 

$35

 

 

$48

 

 

$66

 

 

$-

 

 

$304

 

Additions

 

 

82

 

 

 

169

 

 

 

306

 

 

 

297

 

 

 

198

 

 

 

-

 

 

 

1,052

 

At June 30, 2022

 

$211

 

 

$195

 

 

$341

 

 

$345

 

 

$264

 

 

$-

 

 

$1,356

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Currency translation

 

 

(18)

 

 

-

 

 

 

(21)

 

 

-

 

 

 

-

 

 

 

(257)

 

 

(296)

Net book value at June 30, 2022

 

$381

 

 

$2,724

 

 

$5,206

 

 

$4,195

 

 

$926

 

 

$28,666

 

 

$42,098

 

 

The Company’s intangible asset additions in 2022 primarily consist of assets acquired as part of the February 2022 purchase of JustCBD (Note 8). Information regarding the significant JustCBD intangible assets within the indicated categories of the table above is as follows as at June 30, 2022:

 

 

·

Tradenames: carrying amount $3.2 million with 92 to 104 months of remaining amortization periods

 

·

Customer relationships: carrying amount $1.1 million with 56 to 80 months of remaining amortization periods

 

·

Know-how: carrying amount $0.2 million with 32 months of remaining amortization period

 

The Company’s goodwill is assigned to the following cash generating units (“CGU’s”) as at June 30, 2022:

 

In Thousands of United States dollars

 

 Pharmaceuticals and nutraceuticals

 

 

 Vessel

 

 

 JustCBD

 

 

 Total

 

As at December 31, 2021

 

$379

 

 

$19,675

 

 

$-

 

 

$20,054

 

Acquired through business combinations (Note 8)

 

 

-

 

 

 

-

 

 

 

24,612

 

 

 

24,612

 

Impairment

 

 

-

 

 

 

(16,000)

 

 

-

 

 

 

(16,000)

As at June 30, 2022

 

$379

 

 

$3,675

 

 

$24,612

 

 

$28,666

 

XML 22 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
IMPAIRMENT OF ASSETS
6 Months Ended
Jun. 30, 2022
IMPAIRMENT OF ASSETS  
Impairment Of Assets

10. IMPAIRMENT OF ASSETS

 

The carrying amounts of the Company’s non-financial assets are reviewed for impairment each reporting period or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. At June 30, 2022, the Company’s Vessel CGU had external indicators of impairment primarily due to a 2022 decline in comparable public company share prices which would negatively impact the implied valuation of Vessel. As such, the Company tested the Vessel CGU non-financial assets for impairment as at June 30, 2022. The Vessel CGU was acquired in November 2021 and is part of the Company’s consumer products reportable segment.

 

Vessel’s June 30, 2022 carrying value of $28.0 million is comprised primarily of goodwill and identified intangible assets of $28.0 million and other long-lived assets of $1.4 million. The carrying value is reduced by inseparable market participant liabilities associated with the November 2021 acquisition of Vessel which includes $1.4 million of deferred tax liability and $1.2 million of lease liability. The estimated recoverable amount of Vessel at June 30, 2022 was $11.9 million, resulting in impairment of $16.0 million as the carrying value of the CGU’s assets exceeds the recoverable amount. The impairment is recorded in goodwill impairment caption on the statement of loss and comprehensive loss.

 

The recoverable amount is based on fair value less costs of disposal. The fair value was determined based on guideline public companies similar to Vessel considering financial metrics such as historical revenue growth, gross margin and EBITDA profitability and with operations focused on consumer brands and similar sales channels. An enterprise value to latest twelve months revenue multiple of 1.75 was selected based on consideration of the enterprise value to latest twelve months multiples of the guideline companies. The multiple was applied to Vessel’s revenue for the twelve months ended June 30, 2022. Estimated costs of disposal of 3% were subtracted to arrive at the recoverable amount. The impairment test valuation is considered a Level 3 method within the IFRS 13 fair value hierarchy.

 

After the impairment, Vessel’s carrying value is equal to its recoverable amount. Any change in the significant assumptions could result in additional impairment of its goodwill and long-lived assets as at June 30, 2022. As a sensitivity assessment to the recoverable amount calculations, reducing the selected revenue multiple by 0.5 from 1.75 above down to 1.25 (approximately 29% decrease) would result in additional goodwill impairment of approximately $3.0 million.

XML 23 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES
6 Months Ended
Jun. 30, 2022
LEASES  
Leases

11. LEASES

 

The Company’s leases primarily consist of administrative real estate leases in Colombia and the United States, and the Company’s cultivation property in Santander, Colombia. Information regarding the Company’s leases is as follows:

 

Thousands of United States dollars

 

 Six months ended June 30, 2022

 

 

 Six months ended June 30, 2021

 

Lease expense

 

 

 

 

 

 

Amortization expense by class of underlying asset

 

 

 

 

 

 

Office Space

 

$351

 

 

$40

 

Building

 

 

5

 

 

 

5

 

Land

 

 

27

 

 

 

-

 

Total amortization expense

 

 

383

 

 

 

45

 

Interest on lease liabilities

 

 

83

 

 

 

14

 

Short-term and low value assets lease expense

 

 

510

 

 

 

-

 

Total lease expense

 

$976

 

 

$59

 

 

 

 

 

 

 

 

 

 

Other Information

 

 

 

 

 

 

 

 

Additions to right of use assets

 

$2,053

 

 

$-

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

 

 

 

 

 

 

Financing cash flows from leases (interest)

 

 

69

 

 

 

16

 

Financing cash flows from leases (principal)

 

 

420

 

 

 

70

 

Operating cash flows for short term and low value asset leases

 

 

510

 

 

 

-

 

Total cash outflows from leases

 

$999

 

 

$86

 

 

 

 

 

 

 

 

 

 

Carrying amount of right of use asset by class of underlying asset

 

 

 

 

 

 

 

 

Office Space

 

$2,492

 

 

$231

 

Building

 

 

1,036

 

 

 

16

 

Land

 

 

111

 

 

 

-

 

Total carrying amount of right of use assets

 

$3,639

 

 

$247

 

 

The maturity analysis of the undiscounted contractual balances of the lease liability is as follows:

 

Thousands of United States dollars

 

 As at June 30, 2022

 

2023

 

$1,366

 

2024

 

 

1,251

 

2025

 

 

447

 

2026

 

 

440

 

2027

 

 

373

 

Thereafter

 

 

290

 

Total undiscounted cash flows

 

$4,167

 

Less: present value discount

 

 

(606)

Total lease liabilities

 

$3,561

 

 

Most of the Company’s leases contain renewal options to continue the leases for another term equivalent to the original term, which are generally up to two years. The lease liabilities above include renewal terms that management has executed or is reasonably certain of renewing, which only included leases that would have expired in 2022. The Company’s land lease for 361 hectares of property in Santander, Colombia expires August 31, 2024 and is recorded as a right of use asset in property, plant and equipment. There is an option to extend the lease for an additional five years, unless either the Company or lessor provide notice to terminate the lease at the end of the original term with six months’ notice.
XML 24 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
CAPITAL STOCK
6 Months Ended
Jun. 30, 2022
CAPITAL STOCK  
Capital Stock

12. CAPITAL STOCK

 

Authorized and issued

 

The Company has an unlimited number of common shares, no par value, authorized.

 

The Company had the following significant common share transactions:

 

Six months ended June 30, 2022

 

FEBRUARY 2022 PAYMENT TO JUSTCBD OWNERS

As discussed in Note 8, the Company issued 9,500,000 common shares of the Company valued at $14.7 million, inclusive of a 15% fair value discount for the required six-month holding period of the shares, to the prior owners of JustCBD as part of the Company’s acquisition of JustCBD in February 2022.

 

ACQUISITION OF NONCONTROLLING INTERESTS

On January 18, 2022, the Company issued 100,000 common shares of the Company valued at $0.2 million to acquire the remaining 10% of the outstanding equity interests in Flora Beauty LLC from its minority shareholders. In addition to the common shares, the Company granted a stock option, exercisable for up to 50,000 common shares of the Company at an exercise price of $1.70 per share that expire five years from the date of the grant.

 

On January 31, 2022, the Company issued 30,282 common shares of the Company valued at $0.1 million to complete its acquisition of Breeze by acquiring the remaining 10% of the equity interests in Breeze from its minority shareholders.

 

OTHER OFFERINGS

In January 2022, the Company amended an agreement with a consultant pursuant to which the Company issued 111,112 common shares of the Company valued at $0.2 million and a stock option, exercisable for up to 83,333 common shares of the Company at an exercise price of $2.25 per share that expire five years from the date of the grant.

 

On April 5, 2022, the Company issued 700,000 common shares of the Company valued at $1.3 million as part of a settlement agreement with Boustead Securities, LLC (“Boustead”) to resolve certain disputes arising under a prior underwriting agreement and engagement letter. In addition to the common shares, the Company paid Boustead $0.4 million.

 

SHARE REPURCHASE

On June 16, 2022, the Company announced that its Board of Directors had approved the repurchase of up to $5 million of its common shares. For the six months ended June 30, 2022, no shares were repurchased.

 

Any future repurchases will depend on factors such as market conditions, share price and other opportunities to invest capital for growth. From time to time when management does not possess material nonpublic information about the Company or its securities, the Company may enter a pre-defined plan with a broker to allow for the repurchase of shares at times when the Company ordinarily would not be active in the market due to internal trading blackout periods, insider trading rules or otherwise. Any such plans entered with our broker will be adopted in accordance with applicable securities laws such as the requirements of Rule 10b5-1 under the U.S. Securities Exchange Act of 1934, as amended.

XML 25 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
OPTIONS
6 Months Ended
Jun. 30, 2022
Options

13. OPTIONS

 

In March of 2019, the Company adopted a stock option plan whereby it may grant options for the purchase of common shares to any director, consultant, employee or officer of the Company or its subsidiaries. The aggregate number of shares that may be issuable pursuant to options granted under the Company’s stock option plan will not exceed 10% of the common shares of the Company outstanding (the “Shares”) at the date of grant. The options are non-transferable and non-assignable and may be granted for a term not exceeding five years. The exercise price of the options will be determined by the Board of Directors of the Company at the time of grant, but if the Shares are traded on any stock exchange (the “Exchange”), the exercise price may not be less than the closing price of the Shares on the Exchange on the trading date immediately preceding the date of grant, subject to all applicable regulatory requirements. Stock option vesting terms are subject to the discretion of the Company’s Board of Directors.

Information relating to share options outstanding and exercisable as at June 30, 2022 and December 31, 2021:

 

 

 

Number of options

 

 

Weighted average exercise price

 

 

 

Thousands

 

 

$

 

Balance, December 31, 2021

 

 

5,448

 

 

 

1.96

 

Granted

 

 

471

 

 

 

1.62

 

Exercised

 

 

(512)

 

 

0.15

 

Balance, June 30, 2022

 

 

5,407

 

 

 

2.09

 

 

Date of expiry

Options outstanding

Options exercisable

Exercise price

Grant date fair value vested

Remaining life in years

 

Thousands

Thousands

$

Thousands of Dollars

 

June 28, 2024

949

949

 0.15

35

 2.0

April 23, 2025

117

117

 2.25

344

 2.8

July 6, 2025

317

317

 2.25

252

 3.0

July 15, 2025

84

-

 2.25

84

 3.0

July 31, 2025

17

17

 2.25

23

 3.1

September 8, 2025

66

66

 2.25

92

 3.2

November 4, 2025

666

666

 2.25

918

 3.4

December 23, 2025

500

500

 2.25

689

 3.5

June 3, 2026

241

241

 3.87

686

 3.9

June 10, 2026

167

167

 3.68

455

 3.9

September 21, 2026

16

-

 5.20

54

 4.2

September 25, 2026

240

-

 6.90

1,026

 4.2

December 16, 2026

1,640

175

 2.04

1,590

 4.5

January 17, 2027

 50

50

 1.70

63

 4.6

January 26, 2027

287

217

 1.48

296

 4.6

May 16, 2027

50

-

 1.30

4

 4.9

 

5,407

3,482

 2.09

6,611

 3.6

 

The fair value of stock options issued during the six months ended June 30, 2022 was determined at the time of issuance using the Black-Scholes option pricing model with the following weighted average inputs, assumptions and results:

 

Risk-free annual interest rate

 

 

1.75%

Current stock price

 

$1.58

 

Expected annualized volatility

 

 

100%

Expected life (years)

 

 

4.65

 

Expected annual dividend yield

 

 

0%

Exercise price

 

$1.62

 

 

The total expense related to the options granted in the period ended June 30, 2022 was $2.9 million (2021 - $0.1 million). The options issued in 2022 vest one year following the date of grant if the award holder is still employed or engaged by the Company.

 

No stock options expired or were forfeited in the six months ended June 30, 2022.

XML 26 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
WARRANTS
6 Months Ended
Jun. 30, 2022
Warrants

14.WARRANTS

 

The following tables show warrants outstanding as at June 30, 2022:

 

 

 

 

Number of warrants

 

 

Weighted average exercise price

 

 

 

Thousands

 

 

 

Balance, December 31, 2021

 

 

8,746

 

 

$3.37

 

Exercised

 

 

(473)

 

 

0.49

 

Cancelled/Expired

 

 

(885)

 

 

3.00

 

Balance, June 30, 2022

 

 

7,388

 

 

$3.60

 

 

Date of expiry

 

Warrants outstanding

 

 

Exercise price

 

 

Grant date

fair value

 

 

Remaining life

 in years

 

 

 

 

 

 

Thousands

 

 

$

 

 

Thousands of Dollars

 

 

 

 

July 23, 2021 - September 20, 2022

 

 

1,178

 

 

 

3.00

 

 

 

776

 

 

 

0.12

 

November 18, 2026

 

 

5,750

 

 

 

3.75

 

 

 

8,706

 

 

 

4.39

 

November 18, 2027

 

 

460

 

 

 

3.30

 

 

 

1,055

 

 

 

5.39

 

 

 

 

7,388

 

 

3.60

 

 

10,537

 

 

 

3.77

 

XML 27 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROVISIONS COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2022
PROVISIONS COMMITMENTS AND CONTINGENCIES  
Provisions, Commitments And Contingencies

15. PROVISIONS, COMMITMENTS AND CONTINGENCIES

 

Provisions

The Company’s current known provisions and contingent liabilities consist of termination benefits and legal disputes.

 

Thousands of United States dollars

 

Termination benefits

 

 

Legal disputes

 

 

Sales tax

 

Balance as at December 31, 2021

 

$352

 

 

$1,681

 

 

$-

 

Acquired through business combinations

 

 

-

 

 

 

-

 

 

 

982

 

Payments/settlements

 

 

(352)

 

 

(1,681)

 

 

-

 

Additional provisions

 

 

-

 

 

 

-

 

 

 

407

 

Balance as at June 30, 2022

 

$-

 

 

$-

 

 

$1,389

 

 

The Sales tax provision relates to estimated amounts owed to certain jurisdictions in the Unites States for sales from the Company’s JustCBD operations. The opening balance was acquired during the February 24, 2022 acquisition of JustCBD, with additional provision for estimated amounts due on sales subsequent to the acquisition. The ending balance is recorded within trade payables and accrued liabilities with current liabilities on the statement of financial position, and as a reduction of revenue on the statement of loss and comprehensive loss.

 

The Company records liabilities for legal proceedings in those instances where it can reasonably estimate the amount of the loss and where liability is probable. The Company is engaged from time-to-time in various legal proceedings and claims that have arisen in the ordinary course of business. The outcome of all the proceedings and claims against the Company is subject to future resolution, including the uncertainties of litigation. Based on information currently known to the Company and after consultation with outside legal counsel, management believes that the probable ultimate resolution of any such proceedings and claims, individually or in the aggregate, will not have a material adverse effect on the financial condition of the Company, taken as a whole as at June 30, 2022.

 

On March 18, 2022, the Company received a letter from a law firm representing an undisclosed group of former pre-acquisition shareholders of VBI (the “VBI Shareholders”) seeking to engage in settlement discussions on the basis that the Company was purportedly misleading in its intentions to engage in a capital raising transaction shortly after the completion of the VBI acquisition. We promptly responded in writing and denied the VBI Shareholders presentation of the facts and denied all allegations against the Company. We believe that any potential claims as alleged in the letter are without merit and we intend to defend vigorously against them in connection with any future potential legal proceedings. The VBI Shareholders have not commenced litigation against the Company and it is unknown whether the VBI Shareholders will do so and what their claims may be. The Company believes that an unfavorable settlement in this matter is remote, and, as such, has not accrued a liability as of June 30, 2022.

On June 21, 2022, an action was brought against the Company in the Ontario Superior Court of Justice by Gerardo Andres Garcia Mendez claiming that the Company is obligated to issue 3.0 million (pre-one-for three reverse stock split) common shares to him for a purchase price of $0.05 per share. Mr. Mendez claims he is entitled to such shares as a result of alleged consulting services he performed in 2019. The Company disputes his claims and intends to vigorously defend against this action. The Company believes that an unfavorable settlement in this matter is remote, and, as such, has not accrued a liability as of June 30, 2022.

 

In connection with the Company’s acquisition of JustCBD, the former owners of JustCBD agreed to fully indemnify the Company against any losses which may arise out of certain pre-existing litigation against JustCBD (including all matters disclosed below) as well as litigation which may be brought in the future against JustCBD and pertaining to the period prior to the acquisition. Since these matters are fully indemnified, the Company has not accrued any liability with respect to these claims. As of the date hereof, the following actions are pending against JustCBD:

 

Erin Gilbert et al. vs. Just CBD LLC, et al., Case No. 062019CA020275AXXXCE. This matter involves allegations that JustCBD sold a defective Just CBD mango Vape Cartridge which is alleged to have caused Plaintiff, Erin Gilbert, to suffer personal injuries. The claims asserted against JustCBD include: (1) strict liability design defect; (2) negligent design; (3) strict liability manufacturing defect; (4) negligent manufacturing; (5) warning defects; and (6) loss of consortium. The same allegations were asserted against seven (7) other defendants, including two (2) manufacturers of the actual vape cartridge. To date, JustCBD has vigorously defended the case and the case is in the discovery phase. Currently, this matter is scheduled for trial to commence on September 19, 2022 but it is likely the trial will be continued pending further discovery.

 

William Braley vs. Just Brands USA, Inc., Just Brands FL, LLC, and SSGI Financial Services, Inc., Case No. 21-cv-06812, Northern District of Illinois. This matter involves allegations that the Defendants falsely and deceptively marketed cannabidiol infused gummies as not containing Tetrahydrocannabinol (“THC”). Plaintiff asserts he has suffered damages because after ingesting the gummies he failed an employment related drug test. JustCBD disputes these claims. At this time, JustCBD has filed a motion to dismiss the RICO portion of the complaint and answered and asserted affirmative defenses to the Consumer Protection claims.

 

Management contracts

The Company is party to certain management contracts. As at June 30, 2022, these contracts require payments totaling approximately $2.3 million to be made upon the occurrence of a change in control to the officers of the Company. The Company is also committed to payments to certain individuals upon termination of approximately $1.9 million pursuant to the terms of these contracts. As a triggering event has not taken place, these amounts have not been recorded in these consolidated financial statements.

XML 28 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
INCOME TAXES
6 Months Ended
Jun. 30, 2022
INCOME TAXES  
Income Taxes

16. INCOME TAXES

 

Income tax expense is recognized at an amount determined by multiplying the income (loss) before income taxes for the interim period for each significant jurisdiction by management’s best estimate of the annual income tax rate expected for the full fiscal year for each significant jurisdiction.

 

There was no current or deferred income tax expense recorded for the six months ended June 30, 2022. The Company’s effective income tax rate of nil% for the six months ended June 30, 2022 is different than the statutory rate primarily due to the nonrecognition of deferred tax assets related to net operating losses.

XML 29 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
LOSS PER SHARE
6 Months Ended
Jun. 30, 2022
Loss Per Share

17. LOSS PER SHARE

 

The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive as the Company has a net loss for each period presented:

 

Thousands of securities

 

June 30, 2022

 

 

June 30, 2021

 

Stock options (Note 13)

 

 

5,407

 

 

 

4,202

 

Warrants (Note 14)

 

 

7,388

 

 

 

9,295

 

JustCBD potential additional shares to settle contingent consideration (Note 8)

 

 

13,141

 

 

 

-

 

Total anti-dilutive

 

 

25,936

 

 

 

13,497

 

XML 30 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY DISCLOSURES
6 Months Ended
Jun. 30, 2022
RELATED PARTY DISCLOSURES  
Related Party Disclosures

18. RELATED PARTY DISCLOSURES

 

Key management personnel compensation

 

In addition to their contracted fees, directors and officers also participate in the Company’s stock option program. Certain executive officers are subject to termination notices of 24 to 36 months and change of control payments (Note 15). Key management personnel compensation is comprised of the following:

 

Thousands of United States dollars

 

Six months ended June 30, 2022

 

 

Six months ended June 30, 2021

 

Directors’ and officers’ compensation

 

$816

 

 

$736

 

Share-based payments

 

 

197

 

 

 

1,748

 

 

 

$1,013

 

 

$2,484

 

 

The Company defines key management personnel as those persons having authority and responsibility for planning, directing, and controlling the activities of the Company directly or indirectly, and was determined to be executive officers and directors (executive and non-executive) of the Company. The remuneration of directors and key executives is determined by the Board of Directors of the Company having regard to the performance of individuals and market trends.

 

As at June 30, 2022, $0.0 million of the above directors’ and officers’ compensation was included in the trade payables and accrued liabilities (December 31, 2021 – $0.1 million). These amounts are unsecured, non-interest bearing and due on demand.  The share-based payments amount above for the six months ended June 30, 2021 includes 333,333 common shares to the Chief Executive Officer of the Company, valued at $1.7 million, that were recorded to equity as share issuance costs as payment related to services provided during the Company’s initial public offering process.

  

Related party transactions

During the six months ended June 30, 2022, the Company incurred expenses for consulting, rent and promotion services totaling less than $0.1 million (June 30, 2021 - $0.1 million) from 2227929 Ontario Inc., an entity affiliated with a former director, and expenses for consulting in the amount of $0.3 million (June 30, 2021 - $0.1 million) total from Forbes and Manhattan Inc and 2051580 Ontario Corp., two entities affiliated with a former director. As at June 30, 2022, $0 (December 31, 2021 - $6,000) was owed to 2227929 Ontario Inc., $11,000 (December 31, 2021 - $11,000) was owed to Forbes and Manhattan Inc. and $0 was owed to 2051580 Ontario Corp. These amounts were included in trade payables and accrued liabilities, and are unsecured, non-interest bearing and due on demand. Fred Leigh is a former director of the Company and is also a director and officer of 2227929 Ontario Inc. Stan Bharti is a former director and former Chairman of the Company and is also a director of Forbes and Manhattan Inc.

XML 31 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
6 Months Ended
Jun. 30, 2022
Financial Instruments And Risk Management

19. FINANCIAL INSTRUMENTS AND RISK MANAGMENT

 

Environmental

The Company’s growth and development activities are subject to laws and regulations governing the protection of the environment. These laws and regulations are continually changing and generally becoming more restrictive. The Company believes its operations are materially in compliance with all applicable laws and regulations. The Company has made, and expects to make in the future, expenditures to comply with such laws and regulations.

 

Fair value

The Company’s financial instruments measured at amortized cost as at June 30, 2022 and December 31, 2021 consist of cash, restricted cash, trade and amounts receivable, loans receivable, trade payables and accrued liabilities, lease liabilities, and debt and loans payable. The amounts reflected in the consolidated statements of financial position approximate fair value due to the short-term maturity of these instruments.

 

Financial instruments recorded at the reporting date at fair value are classified into one of three levels based upon the fair value hierarchy. Items are categorized based on inputs used to derive fair value based on:

 

Level 1 - quoted prices that are unadjusted in active markets for identical assets or liabilities

Level 2 - inputs other than quoted prices included in level 1 that are observable for the asset/liability either directly or indirectly; and

Level 3 - inputs for the instruments are not based on any observable market data.

 

The Company’s long-term investments require significant unobservable inputs and as discussed at Note 7, are measured at FVPL and as a Level 3 fair value financial instrument within the fair value hierarchy as at June 30, 2022. As discussed in Note 8, the Company’s other long-term liabilities consist of the estimated fair value of contingent purchase consideration from the acquisition of JustCBD in February 2022. The amount is measured at FVPL as a Level 2 fair value financial instrument within the fair value hierarchy as at June 30, 2022. As valuations of the investments and other long-term liabilities for which market quotations are not readily available are inherently uncertain, may fluctuate within short periods of time and are based on estimates, determination of fair value may differ materially from the values that would have resulted if a ready market existed for the investments. Such changes may have a significant impact on the Company’s financial condition or operating results.

Risk management overview

The Company has exposure to credit, liquidity and market risks from its use of financial instruments. This note provides information about the Company’s exposure to each of these risks, the Company’s objectives, policies and processes for measuring and managing risk. Further quantitative disclosures are included throughout these condensed interim consolidated financial statements.

 

Credit risk

Credit risk is the risk of financial loss to the Company if a counterparty to a financial instrument fails to meet its contractual obligations and arises principally from the Company’s trade and other receivables, loans receivable and cash held with banks and other financial intermediaries.

 

The carrying amount of the cash, restricted cash, trade and amounts receivables and loan receivable represents the maximum credit exposure as presented in the statement of financial position.

 

The Company has assessed that there has been no significant increase in credit risk of the loans receivable from initial recognition based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. As a result, the loss allowance recognized during the period was limited to twelve months expected credit losses. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an insignificant loss allowance on the loans’ receivable and advances as at June 30, 2022 and December 31, 2021.

 

The Company provides credit to certain customers in the normal course of business and has established credit evaluation and monitoring processes to mitigate credit risk. Credit risk for customers is assessed on a case-by-case basis and an allowance for specific expected credit losses is recorded where required, in addition to an estimate of lifetime expected credit losses for the portfolio of accounts receivable. See credit risk analysis for trade receivables at Note 3.

 

The Company held cash and restricted cash of $10.3 million and $37.6 million as at June 30, 2022 and December 31, 2021, respectively, of which, $10.1 million and $37.4 million, respectively, was held with large financial institutions and national central banks. The remaining $0.2 million cash amounts for both periods are held with financial intermediaries in Colombia and the United States. The Company has assessed no significant increase in credit risk from initial recognition based on the availability of funds, and the regulatory and economic environment of the financial intermediary. As a result, the loss allowance recognized during the period was limited to twelve months of expected credit losses. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an insignificant loss allowance on these cash and restricted cash balances as at June 30, 2022 and December 31, 2021.

 

Market risk

Market risk is the risk that changes in market conditions, such as commodity prices, foreign exchange rates, and interest rates, will affect the Company’s net income or the value of financial instruments. The objective of market risk management is to manage and control market risk exposures within acceptable limits, while maximizing the Company’s returns.

 

Foreign currency exchange rate risk is the risk that the fair value of future cash flows will fluctuate due to changes in foreign exchange rates. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk as management has determined that this risk is not significant. As such, the Company’s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates.

 

As at June 30, 2022, the Company had the following monetary assets and liabilities denominated in foreign currencies:

 

 

 

CAD

 

 

COP

 

 

GBP

 

 

EUR

 

 

CHF

 

Thousands of foreign currencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

862

 

 

 

1,673,360

 

 

 

22

 

 

 

1,605

 

 

 

-

 

Amounts receivable

 

 

-

 

 

 

12,946,301

 

 

 

174

 

 

 

-

 

 

 

-

 

Loans receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

250

 

Trade payables

 

 

(152)

 

 

(8,285,897)

 

 

(23)

 

 

(5)

 

 

-

 

Accrued liabilities

 

 

(175)

 

 

(960,040)

 

 

(16)

 

 

-

 

 

 

-

 

Lease liability

 

 

-

 

 

 

(2,166,163)

 

 

(27)

 

 

-

 

 

 

-

 

Long term debt

 

 

-

 

 

 

(40,405)

 

 

-

 

 

 

-

 

 

 

-

 

Net carrying value

 

 

535

 

 

 

3,167,156

 

 

 

130

 

 

 

1,600

 

 

 

250

 

As at December 31, 2021, the Company had the following monetary assets and liabilities denominated in foreign currencies:

 

 

 

CAD

 

 

COP

 

 

EUR

 

 

CHF

 

Thousands of foreign currencies

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

1,393

 

 

 

4,451,775

 

 

 

896

 

 

 

-

 

Amounts receivable

 

 

72

 

 

 

15,775,755

 

 

 

-

 

 

 

-

 

Loans receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

250

 

Trade payables

 

 

(40)

 

 

(5,398,068)

 

 

-

 

 

 

-

 

Accrued liabilities

 

 

(589)

 

 

(2,120,869)

 

 

-

 

 

 

-

 

Lease liability

 

 

-

 

 

 

(1,690,797)

 

 

-

 

 

 

-

 

Long term debt

 

 

-

 

 

 

(72,963)

 

 

-

 

 

 

-

 

Net carrying value

 

 

836

 

 

 

10,944,833

 

 

 

896

 

 

 

250

 

 

Monetary assets and liabilities denominated in Canadian dollars, Colombian pesos, British pounds, Euros and Swiss Francs are subject to foreign currency risk. The Company has estimated that as at June 30, 2022, the effect of a 10% increase or decrease in Canadian dollars, Colombian pesos, British pounds, Euros and Swiss Francs (“CHF”) against the Unites States dollar on financial assets and liabilities would result in an increase or decrease of approximately $0.3 million (December 31, 2021 – $0.5 million) to net loss and comprehensive loss.

 

The Company calculates this sensitivity analysis based on the net financial assets denominated in each currency using the June 30, 2022 exchange rate, then changing the rate by 10%. Management determined 10% is a ‘reasonably possible’ change in foreign currency rates by considering the approximate change in rates in the prior twelve months.

 

It is management’s opinion that the Company is not subject to significant commodity or interest rate risk.

 

Management considers concentration risk with counterparties considering the level of purchases and sales of its business segments (Note 21). Several of the Company’s business units purchase substantially all their inventory or materials from a single supplier.

 

Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting obligations associated with its financial liabilities. The Company’s financial liabilities consist of trade payables and accrued liabilities, loans payable and debt, and lease liabilities as presented on the statement of financial position. The Company had cash and restricted cash as presented on the statement of financial position. The Company has no available credit lines of facilities to draw borrowings from should additional liquidity be needed. The Company’s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company’s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise.

 

Trade payables and accrued liabilities consist of invoices payable to trade suppliers for administration and professional expenditures. The Company processes invoices within a normal payment period. Trade payables have contractual maturities of less than 90 days. Some suppliers of materials and inventory require full prepayment from the Company prior to providing such goods to the Company. See schedule of future lease commitments at Note 11.

 

The Company’s long-term investments in equity of other entities are not publicly traded and there is not an active market to sell the investments for cash.

 

Novel Coronavirus (“COVID-19”)

The Company’s operations could be significantly adversely affected by the effects of a widespread global outbreak of a contagious disease, including the recent outbreak of respiratory illness caused by COVID-19. The Company cannot accurately predict the impact COVID-19 will have on its operations and the ability of others to meet their obligations with the Company, including uncertainties relating to the ultimate geographic spread of the virus, the severity of the disease, the duration of the outbreak, and the length of travel and quarantine restrictions imposed by governments of affected countries. In addition, a significant outbreak of contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could further affect the Company’s operations and ability to finance its operations.

XML 32 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
CAPITAL MANAGEMENT
6 Months Ended
Jun. 30, 2022
Capital Management

20. CAPITAL MANAGEMENT

 

The Company considers the aggregate of its common shares, options, warrants and borrowings as capital. The Company’s capital management objective is to ensure sufficient resources are available to meet day to day operating requirements and to safeguard its ability to continue as a going concern to provide returns for shareholders and benefits for other shareholders.

 

For the six months ended June 30, 2022, the Company had negative cash from operations and the main source of cash flow was generated from 2021 and prior financing activities. Potential business activities are appropriately evaluated by senior management and a formal review and approval process has been established by the Board of Directors. The Company may enter new financing arrangements to meet its objectives for managing capital until the Company’s operating cash flows are sufficient to cover its operational requirements. The Company’s capital management objectives were being met in 2022 primarily from the use of existing cash balances from 2021 and prior issuances of common shares and warrants and generating increasing revenue in 2022 from the Company’s reportable segments as presented in Note 21.

 

The Company’s officers and senior management take full responsibility for managing the Company’s capital and do so through quarterly meetings and regular review of financial information. The Company’s Board of Directors is responsible for overseeing this process.

 

The Company is not subject to any external capital requirements. As discussed in Note 12, on June 16, 2022, the Company announced that it plans to repurchase up to $5 million of its common shares.

XML 33 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENTED INFORMATION
6 Months Ended
Jun. 30, 2022
SEGMENTED INFORMATION  
Segmented Information

21. SEGMENTED INFORMATION

 

The Company is engaged in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products through its Colombia Cosechemos subsidiary. The Company’s other businesses are run through its other Colombia and United States subsidiaries. Management has defined the reportable segments of the Company based on this internal business unit reporting, which is by major product line, and aggregates similar businesses into the Consumer Products segment below. The Corporate segment reflects balances and expenses that do not directly influence business unit operations and includes the Company’s long-term investments. The Corporate segment revenue includes the license of intellectual property.

 

The following tables show information regarding the Company’s segments for the six months ended June 30, 2022 and June 30, 2021. The 2022 segments were updated to reflect the acquisition of JustCBD (Note 8) with High Roller Private Label LLC operations assigned to the Pharmaceuticals and Nutraceuticals segment, and Just Brands LLC assigned to the Consumer Products segment.

  

Thousands of United States dollars

 

Cannabis growth and derivative production

 

 

Consumer products

 

 

Pharmaceuticals and nutraceuticals

 

 

Beverage and food

 

 

Corporate and Eliminations

 

 

Total

 

For the six months ended June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$3

 

 

$13,603

 

 

$3,708

 

 

$252

 

 

$(2,649)

 

$14,917

 

Gross profit

 

 

47

 

 

 

4,304

 

 

 

2,096

 

 

 

99

 

 

 

-

 

 

 

6,546

 

Net (loss) income

 

 

(715)

 

 

(19,420)

 

 

317

 

 

 

(462)

 

 

(12,436)

 

 

(32,716)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the six months ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$-

 

 

$286

 

 

$1,629

 

 

$310

 

 

$(107)

 

$2,118

 

Gross profit

 

 

-

 

 

 

173

 

 

 

752

 

 

 

87

 

 

 

-

 

 

 

1,012

 

Net (loss) income

 

 

(428)

 

 

(857)

 

 

50

 

 

 

(64)

 

 

(3,839)

 

 

(5,138)

Geographical information:

 

Thousands of United States dollars

 

Colombia

 

 

United States

 

 

Canada

 

 

United Kingdom

 

 

Total

 

Non-current assets at June 30, 2022

 

$5,320

 

 

$42,351

 

 

$1,533

 

 

$2,708

 

 

$51,912

 

Total liabilities at June 30, 2022

 

 

2,732

 

 

 

9,290

 

 

 

4,496

 

 

 

81

 

 

 

16,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets at December 31, 2021

 

$4,042

 

 

$29,650

 

 

$3,844

 

 

$-

 

 

$37,536

 

Total liabilities at December 31, 2021

 

 

2,359

 

 

 

3,106

 

 

 

3,073

 

 

 

-

 

 

 

8,538

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$1,631

 

 

$12,887

 

 

$-

 

 

$399

 

 

$14,917

 

Gross profit

 

 

999

 

 

 

5,471

 

 

 

-

 

 

 

76

 

 

 

6,546

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$2,069

 

 

$49

 

 

$-

 

 

$-

 

 

$2,118

 

Gross profit

 

 

1,009

 

 

 

3

 

 

 

-

 

 

 

-

 

 

 

1,012

 

 

In 2022, the Company did not have sales to a single customer exceeding 10% of its consolidated revenue.

XML 34 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2022
SUBSEQUENT EVENTS  
Subsequent Events

22. SUBSEQUENT EVENTS

 

OTHER

 

Subsequent to June 30, 2022, a total of 266 warrants were exercised in exchange 266 common shares and a total of 798,602 warrants expired. Since June 30, 2022, the Company repurchased 366,645 of its common shares under its previously announced share repurchase plan for $250,000.

 

On July 5, 2022, the Company’s shareholders approved the 2022 Flora Growth Incentive Compensation Plan. Pursuant to this plan, the Company has reserved 6 million of its common shares for potential issuance to officers, directors, employees and consultants of the Company. Effective July 5, 2022, no further stock options may be issued under the Company’s 2019 stock option plan.

XML 35 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies)
6 Months Ended
Jun. 30, 2022
Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies)  
Contingent Purchase Consideration

Contingent consideration is measured at its acquisition date fair value and is included as part of the consideration transferred in a business combination, subject to the applicable terms and conditions. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration that is classified as a liability is remeasured at subsequent reporting dates with the corresponding gain or loss recognized in profit or loss. Management exercises judgment to determine the classification of contingent consideration as equity or liability based on the terms of the agreement and potential for the consideration to result in a cash outflow by the Company. Fair value estimates are determined using appropriate valuation techniques based on the nature of the terms in the purchase agreement.

XML 36 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
BASIS OF PRESENTATION (Tables)
6 Months Ended
Jun. 30, 2022
Subsidiaries

Subsidiaries

Country of incorporation

Ownership

Functional currency

Cosechemos YA S.A.S.

Colombia

90%

Colombia Peso (COP)

Flora Growth Corp. Sucursal Colombia

Colombia

100%

Colombia Peso (COP)

Hemp Textiles & Co. LLC

United States

100%

United States Dollar (USD)

Hemp Textiles & Co. S.A.S.

Colombia

100%

Colombia Peso (COP)

Flora Beauty LLC

United States

100%

United States Dollar (USD)

Flora Beauty LLC Sucursal Colombia

Colombia

100%

Colombia Peso (COP)

Kasa Wholefoods Company S.A.S.

Colombia

90%

Colombia Peso (COP)

Kasa Wholefoods Company LLC

United States

100%

United States Dollar (USD)

Grupo Farmaceutico Cronomed S.A.S.

Colombia

100%

Colombia Peso (COP)

Labcofarm Laboratorios S.A.S.

Colombia

100%

Colombia Peso (COP)

Breeze Laboratory S.A.S.

Colombia

100%

Colombia Peso (COP)

Vessel Brand Inc.

United States

100%

United States Dollar (USD)

Just Brands LLC

United States

100%

United States Dollar (USD)

Just Brands International LTD

United Kingdom

100%

British Pound (GBP)

High Roller Private Label LLC

United States

100%

United States Dollar (USD)

Flora Growth US Holdings Corp.

United States

100%

United States Dollar (USD)

Flora Growth Management Corp.

United States

100%

United States Dollar (USD)

Cardiff Brand Corp.

United States

100%

United States Dollar (USD)

Keel Brand Corp.

United States

100%

United States Dollar (USD)

Flora Growth F&B Corp.

United States

100%

United States Dollar (USD)

XML 37 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
TRADE AND AMOUNTS RECEIVABLE (Tables)
6 Months Ended
Jun. 30, 2022
Trade And Other Paybles

 

 

June 30, 2022

 

 

December 31, 2021

 

Thousands of United States dollars

 

 

 

 

 

 

Trade accounts receivable

 

$5,428

 

 

$5,565

 

Allowance for expected credit losses

 

 

(1,679)

 

 

(1,252)

HST receivable

 

 

411

 

 

 

259

 

Other receivables

 

 

932

 

 

 

752

 

Total

 

5,092

 

 

5,324

 

Schedule Of Trade Accounts Receivable Allowance Table Text Block

 

 

June 30, 2022

 

Thousands of United States dollars

 

 

 

Current

 

$1,641

 

1-30 Days

 

 

614

 

31-60 Days

 

 

259

 

61-90 Days

 

 

383

 

91-180 Days

 

 

1,383

 

180+ Days

 

 

1,148

 

Total trade receivables

 

$5,428

 

XML 38 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
BIOLOGICAL ASSETS (Tables)
6 Months Ended
Jun. 30, 2022
Schedule Of Carrying Value Of Biological Assets Table Text Block

Thousands of United States Dollars

 

 

 

Opening balance at December 31, 2021

 

$37

 

Changes in fair value less cost to sell due to biological transformation

 

 

46

 

Transferred to harvested cannabis inventory upon harvest

 

 

(69)

Ending balance at June 30, 2022

 

14

 

XML 39 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVENTORY (Tables)
6 Months Ended
Jun. 30, 2022
INVENTORY  
Schedule Of Inventory

 

 

 

 

 

 

 

Thousands of United States dollars

 

June 30, 2022 

 

 

December 31,

2021 

 

Raw materials and supplies

 

$2,161

 

 

$899

 

Harvested cannabis

 

 

92

 

 

 

35

 

Work in progress

 

 

465

 

 

 

97

 

Finished goods

 

 

6,577

 

 

 

1,962

 

Total

 

$9,295

 

 

$2,993

 

XML 40 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROPERTY PLANT AND EQUIPMENT (Tables)
6 Months Ended
Jun. 30, 2022
PROPERTY PLANT AND EQUIPMENT  
Schedule Of Property Plant And Equipment

In Thousands of United States dollars

 

Construction in progress

 

 

 Machinery and Office equipment

 

 

Buildings

 

 

Vehicles

 

 

 Land

 

 

Subtotal

 

 

 Right of use assets

 

 

Total

 

Cost at December 31, 2021

 

$905

 

 

$1,991

 

 

$928

 

 

$37

 

 

$112

 

 

$3,973

 

 

$1,532

 

 

$5,505

 

Additions

 

 

321

 

 

 

53

 

 

 

23

 

 

 

-

 

 

 

305

 

 

 

702

 

 

 

2,053

 

 

 

2,755

 

Business combinations (Note 8)

 

 

-

 

 

 

506

 

 

 

-

 

 

 

30

 

 

 

-

 

 

 

536

 

 

 

772

 

 

 

1,308

 

Foreign exchange translation

 

 

(52)

 

 

(71)

 

 

(38)

 

 

(1)

 

 

(22)

 

 

(184)

 

 

(49)

 

 

(233)

Cost as at June 30, 2022

 

 

1,174

 

 

 

2,479

 

 

 

913

 

 

 

66

 

 

 

395

 

 

 

5,027

 

 

 

4,308

 

 

 

9,335

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at December 31, 2021

 

 

-

 

 

 

(169)

 

 

(44)

 

 

(10)

 

 

-

 

 

 

(223)

 

 

(303)

 

 

(526)

Depreciation

 

 

-

 

 

 

(229)

 

 

(44)

 

 

(2)

 

 

-

 

 

 

(275)

 

 

(383)

 

 

(658)

Disposals

 

 

-

 

 

 

20

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

20

 

 

 

-

 

 

 

20

 

Foreign exchange translation

 

 

-

 

 

 

12

 

 

 

4

 

 

 

-

 

 

 

-

 

 

 

16

 

 

 

17

 

 

 

33

 

Accumulated depreciation as at June 30, 2022

 

 

-

 

 

 

(366)

 

 

(84)

 

 

(12)

 

 

-

 

 

 

(462)

 

 

(669)

 

 

(1,131)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As at December 31, 2020

 

 

905

 

 

 

1,822

 

 

 

884

 

 

 

27

 

 

 

112

 

 

 

3,750

 

 

 

1,229

 

 

 

4,979

 

As at June 30, 2022

 

$1,174

 

 

$2,113

 

 

$829

 

 

$54

 

 

$395

 

 

$4,565

 

 

$3,639

 

 

$8,204

 

XML 41 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
LONGTERM INVESTMENTS (Tables)
6 Months Ended
Jun. 30, 2022
LONGTERM INVESTMENTS  
Schedule Of Long-term Investments Activity

 

 

Investee common shares

 

 

Warrants CAD 0.30 exercise price

 

 

Warrants CAD 1.00 exercise price

 

 

 

Financial asset hierarchy level

 

Level 3

 

 

Level 3

 

 

Level 3

 

 

 Total

 

Thousands of United States dollars

 

 $

 

 

 $

 

 

 $

 

 

 $

 

Balance at December 31, 2021

 

 

1,987

 

 

 

625

 

 

 

58

 

 

 

2,670

 

Loss on changes in fair value

 

 

(880)

 

 

(403)

 

 

(50)

 

 

(1,333)

Balance at June 30, 2022

 

 

1,107

 

 

 

222

 

 

 

8

 

 

 

1,337

 

Schedule Of Fair Value Of The Warrants

 

 

Warrants CAD 0.30 exercise price

 

 

Warrants CAD 1.00 exercise price

 

Share price

 

$0.32

 

 

$0.32

 

Exercise price

 

$0.23

 

 

$0.78

 

Volatility

 

 

100%

 

 

100%

Risk-free interest rate

 

 

3.1%

 

 

3.1%

Dividend yield

 

 

0.0%

 

 

0.0%

Expected term in years

 

 

0.6

 

 

 

0.6

 

Fair value

 

$0.13

 

 

$0.02

 

Quantity owned

 

 

1,666,667

 

 

 

333,333

 

Fair value

 

$222,000

 

 

$8,000

 

XML 42 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)
6 Months Ended
Jun. 30, 2022
ASSET ACQUISITIONS AND BUSINESS COMBINATIONS  
Schedule Of Major Class Of Assets Acquired And Liabilities

(Thousands of United States dollars)

 

 

 

Current assets

 

 

 

Cash

 

$535

 

Trade receivables

 

 

975

 

Inventory

 

 

5,534

 

Other current assets

 

 

540

 

 

 

 

 

 

Non-current assets

 

 

 

 

Property, plant, and equipment

 

 

537

 

Right of use assets

 

 

772

 

Other non-current assets

 

 

127

 

Intangible asset

 

 

4,757

 

Goodwill

 

 

24,869

 

Total assets

 

$38,646

 

 

 

 

 

 

Current liabilities

 

 

 

 

Trade payables and accrued liabilities

 

$(2,273)

Current lease liabilities

 

 

(644)

Provision for sales tax

 

 

(982)

Other current liabilities

 

 

(99)

Total liabilities

 

$(3,998)

Total net assets acquired

 

$34,648

 

XML 43 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLE ASSETS AND GOODWILL (Tables)
6 Months Ended
Jun. 30, 2022
INTANGIBLE ASSETS AND GOODWILL  
Schedule Of Intangible Assets

 In Thousands of United States dollars

 

License

 

 

Customer Relationships

 

 

Trademarks and Brands

 

 

Patents

 

 

Non-Compete Agreements

 

 

Goodwill

 

 

Total

 

Cost

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2021

 

$610

 

 

$1,759

 

 

$2,211

 

 

$4,300

 

 

$1,190

 

 

$20,054

 

 

$30,124

 

Acquired through business combinations (Note 8)

 

 

-

 

 

 

1,160

 

 

 

3,357

 

 

 

240

 

 

 

-

 

 

 

24,869

 

 

 

29,626

 

Impairment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(16,000)

 

 

(16,000)

At June 30, 2022

 

$610

 

 

$2,919

 

 

$5,568

 

 

$4,540

 

 

$1,190

 

 

$28,923

 

 

$43,750

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2021

 

$129

 

 

$26

 

 

$35

 

 

$48

 

 

$66

 

 

$-

 

 

$304

 

Additions

 

 

82

 

 

 

169

 

 

 

306

 

 

 

297

 

 

 

198

 

 

 

-

 

 

 

1,052

 

At June 30, 2022

 

$211

 

 

$195

 

 

$341

 

 

$345

 

 

$264

 

 

$-

 

 

$1,356

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign Currency translation

 

 

(18)

 

 

-

 

 

 

(21)

 

 

-

 

 

 

-

 

 

 

(257)

 

 

(296)

Net book value at June 30, 2022

 

$381

 

 

$2,724

 

 

$5,206

 

 

$4,195

 

 

$926

 

 

$28,666

 

 

$42,098

 

Schedule Of Goodwill

In Thousands of United States dollars

 

 Pharmaceuticals and nutraceuticals

 

 

 Vessel

 

 

 JustCBD

 

 

 Total

 

As at December 31, 2021

 

$379

 

 

$19,675

 

 

$-

 

 

$20,054

 

Acquired through business combinations (Note 8)

 

 

-

 

 

 

-

 

 

 

24,612

 

 

 

24,612

 

Impairment

 

 

-

 

 

 

(16,000)

 

 

-

 

 

 

(16,000)

As at June 30, 2022

 

$379

 

 

$3,675

 

 

$24,612

 

 

$28,666

 

XML 44 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Tables)
6 Months Ended
Jun. 30, 2022
LEASES  
Schedule Of Leases

Thousands of United States dollars

 

 Six months ended June 30, 2022

 

 

 Six months ended June 30, 2021

 

Lease expense

 

 

 

 

 

 

Amortization expense by class of underlying asset

 

 

 

 

 

 

Office Space

 

$351

 

 

$40

 

Building

 

 

5

 

 

 

5

 

Land

 

 

27

 

 

 

-

 

Total amortization expense

 

 

383

 

 

 

45

 

Interest on lease liabilities

 

 

83

 

 

 

14

 

Short-term and low value assets lease expense

 

 

510

 

 

 

-

 

Total lease expense

 

$976

 

 

$59

 

 

 

 

 

 

 

 

 

 

Other Information

 

 

 

 

 

 

 

 

Additions to right of use assets

 

$2,053

 

 

$-

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

 

 

 

 

 

 

Financing cash flows from leases (interest)

 

 

69

 

 

 

16

 

Financing cash flows from leases (principal)

 

 

420

 

 

 

70

 

Operating cash flows for short term and low value asset leases

 

 

510

 

 

 

-

 

Total cash outflows from leases

 

$999

 

 

$86

 

 

 

 

 

 

 

 

 

 

Carrying amount of right of use asset by class of underlying asset

 

 

 

 

 

 

 

 

Office Space

 

$2,492

 

 

$231

 

Building

 

 

1,036

 

 

 

16

 

Land

 

 

111

 

 

 

-

 

Total carrying amount of right of use assets

 

$3,639

 

 

$247

 

Schedule Of Balances Of Lease Liability

Thousands of United States dollars

 

 As at June 30, 2022

 

2023

 

$1,366

 

2024

 

 

1,251

 

2025

 

 

447

 

2026

 

 

440

 

2027

 

 

373

 

Thereafter

 

 

290

 

Total undiscounted cash flows

 

$4,167

 

Less: present value discount

 

 

(606)

Total lease liabilities

 

$3,561

 

XML 45 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
OPTIONS (Tables)
6 Months Ended
Jun. 30, 2022
Schedule Of Share Options Outstanding And Exercisable

 

 

Number of options

 

 

Weighted average exercise price

 

 

 

Thousands

 

 

$

 

Balance, December 31, 2021

 

 

5,448

 

 

 

1.96

 

Granted

 

 

471

 

 

 

1.62

 

Exercised

 

 

(512)

 

 

0.15

 

Balance, June 30, 2022

 

 

5,407

 

 

 

2.09

 

 

Date of expiry

Options outstanding

Options exercisable

Exercise price

Grant date fair value vested

Remaining life in years

 

Thousands

Thousands

$

Thousands of Dollars

 

June 28, 2024

949

949

 0.15

35

 2.0

April 23, 2025

117

117

 2.25

344

 2.8

July 6, 2025

317

317

 2.25

252

 3.0

July 15, 2025

84

-

 2.25

84

 3.0

July 31, 2025

17

17

 2.25

23

 3.1

September 8, 2025

66

66

 2.25

92

 3.2

November 4, 2025

666

666

 2.25

918

 3.4

December 23, 2025

500

500

 2.25

689

 3.5

June 3, 2026

241

241

 3.87

686

 3.9

June 10, 2026

167

167

 3.68

455

 3.9

September 21, 2026

16

-

 5.20

54

 4.2

September 25, 2026

240

-

 6.90

1,026

 4.2

December 16, 2026

1,640

175

 2.04

1,590

 4.5

January 17, 2027

 50

50

 1.70

63

 4.6

January 26, 2027

287

217

 1.48

296

 4.6

May 16, 2027

50

-

 1.30

4

 4.9

 

5,407

3,482

 2.09

6,611

 3.6

Schedule Of Fair Value Of Stock Options

Risk-free annual interest rate

 

 

1.75%

Current stock price

 

$1.58

 

Expected annualized volatility

 

 

100%

Expected life (years)

 

 

4.65

 

Expected annual dividend yield

 

 

0%

Exercise price

 

$1.62

 

XML 46 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
WARRANTS (Tables)
6 Months Ended
Jun. 30, 2022
Schedule Of Warrants Outstanding

14.WARRANTS

 

The following tables show warrants outstanding as at June 30, 2022:

 

 

 

 

Number of warrants

 

 

Weighted average exercise price

 

 

 

Thousands

 

 

 

Balance, December 31, 2021

 

 

8,746

 

 

$3.37

 

Exercised

 

 

(473)

 

 

0.49

 

Cancelled/Expired

 

 

(885)

 

 

3.00

 

Balance, June 30, 2022

 

 

7,388

 

 

$3.60

 

 

Date of expiry

 

Warrants outstanding

 

 

Exercise price

 

 

Grant date

fair value

 

 

Remaining life

 in years

 

 

 

 

 

 

Thousands

 

 

$

 

 

Thousands of Dollars

 

 

 

 

July 23, 2021 - September 20, 2022

 

 

1,178

 

 

 

3.00

 

 

 

776

 

 

 

0.12

 

November 18, 2026

 

 

5,750

 

 

 

3.75

 

 

 

8,706

 

 

 

4.39

 

November 18, 2027

 

 

460

 

 

 

3.30

 

 

 

1,055

 

 

 

5.39

 

 

 

 

7,388

 

 

3.60

 

 

10,537

 

 

 

3.77

 

XML 47 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROVISIONS COMMITMENTS AND CONTINGENCIES (Tables)
6 Months Ended
Jun. 30, 2022
PROVISIONS COMMITMENTS AND CONTINGENCIES  
Schedule Of Provisions And Contingent Liabilities

Thousands of United States dollars

 

Termination benefits

 

 

Legal disputes

 

 

Sales tax

 

Balance as at December 31, 2021

 

$352

 

 

$1,681

 

 

$-

 

Acquired through business combinations

 

 

-

 

 

 

-

 

 

 

982

 

Payments/settlements

 

 

(352)

 

 

(1,681)

 

 

-

 

Additional provisions

 

 

-

 

 

 

-

 

 

 

407

 

Balance as at June 30, 2022

 

$-

 

 

$-

 

 

$1,389

 

XML 48 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
LOSS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2022
Schedule Of Computation Of Diluted Shares Outstanding

Thousands of securities

 

June 30, 2022

 

 

June 30, 2021

 

Stock options (Note 13)

 

 

5,407

 

 

 

4,202

 

Warrants (Note 14)

 

 

7,388

 

 

 

9,295

 

JustCBD potential additional shares to settle contingent consideration (Note 8)

 

 

13,141

 

 

 

-

 

Total anti-dilutive

 

 

25,936

 

 

 

13,497

 

XML 49 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY DISCLOSURES (Tables)
6 Months Ended
Jun. 30, 2022
RELATED PARTY DISCLOSURES  
Schedule Of Key Management Personnel Compensation

Thousands of United States dollars

 

Six months ended June 30, 2022

 

 

Six months ended June 30, 2021

 

Directors’ and officers’ compensation

 

$816

 

 

$736

 

Share-based payments

 

 

197

 

 

 

1,748

 

 

 

$1,013

 

 

$2,484

 

XML 50 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)
6 Months Ended
Jun. 30, 2022
Schedule Of Assets And Liabilities Denominated In Foreign Currencies

 

 

CAD

 

 

COP

 

 

GBP

 

 

EUR

 

 

CHF

 

Thousands of foreign currencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

862

 

 

 

1,673,360

 

 

 

22

 

 

 

1,605

 

 

 

-

 

Amounts receivable

 

 

-

 

 

 

12,946,301

 

 

 

174

 

 

 

-

 

 

 

-

 

Loans receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

250

 

Trade payables

 

 

(152)

 

 

(8,285,897)

 

 

(23)

 

 

(5)

 

 

-

 

Accrued liabilities

 

 

(175)

 

 

(960,040)

 

 

(16)

 

 

-

 

 

 

-

 

Lease liability

 

 

-

 

 

 

(2,166,163)

 

 

(27)

 

 

-

 

 

 

-

 

Long term debt

 

 

-

 

 

 

(40,405)

 

 

-

 

 

 

-

 

 

 

-

 

Net carrying value

 

 

535

 

 

 

3,167,156

 

 

 

130

 

 

 

1,600

 

 

 

250

 

 

 

CAD

 

 

COP

 

 

EUR

 

 

CHF

 

Thousands of foreign currencies

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

 

1,393

 

 

 

4,451,775

 

 

 

896

 

 

 

-

 

Amounts receivable

 

 

72

 

 

 

15,775,755

 

 

 

-

 

 

 

-

 

Loans receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

250

 

Trade payables

 

 

(40)

 

 

(5,398,068)

 

 

-

 

 

 

-

 

Accrued liabilities

 

 

(589)

 

 

(2,120,869)

 

 

-

 

 

 

-

 

Lease liability

 

 

-

 

 

 

(1,690,797)

 

 

-

 

 

 

-

 

Long term debt

 

 

-

 

 

 

(72,963)

 

 

-

 

 

 

-

 

Net carrying value

 

 

836

 

 

 

10,944,833

 

 

 

896

 

 

 

250

 

XML 51 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENT DISCLOSURES (Tables)
6 Months Ended
Jun. 30, 2022
SEGMENTED INFORMATION  
Schedule Of Geographical Information Of Company's Non-current Assets

Thousands of United States dollars

 

Cannabis growth and derivative production

 

 

Consumer products

 

 

Pharmaceuticals and nutraceuticals

 

 

Beverage and food

 

 

Corporate and Eliminations

 

 

Total

 

For the six months ended June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$3

 

 

$13,603

 

 

$3,708

 

 

$252

 

 

$(2,649)

 

$14,917

 

Gross profit

 

 

47

 

 

 

4,304

 

 

 

2,096

 

 

 

99

 

 

 

-

 

 

 

6,546

 

Net (loss) income

 

 

(715)

 

 

(19,420)

 

 

317

 

 

 

(462)

 

 

(12,436)

 

 

(32,716)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the six months ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$-

 

 

$286

 

 

$1,629

 

 

$310

 

 

$(107)

 

$2,118

 

Gross profit

 

 

-

 

 

 

173

 

 

 

752

 

 

 

87

 

 

 

-

 

 

 

1,012

 

Net (loss) income

 

 

(428)

 

 

(857)

 

 

50

 

 

 

(64)

 

 

(3,839)

 

 

(5,138)

Thousands of United States dollars

 

Colombia

 

 

United States

 

 

Canada

 

 

United Kingdom

 

 

Total

 

Non-current assets at June 30, 2022

 

$5,320

 

 

$42,351

 

 

$1,533

 

 

$2,708

 

 

$51,912

 

Total liabilities at June 30, 2022

 

 

2,732

 

 

 

9,290

 

 

 

4,496

 

 

 

81

 

 

 

16,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets at December 31, 2021

 

$4,042

 

 

$29,650

 

 

$3,844

 

 

$-

 

 

$37,536

 

Total liabilities at December 31, 2021

 

 

2,359

 

 

 

3,106

 

 

 

3,073

 

 

 

-

 

 

 

8,538

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$1,631

 

 

$12,887

 

 

$-

 

 

$399

 

 

$14,917

 

Gross profit

 

 

999

 

 

 

5,471

 

 

 

-

 

 

 

76

 

 

 

6,546

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$2,069

 

 

$49

 

 

$-

 

 

$-

 

 

$2,118

 

Gross profit

 

 

1,009

 

 

 

3

 

 

 

-

 

 

 

-

 

 

 

1,012

 

XML 52 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
NATURE OF OPERATIONS (Details Narrative)
6 Months Ended
Jun. 30, 2022
NATURE OF OPERATIONS (Details Narrative)  
Country of incorporation Canada
Year of incorporation March 13, 2019
Principal Activity The Company is a manufacturer of global cannabis products and brands, building a connected, design-led collective of plant-based wellness and lifestyle brands.
Company's Registered Office 365 Bay Street, Suite 800, Toronto, Ontario, M5H 2V1, Canada
Principal Place Of Business 3406 SW 26th Terrace, Suite C-1, Fort Lauderdale, Florida 33312
XML 53 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
BASIS OF PRESENTATION (Details)
6 Months Ended
Jun. 30, 2022
Subsidiary 20 [member]  
Statement [Line Items]  
Name Of Subsidiary Flora Growth F&B Corp.
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 1 [member]  
Statement [Line Items]  
Name Of Subsidiary Cosechemos YA S.A.S.
Country Of Incorporation Colombia
Ownership Of Subsidiary 90.00%
Functional Currency Of Subsidiary Colombia Peso (COP)
Subsidiary 2 [member]  
Statement [Line Items]  
Name Of Subsidiary Flora Growth Corp. Sucursal Colombia
Country Of Incorporation Colombia
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary Colombia Peso (COP)
Subsidiary 3 [member]  
Statement [Line Items]  
Name Of Subsidiary Hemp Textiles & Co. LLC
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 4 [member]  
Statement [Line Items]  
Name Of Subsidiary Hemp Textiles & Co. S.A.S.
Country Of Incorporation Colombia
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary Colombia Peso (COP)
Subsidiary 5 [member]  
Statement [Line Items]  
Name Of Subsidiary Flora Beauty LLC
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 6 [member]  
Statement [Line Items]  
Name Of Subsidiary Flora Beauty LLC Sucursal Colombia
Country Of Incorporation Colombia
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary Colombia Peso (COP)
Subsidiary 7 [member]  
Statement [Line Items]  
Name Of Subsidiary Kasa Wholefoods Company S.A.S.
Country Of Incorporation Colombia
Ownership Of Subsidiary 90.00%
Functional Currency Of Subsidiary Colombia Peso (COP)
Subsidiary 8 [member]  
Statement [Line Items]  
Name Of Subsidiary Kasa Wholefoods Company LLC
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 9 [member]  
Statement [Line Items]  
Name Of Subsidiary Grupo Farmaceutico Cronomed S.A.S.
Country Of Incorporation Colombia
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary Colombia Peso (COP)
Subsidiary 10 [member]  
Statement [Line Items]  
Name Of Subsidiary Labcofarm Laboratorios S.A.S.
Country Of Incorporation Colombia
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary Colombia Peso (COP)
Subsidiary 11 [member]  
Statement [Line Items]  
Name Of Subsidiary Breeze Laboratory S.A.S.
Country Of Incorporation Colombia
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary Colombia Peso (COP)
Subsidiary 12 [member]  
Statement [Line Items]  
Name Of Subsidiary Vessel Brand Inc.
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 13 [member]  
Statement [Line Items]  
Name Of Subsidiary Just Brands LLC
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 14 [member]  
Statement [Line Items]  
Name Of Subsidiary Just Brands International LTD
Country Of Incorporation United Kingdom
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary British Pound (GBP)
Subsidiary 15 [member]  
Statement [Line Items]  
Name Of Subsidiary High Roller Private Label LLC
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 16 [member]  
Statement [Line Items]  
Name Of Subsidiary Flora Growth US Holdings Corp.
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 17 [member]  
Statement [Line Items]  
Name Of Subsidiary Flora Growth Management Corp.
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 18 [member]  
Statement [Line Items]  
Name Of Subsidiary Cardiff Brand Corp.
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
Subsidiary 19 [member]  
Statement [Line Items]  
Name Of Subsidiary Keel Brand Corp.
Country Of Incorporation United States
Ownership Of Subsidiary 100.00%
Functional Currency Of Subsidiary United States Dollar (USD)
XML 54 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
TRADE AND AMOUNTS RECEIVABLE (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
TRADE AND AMOUNTS RECEIVABLE (Details)    
Trade Accounts Receivable $ 5,428 $ 5,565
Allowance For Expected Credit Losses (1,679) (1,252)
Hst Receivable 411 259
Other Receivables 932 752
Total $ 5,092 $ 5,324
XML 55 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
TRADE AND AMOUNTS RECEIVABLE (Details 1) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
TRADE AND AMOUNTS RECEIVABLE (Details)    
Current $ 1,641  
1-30 Days 614  
31-60 Days 259  
61-90 Days 383  
91-180 Days 1,383  
180+ Days 1,148  
Total Trade Receivables $ 5,428 $ 5,565
XML 56 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
TRADE AND AMOUNTS RECEIVABLE (Details Narrative)
$ in Millions
6 Months Ended
Jun. 30, 2022
USD ($)
TRADE AND AMOUNTS RECEIVABLE (Details)  
Additional Expected Credit Losses $ 0.3
XML 57 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
BIOLOGICAL ASSETS (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
BIOLOGICAL ASSETS (Details)  
Balance, Beginning $ 37
Changes In Fair Value Less Cost To Sell Due To Biological Transformation 46
Transferred To Harvested Cannabis Inventory Upon Harvest (69)
Balance, Ending $ 14
XML 58 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
BIOLOGICAL ASSETS (Details Narrative)
6 Months Ended
Jun. 30, 2022
$ / shares
BIOLOGICAL ASSETS (Details)  
Weighted Average Yield $ 21
Post Harvest Cost Per Gram $ 0.04
Impact On The Fair Value 10.00%
Dried Cannabis Per Gram $ 0.06
Weighted Average Stage of Growth 41.00%
XML 59 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVENTORY (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
INVENTORY (Details)    
Raw Materials And Supplies $ 2,161 $ 899
Harvested Cannabis 92 35
Work In Progress 465 97
Finished Goods 6,577 1,962
Total $ 9,295 $ 2,993
XML 60 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROPERTY PLANT AND EQUIPMENT (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2020
Statement [Line Items]      
Accumulated Depreciation, Depreciation $ 1,712 $ 119  
Property Plant And Equipment 4,565    
Construction in Progress [Member]      
Statement [Line Items]      
Balance, Beginning 905    
Additions 321    
Business Combinations (note 8) 0    
Foreign Exchange Translation (52)    
Balance, Ending 1,174    
Accumulated Depreciation, Balance Beginning 0    
Accumulated Depreciation, Depreciation 0    
Accumulated Depreciation, Disposals 0    
Accumulated Depreciation, Foreign Exchange Translation 0    
Property, plant and equipment, Carrying Value     $ 905
Accumulated Depreciation, Balance Ending 0    
Property Plant And Equipment 1,174    
Total [Member]      
Statement [Line Items]      
Balance, Beginning 5,505    
Additions 2,755    
Business Combinations (note 8) 1,308    
Foreign Exchange Translation (233)    
Balance, Ending 9,335    
Accumulated Depreciation, Balance Beginning (526)    
Accumulated Depreciation, Depreciation 658    
Accumulated Depreciation, Disposals 20    
Accumulated Depreciation, Foreign Exchange Translation 33    
Property, plant and equipment, Carrying Value     4,979
Accumulated Depreciation, Balance Ending (1,131)    
Property Plant And Equipment 8,204    
Buildings      
Statement [Line Items]      
Balance, Beginning 928    
Additions 23    
Business Combinations (note 8) 0    
Foreign Exchange Translation (38)    
Balance, Ending 913    
Accumulated Depreciation, Balance Beginning (44)    
Accumulated Depreciation, Depreciation 44    
Accumulated Depreciation, Disposals 0    
Accumulated Depreciation, Foreign Exchange Translation 4    
Property, plant and equipment, Carrying Value     884
Accumulated Depreciation, Balance Ending (84)    
Property Plant And Equipment 829    
Land      
Statement [Line Items]      
Balance, Beginning 112    
Additions 305    
Business Combinations (note 8) 0    
Foreign Exchange Translation (22)    
Balance, Ending 395    
Accumulated Depreciation, Balance Beginning 0    
Accumulated Depreciation, Depreciation 0    
Accumulated Depreciation, Disposals 0    
Accumulated Depreciation, Foreign Exchange Translation 0    
Property, plant and equipment, Carrying Value     27
Accumulated Depreciation, Balance Ending 0    
Property Plant And Equipment 395    
Machinery and Office Equipment [Member]      
Statement [Line Items]      
Balance, Beginning 1,991    
Additions 53    
Business Combinations (note 8) 506    
Foreign Exchange Translation (71)    
Balance, Ending 2,479    
Accumulated Depreciation, Balance Beginning (169)    
Accumulated Depreciation, Depreciation 229    
Accumulated Depreciation, Disposals 20    
Accumulated Depreciation, Foreign Exchange Translation 12    
Property, plant and equipment, Carrying Value     1,822
Accumulated Depreciation, Balance Ending (366)    
Property Plant And Equipment 2,113    
Vehicles [Member]      
Statement [Line Items]      
Balance, Beginning 37    
Additions 0    
Business Combinations (note 8) 30    
Foreign Exchange Translation (1)    
Balance, Ending 66    
Accumulated Depreciation, Balance Beginning (10)    
Accumulated Depreciation, Depreciation 2    
Accumulated Depreciation, Disposals 0    
Accumulated Depreciation, Foreign Exchange Translation 0    
Property, plant and equipment, Carrying Value     112
Accumulated Depreciation, Balance Ending (12)    
Property Plant And Equipment 54    
Subtotal [Member]      
Statement [Line Items]      
Balance, Beginning 3,973    
Additions 702    
Business Combinations (note 8) 536    
Foreign Exchange Translation (184)    
Balance, Ending 5,027    
Accumulated Depreciation, Balance Beginning (223)    
Accumulated Depreciation, Depreciation 275    
Accumulated Depreciation, Disposals 20    
Accumulated Depreciation, Foreign Exchange Translation 16    
Property, plant and equipment, Carrying Value     3,750
Accumulated Depreciation, Balance Ending (462)    
Property Plant And Equipment 4,565    
Right Of Use Assets [Member]      
Statement [Line Items]      
Balance, Beginning 1,532    
Additions 2,053    
Business Combinations (note 8) 772    
Foreign Exchange Translation (49)    
Balance, Ending 4,308    
Accumulated Depreciation, Balance Beginning (303)    
Accumulated Depreciation, Depreciation 383    
Accumulated Depreciation, Disposals 0    
Accumulated Depreciation, Foreign Exchange Translation 17    
Property, plant and equipment, Carrying Value     $ 1,229
Accumulated Depreciation, Balance Ending (669)    
Property Plant And Equipment $ 3,639    
XML 61 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
LONGTERM INVESTMENTS (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
Statement [Line Items]  
Volatility 100.00%
Risk Free Interest Rate 1.75%
Dividend Yield 0.00%
WarrantsCAD Thirty [member]  
Statement [Line Items]  
Share Price $ 0.32
Exercise Price $ 0.23
Volatility 100.00%
Risk Free Interest Rate 3.10%
Dividend Yield 0.00%
Expected term in years 7 months 6 days
Fair Value $ 0.13
Quantity Owned | $ $ 1,666,667
Fair Value Warrant | $ $ 222,000
WarrantsCAD One [member]  
Statement [Line Items]  
Share Price $ 0.32
Exercise Price $ 0.78
Volatility 100.00%
Risk Free Interest Rate 3.10%
Dividend Yield 0.00%
Expected term in years 7 months 6 days
Fair Value $ 0.02
Quantity Owned | $ $ 333,333
Fair Value Warrant | $ $ 8,000
XML 62 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
LONGTERM INVESTMENTS (Details 1)
$ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
Statement [Line Items]  
Loss On Changes In Fair Value $ (1,333)
Balance, Ending 1,337
Balance, Beginning 2,670
WarrantsCAD Thirty [member]  
Statement [Line Items]  
Loss On Changes In Fair Value (403)
Balance, Ending 222
Balance, Beginning 625
WarrantsCAD One [member]  
Statement [Line Items]  
Loss On Changes In Fair Value (50)
Balance, Ending 8
Balance, Beginning 58
Investee common share [member]  
Statement [Line Items]  
Loss On Changes In Fair Value (880)
Balance, Ending 1,107
Balance, Beginning $ 1,987
XML 63 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
LONGTERM INVESTMENTS (Details Narrative)
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
LONGTERM INVESTMENTS (Details Narrative)  
Purchased Common Shares | $ $ 2,400,000
Exchange Common Shares | shares 225,000
Ownership 9.60%
Ownership Of Diluted Basis 8.60%
Purchased Common Share Of The Investee $ 0.23
Purchased Common Share Of The Investee Second Tranche 0.78
Fair Value Common Share 0.32
Fair Value Common Shares 0.13
Fair Value Common Shares Second Tranch 0.02
Common Shares Price 3.6
Common Shares Value $ 4.8
Fair Value Calculations 10.00%
Common Shares Results 10.00%
Change In Share Price 10.00%
Fair Value | $ $ 111,000
Change in Fair Value, warrants | $ 44,000
Volatality change, fair value | $ $ 14,000
XML 64 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details)
$ in Thousands
Jun. 30, 2022
USD ($)
Cash $ 535
Trade Receivables 975
Inventory 5,534
Other Current Assets 540
Property, Plant And Equipment 537
Right Of Use Assets 772
Other Noncurrent Assets 127
Intangible Assets 4,757
Goodwill 24,869
Total Assets 38,646
Trade Payables And Accrued Liabilities (2,273)
Current lease liabilities (644)
Provision for sales tax (982)
Other current liabilities (99)
Total Liabilities (3,998)
Total Net Assets Acquired $ 34,648
XML 65 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 10 Months Ended
Apr. 05, 2022
Feb. 24, 2022
Jan. 31, 2022
Jan. 18, 2022
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2019
Dec. 31, 2021
Statement [Line Items]                
Revenue         $ (14,917,000) $ (2,118,000) $ 0  
Purchase Consideration Comprised Share   9,500,000            
Intangible Assets         $ 1,200,000      
Useful Lives         7 years      
Consideration $ 400,000              
Intangible Assets         $ 13,432,000     $ 9,736,000
Bottom [Member]                
Statement [Line Items]                
Useful Lives         5 years      
Bottom [Member] | Tradenames [member]                
Statement [Line Items]                
Useful Lives         8 years      
Top [Member]                
Statement [Line Items]                
Useful Lives         7 years      
Top [Member] | Tradenames [member]                
Statement [Line Items]                
Useful Lives         9 years      
JustCBD [Member]                
Statement [Line Items]                
Revenue         $ 10,000,000.0      
Non-controlling Interest   100.00%            
Total purchase consideration   $ 34,600,000            
Consideration   4,000,000.0            
Additional common shares   5            
Trade receivables         291,000      
Increase in net loss         1,600,000      
Increase in combined Revenue         5,200,000      
Comprehensive Loss         400,000      
Shares Issued   $ 3,650,000            
Common shares delivered to the sellers   3,650,000            
Purchase Consideration Comprised   $ 16,000,000.0            
Purchase Consideration Comprised Share   9,500,000            
Company Valued   $ 1,470,000            
Fair Value Discount   15.00%            
Intangible Assets         480,000      
Monte Carlo simulation                
Statement [Line Items]                
Purchase Consideration Comprised Share   100,000            
Volatility   100.00%            
Net Assets Acquired   1.50%            
Exercise price   $ 1.82            
Flora Beauty LLC                
Statement [Line Items]                
Exercise price       $ 1.70        
Interest In Flora Beauty Llc       10.00%        
Company Granted Common Shares       100,000        
Company Granted Common Shares To Flora Beauty LLC       50,000        
Company Granted Common Shares To Mr Breeze     30,282          
Equity Interests Own     10.00%          
Tradename [member]                
Statement [Line Items]                
Intangible Assets         $ 3,400,000      
Noncompete Agreement [member]                
Statement [Line Items]                
Useful Lives         3 years      
Intangible Assets         $ 200,000      
XML 66 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLE ASSETS AND GOODWILL (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
Statement [Line Items]  
Balance, Beginning $ 30,124,000
Additions 0
Acquired Through Business Combinations (note 8) 29,626,000
Impairment (16,000,000)
Accumulated Amortization, Balance Beginning 304,000
Accumulated Amortization, Additions 1,052,000
Accumulated Amortization, Balance Ending 1,356,000
Intangible Assets And Goodwill 42,098,000
Foreign Currency Translation (296,000)
Balance, Ending 43,750,000
Licences [member]  
Statement [Line Items]  
Additions 0
Acquired Through Business Combinations (note 8) 0
Impairment 0
Accumulated Amortization, Balance Beginning 129,000
Accumulated Amortization, Additions 82,000
Accumulated Amortization, Balance Ending 211,000
Intangible Assets And Goodwill 381,000
Foreign Currency Translation (18,000)
Balance, Beginning 610,000
Balance, Ending 610,000
Customer Relationships [Member]  
Statement [Line Items]  
Additions 0
Acquired Through Business Combinations (note 8) 1,160,000
Impairment 0
Accumulated Amortization, Balance Beginning 26,000
Accumulated Amortization, Additions 169,000
Accumulated Amortization, Balance Ending 195,000
Intangible Assets And Goodwill 2,724,000
Foreign Currency Translation 0
Balance, Beginning 1,759,000
Balance, Ending 2,919,000
Trademarks and brands [Member]  
Statement [Line Items]  
Additions 0
Acquired Through Business Combinations (note 8) 3,357,000
Impairment 0
Accumulated Amortization, Balance Beginning 35,000
Accumulated Amortization, Additions 306,000
Accumulated Amortization, Balance Ending 341,000
Intangible Assets And Goodwill 5,206,000
Foreign Currency Translation (21,000)
Balance, Beginning 2,211,000
Balance, Ending 5,568,000
Patents [Member]  
Statement [Line Items]  
Additions 0
Acquired Through Business Combinations (note 8) 240,000
Impairment 0
Accumulated Amortization, Balance Beginning 48,000
Accumulated Amortization, Additions 297,000
Accumulated Amortization, Balance Ending 345,000
Intangible Assets And Goodwill 4,195,000
Foreign Currency Translation 0
Balance, Beginning 4,300,000
Balance, Ending 4,540,000
Non-compete agreements [Member]  
Statement [Line Items]  
Additions 0
Acquired Through Business Combinations (note 8) 0
Impairment 0
Accumulated Amortization, Balance Beginning 66,000
Accumulated Amortization, Additions 198,000
Accumulated Amortization, Balance Ending 264,000
Intangible Assets And Goodwill 926,000
Foreign Currency Translation 0
Balance, Beginning 1,190,000
Balance, Ending 1,190,000
Goodwill [Member]  
Statement [Line Items]  
Additions 0
Acquired Through Business Combinations (note 8) 24,612,000
Impairment (16,000,000)
Accumulated Amortization, Balance Beginning 0
Accumulated Amortization, Additions 0
Accumulated Amortization, Balance Ending 0
Intangible Assets And Goodwill 28,666,000
Foreign Currency Translation (257,000)
Balance, Beginning 20,054,000
Balance, Ending 28,923,000
Acquired Through Business Combinations (note 8) $ 24,869,000
XML 67 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLE ASSETS AND GOODWILL (Details 1)
$ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
Statement [Line Items]  
Goodwill, Balance Beginning $ 20,054
Acquired Through Business Combinations (note 8) 29,626
Impairment (16,000)
Goodwill, Balance ending 28,666
Goodwill [Member]  
Statement [Line Items]  
Goodwill, Balance Beginning 20,054
Acquired Through Business Combinations (note 8) 24,612
Impairment (16,000)
Goodwill, Balance ending 28,666
Goodwill [Member] | Just CBD [Member]  
Statement [Line Items]  
Goodwill, Balance Beginning 0
Acquired Through Business Combinations (note 8) 0
Impairment 0
Goodwill, Balance ending 24,612
Goodwill [Member] | Pharmaceuticals and Nutraceuticals  
Statement [Line Items]  
Goodwill, Balance Beginning 379
Acquired Through Business Combinations (note 8) 24,612
Impairment 0
Goodwill, Balance ending 379
Goodwill [Member] | Vessel [Member]  
Statement [Line Items]  
Goodwill, Balance Beginning 19,675
Acquired Through Business Combinations (note 8) 0
Impairment (16,000)
Goodwill, Balance ending $ 3,675
XML 68 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLE ASSETS AND GOODWILL (Details Narrative)
$ in Millions
6 Months Ended
Jun. 30, 2022
USD ($)
Intangible Assets And Goodwill $ 3.2
Intangible Assets And Goodwill $ 0.2
Description Of Amortization 92 to 104 months of remaining amortization periods
Description Of Amortization 32 months of remaining amortization period
XML 69 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
IMPAIRMENT OF ASSETS (Details Narrative) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Statement [Line Items]    
Deferred Tax $ 1,511 $ 1,511
Goodwill And Identified Intangible Assets 42,098  
Vessels One [Member]    
Statement [Line Items]    
Impairment Of CGU 16,000  
Total Carrying Value 28,000  
Goodwill And Identified Intangible Assets 28,000  
Other Long-lived Assets $ 1,400  
Description to sensitivity assessment to recoverable amount As a sensitivity assessment to the recoverable amount calculations, reducing the selected revenue multiple by 0.5 from 1.75 above down to 1.25 (approximately 29% decrease) would result in additional goodwill impairment of approximately $3.0 million  
Vessel [Member]    
Statement [Line Items]    
Deferred Tax $ 1,400  
Lease Liability 1,200  
Estimated Recoverable Amount $ 11,900  
Description Of Valuation The fair value was determined based on guideline public companies similar to Vessel considering financial metrics such as historical revenue growth, gross margin and EBITDA profitability and with operations focused on consumer brands and similar sales channels. An enterprise value to latest twelve months revenue multiple of 1.75 was selected based on consideration of the enterprise value to latest twelve months multiples of the guideline companies. The multiple was applied to Vessel’s revenue for the twelve months ended June 30, 2022. Estimated costs of disposal of 3% were subtracted to arrive at the recoverable amount. The impairment test valuation is considered a Level 3 method within the IFRS 13 fair value hierarchy  
XML 70 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Amortization Expense By Class Of Underlying Asset    
Total Amortization Expense $ 383 $ 45
Interest On Lease Liabilities 83 14
Short-term And Low Value Assets Lease Expense 510 0
Total Lease Expense 976 59
Other Information    
Additions To Right Of Use Assets 2,053 0
Cash Paid For Amounts Included In The Measurement Of Lease Liabilities    
Financing Cash Flows From Leases (interest) 69 16
Financing Cash Flows From Leases (principal) 420 70
Operating Cash Flows For Short Term And Low Value Asset Leases 510 0
Total Cash Outflows From Leases 999 86
Carrying Amount Of Right Of Use Asset By Class Of Underlying Asset    
Total Carrying Amount Of Right Of Use Assets 3,639 247
Buildings    
Amortization Expense By Class Of Underlying Asset    
Total Amortization Expense 5 5
Carrying Amount Of Right Of Use Asset By Class Of Underlying Asset    
Total Carrying Amount Of Right Of Use Assets 1,036 16
Land    
Amortization Expense By Class Of Underlying Asset    
Total Amortization Expense 27 0
Carrying Amount Of Right Of Use Asset By Class Of Underlying Asset    
Total Carrying Amount Of Right Of Use Assets 111 0
Office Space    
Amortization Expense By Class Of Underlying Asset    
Total Amortization Expense 351 40
Carrying Amount Of Right Of Use Asset By Class Of Underlying Asset    
Total Carrying Amount Of Right Of Use Assets $ 2,492 $ 231
XML 71 R64.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Details 1)
$ in Thousands
Jun. 30, 2022
USD ($)
Statement [Line Items]  
Total Undiscounted Cash Flows $ 4,167
Less: Present Value Discount (606)
Total Lease Liabilities 3,561
2023  
Statement [Line Items]  
Total Undiscounted Cash Flows 1,366
2024  
Statement [Line Items]  
Total Undiscounted Cash Flows 1,251
2025  
Statement [Line Items]  
Total Undiscounted Cash Flows 447
2027  
Statement [Line Items]  
Total Undiscounted Cash Flows 373
Thereafter  
Statement [Line Items]  
Total Undiscounted Cash Flows 290
2026  
Statement [Line Items]  
Total Undiscounted Cash Flows $ 440
XML 72 R65.htm IDEA: XBRL DOCUMENT v3.22.2.2
LEASES (Details Narrative)
6 Months Ended
Jun. 30, 2022
LEASES (Details)  
Description of lease The Company’s land lease for 361 hectares of property in Santander, Colombia expires August 31, 2024
XML 73 R66.htm IDEA: XBRL DOCUMENT v3.22.2.2
CAPITAL STOCK (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
Aug. 05, 2022
Apr. 05, 2022
Feb. 28, 2022
Feb. 24, 2022
Jan. 31, 2022
Jun. 30, 2022
Jul. 05, 2022
Jan. 18, 2022
Statement [Line Items]                
Share Repurchased           $ 5,000    
Stock Issued For Consulting Services Performed, Shares 700,000              
Stock Issued For Consulting Services Performed, Amount $ 1,300              
Cash Paid   $ 400            
Common Shares             6,000,000  
Exercise price           $ 1.62    
Acquisition Of Noncontrolling Interests Flora Beauty LLC                
Statement [Line Items]                
Common Shares               100,000
Common Share Exercisable     50,000          
Exercise price     $ 1.70          
Gross Proceeds     $ 200          
Share Acquired From Minority Interest     10.00%          
Acquisition Of Noncontrolling Interests Breeze                
Statement [Line Items]                
Common Shares         30,282      
Gross Proceeds         $ 10      
Share Acquired From Minority Interest         10.00%      
Other Offering                
Statement [Line Items]                
Stock Issued For Consulting Services Performed, Shares         111,112      
Stock Issued For Consulting Services Performed, Amount         $ 200      
Common Share Exercisable         83,333      
Exercise price         $ 2.25      
Just CBD [Member]                
Statement [Line Items]                
Cash Paid       $ 4,000        
Common Shares     9,500,000          
Business Acquisition, Common Stock, Value of Shares Issued     $ 14,700          
Fair Value Discount     15.00%          
XML 74 R67.htm IDEA: XBRL DOCUMENT v3.22.2.2
OPTIONS (Details) - Stock options
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Statement [Line Items]  
Outstanding Balance, Beginning | shares 5,448
Granted | shares 471
Exercised | shares (512)
Outstanding Balance, Ending | shares 5,407
Weighted Average Exercise Price Outstanding Balance, Beginning | $ / shares $ 1.96
Weighted Average Exercise Price, Granted | $ / shares 1.62
Weighted Average Exercise Price, Exercised | $ / shares 0.15
Weighted Average Exercise Price Outstanding Balance, Ending | $ / shares $ 2.09
XML 75 R68.htm IDEA: XBRL DOCUMENT v3.22.2.2
OPTIONS (Details 1) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Statement [Line Items]    
Exercise Price   $ 3.60
Exercise Price Four    
Statement [Line Items]    
Options Exercisable 17,000  
Exercise Price $ 2.25  
Grant Date Fair Value Vested Amount $ 23  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years 1 month 6 days  
Options Outstanding 17,000  
Exercise Price Five    
Statement [Line Items]    
Options Exercisable 66,000  
Exercise Price $ 2.25  
Grant Date Fair Value Vested Amount $ 92  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years 2 months 12 days  
Options Outstanding 66,000  
Exercise Price Six    
Statement [Line Items]    
Options Exercisable 666,000  
Exercise Price $ 2.25  
Grant Date Fair Value Vested Amount $ 918  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years 4 months 24 days  
Options Outstanding 666,000  
Exercise Price Seven    
Statement [Line Items]    
Options Exercisable 500,000  
Exercise Price $ 2.25  
Grant Date Fair Value Vested Amount $ 689  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years 6 months  
Options Outstanding 500,000  
Exercise Price Eight    
Statement [Line Items]    
Options Exercisable 241,000  
Exercise Price $ 3.87  
Grant Date Fair Value Vested Amount $ 686  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years 10 months 24 days  
Options Outstanding 241,000  
Exercise Price Nine    
Statement [Line Items]    
Options Exercisable 167,000  
Exercise Price $ 3.68  
Grant Date Fair Value Vested Amount $ 455  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years 10 months 24 days  
Options Outstanding 167,000  
Exercise Price Ten    
Statement [Line Items]    
Options Exercisable 0  
Exercise Price $ 5.20  
Grant Date Fair Value Vested Amount $ 54  
Options Outstanding, Weighted Average Remaining Contractual Life 4 years 2 months 12 days  
Options Outstanding 16,000  
Exercise Price Eleven    
Statement [Line Items]    
Options Exercisable 0  
Exercise Price $ 6.90  
Grant Date Fair Value Vested Amount $ 1,026  
Options Outstanding, Weighted Average Remaining Contractual Life 4 years 2 months 12 days  
Options Outstanding 240,000  
Exercise Price Twelve    
Statement [Line Items]    
Options Exercisable 175,000  
Exercise Price $ 2.04  
Grant Date Fair Value Vested Amount $ 1,590  
Options Outstanding, Weighted Average Remaining Contractual Life 4 years 6 months  
Options Outstanding 1,640,000  
Exercise Price Thirteen    
Statement [Line Items]    
Options Exercisable 0  
Exercise Price $ 2.25  
Grant Date Fair Value Vested Amount $ 84  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years  
Options Outstanding 84,000  
Exercise Price Fourteen    
Statement [Line Items]    
Options Exercisable 50,000  
Exercise Price $ 1.70  
Grant Date Fair Value Vested Amount $ 63  
Options Outstanding, Weighted Average Remaining Contractual Life 4 years 7 months 6 days  
Options Outstanding 50,000  
Exercise Price Fifteen    
Statement [Line Items]    
Options Exercisable 217,000  
Exercise Price $ 1.48  
Grant Date Fair Value Vested Amount $ 296  
Options Outstanding, Weighted Average Remaining Contractual Life 4 years 7 months 6 days  
Options Outstanding 287,000  
Exercise Price Sixteen    
Statement [Line Items]    
Options Exercisable 0  
Exercise Price $ 1.30  
Grant Date Fair Value Vested Amount $ 4  
Options Outstanding, Weighted Average Remaining Contractual Life 4 years 10 months 24 days  
Options Outstanding 50,000  
Exercise Price One    
Statement [Line Items]    
Options Exercisable 949,000  
Exercise Price $ 0.15 3.00
Grant Date Fair Value Vested Amount $ 35  
Options Outstanding, Weighted Average Remaining Contractual Life 2 years  
Options Outstanding 949,000  
Exercise Price Two    
Statement [Line Items]    
Options Exercisable 117,000  
Exercise Price $ 2.25 3.75
Grant Date Fair Value Vested Amount $ 344  
Options Outstanding, Weighted Average Remaining Contractual Life 2 years 9 months 18 days  
Options Outstanding 117,000  
Exercise Price Three    
Statement [Line Items]    
Options Exercisable 317,000  
Exercise Price $ 2.25 $ 3.30
Grant Date Fair Value Vested Amount $ 252  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years  
Options Outstanding 317,000  
Stock options    
Statement [Line Items]    
Options Outstanding 5,407,000  
Options Exercisable 3,482,000  
Exercise Price $ 2.09  
Grant Date Fair Value Vested Amount $ 6,611  
Options Outstanding, Weighted Average Remaining Contractual Life 3 years 7 months 6 days  
Options Outstanding 5,407 5,448
XML 76 R69.htm IDEA: XBRL DOCUMENT v3.22.2.2
OPTIONS (Details 2)
6 Months Ended
Jun. 30, 2022
$ / shares
OPTIONS (Details)  
Risk-free Annual Interest Rate 1.75%
Current Stock Price $ 1.58
Expected Annualized Volatility 100.00%
Expected Life (years) 4 years 7 months 24 days
Expected Annual Dividend Yield 0.00%
Exercise Price $ 1.62
XML 77 R70.htm IDEA: XBRL DOCUMENT v3.22.2.2
OPTIONS (Details Narrative) - CAD ($)
$ in Millions
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
OPTIONS (Details)    
Expense Related To Options Granted $ 2.9 $ 0.1
XML 78 R71.htm IDEA: XBRL DOCUMENT v3.22.2.2
WARRANTS (Details)
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Statement [Line Items]  
Number Of Warrants Balance, Beginning 7,388,000
Warrants [Member]  
Statement [Line Items]  
Number Of Warrants, Exercised (473,000)
Number Of Warrants, Cancelled/expired (885,000)
Number Of Warrants Balance, ending 7,388
Weighted Average Exercise Price Outstanding Balance, Beginning | $ / shares $ 3.37
Number Of Warrants Balance, Beginning 8,746,000
Weighted Average Exercise Price, Exercised | $ / shares $ 0.49
Weighted Average Exercise Price, Cancelled/expired | $ / shares 3.00
Weighted Average Exercise Price Outstanding Balance, Ending | $ / shares $ 3.60
XML 79 R72.htm IDEA: XBRL DOCUMENT v3.22.2.2
WARRANTS (Details 1) - USD ($)
$ / shares in Units, shares in Thousands
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Statement [Line Items]    
Grant date fair value vested amount $ 10,537  
Warrants, weighted average remaining contractual life 3 years 9 months 7 days  
Exercise Price   $ 3.60
Warrants Outstanding   7,388
Exercise Price One    
Statement [Line Items]    
Grant date fair value vested amount $ 776  
Warrants, weighted average remaining contractual life 1 month 13 days  
Exercise Price $ 0.15 $ 3.00
Warrants Outstanding   1,178
Date of expiry July 23, 2021 - September 20, 2022  
Exercise Price Two    
Statement [Line Items]    
Grant date fair value vested amount $ 8,706  
Warrants, weighted average remaining contractual life 4 years 4 months 20 days  
Exercise Price $ 2.25 $ 3.75
Warrants Outstanding   5,750
Date of expiry November 18, 2026  
Exercise Price Three    
Statement [Line Items]    
Grant date fair value vested amount $ 1,055  
Warrants, weighted average remaining contractual life 5 years 4 months 20 days  
Exercise Price $ 2.25 $ 3.30
Warrants Outstanding   460
Date of expiry November 18, 2027  
XML 80 R73.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROVISIONS COMMITMENTS AND CONTINGENCIES (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
Sales Tax Member  
Statement [Line Items]  
Acquired through business combinations $ 982,000
Payment settlements 0
Balance ending as at June 30, 2022 1,389,000
Additional Provisions15 407,000
Termination Benefits  
Statement [Line Items]  
Beginning Balance, Amount 352,000
Additional Provisions 0
Acquired through business combinations 0
Payment settlements (352,000)
Balance Ending as at June 30, 2022 0
Legal Disputes  
Statement [Line Items]  
Beginning Balance, Amount 1,681,000
Additional Provisions 0
Acquired through business combinations 0
Payment settlements (1,681,000)
Balance End as at June 30, 2022 $ 0
XML 81 R74.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROVISIONS COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ / shares in Units, shares in Millions, $ in Millions
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
PROVISIONS COMMITMENTS AND CONTINGENCIES (Details)  
Issued Common Shares | shares 3.0
Issued Common Shares | $ / shares $ 0.05
Total Contracts Payment $ 2.3
Payment For Termination $ 1.9
XML 82 R75.htm IDEA: XBRL DOCUMENT v3.22.2.2
LOSS PER SHARE (Details) - shares
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Statement [Line Items]    
Total Anti-dilutive 25,936,000 13,497,000
Just CBD [Member]    
Statement [Line Items]    
Total Anti-dilutive 13,141,000 0
Stock options    
Statement [Line Items]    
Total Anti-dilutive 5,407,000 4,202,000
Warrants [Member]    
Statement [Line Items]    
Total Anti-dilutive 7,388,000 9,295,000
XML 83 R76.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY DISCLOSURES (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
RELATED PARTY DISCLOSURES    
Directors' And Officers' Compensation $ 816 $ 736
Share-based Payments 197 1,748
Total $ 1,013 $ 2,484
XML 84 R77.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY DISCLOSURES (Details Narrative) - USD ($)
shares in Millions
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Statement [Line Items]      
Rent And Promotion Services Expenses $ 100,000 $ 100,000  
Termination description termination notices of 24 to 36 months    
Expenses For Consulting $ 300,000 100,000  
Initial public offering   $ 1,700,000  
Share Based Payments   333,333  
Trade And Other Payables 7,401,000   $ 5,628,000
Ontario Inc.      
Statement [Line Items]      
Amount Owed To Related Parties 0   6,000
Forbes and Manhattan Inc.      
Statement [Line Items]      
Amount Owed To Related Parties 11,000   11,000
Ontario Corp.      
Statement [Line Items]      
Amount Owed To Related Parties 0    
Number of Common Shares      
Statement [Line Items]      
Trade And Other Payables $ 0.0   $ 100,000
XML 85 R78.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details ) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Statement [Line Items]    
Amounts Receivable $ 5,428,000 $ 5,565,000
CAD    
Statement [Line Items]    
Cash 862 1,393
Amounts Receivable 0 72
Loans Receivable 0 0
Trade Payables (152) (40)
Accrued Liabilities (175) (589)
Lease Liabilities 0 0
Long Term Debt 0 0
Net Carrying Value 535 836
COP    
Statement [Line Items]    
Cash 1,673,360 4,451,775
Amounts Receivable 12,946,301 15,775,755
Loans Receivable 0 0
Trade Payables (8,285,897) (5,398,068)
Accrued Liabilities (960,040) (2,120,869)
Lease Liabilities (2,166,163) (1,690,797)
Long Term Debt (40,405) (72,963)
Net Carrying Value 3,167,156 10,944,833
EUR    
Statement [Line Items]    
Cash 1,605 896
Amounts Receivable 0 0
Loans Receivable 0 0
Trade Payables (5) 0
Accrued Liabilities 0 0
Lease Liabilities 0 0
Long Term Debt 0 0
Net Carrying Value 1,600 896
CHF    
Statement [Line Items]    
Cash 0 0
Amounts Receivable 0 0
Loans Receivable 250 250
Trade Payables 0 0
Accrued Liabilities 0 0
Lease Liabilities 0 0
Long Term Debt 0 0
Net Carrying Value 250 $ 250
GBP    
Statement [Line Items]    
Cash 22  
Loans Receivable 0  
Trade Payables (23)  
Accrued Liabilities (16)  
Lease Liabilities (27)  
Long Term Debt 0  
Net Carrying Value 130  
Amounts Receivable $ 174  
XML 86 R79.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Statement [Line Items]    
Financial Assets And Liabilities $ 300 $ 500
Description Of Exchange Rate then changing the rate by 10%. Management determined 10% is a ‘reasonably possible’ change in foreign currency rates by considering the approximate change in rates in the prior twelve months  
Restricted Cash $ 1 2
Credit risk    
Statement [Line Items]    
Restricted Cash 10,300 37,600
Cash 10,100 $ 37,400
Cash Held Amount $ 200  
XML 87 R80.htm IDEA: XBRL DOCUMENT v3.22.2.2
CAPITAL MANAGEMENT (Details Narrative)
$ in Millions
Jun. 16, 2022
USD ($)
CAPITAL MANAGEMENT (Details Narrative)  
Maximum number of shares repurchase, amount $ 5
XML 88 R81.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENTED INFORMATION (Details) - USD ($)
6 Months Ended 10 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2019
Statement [Line Items]      
Revenue $ (14,917,000) $ (2,118,000) $ 0
Gross Profit 6,546,000 1,012,000  
Net loss (32,716,000) (5,138,000)  
Total [Member]      
Statement [Line Items]      
Revenue 14,917,000 2,118,000  
Gross Profit 6,546,000 1,012,000  
Net loss (32,716,000) 5,138,000  
Cannabis Growth and Derivative Production Member      
Statement [Line Items]      
Revenue 3,000 0  
Gross Profit 47,000 0  
Net loss (715,000) (428,000)  
Consumer Products      
Statement [Line Items]      
Revenue 13,603,000 286,000  
Gross Profit 4,304,000 173,000  
Net loss (19,420,000) (857,000)  
Pharmaceuticals and Nutraceuticals      
Statement [Line Items]      
Revenue 3,708,000 1,629,000  
Gross Profit 2,096,000 752,000  
Net loss (317,000) 50,000  
Beverage and food      
Statement [Line Items]      
Revenue 252,000 310,000  
Gross Profit 99,000 87,000  
Net loss (462,000) (64,000)  
Corporate and Eliminations      
Statement [Line Items]      
Revenue (2,649,000) (107,000)  
Gross Profit 0 0  
Net loss $ (12,436,000) $ (3,839,000)  
XML 89 R82.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENTED INFORMATION (Details 1) - USD ($)
6 Months Ended 10 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2019
Dec. 31, 2021
Statement [Line Items]        
Total Liabilities $ 16,599,000     $ 8,538,000
Revenue (14,917,000) $ (2,118,000) $ 0  
Gross Profit 6,546,000 1,012,000    
Colombia        
Statement [Line Items]        
Non-current Assets 5,320,000     4,042,000
Total Liabilities 2,732,000     2,359,000
Revenue 1,631,000 2,069,000    
Gross Profit 999,000 1,009,000    
United States        
Statement [Line Items]        
Non-current Assets 42,351,000     29,650,000
Total Liabilities 9,290,000     3,106,000
Revenue 12,887,000 49,000    
Gross Profit 5,471,000 3,000    
Canada        
Statement [Line Items]        
Non-current Assets 1,533,000     3,844,000
Total Liabilities 4,496,000     3,073,000
Revenue 0 0    
Gross Profit 0 0    
United Kingdom [Member]        
Statement [Line Items]        
Non-current Assets 2,708,000     0
Total Liabilities 81,000     0
Revenue 399,000 0    
Gross Profit 76,000 0    
Total [Member]        
Statement [Line Items]        
Non-current Assets 51,912,000     37,536,000
Total Liabilities 16,599,000     $ 8,538,000
Revenue 14,917,000 2,118,000    
Gross Profit $ 6,546,000 $ 1,012,000    
XML 90 R83.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENTED INFORMATION (Details Narrative)
6 Months Ended
Jun. 30, 2022
CAPITAL MANAGEMENT (Details Narrative)  
consolidated revenue 10.00%
XML 91 R84.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2022
Jul. 05, 2022
Statement [Line Items]    
Common Shares   6,000,000
Subsegments Axis    
Statement [Line Items]    
Common Shares 366,645  
Exchange For Base Fees $ 250,000  
Stock Options Exercised During Period, Shares 266  
Warrants Exercised During Period, Shares 266  
Common Stock, Shares Issued During Period In Exchange Of Stock Options And Warrants Exercised 798,602  
XML 92 flora_6k_htm.xml IDEA: XBRL DOCUMENT 0001790169 2022-01-01 2022-06-30 0001790169 2022-07-05 0001790169 flora:SubsegmentsAxisMember 2022-06-30 0001790169 flora:SubsegmentsAxisMember 2022-01-01 2022-06-30 0001790169 flora:UnitedStatesMember 2022-01-01 2022-06-30 0001790169 flora:UnitedKingdomMember 2022-01-01 2022-06-30 0001790169 flora:CanadaMember 2022-01-01 2022-06-30 0001790169 flora:UnitedKingdomMember 2021-01-01 2021-06-30 0001790169 flora:CanadaMember 2021-01-01 2021-06-30 0001790169 flora:UnitedStatesMember 2021-01-01 2021-06-30 0001790169 flora:ColombiaMember 2021-01-01 2021-06-30 0001790169 flora:ColombiaMember 2022-01-01 2022-06-30 0001790169 flora:ColombiaMember 2021-12-31 0001790169 flora:ColombiaMember 2022-06-30 0001790169 flora:UnitedKingdomMember 2021-12-31 0001790169 flora:UnitedKingdomMember 2022-06-30 0001790169 flora:CanadaMember 2022-06-30 0001790169 flora:UnitedStatesMember 2022-06-30 0001790169 flora:CanadaMember 2021-12-31 0001790169 flora:UnitedStatesMember 2021-12-31 0001790169 flora:TotalMember 2021-01-01 2021-06-30 0001790169 flora:CorporateandEliminationsMember 2021-01-01 2021-06-30 0001790169 flora:BeverageandfoodMember 2021-01-01 2021-06-30 0001790169 flora:PharmaceuticalsandNutraceuticalsMember 2021-01-01 2021-06-30 0001790169 flora:ConsumerProductsMember 2021-01-01 2021-06-30 0001790169 flora:CorporateandEliminationsMember 2022-01-01 2022-06-30 0001790169 flora:BeverageandfoodMember 2022-01-01 2022-06-30 0001790169 flora:PharmaceuticalsandNutraceuticalsMember 2022-01-01 2022-06-30 0001790169 flora:ConsumerProductsMember 2022-01-01 2022-06-30 0001790169 flora:CannabisGrowthandDerivativeProductionMember 2022-01-01 2022-06-30 0001790169 flora:CannabisGrowthandDerivativeProductionMember 2021-01-01 2021-06-30 0001790169 2022-06-16 0001790169 flora:CreditRisksMember 2021-12-31 0001790169 flora:CreditRisksMember 2022-06-30 0001790169 flora:EURMember 2021-12-31 0001790169 flora:COPMember 2021-12-31 0001790169 flora:CADMember 2021-12-31 0001790169 flora:CHFMember 2021-12-31 0001790169 flora:GBPMember 2022-06-30 0001790169 flora:CHFMember 2022-06-30 0001790169 flora:EURMember 2022-06-30 0001790169 flora:COPMember 2022-06-30 0001790169 flora:CADMember 2022-06-30 0001790169 flora:OntarioIncMember 2022-06-30 0001790169 flora:OntarioIncMember 2021-12-31 0001790169 flora:OntarioCorpMember 2022-06-30 0001790169 flora:ForbesAndManhattanIncMember 2021-12-31 0001790169 flora:ForbesAndManhattanIncMember 2022-06-30 0001790169 flora:JustCBDMember 2021-01-01 2021-06-30 0001790169 flora:StockOptionsMember 2021-01-01 2021-06-30 0001790169 flora:SalesTaxMember 2022-01-01 2022-06-30 0001790169 flora:LegalDisputesMember 2022-01-01 2022-06-30 0001790169 flora:TerminationBenefitsMember 2022-01-01 2022-06-30 0001790169 flora:LegalDisputesMember 2021-12-31 0001790169 flora:TerminationBenefitsMember 2021-12-31 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions3Member 2021-12-31 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions2Member 2021-12-31 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions1Member 2021-12-31 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions3Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions2Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions1Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsTwelveMember 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsElevenMember 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsTenMember 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsTwelveMember 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsElevenMember 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsTenMember 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsSixteenMember 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsFifteenMember 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsFourteenMember 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions9Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions8Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions7Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsSixteenMember 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsFifteenMember 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsFourteenMember 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions6Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions9Member 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions5Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions8Member 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions7Member 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsThirteenMember 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions4Member 2022-01-01 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions6Member 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions5Member 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions4Member 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptionsThirteenMember 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions3Member 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions2Member 2022-06-30 0001790169 flora:RangesOfExercisePricesForOutstandingShareOptions1Member 2022-06-30 0001790169 flora:StockOptionsMember 2022-06-30 0001790169 flora:StockOptionsMember 2022-01-01 2022-06-30 0001790169 flora:StockOptionsMember 2021-12-31 0001790169 flora:AcquisitionOfNoncontrollingInterestsBreezeMember 2022-01-01 2022-01-31 0001790169 flora:AcquisitionOfNoncontrollingInterestsFloraBeautyLLCMember 2022-02-01 2022-02-28 0001790169 flora:OtherOfferingMember 2022-01-31 0001790169 flora:AcquisitionOfNoncontrollingInterestsBreezeMember 2022-01-31 0001790169 flora:AcquisitionOfNoncontrollingInterestsFloraBeautyLLCMember 2022-02-28 0001790169 flora:AcquisitionOfNoncontrollingInterestsFloraBeautyLLCMember 2022-01-18 0001790169 2022-04-01 2022-04-05 0001790169 flora:OtherOfferingMember 2022-01-01 2022-01-31 0001790169 2022-08-03 2022-08-05 0001790169 flora:JustCBDMember 2022-02-01 2022-02-28 0001790169 flora:JustCBDMember 2022-02-28 0001790169 flora:LaterThanSixYearsMember 2022-06-30 0001790169 flora:LaterThanFourYearAndNotLaterThanSixYearsMember 2022-06-30 0001790169 flora:LaterThanFiveYearsAndNotLaterThanSixYearsMember 2022-06-30 0001790169 flora:LaterThanFourYearAndNotLaterThanFiveYearsMember 2022-06-30 0001790169 flora:LaterThanThreeYearAndNotLaterThanFourYearsMember 2022-06-30 0001790169 flora:LaterThanTwoYearAndNotLaterThanThreeYearsMember 2022-06-30 0001790169 flora:LandsMember 2021-01-01 2021-06-30 0001790169 flora:BuildingsAndEquipmentMember 2021-01-01 2021-06-30 0001790169 flora:OfficeSpaceMember 2021-01-01 2021-06-30 0001790169 flora:OfficeSpaceMember 2022-01-01 2022-06-30 0001790169 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2022-01-01 2022-06-30 0001790169 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2022-06-30 0001790169 flora:VesselsMember 2022-01-01 2022-06-30 0001790169 flora:VesselsMember 2022-06-30 0001790169 flora:GoodwillsMember flora:PharmaceuticalsAndNutraceuticalsMember 2022-06-30 0001790169 flora:GoodwillsMember flora:VesselMember 2022-06-30 0001790169 flora:GoodwillsMember flora:JustCBDMember 2022-06-30 0001790169 flora:GoodwillsMember flora:VesselMember 2022-01-01 2022-06-30 0001790169 flora:GoodwillsMember flora:JustCBDMember 2022-01-01 2022-06-30 0001790169 flora:GoodwillsMember flora:PharmaceuticalsAndNutraceuticalsMember 2022-01-01 2022-06-30 0001790169 flora:GoodwillsMember flora:VesselMember 2021-12-31 0001790169 flora:GoodwillsMember flora:JustCBDMember 2021-12-31 0001790169 flora:GoodwillsMember flora:PharmaceuticalsAndNutraceuticalsMember 2021-12-31 0001790169 flora:NonCompeteAgreementsMember 2022-06-30 0001790169 flora:NonCompeteAgreementsMember 2022-01-01 2022-06-30 0001790169 flora:NonCompeteAgreementsMember 2021-12-31 0001790169 flora:PatentsAndGoodwillsMember 2022-06-30 0001790169 flora:PatentsAndGoodwillsMember 2022-01-01 2022-06-30 0001790169 flora:PatentsAndGoodwillsMember 2021-12-31 0001790169 flora:TrademarksAndBrandsMember 2022-06-30 0001790169 flora:TrademarksAndBrandsMember 2022-01-01 2022-06-30 0001790169 flora:TrademarksAndBrandsMember 2021-12-31 0001790169 flora:GoodwillsMember 2022-06-30 0001790169 flora:GoodwillsMember 2022-01-01 2022-06-30 0001790169 flora:GoodwillsMember 2021-12-31 0001790169 flora:CustomersRelationshipsMember 2022-06-30 0001790169 flora:CustomersRelationshipsMember 2022-01-01 2022-06-30 0001790169 flora:CustomersRelationshipsMember 2021-12-31 0001790169 flora:LicenceMember 2022-06-30 0001790169 flora:LicenceMember 2022-01-01 2022-06-30 0001790169 flora:LicenceMember 2021-12-31 0001790169 flora:TradenamesMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-06-30 0001790169 ifrs-full:TopOfRangeMember 2022-01-01 2022-06-30 0001790169 ifrs-full:BottomOfRangeMember 2022-01-01 2022-06-30 0001790169 flora:NoncompeteAgreementMember 2022-01-01 2022-06-30 0001790169 flora:TradenamesMember ifrs-full:TopOfRangeMember 2022-01-01 2022-06-30 0001790169 flora:NoncompeteAgreementMember 2022-06-30 0001790169 flora:TradenameMember 2022-06-30 0001790169 flora:JustCBDMember 2022-06-30 0001790169 2022-02-01 2022-02-24 0001790169 flora:MonteCarloSimulationMember 2022-02-24 0001790169 flora:FloraBeautyLLCMember 2022-01-18 0001790169 flora:FloraBeautyLLCMember 2022-01-01 2022-01-31 0001790169 flora:FloraBeautyLLCMember 2022-01-01 2022-01-18 0001790169 flora:JustCBDMember 2022-01-01 2022-06-30 0001790169 2019-03-13 2019-12-31 0001790169 flora:JustCBDMember 2022-02-24 0001790169 flora:MonteCarloSimulationMember 2022-02-01 2022-02-24 0001790169 flora:JustCBDMember 2022-02-01 2022-02-24 0001790169 flora:WarrantsCADOneMember 2021-12-31 0001790169 flora:WarrantsCADThirtyMember 2021-12-31 0001790169 flora:InvesteeCommonShareMember 2022-06-30 0001790169 flora:InvesteeCommonShareMember 2022-01-01 2022-06-30 0001790169 flora:InvesteeCommonShareMember 2021-12-31 0001790169 flora:WarrantsCADOneMember 2022-06-30 0001790169 flora:WarrantsCADOneMember 2022-01-01 2022-06-30 0001790169 flora:WarrantsCADThirtyMember 2022-06-30 0001790169 flora:WarrantsCADThirtyMember 2022-01-01 2022-06-30 0001790169 flora:TotalMember 2020-12-31 0001790169 flora:TotalMember 2022-06-30 0001790169 flora:TotalMember 2022-01-01 2022-06-30 0001790169 flora:TotalMember 2021-12-31 0001790169 flora:RightOfUseAssetsMember 2020-12-31 0001790169 flora:RightOfUseAssetsMember 2022-06-30 0001790169 flora:RightOfUseAssetsMember 2022-01-01 2022-06-30 0001790169 flora:RightOfUseAssetsMember 2021-12-31 0001790169 flora:SubtotalMember 2020-12-31 0001790169 flora:SubtotalMember 2022-06-30 0001790169 flora:SubtotalMember 2022-01-01 2022-06-30 0001790169 flora:SubtotalMember 2021-12-31 0001790169 flora:VehicleMember 2020-12-31 0001790169 flora:VehicleMember 2022-06-30 0001790169 flora:VehicleMember 2022-01-01 2022-06-30 0001790169 flora:VehicleMember 2021-12-31 0001790169 flora:LandsMember 2020-12-31 0001790169 flora:LandsMember 2022-06-30 0001790169 flora:LandsMember 2022-01-01 2022-06-30 0001790169 flora:LandsMember 2021-12-31 0001790169 flora:BuildingsAndEquipmentMember 2020-12-31 0001790169 flora:BuildingsAndEquipmentMember 2022-06-30 0001790169 flora:BuildingsAndEquipmentMember 2022-01-01 2022-06-30 0001790169 flora:BuildingsAndEquipmentMember 2021-12-31 0001790169 flora:MachineryAndOfficeEquipmentMember 2020-12-31 0001790169 flora:MachineryAndOfficeEquipmentMember 2022-06-30 0001790169 flora:MachineryAndOfficeEquipmentMember 2022-01-01 2022-06-30 0001790169 flora:MachineryAndOfficeEquipmentMember 2021-12-31 0001790169 flora:ConstructionsInProgressMember 2020-12-31 0001790169 flora:ConstructionsInProgressMember 2022-06-30 0001790169 flora:ConstructionsInProgressMember 2022-01-01 2022-06-30 0001790169 flora:ConstructionsInProgressMember 2021-12-31 0001790169 flora:SubsidiaryTwentyMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryNineteenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryEighteenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiarySeventeenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiarySixteenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryFifteenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryFourteenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryThirteenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryTwelveMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryElevenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryTenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryNineMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiarySevenMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiarySixMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryEightMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryFiveMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryFourMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryThreeMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryTwoMember 2022-01-01 2022-06-30 0001790169 flora:SubsidiaryOneMember 2022-01-01 2022-06-30 0001790169 flora:NoncontrollingInterestMember 2022-06-30 0001790169 ifrs-full:RetainedEarningsMember 2022-06-30 0001790169 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001790169 flora:WarrantsMember 2022-06-30 0001790169 flora:OptionsMember 2022-06-30 0001790169 flora:CommonStockMember 2022-06-30 0001790169 flora:NoncontrollingInterestMember 2022-01-01 2022-06-30 0001790169 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001790169 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001790169 flora:WarrantsMember 2022-01-01 2022-06-30 0001790169 flora:OptionsMember 2022-01-01 2022-06-30 0001790169 flora:CommonStockMember 2022-01-01 2022-06-30 0001790169 flora:NoncontrollingInterestMember 2021-12-31 0001790169 ifrs-full:RetainedEarningsMember 2021-12-31 0001790169 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001790169 flora:WarrantsMember 2021-12-31 0001790169 flora:OptionsMember 2021-12-31 0001790169 flora:CommonStockMember 2021-12-31 0001790169 2021-06-30 0001790169 flora:NoncontrollingInterestMember 2021-06-30 0001790169 ifrs-full:RetainedEarningsMember 2021-06-30 0001790169 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001790169 flora:WarrantsMember 2021-06-30 0001790169 flora:OptionsMember 2021-06-30 0001790169 flora:CommonStockMember 2021-06-30 0001790169 flora:NoncontrollingInterestMember 2021-01-01 2021-06-30 0001790169 ifrs-full:RetainedEarningsMember 2021-01-01 2021-06-30 0001790169 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0001790169 flora:WarrantsMember 2021-01-01 2021-06-30 0001790169 flora:OptionsMember 2021-01-01 2021-06-30 0001790169 flora:CommonStockMember 2021-01-01 2021-06-30 0001790169 2020-12-31 0001790169 flora:NoncontrollingInterestMember 2020-12-31 0001790169 ifrs-full:RetainedEarningsMember 2020-12-31 0001790169 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001790169 flora:WarrantsMember 2020-12-31 0001790169 flora:OptionsMember 2020-12-31 0001790169 flora:CommonStockMember 2020-12-31 0001790169 2021-01-01 2021-06-30 0001790169 2021-12-31 0001790169 2022-06-30 iso4217:USD shares iso4217:USD shares pure iso4217:CAD 0001790169 true --12-31 2022-06-30 Q2 2022 -105000 -41000 0 0 P9Y P7Y P3Y P5Y P7Y P8Y 0 0 0 0 0 0 0 0 30124000 0 0 0 0 0 6-K/A 001-40397 FLORA GROWTH CORP. 365 Bay Street Suite 800 Toronto ON M5H 2V1 This Report on Form 6-K/A (the “Amendment”) amends the Report on Form 6-K filed on August 15, 2022 (the “Original 6-K”) containing the Unaudited Interim Condensed Consolidated Financial Statements of Flora Growth Corp. (the “Company”) as of and for the six months ended June 30, 2022. The purpose of this Amendment is solely to provide the Company’s Unaudited Interim Condensed Consolidated Financial Statements as of and for the six months ended June 30, 2022 formatted in Inline eXtensible Business Reporting Language (“iXBRL”) in accordance with Rule 405 of Regulation S-T and paragraph C.(6)(a)(ii) of the General Instructions to Form 6-K, attached hereto as Exhibit 99.1. Such Unaudited Interim Condensed Consolidated Financial Statements were previously filed without iXBRL as exhibit 99.2 to the Original 6-K. Except as described above, this Amendment speaks as of the original filing date of the Original 6-K and does not amend, update or restate any information set forth in the Original 6-K or reflect any events that occurred subsequent to the original filing date of the Original 6-K. 10268000 37614000 1000 2000 5092000 5324000 262000 273000 2224000 1700000 14000 37000 9295000 2993000 27156000 47943000 4565000 3750000 3639000 1229000 13432000 9736000 28666000 20054000 1337000 2670000 273000 97000 79068000 85479000 7401000 5628000 10000 18000 1120000 412000 20000 61000 8551000 6119000 138000 0 2411000 908000 1511000 1511000 3958000 0 16599000 8538000 119300000 102428000 6611000 3712000 10047000 10670000 -1675000 -1108000 -71512000 -38536000 -302000 -225000 62469000 76941000 79068000 85479000 -14917000 -2118000 -8415000 -1106000 6502000 1012000 46000 0 -2000 0 6546000 1012000 5243000 2262000 2096000 766000 2429000 1481000 4719000 1180000 601000 143000 2855000 95000 422000 85000 1712000 119000 405000 100000 16000000 0 1178000 -67000 37660000 6164000 -31114000 -5152000 69000 64000 200000 -78000 1333000 0 -32716000 -5138000 0 0 -32716000 -5138000 567000 200000 -33283000 -5338000 -32611000 -5097000 -105000 -41000 -33178000 -5297000 -105000 -41000 -0.42 -0.13 76944000 39604000 38355000 27254000 2396000 3961000 39000 -17287000 -113000 16250000 3333000 16667000 0 0 16667000 -1000 -3000 0 0 -3000 -5040000 0 0 -5040000 0 1349000 0 0 1349000 337000 65000 -5000 0 0 60000 0 95000 0 0 95000 0 -201000 0 0 -201000 0 -5097000 -41000 -5138000 42024000 38943000 2491000 5305000 -162000 -22384000 -154000 24039000 65517000 102428000 3712000 10670000 -1108000 -38536000 -225000 76941000 -250000 0 0 -250000 9500000 14697000 0 0 14697000 811000 1470000 84000 0 0 1554000 131000 220000 63000 -365000 28000 -54000 0 2771000 0 0 2771000 512000 96000 -19000 0 0 77000 473000 132000 -41000 0 0 91000 582000 -582000 0 0 0 -75000 0 0 -75000 0 -567000 0 0 -567000 0 -32611000 -105000 -32716000 76944000 119300000 6611000 10047000 -1675000 -71512000 -302000 62469000 -32716000 -5138000 1712000 119000 3044000 95000 16000000 0 1287000 0 405000 100000 56000 15000 0 0 0 0 -10212000 -4809000 802000 -772000 -699000 -421000 -33000 -1415000 -341000 1647000 -10483000 -5770000 0 16664000 -75000 -2024000 168000 60000 -420000 -61000 -250000 0 -69000 0 130000 -220000 -516000 14419000 0 -275000 0 224000 -722000 -1384000 0 -2430000 -15457000 -1306000 -16179000 -5171000 -168000 -195000 -27346000 3283000 37614000 15523000 10268000 18806000 2053000 0 14917000 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Flora Growth Corp. (the “Company” or “Flora”) was incorporated under the laws of the Province of Ontario, Canada on March 13, 2019. The Company is a manufacturer of global cannabis products and brands, building a connected, design-led collective of plant-based wellness and lifestyle brands. The Company’s registered office is located at 365 Bay Street, Suite 800, Toronto, Ontario, M5H 2V1, Canada and our principal place of business in the United States is located at 3406 SW 26th Terrace, Suite C-1, Fort Lauderdale, Florida 33312.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These interim condensed consolidated financial statements have been prepared on a going concern basis, meaning that the Company will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations.</p> Canada March 13, 2019 The Company is a manufacturer of global cannabis products and brands, building a connected, design-led collective of plant-based wellness and lifestyle brands. 365 Bay Street, Suite 800, Toronto, Ontario, M5H 2V1, Canada 3406 SW 26th Terrace, Suite C-1, Fort Lauderdale, Florida 33312 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>2. BASIS OF PRESENTATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Statement of compliance</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These interim condensed consolidated financial statements have been prepared by management in accordance with International Financial Reporting Standards (“IFRS”) and International Accounting Standards 34, Interim Financial Reporting (“IAS 34”), issued by the International Accounting Standards Board (“IASB”). These interim condensed consolidated financial statements do not include all notes of the type normally included within the annual financial statements and should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December 31, 2021 included in our Annual Report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”), which have been prepared in accordance with IFRS issued by the IASB and interpretations issued by the IFRS Interpretations Committee (“IFRIC”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These consolidated financial statements were approved and authorized for issuance by the Board of Directors of the Company on August 11, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Basis of consolidation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These interim condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions were eliminated on consolidation. Subsidiaries are entities the Company controls when it is exposed, or has rights, to variable returns from its involvement in the entity and can affect those returns through its power to direct the relevant activities of the entity. Subsidiaries are included in the consolidated financial results of the Company from the date of acquisition up to the date of disposition or loss of control. As at June 30, 2022, the Company had the following subsidiaries:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:29%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Subsidiaries</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Country of incorporation</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Ownership</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Functional currency</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cosechemos YA S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">90%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Growth Corp. Sucursal Colombia</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Hemp Textiles &amp; Co. LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Hemp Textiles &amp; Co. S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Beauty LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Beauty LLC Sucursal Colombia</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Kasa Wholefoods Company S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">90%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Kasa Wholefoods Company LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Grupo Farmaceutico Cronomed S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Labcofarm Laboratorios S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Breeze Laboratory S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vessel Brand Inc.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Just Brands LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Just Brands International LTD</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United Kingdom</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">British Pound (GBP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">High Roller Private Label LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Growth US Holdings Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Growth Management Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cardiff Brand Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Keel Brand Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Growth F&amp;B Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Basis of measurement </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The interim condensed consolidated financial statements have been prepared on the historical cost basis, except for certain financial instruments that are measured at fair value and biological assets as explained in the accounting policies included in the audited consolidated financial statements of the Company for the year ended December 31, 2021. Historical cost is generally based on the fair value of the consideration given in exchange for goods and services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The unaudited interim condensed consolidated financial statements are presented in United States dollars (“$”) unless otherwise noted.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Significant Accounting Policies and Critical Judgments and Estimation Uncertainties </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The interim condensed consolidated financial statements were prepared using the same accounting policies, judgments, estimates and assumptions as those used in the Company’s consolidated financial statements for the year ended December 31, 2021, except as noted below for the following new significant transactions that occurred in 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Contingent Purchase Consideration </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contingent consideration is measured at its acquisition date fair value and is included as part of the consideration transferred in a business combination, subject to the applicable terms and conditions. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration that is classified as a liability is remeasured at subsequent reporting dates with the corresponding gain or loss recognized in profit or loss. Management exercises judgment to determine the classification of contingent consideration as equity or liability based on the terms of the agreement and potential for the consideration to result in a cash outflow by the Company. Fair value estimates are determined using appropriate valuation techniques based on the nature of the terms in the purchase agreement.</p> <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:29%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Subsidiaries</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Country of incorporation</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Ownership</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Functional currency</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cosechemos YA S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">90%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Growth Corp. Sucursal Colombia</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Hemp Textiles &amp; Co. LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Hemp Textiles &amp; Co. S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Beauty LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Beauty LLC Sucursal Colombia</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Kasa Wholefoods Company S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">90%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Kasa Wholefoods Company LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Grupo Farmaceutico Cronomed S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Labcofarm Laboratorios S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Breeze Laboratory S.A.S.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Colombia Peso (COP)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vessel Brand Inc.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Just Brands LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Just Brands International LTD</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United Kingdom</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">British Pound (GBP)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">High Roller Private Label LLC</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Growth US Holdings Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Growth Management Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cardiff Brand Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Keel Brand Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:29%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Flora Growth F&amp;B Corp.</p></td><td style="width:23%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States</p></td><td style="width:10%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">100%</p></td><td style="width:21%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">United States Dollar (USD)</p></td></tr></tbody></table> Cosechemos YA S.A.S. Colombia 0.90 Colombia Peso (COP) Flora Growth Corp. Sucursal Colombia Colombia 1 Colombia Peso (COP) Hemp Textiles & Co. LLC United States 1 United States Dollar (USD) Hemp Textiles & Co. S.A.S. Colombia 1 Colombia Peso (COP) Flora Beauty LLC United States 1 United States Dollar (USD) Flora Beauty LLC Sucursal Colombia Colombia 1 Colombia Peso (COP) Kasa Wholefoods Company S.A.S. Colombia 0.90 Colombia Peso (COP) Kasa Wholefoods Company LLC United States 1 United States Dollar (USD) Grupo Farmaceutico Cronomed S.A.S. Colombia 1 Colombia Peso (COP) Labcofarm Laboratorios S.A.S. Colombia 1 Colombia Peso (COP) Breeze Laboratory S.A.S. Colombia 1 Colombia Peso (COP) Vessel Brand Inc. United States 1 United States Dollar (USD) Just Brands LLC United States 1 United States Dollar (USD) Just Brands International LTD United Kingdom 1 British Pound (GBP) High Roller Private Label LLC United States 1 United States Dollar (USD) Flora Growth US Holdings Corp. United States 1 United States Dollar (USD) Flora Growth Management Corp. United States 1 United States Dollar (USD) Cardiff Brand Corp. United States 1 United States Dollar (USD) Keel Brand Corp. United States 1 United States Dollar (USD) Flora Growth F&B Corp. United States 1 United States Dollar (USD) <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contingent consideration is measured at its acquisition date fair value and is included as part of the consideration transferred in a business combination, subject to the applicable terms and conditions. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration that is classified as a liability is remeasured at subsequent reporting dates with the corresponding gain or loss recognized in profit or loss. Management exercises judgment to determine the classification of contingent consideration as equity or liability based on the terms of the agreement and potential for the consideration to result in a cash outflow by the Company. Fair value estimates are determined using appropriate valuation techniques based on the nature of the terms in the purchase agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>3. TRADE AND AMOUNTS RECEIVABLE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company’s trade and amounts receivable are recorded at amortized cost. The trade and other receivables balance as at June 30, 2022 and December 31, 2021 consists of trade accounts receivable, amounts recoverable from the Government of Canada for Harmonized Sales Taxes (“HST”) and other receivables.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,428</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,565</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allowance for expected credit losses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,679</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,252</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">HST receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">411</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">259</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">932</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">752</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$ </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">5,092</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$ </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">5,324</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Changes in the trade accounts receivable allowance in the six months ended June 30, 2022 primarily relate to establishing an allowance for expected credit losses from the acquisition of JustCBD balances. There were no write-offs of trade receivables during the six months ended June 30, 2022. The Company has no amounts written-off that are still subject to collection enforcement activity as at June 30, 2022. There was an additional $0.3 million of expected credit losses recorded in other receivables as at June 30, 2022. The Company’s aging of trade accounts receivable is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,641</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1-30 Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">614</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">31-60 Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">259</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">61-90 Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">383</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">91-180 Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,383</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">180+ Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,148</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total trade receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">5,428</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,428</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,565</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allowance for expected credit losses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,679</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,252</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">HST receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">411</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">259</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">932</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">752</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$ </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">5,092</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$ </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">5,324</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 5428000 5565000 -1679000 -1252000 411000 259000 932000 752000 5092000 5324000 300000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,641</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1-30 Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">614</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">31-60 Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">259</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">61-90 Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">383</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">91-180 Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,383</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">180+ Days</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,148</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total trade receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">5,428</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1641000 614000 259000 383000 1383000 1148000 5428000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4. BIOLOGICAL ASSETS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s biological assets consist of cannabis plants throughout the growth cycle including propagation, vegetative and flowering stages. Cannabis plants cease being biological assets upon harvest when the fair value at time of harvest is transferred to harvested cannabis inventory. The Company has no biological assets with title restricted or pledged as collateral, and no significant commitments for development or acquisition of biological assets as at June 30, 2022. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The changes in the carrying value of biological assets are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands of United States Dollars</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Opening balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Changes in fair value less cost to sell due to biological transformation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">46</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Transferred to harvested cannabis inventory upon harvest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(69</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Ending balance at June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$ </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">14</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The valuation of biological assets is based on an income approach (Level 3) in which the fair value at the point of harvesting is estimated based on selling prices less the costs to sell. For in-process biological assets (growing plants), the fair value at the point of harvest is adjusted based on the stage of growth at period-end. Harvested cannabis is transferred from biological assets at their fair value at harvest to harvested cannabis within inventory.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant inputs and assumptions used in determining the fair value of cannabis plants are as follows as at June 30, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Average selling price per gram of $0.10 – Represents estimated selling price of dried cannabis end products net of excise taxes, where applicable, for the period for all strains of cannabis, which is expected to approximate future selling prices. Increasing this amount results in an increase in fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Weighted average yield of 21 gram per plant – Represents the weighted average number of grams of dried cannabis inventory expected to be harvested from each cannabis plant. Increasing this amount results in an increase in fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Post-harvest cost per gram to complete production of $0.04 – Based on estimated future production costs incurred divided by estimated grams produced in the period. Increasing this amount results in a decrease in fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in the assumptions above of 10% would not have a significant impact on the fair value of biological assets as at June 30, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As at June 30, 2022, the weighted average fair value less cost to complete and cost to sell a gram of dried cannabis was $0.06 per gram. The Company’s biological assets produced 746 kilograms of dried cannabis in the six months ended June 30, 2022 and the Company expects the biological assets will yield 190 kilograms of cannabis when harvested. The weighted average stage of growth for the biological assets was 41%.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands of United States Dollars</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Opening balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Changes in fair value less cost to sell due to biological transformation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">46</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Transferred to harvested cannabis inventory upon harvest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(69</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Ending balance at June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$ </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">14</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 37000 46000 -69000 14000 21 0.04 0.10 0.06 0.41 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>5. INVENTORY </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Inventory is comprised of the following as at June 30, 2022 and December 31, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">December 31,</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021 </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Raw materials and supplies </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,161</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">899</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Harvested cannabis</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>92</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Work in progress</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>465</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">97</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Finished goods</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>6,577</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,962</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>9,295</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,993</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="ffcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">December 31,</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2021 </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Raw materials and supplies </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,161</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">899</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Harvested cannabis</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>92</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Work in progress</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>465</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">97</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Finished goods</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>6,577</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,962</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>9,295</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,993</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 2161000 899000 92000 35000 465000 97000 6577000 1962000 9295000 2993000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>6. PROPERTY, PLANT AND EQUIPMENT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">In Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Construction in progress </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Machinery and Office equipment </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Buildings </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Vehicles </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Land </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Subtotal </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Right of use assets </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cost at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">905</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,991</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">928</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">112</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3,973</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,532</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">5,505</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">321</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">53</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">23</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">305</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">702</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,053</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,755</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Business combinations (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">506</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">30</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">772</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,308</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Foreign exchange translation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(52</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(71</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(38</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(1</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(22</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(184</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(49</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(233</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cost as at June 30, 2022 </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,174</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">2,479</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">913</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">66</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">395</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">5,027</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">4,308</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">9,335</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Accumulated depreciation </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(169</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(44</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(10</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(223</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(303</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(526</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(229</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(44</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(275</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(383</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(658</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Disposals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Foreign exchange translation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">12</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">16</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">17</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">33</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Accumulated depreciation as at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(366</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(84</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(12</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(462</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(669</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(1,131</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Carrying value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">As at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">905</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,822</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">884</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">27</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">112</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">3,750</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,229</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">4,979</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>1,174</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>2,113</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>829</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>54</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>395</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>4,565</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>3,639</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>8,204</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">In Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Construction in progress </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Machinery and Office equipment </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Buildings </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Vehicles </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Land </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Subtotal </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Right of use assets </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cost at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">905</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,991</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">928</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">112</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3,973</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,532</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">5,505</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">321</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">53</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">23</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">305</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">702</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,053</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,755</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Business combinations (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">506</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">30</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">772</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,308</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Foreign exchange translation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(52</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(71</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(38</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(1</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(22</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(184</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(49</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(233</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cost as at June 30, 2022 </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,174</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">2,479</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">913</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">66</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">395</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">5,027</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">4,308</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">9,335</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Accumulated depreciation </strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(169</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(44</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(10</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(223</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(303</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(526</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(229</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(44</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(275</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(383</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(658</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Disposals</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">20</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:10pt">Foreign exchange translation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">12</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">4</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">16</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">17</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">33</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Accumulated depreciation as at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(366</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(84</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(12</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(462</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(669</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(1,131</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Carrying value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">As at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">905</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,822</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">884</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">27</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">112</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">3,750</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,229</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">4,979</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>1,174</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>2,113</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>829</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>54</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>395</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>4,565</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>3,639</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>8,204</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 905000 1991000 928000 37000 112000 3973000 1532000 5505000 321000 53000 23000 0 305000 702000 2053000 2755000 0 506000 0 30000 0 536000 772000 1308000 -52000 -71000 -38000 -1000 -22000 -184000 -49000 -233000 1174000 2479000 913000 66000 395000 5027000 4308000 9335000 0 -169000 -44000 -10000 0 -223000 -303000 -526000 0 229000 44000 2000 0 275000 383000 658000 0 20000 0 0 0 20000 0 20000 0 12000 4000 0 0 16000 17000 33000 0 -366000 -84000 -12000 0 -462000 -669000 -1131000 905000 1822000 884000 27000 112000 3750000 1229000 4979000 1174000 2113000 829000 54000 395000 4565000 3639000 8204000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>7. LONG-TERM INVESTMENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As at June 30, 2022, the Company’s long-term investments consist of common shares and warrants to purchase additional common shares in an early stage European cannabis company. In 2021, the Company purchased common shares from the investee for Euro 2.0 million ($2.4 million), purchased its first tranche of warrants from existing investors in exchange for 225,000 common shares of the Company, and obtained a second tranche of warrants from the investee as an inducement to exercise some of the first tranche of warrants. As at June 30, 2022, the Company owns approximately 9.6% of the investee, or approximately 8.6% on a diluted basis including exercisable warrants of the Company and other investors. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The warrants allow the holder to purchase one common share of the investee for CAD 0.30 ($0.23) for the first tranche, and CAD 1.00 ($0.78) for the second tranche. The warrants were immediately exercisable and expire February 1, 2023. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s cost of the investments was recorded based on the fair value of the consideration exchanged as at the respective transaction dates. The investee is not a publicly listed entity and has no active quoted prices for its common shares or warrants. Subsequent remeasurements are recorded as FVPL as indicated on the unrealized investments loss caption on the statement of loss and comprehensive loss. The Company estimated the fair value of the investments as at June 30, 2022 using Level 3 inputs of the fair value hierarchy with the fair value of the investee common shares at $0.32, the first tranche warrants at $0.13, and the second tranche warrants at $0.02. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The investee common shares were valued considering price to book value and price to tangible book value of the investee (3.6 and 4.8, respectively) as well as comparable guideline publicly traded companies at the time of initial investment. These initial investment multiples were compared to the guideline public company multiples observed as at June 30, 2022 (2.2 price to book value and 3.0 price to tangible value), with these updated valuation multiples applied to the investee’s estimated book value. The Company also considered the status of the investee’s milestones between the purchase date and year-end for indicators of change in value. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the warrants was developed using a Black-Scholes model for each tranche with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants CAD 0.30 exercise price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants CAD 1.00 exercise price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.32</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.32</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.23</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.78</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected term in years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.13</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Quantity owned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,666,667</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">333,333</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">222,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">8,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">The share price is based on the calculated value of the investee’s common shares as discussed above. The volatility considers actual volatility of comparable guideline public companies. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">A schedule of the Company’s long-term investments activity is as follows: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Investee common shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants CAD 0.30 exercise price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants CAD 1.00 exercise price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Financial asset hierarchy level</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> $</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><strong> $ </strong></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> $</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><strong> $ </strong></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,987</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">625</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,670</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss on changes in fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(880</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(403</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,333</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,107</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">222</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">8</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,337</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The loss on changes in fair value appear in the unrealized loss on fair value of investments caption in the statement of loss and comprehensive loss. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As a sensitivity assessment to the fair value calculations, a 10% change in the valuation multiples applied to the investee common shares results in a 10% change in the fair value as at June 30, 2022 of $111,000. Applying a 10% change in share price to the warrants results in an approximately $44,000 change in fair value, and a 10% change in volatility of approximately $14,000. </p> 2400000 225000 0.096 0.086 0.23 0.78 0.32 0.13 0.02 3.6 4.8 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants CAD 0.30 exercise price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants CAD 1.00 exercise price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.32</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.32</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.23</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.78</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected term in years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.6</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.13</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Quantity owned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,666,667</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">333,333</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">222,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">8,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.32 0.32 0.23 0.78 1 1 0.031 0.031 0.000 0.000 P0Y7M6D P0Y7M6D 0.13 0.02 1666667 333333 222000 8000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Investee common shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants CAD 0.30 exercise price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants CAD 1.00 exercise price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Financial asset hierarchy level</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> $</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><strong> $ </strong></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> $</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><strong> $ </strong></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,987</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">625</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,670</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss on changes in fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(880</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(403</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,333</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,107</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">222</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">8</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,337</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1987000 625000 58000 2670000 -880000 -403000 -50000 -1333000 1107000 222000 8000 1337000 0.10 0.10 111000 0.10 44000 14000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>8. ASSET ACQUISITIONS AND BUSINESS COMBINATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Just Brands LLC and High Roller Private Label LLC (collectively “JustCBD”) business combination</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 24, 2022, Flora Growth U.S. Holdings Corp., a wholly-owned subsidiary of the Company, completed the acquisition of 100% of the outstanding equity interests in each of (i) Just Brands LLC and (ii) High Roller Private Label LLC for total purchase consideration of $34.6 million. JustCBD is a manufacturer and distributor of consumable cannabinoid products, including gummies, tinctures, vape cartridges, and creams. JustCBD is based in Florida in the United States and was formed in 2017. The Company acquired JustCBD to expand its product offerings, accelerate its revenue growth, expand its customer and distribution footprints in the United States and for the acquisition of human capital through JustCBD’s management team.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The purchase consideration was comprised of $16.0 million of cash, 9.5 million common shares of the Company valued at $14.7 million, inclusive of a 15% fair value discount for the required six-month holding period of the shares, and $4.0 million of contingent purchase consideration. The contingent purchase consideration is based on a clause in the purchase agreement that provides that if at any time during the 24 months following the acquisition date, the five-day volume weighted average price (“VWAP”) per share of the Company’s common shares as quoted on the Nasdaq Capital Market fails to equal or exceed $5.00, then the Company shall issue a number of additional common shares to the sellers equal to the difference between (x) a fraction, the numerator of which is $47.5 million and the denominator of which is the highest five day VWAP at any point during the 24 months following the closing and (y) the 9.5 million common shares delivered to the sellers at the closing. In no event shall the Company be required to issue more than 3.65 million common shares unless it shall have obtained the consent of the Company’s shareholders to do so. In the event the Company is required to deliver in excess of 3.65 million shares to the sellers (“Excess Shares”) and the Company shall not have obtained shareholder consent, the Company may deliver cash to the sellers in lieu of such Excess Shares determined by a formula set forth in the purchase agreement. The contingent purchase consideration is classified as a financial liability within other long-term liabilities on the statement of financial position as the Company may be required to settle any amounts due in cash instead of common shares if the Company’s common shareholders do not provide requisite shareholder approval to issue additional common shares.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the contingent purchase consideration was determined using a Monte Carlo simulation incorporating Brownian motion with 100,000 trials through a binomial lattice model. The significant inputs to the valuation include the two year time period, the Company’s closing share price at February 24, 2022 ($1.82), estimated Company common share volatility (100%), and risk free rate of 1.5% to discount the ending result to present value. </p><p style="font-size:10pt;font-family:times new roman;margin:0px">The amounts recognized as at the acquisition date for each major class of assets acquired and liabilities assumed are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(Thousands of United States dollars)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">535</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">975</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventory</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,534</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">540</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property, plant, and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">537</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Right of use assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">772</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other non-current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">127</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,757</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Goodwill</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">24,869</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">38,646</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Current liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade payables and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,273</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Current lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(644</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Provision for sales tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(982</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other current liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(99</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,998</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total net assets acquired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">34,648</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the trade receivables reflects a $291,000 discount to the gross contractual amounts as allowance for potentially uncollectible amounts. Since the acquisition date through June 30, 2022, JustCBD revenue was $10.0 million with net loss and comprehensive loss of $0.4 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The intangible assets of $4.8 million are comprised of the following categories and estimated useful lives: tradenames of $3.4 million for eight to nine years, customer relationships of $1.2 million for five to seven years, and know-how of $0.2 million for three years. The Company expects the goodwill and intangible asset values to be deductible for Unites States income tax purposes.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If JustCBD was acquired at January 1, 2022, the combined revenue and net loss of JustCBD and the Company would have increased approximately $5.2 million and $1.6 million, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Acquisition of Minority interests</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 18, 2022, the Company acquired the remaining 10% of the outstanding equity interests in Flora Beauty LLC from its minority shareholder in exchange for 100,000 common shares of the Company and a stock option exercisable for up to 50,000 common shares of the Company at an exercise price of $1.70 per share that expire five years from the date of the grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 31, 2022, the Company completed its acquisition of Breeze by acquiring the remaining 10% of the equity interests in Breeze from its minority shareholders in exchange for 30,282 common shares of the Company.</p> 1 34600000 16000000.0 9500000 1470000 0.15 4000000.0 5 9500000 3650000 3650000 100000 1.82 1 0.015 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(Thousands of United States dollars)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">535</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">975</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventory</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,534</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">540</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Non-current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property, plant, and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">537</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Right of use assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">772</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other non-current assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">127</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Intangible asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,757</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Goodwill</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">24,869</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">38,646</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Current liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade payables and accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,273</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Current lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(644</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Provision for sales tax</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(982</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Other current liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(99</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,998</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total net assets acquired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">34,648</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 535000 975000 5534000 540000 537000 772000 127000 4757000 24869000 38646000 -2273000 -644000 -982000 -99000 -3998000 34648000 291000 10000000.0 400000 480000 3400000 1200000 200000 5200000 1600000 0.10 100000 50000 1.70 0.10 30282 <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>9. INTANGIBLE ASSETS AND GOODWILL</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A continuity of intangible assets for the six months ended June 30, 2022 is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> In Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>License</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Customer Relationships</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Trademarks and Brands</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Patents</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Non-Compete Agreements</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Goodwill</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cost</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">At December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">610</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,759</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,211</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">4,300</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,190</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">20,054</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">30,124</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Acquired through business combinations (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,160</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3,357</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">240</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">24,869</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">29,626</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Impairment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(16,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(16,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">At June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">610</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">2,919</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">5,568</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">4,540</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,190</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">28,923</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">43,750</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Accumulated Amortization</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">At December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">129</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">48</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">66</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">304</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">82</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">169</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">306</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">297</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">198</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,052</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">At June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">211</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">195</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">341</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">345</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">264</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,356</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Foreign Currency translation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(18</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(21</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(257</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(296</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt"><strong>Net book value at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>381</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>2,724</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>5,206</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>4,195</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>926</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>28,666</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>42,098</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s intangible asset additions in 2022 primarily consist of assets acquired as part of the February 2022 purchase of JustCBD (Note 8). Information regarding the significant JustCBD intangible assets within the indicated categories of the table above is as follows as at June 30, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">Tradenames: carrying amount $3.2 million with 92 to 104 months of remaining amortization periods</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">Customer relationships: carrying amount $1.1 million with 56 to 80 months of remaining amortization periods</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">Know-how: carrying amount $0.2 million with 32 months of remaining amortization period</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s goodwill is assigned to the following cash generating units (“CGU’s”) as at June 30, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">In Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Pharmaceuticals and nutraceuticals </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Vessel </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> JustCBD </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Total </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">379</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,675</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">20,054</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Acquired through business combinations (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">24,612</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">24,612</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Impairment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(16,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(16,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">379</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3,675</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">24,612</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">28,666</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> In Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>License</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Customer Relationships</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Trademarks and Brands</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Patents</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Non-Compete Agreements</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Goodwill</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cost</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">At December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">610</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,759</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,211</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">4,300</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,190</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">20,054</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">30,124</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Acquired through business combinations (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,160</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3,357</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">240</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">24,869</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">29,626</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Impairment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(16,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(16,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">At June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">610</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">2,919</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">5,568</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">4,540</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,190</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">28,923</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">43,750</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Accumulated Amortization</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">At December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">129</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">48</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">66</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">304</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">82</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">169</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">306</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">297</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">198</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,052</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">At June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">211</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">195</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">341</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">345</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">264</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">1,356</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Foreign Currency translation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(18</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(21</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(257</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(296</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt"><strong>Net book value at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>381</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>2,724</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>5,206</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>4,195</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>926</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>28,666</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>42,098</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 610000 1759000 2211000 4300000 1190000 20054000 30124000 0 1160000 3357000 240000 0 24869000 29626000 0 0 0 0 0 -16000000 -16000000 610000 2919000 5568000 4540000 1190000 28923000 43750000 129000 26000 35000 48000 66000 0 304000 82000 169000 306000 297000 198000 1052000 211000 195000 341000 345000 264000 0 1356000 -18000 0 -21000 0 0 -257000 -296000 381000 2724000 5206000 4195000 926000 28666000 42098000 3200000 92 to 104 months of remaining amortization periods 200000 32 months of remaining amortization period <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">In Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Pharmaceuticals and nutraceuticals </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Vessel </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> JustCBD </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Total </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As at December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">379</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,675</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">20,054</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Acquired through business combinations (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">24,612</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">24,612</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Impairment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(16,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(16,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">379</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3,675</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">24,612</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">28,666</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 379000 19675000 0 20054000 0 0 24612000 24612000 0 -16000000 0 -16000000 379000 3675000 24612000 28666000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>10. IMPAIRMENT OF ASSETS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The carrying amounts of the Company’s non-financial assets are reviewed for impairment each reporting period or whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds its recoverable amount. At June 30, 2022, the Company’s Vessel CGU had external indicators of impairment primarily due to a 2022 decline in comparable public company share prices which would negatively impact the implied valuation of Vessel. As such, the Company tested the Vessel CGU non-financial assets for impairment as at June 30, 2022. The Vessel CGU was acquired in November 2021 and is part of the Company’s consumer products reportable segment. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vessel’s June 30, 2022 carrying value of $28.0 million is comprised primarily of goodwill and identified intangible assets of $28.0 million and other long-lived assets of $1.4 million. The carrying value is reduced by inseparable market participant liabilities associated with the November 2021 acquisition of Vessel which includes $1.4 million of deferred tax liability and $1.2 million of lease liability. The estimated recoverable amount of Vessel at June 30, 2022 was $11.9 million, resulting in impairment of $16.0 million as the carrying value of the CGU’s assets exceeds the recoverable amount. The impairment is recorded in goodwill impairment caption on the statement of loss and comprehensive loss. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The recoverable amount is based on fair value less costs of disposal. The fair value was determined based on guideline public companies similar to Vessel considering financial metrics such as historical revenue growth, gross margin and EBITDA profitability and with operations focused on consumer brands and similar sales channels. An enterprise value to latest twelve months revenue multiple of 1.75 was selected based on consideration of the enterprise value to latest twelve months multiples of the guideline companies. The multiple was applied to Vessel’s revenue for the twelve months ended June 30, 2022. Estimated costs of disposal of 3% were subtracted to arrive at the recoverable amount. The impairment test valuation is considered a Level 3 method within the IFRS 13 fair value hierarchy.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After the impairment, Vessel’s carrying value is equal to its recoverable amount. Any change in the significant assumptions could result in additional impairment of its goodwill and long-lived assets as at June 30, 2022. As a sensitivity assessment to the recoverable amount calculations, reducing the selected revenue multiple by 0.5 from 1.75 above down to 1.25 (approximately 29% decrease) would result in additional goodwill impairment of approximately $3.0 million. </p> 28000000.0 28000000.0 1400000 1400000 1200000 11900000 16000000.0 The fair value was determined based on guideline public companies similar to Vessel considering financial metrics such as historical revenue growth, gross margin and EBITDA profitability and with operations focused on consumer brands and similar sales channels. An enterprise value to latest twelve months revenue multiple of 1.75 was selected based on consideration of the enterprise value to latest twelve months multiples of the guideline companies. The multiple was applied to Vessel’s revenue for the twelve months ended June 30, 2022. Estimated costs of disposal of 3% were subtracted to arrive at the recoverable amount. The impairment test valuation is considered a Level 3 method within the IFRS 13 fair value hierarchy As a sensitivity assessment to the recoverable amount calculations, reducing the selected revenue multiple by 0.5 from 1.75 above down to 1.25 (approximately 29% decrease) would result in additional goodwill impairment of approximately $3.0 million <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>11. LEASES </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s leases primarily consist of administrative real estate leases in Colombia and the United States, and the Company’s cultivation property in Santander, Colombia. Information regarding the Company’s leases is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Six months ended June 30, 2022 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> Six months ended June 30, 2021 </p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Lease expense</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Amortization expense by class of underlying asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Office Space</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>351</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Building</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>5</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Land</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>27</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total amortization expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>383</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">45</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Interest on lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>83</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Short-term and low value assets lease expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>510</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total lease expense</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>976</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">59</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Other Information</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Additions to right of use assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,053</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Cash paid for amounts included in the measurement of lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Financing cash flows from leases (interest)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>69</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Financing cash flows from leases (principal)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>420</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">70</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Operating cash flows for short term and low value asset leases </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>510</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total cash outflows from leases</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>999</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">86</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Carrying amount of right of use asset by class of underlying asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Office Space</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,492</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">231</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Building</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,036</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Land</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>111</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total carrying amount of right of use assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3,639</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">247</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The maturity analysis of the undiscounted contractual balances of the lease liability is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> As at June 30, 2022 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,366</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,251</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>447</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>440</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>373</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>290</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total undiscounted cash flows</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,167</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Less: present value discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(606</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3,561</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p>Most of the Company’s leases contain renewal options to continue the leases for another term equivalent to the original term, which are generally up to two years. The lease liabilities above include renewal terms that management has executed or is reasonably certain of renewing, which only included leases that would have expired in 2022. The Company’s land lease for 361 hectares of property in Santander, Colombia expires August 31, 2024 and is recorded as a right of use asset in property, plant and equipment. There is an option to extend the lease for an additional five years, unless either the Company or lessor provide notice to terminate the lease at the end of the original term with six months’ notice. <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> Six months ended June 30, 2022 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> Six months ended June 30, 2021 </p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Lease expense</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Amortization expense by class of underlying asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Office Space</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>351</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Building</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>5</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Land</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>27</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total amortization expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>383</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">45</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Interest on lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>83</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Short-term and low value assets lease expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>510</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total lease expense</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>976</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">59</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Other Information</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Additions to right of use assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,053</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Cash paid for amounts included in the measurement of lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Financing cash flows from leases (interest)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>69</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Financing cash flows from leases (principal)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>420</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">70</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Operating cash flows for short term and low value asset leases </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>510</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total cash outflows from leases</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>999</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">86</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Carrying amount of right of use asset by class of underlying asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Office Space</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,492</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">231</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Building</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,036</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Land</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>111</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total carrying amount of right of use assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3,639</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">247</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 351000 40000 5000 5000 27000 0 383000 45000 83000 14000 510000 0 976000 59000 2053000 0 69000 16000 420000 70000 510000 0 999000 86000 2492000 231000 1036000 16000 111000 0 3639000 247000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> As at June 30, 2022 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,366</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,251</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>447</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>440</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>373</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>290</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total undiscounted cash flows</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,167</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:40pt">Less: present value discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(606</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:20pt">Total lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3,561</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1366000 1251000 447000 440000 373000 290000 4167000 -606000 3561000 The Company’s land lease for 361 hectares of property in Santander, Colombia expires August 31, 2024 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>12. CAPITAL STOCK </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Authorized and issued</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has an unlimited number of common shares, no par value, authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company had the following significant common share transactions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Six months ended June 30, 2022</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>FEBRUARY 2022 PAYMENT TO JUSTCBD OWNERS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As discussed in Note 8, the Company issued 9,500,000 common shares of the Company valued at $14.7 million, inclusive of a 15% fair value discount for the required six-month holding period of the shares, to the prior owners of JustCBD as part of the Company’s acquisition of JustCBD in February 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>ACQUISITION OF NONCONTROLLING INTERESTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 18, 2022, the Company issued 100,000 common shares of the Company valued at $0.2 million to acquire the remaining 10% of the outstanding equity interests in Flora Beauty LLC from its minority shareholders. In addition to the common shares, the Company granted a stock option, exercisable for up to 50,000 common shares of the Company at an exercise price of $1.70 per share that expire five years from the date of the grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 31, 2022, the Company issued 30,282 common shares of the Company valued at $0.1 million to complete its acquisition of Breeze by acquiring the remaining 10% of the equity interests in Breeze from its minority shareholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>OTHER OFFERINGS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In January 2022, the Company amended an agreement with a consultant pursuant to which the Company issued 111,112 common shares of the Company valued at $0.2 million and a stock option, exercisable for up to 83,333 common shares of the Company at an exercise price of $2.25 per share that expire five years from the date of the grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 5, 2022, the Company issued 700,000 common shares of the Company valued at $1.3 million as part of a settlement agreement with Boustead Securities, LLC (“Boustead”) to resolve certain disputes arising under a prior underwriting agreement and engagement letter. In addition to the common shares, the Company paid Boustead $0.4 million.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>SHARE REPURCHASE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 16, 2022, the Company announced that its Board of Directors had approved the repurchase of up to $5 million of its common shares. For the six months ended June 30, 2022, no shares were repurchased.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any future repurchases will depend on factors such as market conditions, share price and other opportunities to invest capital for growth. From time to time when management does not possess material nonpublic information about the Company or its securities, the Company may enter a pre-defined plan with a broker to allow for the repurchase of shares at times when the Company ordinarily would not be active in the market due to internal trading blackout periods, insider trading rules or otherwise. Any such plans entered with our broker will be adopted in accordance with applicable securities laws such as the requirements of Rule 10b5-1 under the U.S. Securities Exchange Act of 1934, as amended.</p> 9500000 14700000 0.15 100000 200000 0.10 50000 1.70 30282 10000 0.10 111112 200000 83333 2.25 700000 1300000 400000 5000000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>13. OPTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In March of 2019, the Company adopted a stock option plan whereby it may grant options for the purchase of common shares to any director, consultant, employee or officer of the Company or its subsidiaries. The aggregate number of shares that may be issuable pursuant to options granted under the Company’s stock option plan will not exceed 10% of the common shares of the Company outstanding (the “Shares”) at the date of grant. The options are non-transferable and non-assignable and may be granted for a term not exceeding five years. The exercise price of the options will be determined by the Board of Directors of the Company at the time of grant, but if the Shares are traded on any stock exchange (the “Exchange”), the exercise price may not be less than the closing price of the Shares on the Exchange on the trading date immediately preceding the date of grant, subject to all applicable regulatory requirements. Stock option vesting terms are subject to the discretion of the Company’s Board of Directors.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Information relating to share options outstanding and exercisable as at June 30, 2022 and December 31, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted average exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>$</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,448</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.96</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>471</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1.62</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(512</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>0.15</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>5,407</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>2.09</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date of expiry</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options outstanding </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options exercisable </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise price</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant date fair value vested </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining life in years </strong></p></td></tr><tr style="height:15px"><td style="width:14%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands</strong></p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands</strong></p></td><td style="width:7%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>$</strong></p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands of Dollars</strong></p></td><td style="width:13%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">June 28, 2024</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">949</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">949</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 0.15 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">35</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 2.0 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">April 23, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">117</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">117</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">344</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 2.8 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">July 6, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">317</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">317</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">252</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.0 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">July 15, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">84</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">84</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.0 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">July 31, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">17</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">17</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">23</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.1 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 8, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">66</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">66</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">92</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.2 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">November 4, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">666</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">666</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">918</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.4 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">December 23, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">500</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">500</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">689</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.5 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">June 3, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">241</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">241</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 3.87 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">686</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.9 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">June 10, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">167</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">167</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 3.68 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">455</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.9 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 21, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">16</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 5.20 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">54</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.2 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 25, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">240</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 6.90 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1,026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.2 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">December 16, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1,640</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">175</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.04 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1,590</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.5 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">January 17, 2027</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 50</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">50</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 1.70 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">63</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.6 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">January 26, 2027</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">287</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">217</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 1.48 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">296</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.6 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">May 16, 2027</p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">50</p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-</p></td><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 1.30 </p></td><td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4</p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.9 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5,407</p></td><td style="BORDER-BOTTOM: black 3px double;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3,482</p></td><td style="BORDER-BOTTOM: black 3px double;width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.09 </p></td><td style="BORDER-BOTTOM: black 3px double;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">6,611</p></td><td style="BORDER-BOTTOM: black 3px double;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.6 </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of stock options issued during the six months ended June 30, 2022 was determined at the time of issuance using the Black-Scholes option pricing model with the following weighted average inputs, assumptions and results:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free annual interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.75</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current stock price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.58</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected annualized volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected life (years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.65</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected annual dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1.62</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The total expense related to the options granted in the period ended June 30, 2022 was $2.9 million (2021 - $0.1 million). The options issued in 2022 vest one year following the date of grant if the award holder is still employed or engaged by the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">No stock options expired or were forfeited in the six months ended June 30, 2022.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted average exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>$</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance, December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,448</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.96</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>471</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1.62</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(512</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>0.15</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>5,407</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>2.09</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date of expiry</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options outstanding </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options exercisable </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise price</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant date fair value vested </strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining life in years </strong></p></td></tr><tr style="height:15px"><td style="width:14%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands</strong></p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands</strong></p></td><td style="width:7%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>$</strong></p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Thousands of Dollars</strong></p></td><td style="width:13%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">June 28, 2024</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">949</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">949</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 0.15 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">35</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 2.0 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">April 23, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">117</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">117</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">344</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 2.8 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">July 6, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">317</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">317</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">252</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.0 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">July 15, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">84</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">84</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.0 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">July 31, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">17</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">17</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">23</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.1 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 8, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">66</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">66</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">92</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.2 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">November 4, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">666</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">666</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">918</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.4 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">December 23, 2025</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">500</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">500</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.25 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">689</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.5 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">June 3, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">241</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">241</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 3.87 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">686</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.9 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">June 10, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">167</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">167</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 3.68 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">455</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.9 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 21, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">16</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 5.20 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">54</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.2 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">September 25, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">240</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 6.90 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1,026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.2 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">December 16, 2026</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1,640</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">175</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.04 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1,590</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.5 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">January 17, 2027</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 50</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">50</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 1.70 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">63</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.6 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">January 26, 2027</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">287</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">217</p></td><td style="width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 1.48 </p></td><td style="width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">296</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.6 </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">May 16, 2027</p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">50</p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-</p></td><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 1.30 </p></td><td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4</p></td><td style="BORDER-BOTTOM: 1px solid;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 4.9 </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:14%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">5,407</p></td><td style="BORDER-BOTTOM: black 3px double;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3,482</p></td><td style="BORDER-BOTTOM: black 3px double;width:7%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> 2.09 </p></td><td style="BORDER-BOTTOM: black 3px double;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">6,611</p></td><td style="BORDER-BOTTOM: black 3px double;width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> 3.6 </p></td></tr></tbody></table> 5448 1.96 471 1.62 -512 0.15 5407 2.09 949000 949000 0.15 35000 P2Y 117000 117000 2.25 344000 P2Y9M18D 317000 317000 2.25 252000 P3Y 84000 2.25 84000 P3Y 17000 17000 2.25 23000 P3Y1M6D 66000 66000 2.25 92000 P3Y2M12D 666000 666000 2.25 918000 P3Y4M24D 500000 500000 2.25 689000 P3Y6M 241000 241000 3.87 686000 P3Y10M24D 167000 167000 3.68 455000 P3Y10M24D 16000 5.20 54000 P4Y2M12D 240000 6.90 1026000 P4Y2M12D 1640000 175000 2.04 1590000 P4Y6M 50000 50000 1.70 63000 P4Y7M6D 287000 217000 1.48 296000 P4Y7M6D 50000 1.30 4000 P4Y10M24D 5407000 3482000 2.09 6611000 P3Y7M6D <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free annual interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.75</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current stock price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.58</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected annualized volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected life (years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.65</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected annual dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercise price</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1.62</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.0175 1.58 1 P4Y7M24D 0 1.62 2900000 100000 <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>14.WARRANTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following tables show warrants outstanding as at June 30, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of warrants</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted average exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Thousands</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>8,746</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3.37</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(473</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.49</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cancelled/Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(885</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.00</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>7,388</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3.60</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date of expiry</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants outstanding</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant date </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>fair value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining life</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> in years</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="14" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Thousands</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">$ </td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Thousands of Dollars </td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">July 23, 2021 - September 20, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,178</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">776</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.12</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">November 18, 2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,750</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.75</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,706</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.39</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">November 18, 2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">460</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.30</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,055</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.39</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">7,388</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"/><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3.60</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"/><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">10,537</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3.77</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>14.WARRANTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following tables show warrants outstanding as at June 30, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of warrants</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted average exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Thousands</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, December 31, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>8,746</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>3.37</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(473</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.49</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cancelled/Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(885</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.00</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>7,388</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>3.60</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date of expiry</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants outstanding</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant date </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>fair value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Remaining life</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> in years</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="14" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Thousands</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">$ </td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;">Thousands of Dollars </td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">July 23, 2021 - September 20, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,178</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.00</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">776</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.12</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">November 18, 2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,750</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.75</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,706</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.39</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">November 18, 2027</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">460</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.30</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,055</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.39</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">7,388</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"/><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3.60</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"/><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">10,537</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3.77</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 8746000 3.37 -473000 0.49 -885000 3.00 7388 3.60 July 23, 2021 - September 20, 2022 1178000 3.00 776 P0Y1M13D November 18, 2026 5750000 3.75 8706 P4Y4M20D November 18, 2027 460000 3.30 1055 P5Y4M20D 7388000 3.60 10537 P3Y9M7D <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>15.</strong> <strong>PROVISIONS, COMMITMENTS AND CONTINGENCIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Provisions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s current known provisions and contingent liabilities consist of termination benefits and legal disputes. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Termination benefits</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Legal disputes</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Sales tax</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Balance as at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">352</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,681</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Acquired through business combinations</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">982</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Payments/settlements</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(352</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,681</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Additional provisions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">407</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Balance as at June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,389</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Sales tax provision relates to estimated amounts owed to certain jurisdictions in the Unites States for sales from the Company’s JustCBD operations. The opening balance was acquired during the February 24, 2022 acquisition of JustCBD, with additional provision for estimated amounts due on sales subsequent to the acquisition. The ending balance is recorded within trade payables and accrued liabilities with current liabilities on the statement of financial position, and as a reduction of revenue on the statement of loss and comprehensive loss.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records liabilities for legal proceedings in those instances where it can reasonably estimate the amount of the loss and where liability is probable. The Company is engaged from time-to-time in various legal proceedings and claims that have arisen in the ordinary course of business. The outcome of all the proceedings and claims against the Company is subject to future resolution, including the uncertainties of litigation. Based on information currently known to the Company and after consultation with outside legal counsel, management believes that the probable ultimate resolution of any such proceedings and claims, individually or in the aggregate, will not have a material adverse effect on the financial condition of the Company, taken as a whole as at June 30, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 18, 2022, the Company received a letter from a law firm representing an undisclosed group of former pre-acquisition shareholders of VBI (the “VBI Shareholders”) seeking to engage in settlement discussions on the basis that the Company was purportedly misleading in its intentions to engage in a capital raising transaction shortly after the completion of the VBI acquisition. We promptly responded in writing and denied the VBI Shareholders presentation of the facts and denied all allegations against the Company. We believe that any potential claims as alleged in the letter are without merit and we intend to defend vigorously against them in connection with any future potential legal proceedings. The VBI Shareholders have not commenced litigation against the Company and it is unknown whether the VBI Shareholders will do so and what their claims may be. The Company believes that an unfavorable settlement in this matter is remote, and, as such, has not accrued a liability as of June 30, 2022.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">On June 21, 2022, an action was brought against the Company in the Ontario Superior Court of Justice by Gerardo Andres Garcia Mendez claiming that the Company is obligated to issue 3.0 million (pre-one-for three reverse stock split) common shares to him for a purchase price of $0.05 per share. Mr. Mendez claims he is entitled to such shares as a result of alleged consulting services he performed in 2019. The Company disputes his claims and intends to vigorously defend against this action. The Company believes that an unfavorable settlement in this matter is remote, and, as such, has not accrued a liability as of June 30, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In connection with the Company’s acquisition of JustCBD, the former owners of JustCBD agreed to fully indemnify the Company against any losses which may arise out of certain pre-existing litigation against JustCBD (including all matters disclosed below) as well as litigation which may be brought in the future against JustCBD and pertaining to the period prior to the acquisition. Since these matters are fully indemnified, the Company has not accrued any liability with respect to these claims. As of the date hereof, the following actions are pending against JustCBD:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Erin Gilbert et al. vs. Just CBD LLC, et al., Case No. 062019CA020275AXXXCE. This matter involves allegations that JustCBD sold a defective Just CBD mango Vape Cartridge which is alleged to have caused Plaintiff, Erin Gilbert, to suffer personal injuries. The claims asserted against JustCBD include: (1) strict liability design defect; (2) negligent design; (3) strict liability manufacturing defect; (4) negligent manufacturing; (5) warning defects; and (6) loss of consortium. The same allegations were asserted against seven (7) other defendants, including two (2) manufacturers of the actual vape cartridge. To date, JustCBD has vigorously defended the case and the case is in the discovery phase. Currently, this matter is scheduled for trial to commence on September 19, 2022 but it is likely the trial will be continued pending further discovery.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">William Braley vs. Just Brands USA, Inc., Just Brands FL, LLC, and SSGI Financial Services, Inc., Case No. 21-cv-06812, Northern District of Illinois. This matter involves allegations that the Defendants falsely and deceptively marketed cannabidiol infused gummies as not containing Tetrahydrocannabinol (“THC”). Plaintiff asserts he has suffered damages because after ingesting the gummies he failed an employment related drug test. JustCBD disputes these claims. At this time, JustCBD has filed a motion to dismiss the RICO portion of the complaint and answered and asserted affirmative defenses to the Consumer Protection claims.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Management contracts</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is party to certain management contracts. As at June 30, 2022, these contracts require payments totaling approximately $2.3 million to be made upon the occurrence of a change in control to the officers of the Company. The Company is also committed to payments to certain individuals upon termination of approximately $1.9 million pursuant to the terms of these contracts. As a triggering event has not taken place, these amounts have not been recorded in these consolidated financial statements.</p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Termination benefits</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Legal disputes</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Sales tax</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Balance as at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">352</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,681</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Acquired through business combinations</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">982</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Payments/settlements</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(352</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,681</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Additional provisions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">407</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Balance as at June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,389</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 352000 1681000 0 0 982000 -352000 -1681000 0 0 0 407000 0 0 1389000 3000000.0 0.05 2300000 1900000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>16. INCOME TAXES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Income tax expense is recognized at an amount determined by multiplying the income (loss) before income taxes for the interim period for each significant jurisdiction by management’s best estimate of the annual income tax rate expected for the full fiscal year for each significant jurisdiction.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There was no current or deferred income tax expense recorded for the six months ended June 30, 2022. The Company’s effective income tax rate of nil% for the six months ended June 30, 2022 is different than the statutory rate primarily due to the nonrecognition of deferred tax assets related to net operating losses.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>17. LOSS PER SHARE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive as the Company has a net loss for each period presented:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of securities</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>June 30, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Stock options (Note 13)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,407</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,202</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Warrants (Note 14)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,388</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,295</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">JustCBD potential additional shares to settle contingent consideration (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,141</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total anti-dilutive</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">25,936</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">13,497</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of securities</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>June 30, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Stock options (Note 13)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,407</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,202</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Warrants (Note 14)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,388</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,295</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">JustCBD potential additional shares to settle contingent consideration (Note 8)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">13,141</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total anti-dilutive</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">25,936</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">13,497</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 5407000 4202000 7388000 9295000 13141000 25936000 13497000 <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>18. RELATED PARTY DISCLOSURES </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;"><strong>Key management personnel compensation</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition to their contracted fees, directors and officers also participate in the Company’s stock option program. Certain executive officers are subject to termination notices of 24 to 36 months and change of control payments (Note 15). Key management personnel compensation is comprised of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Six months ended June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Six months ended June 30, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Directors’ and officers’ compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">816</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">736</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share-based payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">197</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,748</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,013</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,484</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company defines key management personnel as those persons having authority and responsibility for planning, directing, and controlling the activities of the Company directly or indirectly, and was determined to be executive officers and directors (executive and non-executive) of the Company. The remuneration of directors and key executives is determined by the Board of Directors of the Company having regard to the performance of individuals and market trends. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As at June 30, 2022, $0.0 million of the above directors’ and officers’ compensation was included in the trade payables and accrued liabilities (December 31, 2021 – $0.1 million). These amounts are unsecured, non-interest bearing and due on demand.  The share-based payments amount above for the six months ended June 30, 2021 includes 333,333 common shares to the Chief Executive Officer of the Company, valued at $1.7 million, that were recorded to equity as share issuance costs as payment related to services provided during the Company’s initial public offering process.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Related party transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six months ended June 30, 2022, the Company incurred expenses for consulting, rent and promotion services totaling less than $0.1 million (June 30, 2021 - $0.1 million) from 2227929 Ontario Inc., an entity affiliated with a former director, and expenses for consulting in the amount of $0.3 million (June 30, 2021 - $0.1 million) total from Forbes and Manhattan Inc and 2051580 Ontario Corp., two entities affiliated with a former director. As at June 30, 2022, $0 (December 31, 2021 - $6,000) was owed to 2227929 Ontario Inc., $11,000 (December 31, 2021 - $11,000) was owed to Forbes and Manhattan Inc. and $0 was owed to 2051580 Ontario Corp. These amounts were included in trade payables and accrued liabilities, and are unsecured, non-interest bearing and due on demand. Fred Leigh is a former director of the Company and is also a director and officer of 2227929 Ontario Inc. Stan Bharti is a former director and former Chairman of the Company and is also a director of Forbes and Manhattan Inc.</p> termination notices of 24 to 36 months <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Six months ended June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Six months ended June 30, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Directors’ and officers’ compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">816</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">736</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Share-based payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">197</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,748</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,013</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,484</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 816000 736000 197000 1748000 1013000 2484000 0.0 100000 333333000000 1700000 100000 100000 300000 100000 0 6000 11000 11000 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>19. FINANCIAL INSTRUMENTS AND RISK MANAGMENT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Environmental</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s growth and development activities are subject to laws and regulations governing the protection of the environment. These laws and regulations are continually changing and generally becoming more restrictive. The Company believes its operations are materially in compliance with all applicable laws and regulations. The Company has made, and expects to make in the future, expenditures to comply with such laws and regulations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Fair value</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments measured at amortized cost as at June 30, 2022 and December 31, 2021 consist of cash, restricted cash, trade and amounts receivable, loans receivable, trade payables and accrued liabilities, lease liabilities, and debt and loans payable. The amounts reflected in the consolidated statements of financial position approximate fair value due to the short-term maturity of these instruments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments recorded at the reporting date at fair value are classified into one of three levels based upon the fair value hierarchy. Items are categorized based on inputs used to derive fair value based on:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - quoted prices that are unadjusted in active markets for identical assets or liabilities</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - inputs other than quoted prices included in level 1 that are observable for the asset/liability either directly or indirectly; and</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - inputs for the instruments are not based on any observable market data.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s long-term investments require significant unobservable inputs and as discussed at Note 7, are measured at FVPL and as a Level 3 fair value financial instrument within the fair value hierarchy as at June 30, 2022. As discussed in Note 8, the Company’s other long-term liabilities consist of the estimated fair value of contingent purchase consideration from the acquisition of JustCBD in February 2022. The amount is measured at FVPL as a Level 2 fair value financial instrument within the fair value hierarchy as at June 30, 2022. As valuations of the investments and other long-term liabilities for which market quotations are not readily available are inherently uncertain, may fluctuate within short periods of time and are based on estimates, determination of fair value may differ materially from the values that would have resulted if a ready market existed for the investments. Such changes may have a significant impact on the Company’s financial condition or operating results.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Risk management overview </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has exposure to credit, liquidity and market risks from its use of financial instruments. This note provides information about the Company’s exposure to each of these risks, the Company’s objectives, policies and processes for measuring and managing risk. Further quantitative disclosures are included throughout these condensed interim consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Credit risk</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Credit risk is the risk of financial loss to the Company if a counterparty to a financial instrument fails to meet its contractual obligations and arises principally from the Company’s trade and other receivables, loans receivable and cash held with banks and other financial intermediaries.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The carrying amount of the cash, restricted cash, trade and amounts receivables and loan receivable represents the maximum credit exposure as presented in the statement of financial position.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has assessed that there has been no significant increase in credit risk of the loans receivable from initial recognition based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. As a result, the loss allowance recognized during the period was limited to twelve months expected credit losses. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an insignificant loss allowance on the loans’ receivable and advances as at June 30, 2022 and December 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company provides credit to certain customers in the normal course of business and has established credit evaluation and monitoring processes to mitigate credit risk. Credit risk for customers is assessed on a case-by-case basis and an allowance for specific expected credit losses is recorded where required, in addition to an estimate of lifetime expected credit losses for the portfolio of accounts receivable. See credit risk analysis for trade receivables at Note 3.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company held cash and restricted cash of $10.3 million and $37.6 million as at June 30, 2022 and December 31, 2021, respectively, of which, $10.1 million and $37.4 million, respectively, was held with large financial institutions and national central banks. The remaining $0.2 million cash amounts for both periods are held with financial intermediaries in Colombia and the United States. The Company has assessed no significant increase in credit risk from initial recognition based on the availability of funds, and the regulatory and economic environment of the financial intermediary. As a result, the loss allowance recognized during the period was limited to twelve months of expected credit losses. Based on historical information, and adjusted for forward-looking expectations, the Company has assessed an insignificant loss allowance on these cash and restricted cash balances as at June 30, 2022 and December 31, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Market risk</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Market risk is the risk that changes in market conditions, such as commodity prices, foreign exchange rates, and interest rates, will affect the Company’s net income or the value of financial instruments. The objective of market risk management is to manage and control market risk exposures within acceptable limits, while maximizing the Company’s returns.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Foreign currency exchange rate risk is the risk that the fair value of future cash flows will fluctuate due to changes in foreign exchange rates. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk as management has determined that this risk is not significant. As such, the Company’s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As at June 30, 2022, the Company had the following monetary assets and liabilities denominated in foreign currencies:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CAD</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>COP</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>GBP</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>EUR</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CHF</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of foreign currencies</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">862</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,673,360</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">22</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,605</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,946,301</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">174</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loans receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">250</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(152</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8,285,897</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(23</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(175</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(960,040</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(16</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,166,163</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(27</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(40,405</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net carrying value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">535</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3,167,156</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">130</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,600</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">250</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">As at December 31, 2021, the Company had the following monetary assets and liabilities denominated in foreign currencies:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CAD</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>COP</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>EUR</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CHF</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of foreign currencies</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,393</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,451,775</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">896</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">72</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,775,755</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loans receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">250</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(40</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,398,068</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(589</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,120,869</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,690,797</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(72,963</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net carrying value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">836</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">10,944,833</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">896</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">250</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Monetary assets and liabilities denominated in Canadian dollars, Colombian pesos, British pounds, Euros and Swiss Francs are subject to foreign currency risk. The Company has estimated that as at June 30, 2022, the effect of a 10% increase or decrease in Canadian dollars, Colombian pesos, British pounds, Euros and Swiss Francs (“CHF”) against the Unites States dollar on financial assets and liabilities would result in an increase or decrease of approximately $0.3 million (December 31, 2021 – $0.5 million) to net loss and comprehensive loss.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company calculates this sensitivity analysis based on the net financial assets denominated in each currency using the June 30, 2022 exchange rate, then changing the rate by 10%. Management determined 10% is a ‘reasonably possible’ change in foreign currency rates by considering the approximate change in rates in the prior twelve months.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">It is management’s opinion that the Company is not subject to significant commodity or interest rate risk.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Management considers concentration risk with counterparties considering the level of purchases and sales of its business segments (Note 21). Several of the Company’s business units purchase substantially all their inventory or materials from a single supplier.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Liquidity risk</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Liquidity risk is the risk that the Company will encounter difficulty in meeting obligations associated with its financial liabilities. The Company’s financial liabilities consist of trade payables and accrued liabilities, loans payable and debt, and lease liabilities as presented on the statement of financial position. The Company had cash and restricted cash as presented on the statement of financial position. The Company has no available credit lines of facilities to draw borrowings from should additional liquidity be needed. The Company’s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company’s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade payables and accrued liabilities consist of invoices payable to trade suppliers for administration and professional expenditures. The Company processes invoices within a normal payment period. Trade payables have contractual maturities of less than 90 days. Some suppliers of materials and inventory require full prepayment from the Company prior to providing such goods to the Company. See schedule of future lease commitments at Note 11.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s long-term investments in equity of other entities are not publicly traded and there is not an active market to sell the investments for cash.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Novel Coronavirus (“COVID-19”)</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s operations could be significantly adversely affected by the effects of a widespread global outbreak of a contagious disease, including the recent outbreak of respiratory illness caused by COVID-19. The Company cannot accurately predict the impact COVID-19 will have on its operations and the ability of others to meet their obligations with the Company, including uncertainties relating to the ultimate geographic spread of the virus, the severity of the disease, the duration of the outbreak, and the length of travel and quarantine restrictions imposed by governments of affected countries. In addition, a significant outbreak of contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could further affect the Company’s operations and ability to finance its operations.</p> 10300000 37600000 10100000 37400000 200000 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CAD</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>COP</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>GBP</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>EUR</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CHF</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of foreign currencies</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">862</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,673,360</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">22</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,605</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,946,301</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">174</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loans receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">250</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(152</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8,285,897</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(23</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(175</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(960,040</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(16</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,166,163</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(27</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(40,405</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net carrying value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">535</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3,167,156</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">130</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1,600</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">250</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CAD</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>COP</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>EUR</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CHF</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thousands of foreign currencies</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,393</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,451,775</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">896</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">72</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,775,755</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loans receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">250</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade payables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(40</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5,398,068</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(589</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,120,869</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,690,797</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long term debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(72,963</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net carrying value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">836</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">10,944,833</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">896</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">250</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 862 1673360 22 1605 0 0 12946301 174 0 0 0 0 0 0 250 -152 -8285897 -23 -5 0 -175 -960040 -16 0 0 0 -2166163 -27 0 0 0 -40405 0 0 0 535 3167156 130 1600 250 1393 4451775 896 0 72 15775755 0 0 0 0 0 250 -40 -5398068 0 0 -589 -2120869 0 0 0 -1690797 0 0 0 -72963 0 0 836 10944833 896 250 300000 500000 then changing the rate by 10%. Management determined 10% is a ‘reasonably possible’ change in foreign currency rates by considering the approximate change in rates in the prior twelve months <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>20. CAPITAL MANAGEMENT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers the aggregate of its common shares, options, warrants and borrowings as capital. The Company’s capital management objective is to ensure sufficient resources are available to meet day to day operating requirements and to safeguard its ability to continue as a going concern to provide returns for shareholders and benefits for other shareholders. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the six months ended June 30, 2022, the Company had negative cash from operations and the main source of cash flow was generated from 2021 and prior financing activities. Potential business activities are appropriately evaluated by senior management and a formal review and approval process has been established by the Board of Directors. The Company may enter new financing arrangements to meet its objectives for managing capital until the Company’s operating cash flows are sufficient to cover its operational requirements. The Company’s capital management objectives were being met in 2022 primarily from the use of existing cash balances from 2021 and prior issuances of common shares and warrants and generating increasing revenue in 2022 from the Company’s reportable segments as presented in Note 21. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s officers and senior management take full responsibility for managing the Company’s capital and do so through quarterly meetings and regular review of financial information. The Company’s Board of Directors is responsible for overseeing this process. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is not subject to any external capital requirements. As discussed in Note 12, on June 16, 2022, the Company announced that it plans to repurchase up to $5 million of its common shares. </p> 5000000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>21. SEGMENTED INFORMATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company is engaged in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products through its Colombia Cosechemos subsidiary. The Company’s other businesses are run through its other Colombia and United States subsidiaries. Management has defined the reportable segments of the Company based on this internal business unit reporting, which is by major product line, and aggregates similar businesses into the Consumer Products segment below. The Corporate segment reflects balances and expenses that do not directly influence business unit operations and includes the Company’s long-term investments. The Corporate segment revenue includes the license of intellectual property. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following tables show information regarding the Company’s segments for the six months ended June 30, 2022 and June 30, 2021. The 2022 segments were updated to reflect the acquisition of JustCBD (Note 8) with High Roller Private Label LLC operations assigned to the Pharmaceuticals and Nutraceuticals segment, and Just Brands LLC assigned to the Consumer Products segment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Cannabis growth and derivative production</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Consumer products</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Pharmaceuticals and nutraceuticals</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Beverage and food</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Corporate and Eliminations</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>For the six months ended June 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">13,603</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3,708</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">252</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(2,649</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">14,917</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Gross profit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">47</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">4,304</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,096</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">99</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">6,546</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Net (loss) income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(715</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(19,420</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">317</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(462</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(12,436</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(32,716</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>For the six months ended June 30, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">286</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,629</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">310</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(107</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,118</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Gross profit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">173</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">752</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">87</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,012</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Net (loss) income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(428</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(857</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(64</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(3,839</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(5,138</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">Geographical information:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Colombia</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>United States</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Canada</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>United Kingdom</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Non-current assets at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>5,320</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>42,351</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,533</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,708</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>51,912</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total liabilities at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,732</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>9,290</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,496</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>81</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>16,599</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Non-current assets at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,042</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,650</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,844</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total liabilities at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,359</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,106</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,073</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,538</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Six months ended June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"><strong>Net revenue</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,631</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>12,887</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>399</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>14,917</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"><strong>Gross profit</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>999</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>5,471</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>76</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,546</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Six Months Ended June 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Net revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,069</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">49</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,118</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Gross profit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,009</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,012</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2022, the Company did not have sales to a single customer exceeding 10% of its consolidated revenue. </p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Cannabis growth and derivative production</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Consumer products</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Pharmaceuticals and nutraceuticals</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Beverage and food</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Corporate and Eliminations</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>For the six months ended June 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">13,603</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3,708</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">252</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(2,649</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">14,917</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Gross profit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">47</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">4,304</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,096</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">99</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">6,546</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Net (loss) income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(715</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(19,420</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">317</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(462</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(12,436</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(32,716</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>For the six months ended June 30, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">286</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,629</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">310</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(107</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">2,118</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Gross profit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">173</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">752</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">87</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">1,012</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Net (loss) income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(428</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(857</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(64</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(3,839</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(5,138</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thousands of United States dollars</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Colombia</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>United States</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Canada</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>United Kingdom</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Non-current assets at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>5,320</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>42,351</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,533</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,708</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>51,912</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total liabilities at June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>2,732</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>9,290</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,496</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>81</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>16,599</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Non-current assets at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,042</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">29,650</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,844</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37,536</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total liabilities at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,359</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,106</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,073</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,538</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Six months ended June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"><strong>Net revenue</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,631</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>12,887</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>399</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>14,917</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"><strong>Gross profit</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>999</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>5,471</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>76</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,546</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Six Months Ended June 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Net revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,069</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">49</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,118</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Gross profit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,009</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,012</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3000 13603000 3708000 252000 -2649000 14917000 47000 4304000 2096000 99000 0 6546000 -715000 -19420000 -317000 -462000 -12436000 -32716000 0 286000 1629000 310000 -107000 2118000 0 173000 752000 87000 0 1012000 -428000 -857000 50000 -64000 -3839000 5138000 5320000 42351000 1533000 2708000 51912000 2732000 9290000 4496000 81000 16599000 4042000 29650000 3844000 0 37536000 2359000 3106000 3073000 0 8538000 1631000 12887000 0 399000 14917000 999000 5471000 0 76000 6546000 2069000 49000 0 0 2118000 1009000 3000 0 0 1012000 0.10 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>22. SUBSEQUENT EVENTS </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>OTHER</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subsequent to June 30, 2022, a total of 266 warrants were exercised in exchange 266 common shares and a total of 798,602 warrants expired. Since June 30, 2022, the Company repurchased 366,645 of its common shares under its previously announced share repurchase plan for $250,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 5, 2022, the Company’s shareholders approved the 2022 Flora Growth Incentive Compensation Plan. Pursuant to this plan, the Company has reserved 6 million of its common shares for potential issuance to officers, directors, employees and consultants of the Company. Effective July 5, 2022, no further stock options may be issued under the Company’s 2019 stock option plan.</p> 266 266 798602 366645 250000 6000000 EXCEL 93 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

4P#O&'DT%20'%2<*7A9)H# G0%9DQ:'-=4_D5 ME>D0J\COX,O07NVZ:0GR [\)>J>RTZCL'%49,]UP2)$ TM<7C3:E[@.0HH& ME"ITQZ6$UM-8LP8[6L[=H-O;4]P6A7W<+MEO)/M')=](]8=J^@=I.ZZ[)^TP M!ON]=F%!(RPX*NQ192!VI+46+CC(V_/PGK;#F.Y'1>LVVKK'3R-7A+7IZ1X> M*J>W+Z@ER,.=/47V3KLT3]4]$0M:2,1@KF'.15?C1=W^ZXGB9=5!9USI?EP- M,_UB@C !>G_.N7J;F*; MD"C5@EYQ[I$%/9J+.$KAD2&>)PEA;[<0TVU?P]KNQ"1:K84ZH0>]C*Q@"N(I M>V1RIMO17:994XX#&G\*UJ(=5_S-+2 )_*)M6>NZ&@IS+FA2B25!$J7ED;Q6?=@38/N$P*P$YM\* MK$I@%4%+LB+6B @2]!C=(J:JI9L:%+TIU#)-E*I_<2J8O!I)G0AFD\%HC 8/ M(S2X__GT,)NBR7@XOGL>W/X8H\L1"!+%'.$KU$%/TQ&ZO+A"%RA*T6Q-_I0F(H,SVLEKPMES1/+/D]3Z^197Q&IF&:#?)ANWP$H93C0H[?RW49ONZ M67? +/RL?^G 55/,TM=N]E6/WPW/2 A]33Y?'-@&M.#C!^P:7YI"_R>S=RVP MZA98;>[!,&<,4M&4L10ZA5"]$38!=FW9]LT^>ZO[F>QVS6ZWLN..9: 1>6N\ M$4NINT?O8OL OM7^3'BGAG=:X2W<<4_3.T?TIN,?T+?ZGTGOUO1N*[V+._YI M>O>(WO*L _I6_S/INS5]MY7>QQWLG<;O'N'C8_[6%<[D]VI^K_W&]XQ/)^F] M8WIL>P?TK?YGTOLUO=]*/Z."Q&C&R +0!$*(-F0>0V,6_^@5Y-CF89:&(L=U MZJ*24=_;)]4WRCUAJRCE*(:EE!G77:EGY;Y?3@3-BJUS3H7J&T\T[ @ S00 !D !X M;"]W;W)K&ULI51M;]HP$/XK)Z^:BC21$"C;6(@4 M7J9U*ET%I?MLDH-8=>S,-B_[][,=R)A$^;(OB>]\SW//7>X2[Z5ZU06B@4/) MA1Z2PIAJ$ 0Z*["DNBTK%/9F+55)C375)M"50II[4,F#* S[04F9($GL?4\J MB>76<";P28'>EB55OT?(Y7Y(.N3DF+--89PC2.**;G"!9ED]*6L%#4O.2A2: M20$*UT.2=@:CGHOW 2\,]_KL#*Z2E92OSKC/AR1T@I!C9AP#M:\=CI%S1V1E M_#IRDB:E YZ?3^Q??>VVEA75.);\)\M-,22?".2XIEMNYG+_#8_UW#F^3'+M MG["O8_M= ME6&UD>P59!R43]IH=C'\X 4?0&(#H"(J^[3N153JBA2:SD'I2+ MMFSNX$OU:"N."?=1%D;96V9Q)GF>IY,II(\32&<_EH_/"YA/Q]/[EW3T,(7; M"1K*N(9'JA1U[6O!#3 !,\:Y[:F. V,U.*8@.^8;U?FB-_+U82:%*31,18[Y MO_C :F\*B$X%C**KA-^WH@W=\ -$813!I'G.W+13#M-#92@SJC9,:."XMM"P_?&.@*J7IS:,K/S KJ2QX^^/A?W?H'(!]GXM MI3D9+D'S!TO^ %!+ P04 " #L,C-5+G)2Q*," !@!@ &0 'AL+W=O M0L35%VQ?B<^YY.9N[C+9"/JL,4<-+SK@:.YG6 MQ:7KJCC#G*@+42 W;]9"YD2;4*:N*B22I +ES/4Z'=_-">5.,*KV[F4P$J5F ME..]!%7F.9&O(3*Q'3M=9[_Q0--,VPTW&!4DQ0CU8W$O3>0V+ G-D2LJ.$A< MCYU)]S(< M3B-I@8?K/?MU5;NI94443@7[01.=C9W/#B2X)B73#V)[@[MZ!I8O%DQ5O["M M-X[ &\'\"K?M5#E2J2E>4L-3@?A_&YQ]VT^G2Q@$D57RPA.9Z@)9>H,3H!R6&:B M5(0G:N1JHV=1;KSC#FMN[QUN'VX%UYF"*YY@\B?>-3X;L][>;.@=)?Q>\@OH M=<[!ZW@>/$8S.#TY.\+;:PZA5_'V_O\0VJJNR?KM9+:++E5!8AP[IDT4R@TZ MP<MCFL.085AVW+3= ;CMQ-B^Z@ MT1TH8,[AFE )3X25" M4"J9":5@*B$QKP&ULE57K;YLP$/]73FR:-FD* MA#S5$:0D?65JUZCI6NVC Y=@U=B9;4+WW\\V"4LGBM0O^'6_QQWXB$HAGU6& MJ.$E9UQ-O$SKW9GOJR3#G*B.V"$W)QLA5> M'+F]I8PC46A&.2XEJ"+/B?PS0R;*B=?UCAOW=)MIN^''T8YL<87ZYVXIS:*JSB3?V(,4-*9B^%^4U'O(9 M6+Y$,.6>4%:Q/1.<%$J+_ V#G+*JY&\'.IP @@';P#" R!TOBLAY_*<:!)' M4I0@;;1ALQ.7JD,;UF$]O8+I:73RLX/,Y:D*9 M@A]$2F)K]B7RM9&R #\YT,XJVO -VB'<"JXS!1<\Q?0UWC<6:Y_AT>7H.>H>^\N06/B%5F_FH3.U(PE./'-) M%,H]>O&G#]UA\*W%:K^VVF]CCY_<1X8I3/+ MW!16PQV'APSADE )CX05V*1?,8U?Z;]1@%$M/VJ5/Y?45'Y.."=KJEJS'S5E M/VR6']?RX_>]^Y6V3[$Q+D2ILR8?XX8J]/\O@W_2/7*46]%%:A_3O%?4$L#!!0 ( .PR,U5HS^J^FP( %$' 9 >&PO M=V]R:W-H965TW>9K:^'8F>TT[-_/3D)4FE#QL)?&EW..S['KS\.2BV>Y 5#H):-, MCJR-4OFY;"91RIXU,D@7GSZ9SDXXLQQ@""DME%+#^;&$,E!HA M;>-/HVFU2QKB;OM5_:K*KK,LL(0QIT\D59N1=6:A%%:XH&K&RVMH\@1&;\FI MK'Y166,'@866A50\:\C:0498_<4OS3[L$-S!.P2O(7@?)?@-P:^"ULZJ6!.L M<#(4O$3"H+6::51[4[%U&L+,*[^U^PW.IZ PH3*$_05 M/.^H_"W:*?.<+\AS/ZZ&/ M#],GL-1TMZ*[;^FVSMF&]=JP7J7G?SQL7Z9:9- O8J[5NC+#);K%"@3!5*(+EJ)YD>>40.]1UEI!I64N M_S;QW%!O^W8W3A=T%LMR<-#E-=:II8(4C3%C>$%ZW=4:X<["L;?G MK0OQ@WYK06LM.&CM29<@=,/05/"U/IY>8T%GU4$8[#GK8N*HWUG8.@L/.KLB MC.A;GZ(?G/??S+"S9AA$T9ZQ+LB-0Z_?6M1:BPY:N^<*TSY'4>>_$WOQ_E9U M05X<^WN.[)V"9QZ;6RS6A$E$8:5ISFFD^:(NX'5'\;RJ@0NN=$6MFAO]YH$P M #V_XER]=DQ9;5_1Y!]02P,$% @ [#(S5<2L.FTI#0 AHH !D !X M;"]W;W)K&ULO9UM_"J7;NDJJX@@8'K.V MJVSAKMJZUY@:6RI(H$74)Q\^P-9TC T[F%PS[Y)+%G\&_YFT$^M MIOOT(2^^E4O.*^O'9IV59Y-E5=V_F4[+^9)OTO)U?L^S^C>W>;%)J_IA<3+G8;;=93U[:#Z29=99/ST]USU\7Y:;ZMUJN,7Q=6N=ULTN+G)5_G#V<3 M9W)XXN/J;EDU3TS/3^_3._Z)5U_NKXOZT?2HLEAM>%:N\LPJ^.W9Y,)YDSA. MV&RQ>\G7%7\H6S];S;'[?ZV'Q]<&WL2:;\LJW^PWKO=@L\H>_T]_[)UH;5#K]&_@[C=PNQL\ M%8'M-V!#-_#V&W@[9QX/9>=#DE;I^6F1/UA%\^I:K?EA9^9NZ_KP5UGSA_]4 M%?5O5_5VU?GUQP_75Q\__]>Z?G?Q^V?KXO?$NOK/E[?7[Z_J1R\27J6K=?G2 M.K&^?$JL%[^\M'ZQ5IGU>9EORS1;E*?3JMZ)1FHZWP>\? SH/A$PL-[G6;4L MK:MLP1?R]M-ZYX]'X!Z.X-)%!?^]S5Y;S'YEN;;K]NS/;/CF3L_F";YYPN?U MYLYN["='GM"[U.55KQ>6)7UY[OZ5];;^E'YOSZ;'W6\?IWF>O&F MO$_G_&Q27Q!*7GSGD_-__L,)[%_[/*(42XC$)/^\HW\>IGY^,9]O-]MU;>+" M2G@=8+Y*FPO,*^E1GY^/NOY.M[EIYD1/+KTG0'1QY^/[Q M\'WT\*^+^BVAJ'Y:U^NT/H,[3GT9J]VZJZ.4UI_O^>:&%[WK#)7476>48@F1 MF&1E>+0R)+I.A93^48HE1&*2?]'1OP@]%2_3>H'.^2OKDM^MLFR5W?5Y%X'E M&=O=U8G&T;6$2$RR)#Y:$N.7[L5BU:S,7JB(@1.L>;N6G$#E=9T@$I.<<&Q! M939^>FS+^IGZRC3+-S>K;/>F55HOLKSB5O2RE[ILX)#=\0>/J6L0E9KL4(M; M'=2AFOIKIL^LJQ_S99K=<>MSD6;E^LFW][UUQ4TCK8K1&JR*X*O'10_$4#<^X5?D??JZ#(CA6DJ M-=DN@=..*9[>"Z-.$:'RWBD3X.T(\G9P]$:<6I7W>9FN^S\M0P0'-I$".)6: M;)- < =G\*=MTKZB!VKG2'F;2DUV3A"W@P+I\;/=*^M^]^$NK3_<\<.'NU?6 M+"V*G_55R_J:KK>\US!2%"=52_9J[4_6;=25+1.0[>"4K;[8(^^-$+[!Z47* MWE1JLE>"OATI6LT68 +Z"XQ4K6$ M2DTV3P"[ZQ!E#%Q*"I^1JB54:K*)@NG=@4R/0JH+L=[W0>( #Z5MC FL=P76 MNPJLQY('+H1V-_2!'Z3<3J4F^R&XW<6Y73^!X$)>=Y@==4TB178J-=DD@>PN MCNRZQ.E"5C]Q&>M:1(KK5&JR10+771S7!R017,CA,6-@=9&B.)6:[(I <1=' M\67=7QGM+\C-P'C3, XP[/G MS\XEX/K:Y0>DC,Y@JM^+P[@_F< $>S.95760_=N%[_P2-J^F(![)N">*> > M2R4PB.XN( 52<*=2D]T0X,X4A2K:B02F3ISC,;4=,H'K3. ZPW%=&S8AIY\P ML*)(09U*32[)%*#N*:I9U$D$#Q)X['07%AY&UQ0J-=D4@> >CN#/S"%X/?4L M7A>6\%W0-LQ$[ML3_.V-Y6]E:2^D;V@5*7I3J3UIP\\@=O>V,(7=?K @Q!^$H$3C!3"J=1DMP2$>\.*788F#SS(Y9$;=QTB M!7,J-=DA >8>#N;OZC77ZP0E6\](U1(J-=DR0>I>3)0V\"CQ>T:JEE"IR3<8 M"9CW!\(\BJ<^Y'D'W$V%1]*^L\@$S_N"YWT%SV-I Q_2.@,%&7@ ;3M,T+HO M:-U75*IHYPU\2.E=^L1C:CMD M)] >D^#NFZC.E#.C]QP9(BY7,J-=DAP>>^ M(CVNSAOX$+Q9#!86*7I3J7X[&UG3*!W+Y ;G]L40N:-/ A>0.;2+F;2DVV27"W/[:21?N"KDZ4 MX_NB[9P)_/8%?OO#*LQ')PUP?5TJ)U5+_)[JF[ _9Q (U@[&5KBH@F^#L0_!T,*VD9FC$(>I 4]LA$T@>""0/<"1_G\Z7]5/%S]W* M^W![NVI.H(-'>!,$2O">D:HE5&JRJP+C ZJ.+0%IRQ92M81*3391D'XPD/11 M=@T@[#MQW"VBPD-I&V."]@-!^X&"]K&L0@!9WN]^9XKK:[MAI'U+JW^+HF1% M.ZD00(CW[6ZE-1Y5VR,3&!\(C ]PC->ET*"G&#T$:XJ4X*G49(<$P0<#>Z\@ M\ 31W/7"[O<)>!QM5TS0>2#H/!A;=3XHKQ#T5+4X 7",E+FIU.0.2(+.P[%T MKDHMA)#-7?!M%1Y=URLJ-=DK0>?AV&H7-+D00D@']S3@D;5],L'HH6#T<&R1 MB^YU/>SI[=+-%N,[HVV="1 /!8B'P^K-1Z<7<'U=/B=52T*8_'>B5O9?]DQP M=SBV D:=8 @AC9^PH,M6^ YHVV""QD-!XR%M>\40 KKK@+)&/*BV1280/12( M'N*(_I4O5_,UQWLJXAK:*XT4WZG49/]:?17)&BO2=E:D;:UH@O!#0?@A17?% M$$(^"[MKDQ3QJ=1D6P3BA\_HL!A"@ >D14KO5&IR_TU![Q%UB\6HYR[1KD5X M4%V+J-1DBP2T1[0]%J.>FO1N)@$/J6V0"5J/!*U'SVZQ&$$,!XR$1]'VQ 2& M1P+#(Z,-%J.>*A<'K#)2MJ92DPT3#!Z-97!5&B&"!-[]A(?'UG;*!'Y' K\C M(RT6(W7)"QY8VR83"!X)!(_^KA:+D;H$!M\7;>=,P'\##ZEM MD DJCP65QSB5?]K>5,HNB[B&[BHC54NHU&3_!++'5%T68](.+J1J"96:;*+ M^IBBRV(,R9[%83>YAX?2-L8$V\>"[>-G=%F,(;F'=O=JC@?0ML,$N<>"W&-% MU8IV"B&&Q.ZS[L=!/*JV1R:8/1;,'M/V6(Q[>BPZX%Y'/*BV129X/1:\'C^[ MQV+<5\;B=I.5>!QM5TRP>"Q8/#;:8S'N*6MQ0:L6?!^T'3.1]8X%BL>F>BS& M/>4N8;<6%H^N[96144.M64-&>BS& WHLXI&U?3(SB*@]B>COZK)XB"1] NV^ M^2EV1]<^,KF.?ZTY1;;A5HN* +JD3BN7'.3D;]%\NS^OX-ANRSAS_18/VG)[ MG #,>\)W0=\+([.-[-9P(YNVY^)!3S$!4A%6WRWV@'(%')==QIC4"RG]&;\;"Q3&?@C@A%#'U33%"_8[>&'-G4 M+1H/BE*N)H1G#^U\(RJYCE&M"40&AE$VIY$JAA%^HPI MDCTC2ED$#:/E>#,S2MM#2D=/*<6'20X93TH\G]3,@-+VA-+1(TKU9P3#]+S3 M3;(J=D??/R/LWIY;JAA<^OP$!>F TAFM7'*0:X^6=-IW6W6,:Z'ZZ%&F Q(4 M/=-+3P)POYQB%_2], +P[1FF X>8#DY0] P&90&#/M$R/97GZZX<4=G_'UNK3F^3:KY9NWT>.S5L%O&QO?7+B3*7C^TGDS/OTZ+FCM):\]M:TG[=W 52-$F.PX,JOZ__4A/K)J^J?+/[<&PO=V]R:W-H965T[FEX6.AVM1OO!)0>PFL2L;:!(\^/'3M(8EL1E.ET^0)SXO.]Q M..<)IK/BXE'. !1Z2N)4=KV94O,3WY?C&214'O(YI/K*A(N$*CT44U_.!= H M"TIBGP1!TT\H2[U>)SMW*WH=OE Q2^%6(+E($BK69Q#S5=?#WO.)(9O.E#GA M]SIS.H41J"_S6Z%'?JD2L012R7B*!$RZWBD^.2-M$Y#-N&>PDAO'R"SE@?-' M,[B,NEY@,H(8QLI(4/VQA'.(8Z.D\_BW$/5*3Q.X>?RL?I$M7B_F@4HXY_%7 M%JE9UVM[*(()7<1JR%=_0+&@AM$;\UAF[VB5SPVUXW@A%4^*8#U.6)I_TJ?B M1FP&A#4!I @@6=ZY499EGRK:ZPB^0L+,UFKF(%MJ%JV38ZGY5D9*Z*M,QZG> MYYOK3W>#X16ZO+X?C.ZN!M=W(_2^#XJR6'[H^$I[F)G^N- [R_5(C5X37?%4 MS20:I!%$V_&^SJU,D#PG>$:<@G\NTD,4!K\C$A""OHSZZ/W!!W2 ?"1G5(!T M6(3E/0@SB[#&8J2H EUI"GW[K"^A2SV2_U2M/=4P5BYE:5V66Q[:S6-.)RQ[N^,L*NT9IUW#: M#9E\1!<"].U(%>CE*#34MZG*.Q?"P89Y 4>V4YM,M4 MVV]4M.W_(1 B/X=65<4EHG8";,M?M]H*+K@[99Z)1>Q!2,^?B-^ M8R=B7YDHL30E;IJ^@'!2A=(ZAA.+4N)&Z M#">6G\3-SY]@>*&T+\.)I2EQ0_!EAI/=7Y@U[4HL)HD;D_LS_ 6A_1E.+$Z) M&Z=NAA?!V]47U)6]92AQ,W0_AI-=?H;9J\;>\I.X^;D_P@NAS13:NP#W-S:F M"8AIMOV6:,P7J* MS[-M[@-7>M.<'&ULM5=;;]HP M&/TK5E9-G=0VL8$ '40JO6Q,O:GT\E#MP84/$C6QF6V@_?>SDS2A(\FJ-GTA M\>4[YY@<']F]%1>/T@=0Z"D*F>Q;OE+S?=N68Q\B*O?X')@>F7(14:6;8F;+ MN0 ZB8NBT":.X]H1#9CE]>*^2^'U^$*% 8-+@>0BBJAX'D#(5WT+6R\=5\', M5Z;#]GIS.H,1J)OYI= M.T.9!!$P&7"&!$S[U@'>'Y"X()YQ&\!*KKTCLY0' MSA]-8SCI6XY1!"&,E8&@^K&$0PA#@Z1U_$E!K8S3%*Z_OZ"?Q(O7BWF@$@YY M>!=,E-^W.A::P)0N0G7%5S\A75#+X(UY*.-?M$KF-O7D\4(J'J7%6D$4L.1) MG](_8JV D)("DA:06'="%*L\HHIZ/<%72)C9&LV\Q$N-J[6X@)FO,E)"CP:Z M3GFG%^<_KH^OSM#P_/9X='UV?'X]0MM'H&@02H2_H2T4,'3M\X6D;")[MM*D MIM0>IP2#A("4$+CHC#/E2W3,)C!Y76]KL9EB\J)X0"H!?RW8'FHX.X@XA*"; MT1':WOI6@=O(_HE&C-LHP1TIJD#[3:'[4SV$AKHE?Q\5*IN9RF85NG?*I407#!WZE,U HB%#)S00Z):&"R@2 MF\"U8CBS19?>+FXT&CU[6:"BE:EH5:H8T)"R,>R8CQJP61%O N"N\6K:=C&M MF]&Z;Z,=P"Q@K(39W6 F;MLI9FYGS.U*YCLJ!&5*'AX=\U,@IPBL_$5)" MO!:[N 8KIR#KW"YIE7"3G)N\VJ=)<)[)N*Y0QI^1RCB/95QS M+J=XKPS=*DDIG.@1B%M]$I';M@JGDN)[U9K>=@^2, MGT]/KDIG5&@Y$H4PU:7.7EM3B^3VD304G\N]/TA?O7UC0V$F:#'IYRK MEX8AR.Z WE]02P,$% @ [#(S59=Q!T2Y P +0T !D !X;"]W;W)K M&ULM9?9;N,V%(9?A5"#8@8(+)'>4UO ./&T*9K$ MB#WI-2/1%C$2Z9*4G0'Z\"5%64M+"9V@]86U\?SGXZ*?1XLS%U]E0H@";UG* MY-)+E#K>^+Z,$I)A.>!'PO23/1<95OI2''QY% 3'15"6^B@()GZ&*?/"17%O M(\(%SU5*&=D((/,LP^+;BJ3\O/2@=[GQ3 ^),C?\<''$![(EZLMQ(_257ZG$ M-"-,4LZ (/NE]PG>K%!@ HH6+Y2<9>,?H[C56R]&8>B,D>YZEZYN=? M2-FAL=&+>"J+?W"V;<WK\>;=^?@#WCR_K[>YA M_;C;@@]W1&&:2O"(A>3,-J4(9%IN'_ M,"A6>>16-N_8C3SBB"P]_1))(D[$"W_\ 4Z"GWJX1Q7WJ$\]W.0B2O02C<$M MSS*]YK=V8/X$5RY4*S8NQ,S;>PK1*#"_A7]R4(PKBG$OQ?I-0[ #^0>$:WXL MB16<-$G0N!-D4H%,>D&>SHP(F="C*Z4-A4$C9S (YA-WRFF5#CI<:UKX*^XVUG;T8&&=VJS)O)!\-NM9D;:>PWT^;DX'3 M*$^QJ6?=_K)=Z2O+17V>^JMW4WN+V;1 M/?G3[TA?^R?L-]#&\'?LHZ5 X-UZAN;4K,U-@X8OU'!9D0< MBCI=@HCG3-EBMKI;?0M\LA5PW=Q^2#Q@<:!,@I3L=:C>%'1N86MS>Z'XL:B' M7[G2U75QFNCO&2), _U\S[FZ7)@$U1=2^!=02P,$% @ [#(S5?=I]4-B M P V H !D !X;"]W;W)K&ULC99=DYHP%(;_ M2H;I13M3EV^0CCJC[K:UT[IV6=OK"%$R#8E-@N[^^R:@:,N'O5D)<,[SGNS) MRQD=&?\E,H0D>,D)%6,CDW+_P31%DJ$0ZF6?&>*/42O,T38<6S8QOG&$]YE4M\P)Z,] MW*$8R?5^Q=7*K+.D.$=48$8!1]NQ,;4_S.Q0!Y1O_,#H**ZN@2YEP]@OO5BD M8\/2BA!!B=0IH/HYH#DB1&=2.GZ?DAHU4P=>7Y^S?RR+5\5LH$!S1G[B5&9C M8VB %&UA0>03.WY&IX)\G2]A1)1_P;%Z-[0,D!1"LOP4K!3DF%:_\.6T$5S=;Q8/L0QF#]^FRV6T^K)VWLD(2;B'7@#, 7/ M&2L$I*D8F5))T0G-Y(2=55BG _NEH'? M=X#QW(.4P1>$()P@>X(:AU M%ZH4P14W"CNX7LWU>KD+>D!4,O[:QO,:/-]WO7:@7P/]7N"CS! '\X)SQ053 M(9!LK=5OLCVK'1W4Z* 7O>+*?KA\?0]6!&HX3<'#[P+OE2_(-@U!4X,;MFL( M:PUAKX;2J,#C%JP%ZJD^;)##T&DG#VOR\#\V?LEHL!M+QAD'4P;SR0;O_.#,) M24^EI_!KKCL,O*"#>S$LN]^Q*AM9P=?20\H.GR8)+U *OF*XP01+W.XMI\37 MB@:.$[H=BBZ^9O<;V_FD$Z2^=H#<$-%TN$'@=3B.??$XN]_DU,$_X/++KP8/ M(*#>&@E?6A4T/6\0#3N.GGTQ/?M_7.]\\F[M0M/[!E%72U[,S^YWOZHE;W5! MT_(&;A0-.^ 7U[/[;:^"+]'9=517*N/E*&T5$3:^KZX7>/^*,*_F%#WS?8-\ MAZE0G;95<=9=J!+P:HRJ%I+MR]%EPZ0:A,K+3(V>B.L7U/,M8_*\T--0/&ULK=UA<]HX @;@OZ+A;FYV9[8!&QM(+LE,@B5+.VW:*VWO M0^<^.* $3XU-;9.T-_?CSP8G0B $WKY?=A- C\!Y"\(O-I?/6?ZMF$M9DA^+ M)"VN.O.R7%YTN\5T+A=1<98M95I=\Y#EBZBL?LT?N\4RE]%L/6B1=-U>;]!= M1'':N;Y<7_8AO[[,5F42I_)#3HK58A'E/V]EDCU?=9S.RP4?X\=Y65_0O;Y< M1H]R(LO/RP]Y]5OW59G%"YD6<9:27#Y<=6Z<"S'HU0/6M_@2R^=BZV=2/Y3[ M+/M6_R)F5YU>?8]D(J=E3435_Y[D6"9)+57WXWN#=E[GK =N__RBL_6#KQ[, M?53(<9;\.YZ5\ZO.J$-F\B%:)>7'[)G+Y@'YM3?-DF+]7_*\N>W0[Y#IJBBS M13.XN@>+.-W\/_K1;(BM 8YW8(#;#'!W!QR:H=\,Z)\Z@]<,\$X=X#<#_%/O MTJ 9,#AUAF$S8+@[8'!@P*@9,#IUAO-FP/DZ#IN_W_J/'T1E='V99\\DKV]= M:?4/ZP2M1U=_\SBMPSXI\^K:N!I77M],)O03N1G_Z[.8B$_B_=V$W-P%Y/;S M1-S1R82,W[^[%7D,^3@/SV]]\ONV5U?VJU M.VWF'F_F=@_,[9!W65K."T+3F9P9QC/[^,&Q\?S(_#T+T*TVY.O6=%^VYJUK M%6^6^1GI^7\0M^>ZI@UB'\[D_1EQO8/# _OP/Z/TC/2=@\/I"<.=T<'A[,CP M53U[[^#P\/3ACNEO:1\>R.G+8W?.#"T'_]9]5?>_T#WJ2,2EF] M)I3DZ]OJ*B*JWXK_&.[7[<;QS$[]4G=1+*.IO.I4KV6%S)]DY_H??W,&O7^: MXH7$ B1&D1A#8B$2XTA,@# MP-YK@#V;?OU1/LET)4V)M0YLFU@D%B QBL38 M!O/76+W^?+I^XWCGSK#7ZUUVG[;C:+BEZSBCO1OR_1ONW$* 'H&6'_\U/[XU M/Q]6^71>+4+).*L6QC-9+Q>JM>TX6RSSN) S,IE'N3%>5K=MO#;88&LCG?N] MWM[&#)"34B3&D%B(Q#@2$R!,R^K@-:L#:U9%6D;I8WR?2')3%+(L3+&T$FUC MB<0")$:1&!OL/44YKN%?7XBVH?:LX;N-BO+;$&^OI.+>YD; M=_/8A;:9@VH!5*-0C4&U$*IQJ"90FI[AK1[ >VQ;"!4E)%: -4H5&-0+81J M'*H)E*9'V551=G_IC9-]>.L ([4 JE&HQHYL=O_PNR?H_>!03: T/:RJ*'*L MN_%WUP[D?^13'LUD&BUD0;XN+"L*:',$U0*H1J$:@VHA5.-03: T/=FJ07(\ MU(H"6BE!M0"J4:C&H%H(U3A4$RA-C[(JLQQ[FW5T10$MK:!: -4H5&-'-OO( MLJ* 5EE03: T/:RJS7+L==:G;&G?%0&MLJ!: -4H5&-0+81J'*H)E*8'6/5> MSA"U<(!V8% M@&H4JC&H%D(U#M4$2M.CK/HQQUZ0'5TX((N7,50+H!J%:NS( M9K<4N=#[P:&:0&EZ6%5UYMB[L^V%0XO]$- V#:H%4(U"-0;50JC&H9I :?I' M\E4[Y_9 RPD76M)!M0"J4:C&H%H(U3A4$RA-C[(JZ5QK!03: T/:RJAG/M?="?JZ(\MSEZ5OIEE: MYEE27?5(1%K*:I[2&%1HT=9HH^T_W\Z!8= )*51C4"V$:ARJ"92F)U0U:NZQ M1JV,$K)\.:1Q>NRH!SO7.J7[AU'UO8'I*$;HO!2J,:@60C4.U01*T\.JVC/7 M?A#3T6-R[.-;IW.C;1]BZYE> 0/HM!2J,:@60C4.U01*T\.I^C#77LSM%TV ZATW*H M)E":GE%54_7M?>9 ZF%MDE0C4&U$*IQJ"90FIY:U3CU?^WDA,:\0ING1M.*PX%QMRET7@K5 M&%0+H1J':@*EZ8%5!53?7D#]];-IVN'6L1WL/2/3?BEH$075!$K3OQ] %5&> MO8BJOSJE6I!&>9*1(EZLDH,?.+%#;4,*U0*H1J$:@VHA5.-03: T/7K%X\)''YTQA,:+_5:+;/_$,GI%"-0;40 MJG&H)E":GLFM[[^R-UMWLFS>=Y&;Z?=5G)OW8-F5UN'<:/6IH+?V#_3V=A! M9Z50C4&U$*IQJ"90FIY0U6)Y]A:+_I#YM'I-)]4K^]3\D@[MK!IMN/W,>39R M=Z,)[:N@&H-J(53C4$V@-#V:JJ_R['T52[(\(KFY5B^7;6RSZ?157 MSZGY5(V6;V^T M7L_G;CV=NQUIG4ZD%D U"M485 NA&H=J J7I,5:UE^^#=LOZT/H+J@50C4(U M!M5"J,:AFD!I>I153>;;:[*3/N)M-UJG&-J3034*U9AO.FVBZ=P#T&DY5!,H M30^HJL!\^Q%<=UDZK=Z-R;(*Z&/UEFOSM&M;/4";,*@60#4*U1A4"Z$:AVH" MI>F)5DV8/T*M'J"-&%0+H!J%:@RJA5"-0S6!TO0HJ^K,MU=GQ[X,QCZ\=8"A M51E4HU"-'=GL_<-?!@.]'QRJ"92FA76@^K/!L=,6GK#4M1MM$PO5 JA&H1IK MM.VEKO$T<-!9.503*&V3SVXQE[(,HC*ZOES(_%&.99(49'V4=[TXV+J4Y/*A M_F[$BQNWT]V[?.Q<4,=P.7,NPO7E7<5?7RZC1_DNRA_CM"")?*BFZIT-JS]+ M'C_.7W\IL^55Q^F0^ZPLL\7ZQ[F,9C*O;U!=_Y!EY*!P LS$ !D !X;"]W;W)K&ULM9MM;]LV$,>_"N$-0P>LM?@HN4L,.$G794@?T+3KBV(O%)NQ MA>K!D^1DVZK MLER_'(^+^4HG8?$B6^O4_'*?Y4E8FL-\.2[6N0X7=:,D'C//4^,DC-+1]*S^ M[GT^/=H M4:[.1\&(+/1]N(G+#]GC[WIW0;*R-\_BHOY+'K?G"G/R?%.46;)K;")(HG3[ M/_QGUQ$'#1AS-&"[!JR.>^NHCO(J+,/I69X]DKPZVUBK/M276KOR.SV]M7'6S)[>T5>OWMW]?GZYH8\N])E&,7% MSV?CTGBKVHSG.\L76\O,85F1-UE:K@KR*EWHQ??MQR;*?:CL6Z@7##7XQR9] M0;CW"V$>8^33[15Y]N//B%V^[P)>V^4.N[=E6&HST$KRY<;\1*[-4?%7TP5O M[8AF.]7\>5FLP[D^'YD)4NC\08^F/_U E?Y]RY1[[/%(JIF4='D=-M4'3AU M>%-[;PKW-O][$^5Z03ZN\FRS7)&+36%.*0IRF25W41K6H9!G:59J$C2.367% MQ":**6='^/O0?#2TZV0=1GDU6IJ\^I;7Y[3RZ70;[-T&+3TRWR2;V S4!9DE M65Y&_]6=8(;#=ES@PR*PXN*>>U!,]D%->@:%#I>)%0SU)'-&0SU F3>PDPR* M'#VT,_U=5%RZQPL] "S%1TQ:ANDRNHLUF16%+@LR2Q?D=98M'J,X;HR%6K$( MYDT"=S ,@F%H,$;)C$ZEY'*3YSJ=_TL^YF%:Q'4W-8;"[!%M)I([$H N16D) M/$/N";?[@?O2/9LHP)3B-+V)YN;R=4&^)#JYTWDC[G$;/7E/ ;E4GDB7* KO MOH$"K6D+KK'93FT2N^X>,)CB$#Z!/E ;U:ZP@-$4AS2N#=2&L,LC )CV)7 G M6: -*&83Y_1B0&+6E\3H6&$VA .W,#! ,,,1/$08F UC1JD[*$ QPU%\O"XP M&\8\0$(!%C.J K/!_)RZY8D!EMDIDMR=D4/WBKI5@0%Q&9[E=M D9B>[ MJ&^ *,,A>ED_Z^FV*? 869?R)]8BC.^P8*7&8M MR3/*G,Y89H!EUH;EP?K$&M"\?91H#HX#FSG.9EREN(U@ET? +Q^*7W2Z\P8" MNS-0#@#F.(![BA2W*4R56S3YP3($3N$A*L5M(M.)= <%1.8XD8]7*6[3F?G( M$@0'/',%XG;22WV)#!* +L=3WPX2Q>W4EDTHXAQ MRG&0FOY>Z"3,OQ8D-*/@SG3_ I\50]N++KC9^N9N^ MXF#-%Z=O3XD2-H*YYY9, 006+#Y6HD3#BC%#.@50+7!4=]PNL)-?ACW="B"OP%/@#CHE[!172N5^C)1 M4XG3]+T9H&F)*Q-NHB?P)?!7TA,IDT1!WC=08+%LR9+1G9_.*): 8MF&XL'* M)&T=X-*&KD!F&#!7MNW0]1(FV;0M MY\X8)'!7MJT(]Q"QQ'E\K#!)&\ZN M35W LL*QW$V3E)WM"HYLH2I@KL)SW@Z:I!JVWB2"#@4<53A'WV;I\WF6K+6A M5KC,=0U_7*)PBSW)KP#$ZE1U$>HI"B,44%FU9,D8Z35[ESL(5@%?UK9; AXI-7XKLNBN KQJZ M38<0R08Q4^[5-!]H[+>L Q^M3KY-Y@E64@-@]G$P'RM.ODUI5PS 9Q_GE/:VE,SY@%W_2:LC M_,XI< #0#9ZD,"+HO (< '2#IRN*"#H#. !Z>NAPAL&+- (1E$ #0.3EL1 M$3141#!D+3P - >G*(D(&C;=/$^Z\X0 N!L,+HH([&26!1/&W=X!IL&3EP+O M/,COV!8T;=F.#^KH$YTOZ[<%"C+/-FFY+:G??[M_(V&VK<.'T[>O,[P)]/4>U%I4KY]0V![4&;KNBK_+BO++*D_KG2XT'EU@OG]/C-7M#NH'.S? MTYC^#U!+ P04 " #L,C-54B/0(RT$ 4% &0 'AL+W=OCVFMJM&MWV8 M[H-)#(F6V,QVRDZZ/_Z<'XV9DO@"Q[Y [/A]WL>\?AX;C_>,?Q4A(1)\3V(J M)E8HY>[:MH4?D@2+*[8C5+W9,)Y@J9I\:XL=)SC(@Y+81H[CV0F.J#4=YWU/ M?#IFJ8PC2IXX$&F28/[WG,1L/[&@]=KQ(=J&,NNPI^,=WI(5D1]W3URU[ HE MB!)"1<0HX&0SL6;P>N[F ?F(3Q'9BX-GD$UES=C7K+$,)I:3,2(Q\64&@=77 M"[DA<9PA*1[?2E"KRID%'CZ_HO^13UY-9HT%N6'QYRB0X<0:6B @&YS&\@/; M_TG*"?4S/)_%(O\$^V)L7PWV4R%94@8K!DE$BV_\O?PA#@(0:@E 90#*>1>) M\&RT0LL>\JGFT8I<1+.JK"17;R,5)Z?+Q^?9X]UR?G\+9JO5 M[?,*S!X7X.[]^\7GY?T]N%@0B:-8 '@)WH"(@N>0I0+30(QMJ=)G(+9?IIH7 MJ5!+*@\\,"I# 6YI0((?XVU%N^*.7KG/D1'P74JO@.N\!V'YIX-"O./2-'&;^MS3B)%#+@K-T&X)Y*M00(< -2]81Q9GR!+B@ M3!(PO&SB523P#GF-/.0U\_(J7IZ1US+9X8AG)6Q*Z=52_J9JXCC-.0=5SL&1 M]2 T:"G&H#[IH>>U3'I8$1AV(@"^/)!D37CCBC5"G+AB1Q7!T9ET-?H)+*&C M+=$YI[)*-*^;M."!,\.?+:XRPP_4>AY$+=20IH;^A[[*X*X"@]J7H=%0CY)8 M"=518U"[+NQFNY7*P#_@G=JGP&??41:V=&O;/)#YH]/Q3B6KKAF;O M/E9]=3=O6V?:R:'9RL^AO+K%M]'2_@[-!O\?JAMVSJ@-&QJ=]CC!C8[Q&J3= M&'5SXT/!/858G@M YBW K,,RN(,.D39O M9#YG'Z-#5#]1MY=#NS+JYLJ'*ORDJD',QTTSZJDK61LY&IQ+/;RX+WO M7"T0 6*R4:'.U4"EYL455-&0;)=?^ZR9E"S)'T." \*S >K]AJDBEHTL0741 M./T74$L#!!0 ( .PR,U7)# X[:P( !<& 9 >&PO=V]R:W-H965T M,JXE7:EU?^+Y* M2ZR(ZHD:N;G)A:R(-J8L?%5+))D+JI@?!L'8KPCE7ARYLP<91V*M&>7X($&M MJXK(GU-DHIEX?6][\$B+4ML#/XYJ4N 2]7/]((WE=R@9K9 K*CA(S"=>TK^8 MCJV_<_A.L5$[>[!*5D*\6F.>3;S $D*&J;8(Q"QO>(F,62!#X\<&T^M2VL#= M_1;]J]-NM*R(PDO!7FBFRXGWQ8,,<[)F^E$TWW"C9V3Q4L&4>T+3^HY''J1K MI46U"38,*LK;E;QOZK 3,.H?" @W :'CW29R+&=$DSB2H@%IO0V:W3BI+MJ0 MH]R^E*66YI::.!W/%T_)XGH^O;V"9+F\>EI"LIC!]?W][&5^>PNG,]2$,@4+ M(B6Q!3R#$Z <[BACIJHJ\K5A8;'\=)-QVF8,#V00\&P2<(@S"$Y^4,3D_.CN .NM(,'.[P4&FX)KR@*X:0*(5: M0<(SN!8B:XSX?<);O'.'9[OA+1[TPLA_VT-BV)$8?C")X3\D@D,D1AV)T5$2 M,U2II+5KH_LMF.H-;2H7>NOA#:#Q&U+,[E16@=SGPNAMX9-T/T+ MXM]02P,$% @ [#(S5>V7A:73!0 C14 !D !X;"]W;W)K&ULM5A=<]HZ$/TK._1CVID6;/,1TB;,$)+VTDF:3*"]#YW[ M(&P9:RI;OI(,R;^_*QD,%$>YR9"78%O:LWM6TNZ)3I9"_E8)I1KN4IZITT:B M=?ZIU5)A0E.BFB*G&8[$0J9$XZN?U6BEA66-P8K_=R,&) M*#1G&;V1H(HT)?+^C'*Q/&WXC?6'6S9/M/G0&ISD9$XG5/_(;R2^M2J4B*4T M4TQD(&E\VACZGT9^WQC8&3\97:JM9S!49D+\-B_CZ+3AF8@HIZ$V$ 1_%G1$ M.3=(&,>_*]!&Y=,8;C^OT;]8\DAF1A0="?XWBW1RVN@W(*(Q*;B^%, A6!L$?!G[G 8/V MRJ!MB9:165KG1)/!B11+D&8VHID'FQMKC6Q89I9QHB6.,K33@_'5S7!\>W7Q M?0K77V XF5Q,)_#NG&K"N(+O1$IB\OP>/L*/R3F\>_T>7@/+8)J(0I$L4B<-F#*Y'I1,%%%M%HU[Z%X5<<@C6'L\ )^*W(FM#V/D#@ M!4%-/".W^3D-T=RWYKXCG':5TK;%:S^ -]%$4]SI&GY=XA",\4W]4Y>G$J=3 MCV,.\">5DY">-O"$*BH7M#%X^\KO>9_K2!X(;(=RIZ+<<:%C"F,J)8U@2N[J MB);676MM"LMBX'=]S/5BF\ CDW8"ZU:!=9V!?14B6C+.89A%,(YP45C,,,YQ MIDDV9S-.8:@4U;7;N(3N;074";SC_A]A.P-X9MY[%;V>D]Y/BL'C.;W&;?;K MBJ8S*FLWFA/EJ1OM0& [A(\JPD<'.EM'AZ1\(+ =ROV*B]755;8CS%TA_!LPNQ%"GXS:,ND!GB0B26EJC?#+KPCN2Y%'<,52_E]Q MYL>*E/.T::N=KI3 M]=R%WX@QWRE\5BW2V1W="$_M%8="V^6[46)^YT =TG=JNB?3/A#:+NV-SO/= M0N\Q!;HR?ZQ(O828\S=JSG?+N4MS(N&2D1GC6#5J>?3V.WVPS^,E-)J_$6F^ M4Q -+I2VU2&"VZTJ-WRXFA[M+XY_O,_J)628O]%AOEN(;;<05&)&P=A:75=P5[?PSYDVYW)7=4=J\RMDV$#-'--$_W?SM9.U-IRLQ#5"C3!+&(5C@D# M^R(W,K!:D[>O^H%_]'D3?2RDQ=MU1\T]"'PK$'Y]B]&$S1D*A=(VDHBI7& 2 MS7/[#2RI1&%0S+0DECRZ176-8@V(?D!BE$%O=7-+?K'>RU=G##T)<.DKFZ-W ?BJ6>WM77AA9MM;N\!3>S( ML;S[JKY6=XU#>\/6VDPO+RJO['Y7P&F,IAYNJ0;(\NZO?-$BM]=G,Z&U2.UC M0@EFR$S \5@(O7XQ#JH;V,%_4$L#!!0 ( .PR,U5[YGX,*@4 *P< 9 M >&PO=V]R:W-H965TMR:PHNYFS@D%M\HV8NC:Q"'\A2&W^.; M&V_<^9S(GOQTB*Q[\9:"L?,W8\OCZ@7R?!JV">L"#ST/^' M>G([;@U:P"-K'/GR:[C_BV0!=6.\5>B+Y"_8I[9]->(J$C(,,F=U'U"6_LO\ 9"# MD('/_'1WV$#'S5/G)GAN#=XT"+FD_^&D':]>U,02!,Q>P=S'0H#%&CRJN+G_ M2MD&3(4@TI3"=(B.>8AX#E^('5Z1<4M-4D'X,VE-?O\-]IP_3?%; BMEHY-G MH].$/GD()?:!*2>FL%.L;H(5KS3/$W?@CMK/Q]'H-IUN;E+BV,TY=ALYWC!) M5.02+!BX)6KR@UN*GZA/)27&!D_A>D<4-):Z">R86?9REKU&ELNMRN$7Q30 M4^:!6^7]#?L129M(9,P;DMO3*'6A4Z&MVSAFUOV<=?^$^K_)K:^-.^SW*MQT MF^[03&Z0DQLT3M6%W!(.;EBZ[:G>-%$;V)R*EL!*T0[S:(>-I9AZ'HV#%. A M!,G&G*Q&XM!!IN"'6LZ1TZWVNFY4TS30*;8?I[$R5'!&_T@[QVGRF"' M?3-QI)'JH.I:9C#JUS5FL;G#QMURLM@1KI:*"G/5H\GR#!YJEN2*5D+ MXNFN+V'OEEFP41B\>S&PA%9.4:$/8+- .-3SA$29BZMO_F[/U:JK6Z%.OZ:\ MA4J S3)A%E'?4ZS-Q!I]WUTE2VCE2 O) 9LUAY77 VA5E-A"*V>DD"6P69>\ M[Q4!ZFJC6VW1)I/R*V8A2-!;@N0CUA]D58S80BNGJ! CJ%F,_.CZ@PQ*PW&K M;P$FJYK=!15Z!#7KD5O,/".E1K=WU\<26CG(0KJ@G_!A EG],F$+K9R10@$A MFQ\GD*YK4+_:G;I-C4Y#A?1!OT+Z(*O2QQ9:.46%]$$?*WV0+FH@A-7:GOQQ M!!6Z!S7KGL5Z35<$+./<&(E9E3ZVT,K!%M('_03I@ZQ*'UMHY8P4T@?9E#Y( MUS5N5^M2W:A3TZ9NH7[<7Z%^7*OJQQ9:.46%^G$_5OUD\,??M5%GB"K5-5FY ML%+>]M&Y3T#X)CD.$V 5,TJ/5?*G^9';-#EHJCR?P8MY>G!6P*3G>'>8;R@3 MP"=K!>F<]Q4CGAZ-I31_ M4$L#!!0 ( .PR,U7R."9'4 , +L/ 9 >&PO=V]R:W-H965TICTXR4VP M"CBSG:3[][.!0KH2ND;D)<'@>^[Q/?:QW=]P\2A# (6>XBB1 RM4:MFS;3D- M(:;RE"\AT5_F7,14Z:98V'(I@,[2H#BRB>/X=DQ98@7]]-U(!'V^4A%+8"20 M7,4Q%7_.(>*;@86MYQ>W;!$J\\(.^DNZ@#&H^^5(Z)9=H,Q8#(ED/$$"Y@/K M#/?.B6L"TAX/##9RZQF9H4PX?S2-F]G <@PCB&"J# 35?VNX@"@R2)K'[QS4 M*G*:P.WG9_3K=/!Z,!,JX8)'/]A,A0.K8Z$9S.DJ4K=\\Q7R ;4,WI1',OU% MFZROZUEHNI**QWFP9A"S)/NG3WDAM@((V1% \@"2\LX2I2POJ:)!7_ -$J:W M1C,/Z5#3:$V.)4:5L1+Z*]-Q*AA>G8VOQNCX$A1ED43X!!TAEJ"[D*\D36:R M;RN=QG2VISGD>09)=D!^6R6GR'4^(>(0@N['E^CXZ.0EC*U9%E1)096DN.X. MW+&B"O2$4.CG4']"-[HE?U7QRW"\:APSSWMR2:OY7UG,#*Z5PIDUM X\[+?[]KJ" MA%>0\&I)#$'*'AJ9T>ER/=!H!>@R)U3%(4/SMSA\]AV_FD.KX-#ZCT(,02\9 M-&1TPB*F&%26H/4JO=OR<75ZOTCOUZ;7D\^MRE4;M>?<:!>:V1L5:8[A$7CTJ.QVY2.M6Z_+]'2QW&]D;]?Q]=6[GD[ M=A-<6CFN]W(M8[LR6VW8OM4I+1[[3_C6L/>0\;VZRVQ[>Z0L31V M_(:SAZ!/[G,%HC)G;?"^-2H-'W>;$O,0FP I-P%2Z]WO%S/'VQ:3=)UJ,4EI M\:3>XO6:]"NSU8;M6YVM0WICI_1#[ &DW -(PP=U4G%2]_Z5T=ZZBIEK[7&PO=V]R:W-H965T M&V2 M@UCU0V8[A7[[G1W(F$31WB1^N/_/_TON/-D8^^(J1 ];);6;LLK[>IPDKJA0 M<7=I:M2TLS)6<4]3NTY<;9&74:1DDJ7I,%%<:)9/XMJ3S2>F\5)H?++@&J6X M?9NC-)LIZ[']PK-85SXL)/FDYFM,5EW9! >CO?T M3S%WRF7)'=X:^4N4OIJR$8,25[R1_MEL/N,NGZO *XQT\0F;-C:[9E TSANU M$Y,#)73[YMO==S@0C-)W!-E.D$7?[4'1Y1WW/)]8LP$;HHD6!C'5J"9S0H>? MLO"6=@7I?/[U?K:X7\"'._1<2 ??N+4\?*B/D\03/T0EQ8XU;UG9.ZPA/!KM M*P?WNL3R7WU"OCISV=[_ZQH'DNFQY0(T,_6$/*NH+3CF$DVI+76[]&P@-"ZX] M1:.]((HT:BDXX+86(736K*DDH=^+OV1P+.7DH!85VG7L. >%:;1OR[);[9IZ MUM;RW_#V1GCD=BTTF<<52=/+ZRL&MNVR=N)-'2M[:3SU21Q6=#&A#0&TOS+& M[R?A@.ZJR_\ 4$L#!!0 ( .PR,U7F(S9E#0@ &U: 9 >&PO=V]R M:W-H965T.* $3VV+E433[E]_MG&P!4;@NT]>M&#X/A+.$RSY8^OVE8NO MU!S&[Y5B5QQAX$D=LTC<2/.4OXZUW/[KUM^!2_K%6QH3^[ MW40O[)&I+YL'D3_K[RFK.&69C'E&!'N^Z]W;[^A@4!24[_@]9J^R\9@4'^6) M\Z_%$[JZZUE%CUC"EJI 1/E_W]B")4E!ROOQ9P7M[=LL"IN/W^A^^>'S#_,4 M2;;@R;_CE5K?]:8]LF+/T391G_AKR*H/-"IX2Y[(\E_R6KW7ZI'E5BJ>5L5Y M#](XV_T??:]V1*/ 'IXH<*H"Y]*"054P."P8G2@85@7#2UL8506C2PO&5<'X MTBY-JH+)I2U,JX+II04W5<%-J_+X^>/B7^1GEZDH3B3Y+1(B*C3\A?R#?'ET MR<\__4)^(GTBUY%@DL09^9+%2E[E&_/'G]=\*Z-L)6_[*N]4@>XOJPZXNPXX M)SI@DP\\4VM)O&S%5BWU@;E^;*COYSMCOT>E M/XLSY1MA+'?-Y3Y[NB;.]&2Y=TGY\&2Y;R[_-6+<=?2"SMNMNTX38;#_TQB4O,$)WJ.*%,N_UQ7YXWW^$J'Y,_F?EG[-=YQA M.Z$N8C80$2%B)A% 33 M!![N!1Z:Z+/'XKN:?&*;K5BN\P%!V[?KW(CHZBX2YB)A'A+F(V'!#C8J8<70 M]-ML9%G6;?];TTEDBQ0$TYP<[9TR&/ M>5OQ,A]=/#!1#./9ZHJ4#K<-*^:[=L:-_3:QK*,]MS!VIZN22)B'A/E(6("$ MA4@8!<$T=<=[=<=0=>]3OLU4F[KCHS]Y>W DKK$S7<5%PCPDS$?" B0L1,(H M"*:).]F+.S&*NXCDFCQ$<>OQWUC:]?@_.1)[>.BUBVS00\)\)"Q PD(DC()@ MFHK3O8I3LXH\37EF.*H;R[OJB(2Y2)B'A/E(6("$A=.C,=K8:AFD45"CFI(W M>R5OC$IZWYE8QI*1C!%\RUGJ=R]P,Z&PF-+BJ:,TSL\[Q=R8TD8+2 B@MA-(H MBJ:;6<=2]IEE.9#:0&4%D)I%$735:[C,=NODRC$G5Q_5FHE\,O;,1#X':S43&EU!:2Z4YD%I M/I060&DAE$91-%WA.N!R4+=K.=!X"TISH30/2O.AM !*"Z$TBJ+I*MO S,'>Z77Z=AES M0YTEA@9K4)H'I?G.!:%? &TRA-(HBJ8;7 =KCCE8ZW+)C!G5V5%HE@:E>5": M7]&:7[330?YS:"DT38/2*(JF6UJG:8XY33M_R8P9T-E-:%H&I7E0FE_1FI?S M.-?.Z%!-: H&I5$435>S3L$<\]U>OVZE(HNY2_[XP-(G)MIG8] #$ISH30/ M2O.AM !*"Z$TBJ+I%M)5M&^'.E<'72J]5D:(H&I;D53GSK6:*9T%Q2YF.&@+^4>'?F*7*<2N4XA= MJ!"[4B$T\^HWEJ1-F7@IUS.6I/1NMQ;K?NM^S>3[<-M82.]AN.R1^/+ZD:CK:,'XG,@")[HN< MBK&325F>N*Y(,BBPZ+ 2J.I9,%Y@J:I\Z8J2 TY-4)&[@>>%;H$)=>*1:9OQ M>,16,B<49AR)55%@_FL".=N,'=_9-ER3929U@QN/2KR$.O5YCEZ?@\0D%V_0,9I+EMPA M5NIE$R-7*AL]V$TJR8F5# Y(ANB249D)=$%32!_&NPJO9@RVC).@5?#CBG90 MUSM"@1<$Z"5RD<@P!U%]6ARZ]2ITC4/W@,-<8@GJK$GT_9/J0E-5$S^:IFYU M>LTZ^@J=B!(G,';4'1' U^#$KU[XH?>VA;)74_;:U..KE102TY30)9K@'-,$ MCM $EH12W?2[<3TLMA4.C;"^J.NXW^L-1NZZ :=?X_1;<=YS3"6DK;[]1[Z] MR&^V#6O;L-7VXAYX0L03QN$CX^.^'S0[1[5S]._K?V'K;2Q1P^)[43/+H&89 MM++P/4 U;]@3&XKVJ#^*Q/_ 5!+ P04 M " #L,C-5YDU7H)<+ "$< &0 'AL+W=O]/&'SS'KRSY?4SR'%\\%^77ZH&QVONV7FVJR\E# M73^^G,VJ^0-;Y]6T>&2;YI&[HESG=7.SO)]5CR7+%[M!Z]6,^GX\6^?+S>3J M8G??^_+JHMC6J^6&O2^]:KM>Y^7WUVQ5/%].R.1PQX?E_4/=WC&[NGC,[]DM MJS\]OB^;6[-CE,5RS3;5LMAX);N[G+PB+Z\)#=L1NZ=\7K+GBOO;:[5\*8JO M[8UWB\N)W[XDMF+SNHV1-_\]L6NV6K6AFA?R5Q=U^4?,E MK]AUL?ISN:@?+B?IQ%NPNWR[JC\4S_]FG:*HC3VD_4FK_.KB[)X M]LKVV4VT]H_=L=F-;M0L-^W[>%N7S:/+9EQ]=?/^X[N;/VZ]G]^P.E^N*H_\ MXOW#^W3[QOOYIU^\G[R95SWD):N\Y<;[M%G6U8OFSN;OCP_%MLHWB^IB5C:WSX&S9OAI/=<(*\G.!X2(-=O.!$O-LZKUESJM?>?W]K'O+>-;>J M_\F.TSY.*(_37L$OJ\=\SBXGS25:L?*)3:[^_C<2^_^4B;04K"A7 M;[^Q^7,Z93"HZ7E?J/EBR"]9^4#U=!=/X8O8D41 =%40:"KQ?BVTI MDX$&T95A*5A/;WS4&ULZ26.;DBT%ZTE.CI(3]"V^>6R-H_G8V;_5^9>5]$S= M!XFYDXLDON\?3Z^]$#25H9#T*"0]\VI+A0N$3FDTD( F,920'25DJ(1_E7ES MZC6.U5QJ^;+T/N>K+?,^LZIF"^_5NMAN:IFN?="(UQ4,5*%Y#541']S4'W6. MW6SKJF[L<;FY?^']N6.)5M@3*QLX\CZPEK":Q[SKQ@G+!F6V^&XXTB.ZQD2\M41" M?3& .42'LAZ;AKT04"$6 @@D/0P$-NE]^D6BP132?9 M!1]1X"/J6[(0:@E6NAD %^A# 7WH./116 @5T2>6G;=X-E,UP#Y4AWVD0N@8 M#\'3F,H G*$H-YAZ2!>UYR$D'4IS@2P4D(6.0Q:;)J)(>3"1\& B-#QI(G@H MTZ,##$1Q!AII(ET4]=7H H4HH!#%46CH(NR);:1RK$[DV(K6%PV41!-;/F() M6#K9+O"' O[0D?W11 ME%MF^N5([=U2H7@!0 ( 6AK34ZJRM7MJ+U90/Y!./( M1^$?@4@^-"22,]<%^01 /H$.^4B%Q)*5PC09RG#!,@&P3(!/OYCZ1R+QCW@H MS06O!, K@?9TS?G^@:<\+H?X([Z(X+%,#P\ 4( #T%@CR49>CBXX* 0."G$. M&AC)'\W#TIT 5B=V;$7K:P9 "HDE'PDM,4LGVP4!A4! X3@"4OA(*!(0B25K M>7@V4S5 0*$. 4F%!+(=)\-)'SR-J0QN#PX^ V/H(UU4WD?":/@5"T]M*@VX M)=2>L3G;1Q0IM7P$CV5Z> "$0AR$1OI(%T5].;K@H1!X*,1Y:. C'^7367@0 M[<]3%YP4 B>%J2T;L40LG6P7_!,"_X3C^$=E(R+_"*>L"_2) 'TB'?21;AST M!0>)IL.E9SR+J0J F0B?>C$TD"XJ;R!1.%3F@E\;F;/]0I PU%M7Q M4*9'!_@GPOEGI'UT4?KV(;H'GLQ4#%!0A%/0<#IK=6H]!(^CO9?7!2!%W.[E MR)*!1':W,+L GPC )QH'/@H#B43P$!93 M%8 Q$3[W8FH@J6 @Q*?#J2P\MZDV8)5(>Z[F? O!4VI9B L B@& 8NU]SS+! M793^3)9D203/9JH&0"C&06CX#>29K>3;>_$XVL41+B I!DB*J24/B:WN:K85 MK2\;Z"<>1S\*#XDE])-$DE/7!?[$@#^Q#OY(A822-75_".QX&E,9P#,Q/OMB MZ"1=U)Z31)GP%CDIO.(JK[1G:\YV$D7*<,2B.A["]*@ <7:^YZE0B7E6;'4 M0ER@4 PH%.O4:'D?'Y9ES>1?1/!(VI^F+C I!DR*,ULF8G5?LZUH_[+F;/=0I.R60F27'3[2]& [20X[8PTC2Y*W'M;)36]+I@G >9) MM$O03UD&'DGWL]-6M+YNX*'$5BEZ8G4+LZUH?=E<-;J="()[N#)3,4 M[B3GEJ0G8DTZF0YW8N%93%4 O"1.JM(3L2P]'I:EXYE-&P8 GZ0_OBY=D?+P MG2,YS%Z=+DS'(YD>'&">U$IA>BI69\FN1#R9J1@@GU2S,/WNE(G@@70_36U% MZ\L&+$IMU::G5OBL7I-!NN@N"I3:4!M*0_OCI=D5+'1YQTY>':\E@I M3D_%ZBR:RBY&%S"4 @RENM7I)XW$ZDR.K6C]OD1 2IFM"O7,ZD9F6]'ZLH&! M,BL5ZIG(0,/3%D]D*@3X)SNW.#T3B]/)5&@CY0)G,L"9S$EM>B;6I@^GK_#$ MIL( 6#+M&9NS#421,M39R8O',CT\0$"9E=+T3"S0DGT5P9.9B@$.RK0JTV_D M]2!X$.V/41=\E $?9;;JTC.K^Y=M1>O+!O+)K-2E9R+Y9&$F.6^=M";D>A.> M6Y>>B77I_I0,UT R<=\RV,R@P2#?8=!)N?DA+.\-@=#5"\]MW#Z1ZQ'H__B* MGI]0S'4^(!0[H!8*38_A%%>6XI\QHJX+H*^5L'YQ^="+LAN#T%;X0:R MN2Z"?FC)&@Z1K$EWP33$YWH.^E;*S@]A>IL[I+T_\7S&BKCV@_ZYI>>'"*H^ MBMW3".$_EZ=)=,HHN$:"OI.Z\D/8GE&$PZ\1BN3&;P'7"=#_\;7EJIR=4WC9 M<4=NBG3;==)=T.?:"_I6RLL/849<=DZ:*_/=E16]CH5=5263OX^V6AUWPAUU M3N9;)]NJ,R>V&B,?I#L!(+[1LJ+3\ECS("( !?+&T4X B&^CC#1"PX MEYF'Y&G!]-1W#+[CL:+EL:EU=&%[2QB1T˚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end XML 94 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 95 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 96 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 265 391 1 false 104 0 false 5 false false R1.htm 000001 - Document - Cover Sheet http://flora.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - Interim Condensed Consolidated Statements of Financial Position Sheet http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition Interim Condensed Consolidated Statements of Financial Position Statements 2 false false R3.htm 000003 - Statement - Interim Condensed Consolidated Statements of Loss on Comprehensive Loss Sheet http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss Interim Condensed Consolidated Statements of Loss on Comprehensive Loss Statements 3 false false R4.htm 000004 - Statement - Interim Condensed Consolidated Statement of Shareholders' Equity (Deficiency) Sheet http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency Interim Condensed Consolidated Statement of Shareholders' Equity (Deficiency) Statements 4 false false R5.htm 000005 - Statement - Interim Condensed Consolidated Statement of Cash Flows Sheet http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows Interim Condensed Consolidated Statement of Cash Flows Statements 5 false false R6.htm 000006 - Disclosure - NATURE OF OPERATIONS Sheet http://flora.com/role/NatureOfOperations NATURE OF OPERATIONS Notes 6 false false R7.htm 000007 - Disclosure - BASIS OF PRESENTATION Sheet http://flora.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 7 false false R8.htm 000008 - Disclosure - TRADE AND AMOUNTS RECEIVABLE Sheet http://flora.com/role/TradeAndAmountsReceivable TRADE AND AMOUNTS RECEIVABLE Notes 8 false false R9.htm 000009 - Disclosure - BIOLOGICAL ASSETS Sheet http://flora.com/role/BiologicalAssets BIOLOGICAL ASSETS Notes 9 false false R10.htm 000010 - Disclosure - INVENTORY Sheet http://flora.com/role/INVENTORY INVENTORY Notes 10 false false R11.htm 000011 - Disclosure - PROPERTY PLANT AND EQUIPMENT Sheet http://flora.com/role/PropertyPlantAndEquipment PROPERTY PLANT AND EQUIPMENT Notes 11 false false R12.htm 000012 - Disclosure - LONGTERM INVESTMENTS Sheet http://flora.com/role/LongtermInvestments LONGTERM INVESTMENTS Notes 12 false false R13.htm 000013 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS Sheet http://flora.com/role/AssetAcquisitionsAndBusinessCombinations ASSET ACQUISITIONS AND BUSINESS COMBINATIONS Notes 13 false false R14.htm 000014 - Disclosure - INTANGIBLE ASSETS AND GOODWILL Sheet http://flora.com/role/IntangibleAssetsAndGoodwill INTANGIBLE ASSETS AND GOODWILL Notes 14 false false R15.htm 000015 - Disclosure - IMPAIRMENT OF ASSETS Sheet http://flora.com/role/ImpairmentOfAssets IMPAIRMENT OF ASSETS Notes 15 false false R16.htm 000016 - Disclosure - LEASES Sheet http://flora.com/role/LEASES LEASES Notes 16 false false R17.htm 000017 - Disclosure - CAPITAL STOCK Sheet http://flora.com/role/CapitalStock CAPITAL STOCK Notes 17 false false R18.htm 000018 - Disclosure - OPTIONS Sheet http://flora.com/role/OPTIONS OPTIONS Notes 18 false false R19.htm 000019 - Disclosure - WARRANTS Sheet http://flora.com/role/WARRANTS WARRANTS Notes 19 false false R20.htm 000020 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES Sheet http://flora.com/role/ProvisionsCommitmentsAndContingencies PROVISIONS COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 000021 - Disclosure - INCOME TAXES Sheet http://flora.com/role/IncomeTaxes INCOME TAXES Notes 21 false false R22.htm 000022 - Disclosure - LOSS PER SHARE Sheet http://flora.com/role/LossPerShare LOSS PER SHARE Notes 22 false false R23.htm 000023 - Disclosure - RELATED PARTY DISCLOSURES Sheet http://flora.com/role/RelatedPartyDisclosures RELATED PARTY DISCLOSURES Notes 23 false false R24.htm 000024 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Sheet http://flora.com/role/FinancialInstrumentsAndRiskManagement FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Notes 24 false false R25.htm 000025 - Disclosure - CAPITAL MANAGEMENT Sheet http://flora.com/role/CapitalManagement CAPITAL MANAGEMENT Notes 25 false false R26.htm 000026 - Disclosure - SEGMENTED INFORMATION Sheet http://flora.com/role/SegmentedInformation SEGMENTED INFORMATION Notes 26 false false R27.htm 000027 - Disclosure - SUBSEQUENT EVENTS Sheet http://flora.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 27 false false R28.htm 000028 - Disclosure - Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies) Sheet http://flora.com/role/SignificantAccountingPoliciesAndCriticalJudgmentsAndEstimationUncertaintiesPolicies Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies) Policies 28 false false R29.htm 000029 - Disclosure - BASIS OF PRESENTATION (Tables) Sheet http://flora.com/role/BasisOfPresentationTables BASIS OF PRESENTATION (Tables) Tables http://flora.com/role/BasisOfPresentation 29 false false R30.htm 000030 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Tables) Sheet http://flora.com/role/TradeAndAmountsReceivableTables TRADE AND AMOUNTS RECEIVABLE (Tables) Tables http://flora.com/role/TradeAndAmountsReceivable 30 false false R31.htm 000031 - Disclosure - BIOLOGICAL ASSETS (Tables) Sheet http://flora.com/role/BiologicalAssetsTables BIOLOGICAL ASSETS (Tables) Tables http://flora.com/role/BiologicalAssets 31 false false R32.htm 000032 - Disclosure - INVENTORY (Tables) Sheet http://flora.com/role/InventoryTables INVENTORY (Tables) Tables http://flora.com/role/INVENTORY 32 false false R33.htm 000033 - Disclosure - PROPERTY PLANT AND EQUIPMENT (Tables) Sheet http://flora.com/role/PropertyPlantAndEquipmentTables PROPERTY PLANT AND EQUIPMENT (Tables) Tables http://flora.com/role/PropertyPlantAndEquipment 33 false false R34.htm 000034 - Disclosure - LONGTERM INVESTMENTS (Tables) Sheet http://flora.com/role/LongtermInvestmentsTables LONGTERM INVESTMENTS (Tables) Tables http://flora.com/role/LongtermInvestments 34 false false R35.htm 000035 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Tables) Sheet http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsTables ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Tables) Tables http://flora.com/role/AssetAcquisitionsAndBusinessCombinations 35 false false R36.htm 000036 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) Sheet http://flora.com/role/IntangibleAssetsAndGoodwillTables INTANGIBLE ASSETS AND GOODWILL (Tables) Tables http://flora.com/role/IntangibleAssetsAndGoodwill 36 false false R37.htm 000037 - Disclosure - LEASES (Tables) Sheet http://flora.com/role/LeasesTables LEASES (Tables) Tables http://flora.com/role/LEASES 37 false false R38.htm 000038 - Disclosure - OPTIONS (Tables) Sheet http://flora.com/role/OptionsTables OPTIONS (Tables) Tables http://flora.com/role/OPTIONS 38 false false R39.htm 000039 - Disclosure - WARRANTS (Tables) Sheet http://flora.com/role/WarrantsTables WARRANTS (Tables) Tables http://flora.com/role/WARRANTS 39 false false R40.htm 000040 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://flora.com/role/ProvisionsCommitmentsAndContingenciesTables PROVISIONS COMMITMENTS AND CONTINGENCIES (Tables) Tables http://flora.com/role/ProvisionsCommitmentsAndContingencies 40 false false R41.htm 000041 - Disclosure - LOSS PER SHARE (Tables) Sheet http://flora.com/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://flora.com/role/LossPerShare 41 false false R42.htm 000042 - Disclosure - RELATED PARTY DISCLOSURES (Tables) Sheet http://flora.com/role/RelatedPartyDisclosuresTables RELATED PARTY DISCLOSURES (Tables) Tables http://flora.com/role/RelatedPartyDisclosures 42 false false R43.htm 000043 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) Sheet http://flora.com/role/FinancialInstrumentsAndRiskManagementTables FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) Tables http://flora.com/role/FinancialInstrumentsAndRiskManagement 43 false false R44.htm 000044 - Disclosure - SEGMENT DISCLOSURES (Tables) Sheet http://flora.com/role/SegmentDisclosuresTables SEGMENT DISCLOSURES (Tables) Tables 44 false false R45.htm 000045 - Disclosure - NATURE OF OPERATIONS (Details Narrative) Sheet http://flora.com/role/NatureOfOperationsDetailsNarrative NATURE OF OPERATIONS (Details Narrative) Details http://flora.com/role/NatureOfOperations 45 false false R46.htm 000046 - Disclosure - BASIS OF PRESENTATION (Details) Sheet http://flora.com/role/BasisOfPresentationDetails BASIS OF PRESENTATION (Details) Details http://flora.com/role/BasisOfPresentationTables 46 false false R47.htm 000047 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details) Sheet http://flora.com/role/TradeAndAmountsReceivableDetails TRADE AND AMOUNTS RECEIVABLE (Details) Details http://flora.com/role/TradeAndAmountsReceivableTables 47 false false R48.htm 000048 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details 1) Sheet http://flora.com/role/TradeAndAmountsReceivableDetails1 TRADE AND AMOUNTS RECEIVABLE (Details 1) Details http://flora.com/role/TradeAndAmountsReceivableTables 48 false false R49.htm 000049 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details Narrative) Sheet http://flora.com/role/TradeAndAmountsReceivableDetailsNarrative TRADE AND AMOUNTS RECEIVABLE (Details Narrative) Details http://flora.com/role/TradeAndAmountsReceivableTables 49 false false R50.htm 000050 - Disclosure - BIOLOGICAL ASSETS (Details) Sheet http://flora.com/role/BiologicalAssetsDetails BIOLOGICAL ASSETS (Details) Details http://flora.com/role/BiologicalAssetsTables 50 false false R51.htm 000051 - Disclosure - BIOLOGICAL ASSETS (Details Narrative) Sheet http://flora.com/role/BiologicalAssetsDetailsNarrative BIOLOGICAL ASSETS (Details Narrative) Details http://flora.com/role/BiologicalAssetsTables 51 false false R52.htm 000052 - Disclosure - INVENTORY (Details) Sheet http://flora.com/role/InventoryDetails INVENTORY (Details) Details http://flora.com/role/InventoryTables 52 false false R53.htm 000053 - Disclosure - PROPERTY PLANT AND EQUIPMENT (Details) Sheet http://flora.com/role/PropertyPlantAndEquipmentDetails PROPERTY PLANT AND EQUIPMENT (Details) Details http://flora.com/role/PropertyPlantAndEquipmentTables 53 false false R54.htm 000054 - Disclosure - LONGTERM INVESTMENTS (Details) Sheet http://flora.com/role/LongtermInvestmentsDetails LONGTERM INVESTMENTS (Details) Details http://flora.com/role/LongtermInvestmentsTables 54 false false R55.htm 000055 - Disclosure - LONGTERM INVESTMENTS (Details 1) Sheet http://flora.com/role/LongtermInvestmentsDetails1 LONGTERM INVESTMENTS (Details 1) Details http://flora.com/role/LongtermInvestmentsTables 55 false false R56.htm 000056 - Disclosure - LONGTERM INVESTMENTS (Details Narrative) Sheet http://flora.com/role/LongtermInvestmentsDetailsNarrative LONGTERM INVESTMENTS (Details Narrative) Details http://flora.com/role/LongtermInvestmentsTables 56 false false R57.htm 000057 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details) Sheet http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details) Details http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsTables 57 false false R58.htm 000058 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative) Sheet http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative) Details http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsTables 58 false false R59.htm 000059 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details) Sheet http://flora.com/role/IntangibleAssetsAndGoodwillDetails INTANGIBLE ASSETS AND GOODWILL (Details) Details http://flora.com/role/IntangibleAssetsAndGoodwillTables 59 false false R60.htm 000060 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 1) Sheet http://flora.com/role/IntangibleAssetsAndGoodwillDetails1 INTANGIBLE ASSETS AND GOODWILL (Details 1) Details http://flora.com/role/IntangibleAssetsAndGoodwillTables 60 false false R61.htm 000061 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Sheet http://flora.com/role/IntangibleAssetsAndGoodwillDetailsNarrative INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Details http://flora.com/role/IntangibleAssetsAndGoodwillTables 61 false false R62.htm 000062 - Disclosure - IMPAIRMENT OF ASSETS (Details Narrative) Sheet http://flora.com/role/ImpairmentOfAssetsDetailsNarrative IMPAIRMENT OF ASSETS (Details Narrative) Details http://flora.com/role/ImpairmentOfAssets 62 false false R63.htm 000063 - Disclosure - LEASES (Details) Sheet http://flora.com/role/LeasesDetails LEASES (Details) Details http://flora.com/role/LeasesTables 63 false false R64.htm 000064 - Disclosure - LEASES (Details 1) Sheet http://flora.com/role/LeasesDetails1 LEASES (Details 1) Details http://flora.com/role/LeasesTables 64 false false R65.htm 000065 - Disclosure - LEASES (Details Narrative) Sheet http://flora.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://flora.com/role/LeasesTables 65 false false R66.htm 000066 - Disclosure - CAPITAL STOCK (Details Narrative) Sheet http://flora.com/role/CapitalStockDetailsNarrative CAPITAL STOCK (Details Narrative) Details http://flora.com/role/CapitalStock 66 false false R67.htm 000067 - Disclosure - OPTIONS (Details) Sheet http://flora.com/role/OptionsDetails OPTIONS (Details) Details http://flora.com/role/OptionsTables 67 false false R68.htm 000068 - Disclosure - OPTIONS (Details 1) Sheet http://flora.com/role/OptionsDetails1 OPTIONS (Details 1) Details http://flora.com/role/OptionsTables 68 false false R69.htm 000069 - Disclosure - OPTIONS (Details 2) Sheet http://flora.com/role/OptionsDetails2 OPTIONS (Details 2) Details http://flora.com/role/OptionsTables 69 false false R70.htm 000070 - Disclosure - OPTIONS (Details Narrative) Sheet http://flora.com/role/OptionsDetailsNarrative OPTIONS (Details Narrative) Details http://flora.com/role/OptionsTables 70 false false R71.htm 000071 - Disclosure - WARRANTS (Details) Sheet http://flora.com/role/WarrantsDetails WARRANTS (Details) Details http://flora.com/role/WarrantsTables 71 false false R72.htm 000072 - Disclosure - WARRANTS (Details 1) Sheet http://flora.com/role/WarrantsDetails1 WARRANTS (Details 1) Details http://flora.com/role/WarrantsTables 72 false false R73.htm 000073 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Details) Sheet http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails PROVISIONS COMMITMENTS AND CONTINGENCIES (Details) Details http://flora.com/role/ProvisionsCommitmentsAndContingenciesTables 73 false false R74.htm 000074 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetailsNarrative PROVISIONS COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://flora.com/role/ProvisionsCommitmentsAndContingenciesTables 74 false false R75.htm 000075 - Disclosure - LOSS PER SHARE (Details) Sheet http://flora.com/role/LossPerShareDetails LOSS PER SHARE (Details) Details http://flora.com/role/LossPerShareTables 75 false false R76.htm 000076 - Disclosure - RELATED PARTY DISCLOSURES (Details) Sheet http://flora.com/role/RelatedPartyDisclosuresDetails RELATED PARTY DISCLOSURES (Details) Details http://flora.com/role/RelatedPartyDisclosuresTables 76 false false R77.htm 000077 - Disclosure - RELATED PARTY DISCLOSURES (Details Narrative) Sheet http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative RELATED PARTY DISCLOSURES (Details Narrative) Details http://flora.com/role/RelatedPartyDisclosuresTables 77 false false R78.htm 000078 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details ) Sheet http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details ) Details http://flora.com/role/FinancialInstrumentsAndRiskManagementTables 78 false false R79.htm 000079 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative) Sheet http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative) Details http://flora.com/role/FinancialInstrumentsAndRiskManagementTables 79 false false R80.htm 000080 - Disclosure - CAPITAL MANAGEMENT (Details Narrative) Sheet http://flora.com/role/CapitalManagementDetailsNarrative CAPITAL MANAGEMENT (Details Narrative) Details http://flora.com/role/CapitalManagement 80 false false R81.htm 000081 - Disclosure - SEGMENTED INFORMATION (Details) Sheet http://flora.com/role/SegmentedInformationDetails SEGMENTED INFORMATION (Details) Details http://flora.com/role/SegmentedInformation 81 false false R82.htm 000082 - Disclosure - SEGMENTED INFORMATION (Details 1) Sheet http://flora.com/role/SegmentedInformationDetails1 SEGMENTED INFORMATION (Details 1) Details http://flora.com/role/SegmentedInformation 82 false false R83.htm 000083 - Disclosure - SEGMENTED INFORMATION (Details Narrative) Sheet http://flora.com/role/SegmentedInformationDetailsNarrative SEGMENTED INFORMATION (Details Narrative) Details http://flora.com/role/SegmentedInformation 83 false false R84.htm 000084 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://flora.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://flora.com/role/SubsequentEvents 84 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 24 fact(s) appearing in ix:hidden were eligible for transformation: flora:AccumulatedAmortization, flora:IntangibleAssetsAndGoodwillCost, flora:NonControllingInterests, flora:NumberOfOptionsExercisable, ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill, ifrs-full:BiologicalAssets, ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares, ifrs-full:Revenue, ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill, ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment - flora_6k.htm 1 flora_6k.htm flora_ex991.htm flora-20220630.xsd flora-20220630_cal.xml flora-20220630_def.xml flora-20220630_lab.xml flora-20220630_pre.xml http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full http://xbrl.sec.gov/dei/2021q4 true true JSON 99 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "flora_6k.htm flora_ex991.htm": { "axisCustom": 0, "axisStandard": 22, "contextCount": 265, "dts": { "calculationLink": { "local": [ "flora-20220630_cal.xml" ] }, "definitionLink": { "local": [ "flora-20220630_def.xml" ] }, "inline": { "local": [ "flora_6k.htm", "flora_ex991.htm" ] }, "labelLink": { "local": [ "flora-20220630_lab.xml" ] }, "presentationLink": { "local": [ "flora-20220630_pre.xml" ] }, "schema": { "local": [ "flora-20220630.xsd", "reference-2009-12-16.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 604, "entityCount": 1, "hidden": { "http://flora.com/20220630": 8, "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 16, "http://xbrl.sec.gov/dei/2021q4": 6, "total": 30 }, "keyCustom": 211, "keyStandard": 180, "memberCustom": 99, "memberStandard": 5, "nsprefix": "flora", "nsuri": "http://flora.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_6k.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://flora.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_6k.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - INVENTORY", "role": "http://flora.com/role/INVENTORY", "shortName": "INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - PROPERTY PLANT AND EQUIPMENT", "role": "http://flora.com/role/PropertyPlantAndEquipment", "shortName": "PROPERTY PLANT AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - LONGTERM INVESTMENTS", "role": "http://flora.com/role/LongtermInvestments", "shortName": "LONGTERM INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS", "role": "http://flora.com/role/AssetAcquisitionsAndBusinessCombinations", "shortName": "ASSET ACQUISITIONS AND BUSINESS COMBINATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - INTANGIBLE ASSETS AND GOODWILL", "role": "http://flora.com/role/IntangibleAssetsAndGoodwill", "shortName": "INTANGIBLE ASSETS AND GOODWILL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - IMPAIRMENT OF ASSETS", "role": "http://flora.com/role/ImpairmentOfAssets", "shortName": "IMPAIRMENT OF ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - LEASES", "role": "http://flora.com/role/LEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - CAPITAL STOCK", "role": "http://flora.com/role/CapitalStock", "shortName": "CAPITAL STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfOptionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - OPTIONS", "role": "http://flora.com/role/OPTIONS", "shortName": "OPTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfOptionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "flora:ScheduleOfWarrantsOutstanding", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - WARRANTS", "role": "http://flora.com/role/WARRANTS", "shortName": "WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "flora:ScheduleOfWarrantsOutstanding", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - Interim Condensed Consolidated Statements of Financial Position", "role": "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "shortName": "Interim Condensed Consolidated Statements of Financial Position", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "lang": null, "name": "ifrs-full:TradeAndOtherCurrentReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES", "role": "http://flora.com/role/ProvisionsCommitmentsAndContingencies", "shortName": "PROVISIONS COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000021 - Disclosure - INCOME TAXES", "role": "http://flora.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000022 - Disclosure - LOSS PER SHARE", "role": "http://flora.com/role/LossPerShare", "shortName": "LOSS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000023 - Disclosure - RELATED PARTY DISCLOSURES", "role": "http://flora.com/role/RelatedPartyDisclosures", "shortName": "RELATED PARTY DISCLOSURES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfFinancialInstrumentsAndRiskExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000024 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "role": "http://flora.com/role/FinancialInstrumentsAndRiskManagement", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfFinancialInstrumentsAndRiskExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfFinancialRiskCapitalManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000025 - Disclosure - CAPITAL MANAGEMENT", "role": "http://flora.com/role/CapitalManagement", "shortName": "CAPITAL MANAGEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfFinancialRiskCapitalManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000026 - Disclosure - SEGMENTED INFORMATION", "role": "http://flora.com/role/SegmentedInformation", "shortName": "SEGMENTED INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:SubsequentEvents", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000027 - Disclosure - SUBSEQUENT EVENTS", "role": "http://flora.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:SubsequentEvents", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ContingentPurchaseConsideration", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000028 - Disclosure - Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies)", "role": "http://flora.com/role/SignificantAccountingPoliciesAndCriticalJudgmentsAndEstimationUncertaintiesPolicies", "shortName": "Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ContingentPurchaseConsideration", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfSubsidiariesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000029 - Disclosure - BASIS OF PRESENTATION (Tables)", "role": "http://flora.com/role/BasisOfPresentationTables", "shortName": "BASIS OF PRESENTATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfSubsidiariesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - Interim Condensed Consolidated Statements of Loss on Comprehensive Loss", "role": "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss", "shortName": "Interim Condensed Consolidated Statements of Loss on Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "lang": null, "name": "ifrs-full:CostOfSales", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfTradeAndOtherPayblesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000030 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Tables)", "role": "http://flora.com/role/TradeAndAmountsReceivableTables", "shortName": "TRADE AND AMOUNTS RECEIVABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfTradeAndOtherPayblesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfCarryingValueOfBiologicalAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000031 - Disclosure - BIOLOGICAL ASSETS (Tables)", "role": "http://flora.com/role/BiologicalAssetsTables", "shortName": "BIOLOGICAL ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfCarryingValueOfBiologicalAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfInventory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000032 - Disclosure - INVENTORY (Tables)", "role": "http://flora.com/role/InventoryTables", "shortName": "INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfInventory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000033 - Disclosure - PROPERTY PLANT AND EQUIPMENT (Tables)", "role": "http://flora.com/role/PropertyPlantAndEquipmentTables", "shortName": "PROPERTY PLANT AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfLongTermInvestmentsActivity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000034 - Disclosure - LONGTERM INVESTMENTS (Tables)", "role": "http://flora.com/role/LongtermInvestmentsTables", "shortName": "LONGTERM INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfLongTermInvestmentsActivity", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfMajorClassOfAssetsAcquiredAndLiabilities", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000035 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)", "role": "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsTables", "shortName": "ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfMajorClassOfAssetsAcquiredAndLiabilities", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000036 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)", "role": "http://flora.com/role/IntangibleAssetsAndGoodwillTables", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfLeases", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000037 - Disclosure - LEASES (Tables)", "role": "http://flora.com/role/LeasesTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfLeases", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfShareOptionsOutstandingAndExercisable", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000038 - Disclosure - OPTIONS (Tables)", "role": "http://flora.com/role/OptionsTables", "shortName": "OPTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfShareOptionsOutstandingAndExercisable", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000039 - Disclosure - WARRANTS (Tables)", "role": "http://flora.com/role/WarrantsTables", "shortName": "WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2020-12-31_flora_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - Interim Condensed Consolidated Statement of Shareholders' Equity (Deficiency)", "role": "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "shortName": "Interim Condensed Consolidated Statement of Shareholders' Equity (Deficiency)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2020-12-31_flora_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfProvisionsAndContingentLiabilities", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000040 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://flora.com/role/ProvisionsCommitmentsAndContingenciesTables", "shortName": "PROVISIONS COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfProvisionsAndContingentLiabilities", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfComputationOfDilutedSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000041 - Disclosure - LOSS PER SHARE (Tables)", "role": "http://flora.com/role/LossPerShareTables", "shortName": "LOSS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfComputationOfDilutedSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfKeyManagementPersonnelCompensation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000042 - Disclosure - RELATED PARTY DISCLOSURES (Tables)", "role": "http://flora.com/role/RelatedPartyDisclosuresTables", "shortName": "RELATED PARTY DISCLOSURES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfKeyManagementPersonnelCompensation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfAssetsAndLiabilitiesDenominatedInForeignCurrencies", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000043 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)", "role": "http://flora.com/role/FinancialInstrumentsAndRiskManagementTables", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:ScheduleOfAssetsAndLiabilitiesDenominatedInForeignCurrencies", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfDetailedInformationAboutGeographicalInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000044 - Disclosure - SEGMENT DISCLOSURES (Tables)", "role": "http://flora.com/role/SegmentDisclosuresTables", "shortName": "SEGMENT DISCLOSURES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DisclosureOfDetailedInformationAboutGeographicalInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfGoingConcernExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:IncorporationCountry", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000045 - Disclosure - NATURE OF OPERATIONS (Details Narrative)", "role": "http://flora.com/role/NatureOfOperationsDetailsNarrative", "shortName": "NATURE OF OPERATIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfGoingConcernExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:IncorporationCountry", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "flora:DisclosureOfSubsidiariesTableTextBlock", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30_flora_SubsidiaryTwentyMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:NameOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000046 - Disclosure - BASIS OF PRESENTATION (Details)", "role": "http://flora.com/role/BasisOfPresentationDetails", "shortName": "BASIS OF PRESENTATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "flora:DisclosureOfSubsidiariesTableTextBlock", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30_flora_SubsidiaryTwentyMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:NameOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:DisclosureOfTradeAndOtherPayblesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:TradeReceivables", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000047 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details)", "role": "http://flora.com/role/TradeAndAmountsReceivableDetails", "shortName": "TRADE AND AMOUNTS RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:DisclosureOfTradeAndOtherPayblesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "lang": null, "name": "flora:AllowanceForExpectedCreditLosses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfTradeAccountsReceivableAllowanceTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentTradeReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000048 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details 1)", "role": "http://flora.com/role/TradeAndAmountsReceivableDetails1", "shortName": "TRADE AND AMOUNTS RECEIVABLE (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfTradeAccountsReceivableAllowanceTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentTradeReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:AdditionalExpectedCreditLosses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000049 - Disclosure - TRADE AND AMOUNTS RECEIVABLE (Details Narrative)", "role": "http://flora.com/role/TradeAndAmountsReceivableDetailsNarrative", "shortName": "TRADE AND AMOUNTS RECEIVABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:AdditionalExpectedCreditLosses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - Interim Condensed Consolidated Statement of Cash Flows", "role": "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows", "shortName": "Interim Condensed Consolidated Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "lang": null, "name": "ifrs-full:DepreciationAndAmortisationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfCarryingValueOfBiologicalAssetsTableTextBlock", "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:BiologicalAssets", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000050 - Disclosure - BIOLOGICAL ASSETS (Details)", "role": "http://flora.com/role/BiologicalAssetsDetails", "shortName": "BIOLOGICAL ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfCarryingValueOfBiologicalAssetsTableTextBlock", "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "lang": null, "name": "ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "flora:WeightedAverageYieldPerGram", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000051 - Disclosure - BIOLOGICAL ASSETS (Details Narrative)", "role": "http://flora.com/role/BiologicalAssetsDetailsNarrative", "shortName": "BIOLOGICAL ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "flora:WeightedAverageYieldPerGram", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "flora:ScheduleOfInventory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000052 - Disclosure - INVENTORY (Details)", "role": "http://flora.com/role/InventoryDetails", "shortName": "INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "flora:ScheduleOfInventory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DepreciationPropertyPlantAndEquipment", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000053 - Disclosure - PROPERTY PLANT AND EQUIPMENT (Details)", "role": "http://flora.com/role/PropertyPlantAndEquipmentDetails", "shortName": "PROPERTY PLANT AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfPropertyPlantAndEquipment", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2021-12-31_flora_ConstructionsInProgressMember", "decimals": "-3", "lang": null, "name": "ifrs-full:PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfFairValueOfStockOptions", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000054 - Disclosure - LONGTERM INVESTMENTS (Details)", "role": "http://flora.com/role/LongtermInvestmentsDetails", "shortName": "LONGTERM INVESTMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfFairValueOfTheWarrants", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30_flora_WarrantsCADThirtyMember", "decimals": "INF", "lang": null, "name": "flora:FairValueSharePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfLongTermInvestmentsActivity", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "flora:LossOnChangesInFairValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000055 - Disclosure - LONGTERM INVESTMENTS (Details 1)", "role": "http://flora.com/role/LongtermInvestmentsDetails1", "shortName": "LONGTERM INVESTMENTS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfLongTermInvestmentsActivity", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "flora:LossOnChangesInFairValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:PurchaseofCommonShares", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000056 - Disclosure - LONGTERM INVESTMENTS (Details Narrative)", "role": "http://flora.com/role/LongtermInvestmentsDetailsNarrative", "shortName": "LONGTERM INVESTMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:PurchaseofCommonShares", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfMajorClassOfAssetsAcquiredAndLiabilities", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashTransferred", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000057 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details)", "role": "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails", "shortName": "ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfMajorClassOfAssetsAcquiredAndLiabilities", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashTransferred", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000058 - Disclosure - ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)", "role": "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "shortName": "ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-02-01to2022-02-24", "decimals": "-5", "lang": null, "name": "flora:PurchaseconsiderationcomprisedShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfIntangibleAssets", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000059 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)", "role": "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfIntangibleAssets", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "lang": null, "name": "flora:AccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGoingConcernExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000006 - Disclosure - NATURE OF OPERATIONS", "role": "http://flora.com/role/NatureOfOperations", "shortName": "NATURE OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGoingConcernExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000060 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 1)", "role": "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfGoodwill", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2021-12-31_flora_GoodwillsMember", "decimals": "-3", "lang": null, "name": "ifrs-full:Goodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:IntangibleAssetsAndGoodwillOne", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000061 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative)", "role": "http://flora.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:IntangibleAssetsAndGoodwillOne", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DeferredTaxLiabilities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000062 - Disclosure - IMPAIRMENT OF ASSETS (Details Narrative)", "role": "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative", "shortName": "IMPAIRMENT OF ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30_ifrs-full_ActuarialAssumptionOfDiscountRatesMember", "decimals": "-5", "lang": null, "name": "flora:ImpairmentOfCgu", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "flora:ScheduleOfLeases", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:AmortisationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000063 - Disclosure - LEASES (Details)", "role": "http://flora.com/role/LeasesDetails", "shortName": "LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "flora:ScheduleOfLeases", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:AmortisationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "flora:ScheduleOfBalancesOfLeaseLiability", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "flora:DerivativeFinancialLiabilitiesUndiscounted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000064 - Disclosure - LEASES (Details 1)", "role": "http://flora.com/role/LeasesDetails1", "shortName": "LEASES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "flora:ScheduleOfBalancesOfLeaseLiability", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "flora:DerivativeFinancialLiabilitiesUndiscounted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DescriptionOfLease", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000065 - Disclosure - LEASES (Details Narrative)", "role": "http://flora.com/role/LeasesDetailsNarrative", "shortName": "LEASES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "flora:DescriptionOfLease", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-6", "first": true, "lang": null, "name": "flora:ShareRepurchased", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000066 - Disclosure - CAPITAL STOCK (Details Narrative)", "role": "http://flora.com/role/CapitalStockDetailsNarrative", "shortName": "CAPITAL STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-6", "first": true, "lang": null, "name": "flora:ShareRepurchased", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfShareOptionsOutstandingAndExercisable", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2021-12-31_flora_StockOptionsMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000067 - Disclosure - OPTIONS (Details)", "role": "http://flora.com/role/OptionsDetails", "shortName": "OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "flora:ScheduleOfShareOptionsOutstandingAndExercisable", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30_flora_StockOptionsMember", "decimals": "0", "lang": null, "name": "flora:NumberOfShareOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory", "flora:ScheduleOfWarrantsOutstanding", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:ExercisePriceOfOutstandingShareOptions2019", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000068 - Disclosure - OPTIONS (Details 1)", "role": "http://flora.com/role/OptionsDetails1", "shortName": "OPTIONS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "flora:ScheduleOfShareOptionsOutstandingAndExercisable", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30_flora_RangesOfExercisePricesForOutstandingShareOptions4Member", "decimals": "-3", "lang": null, "name": "flora:NumberOfOptionsExercisable", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfFairValueOfStockOptions", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000069 - Disclosure - OPTIONS (Details 2)", "role": "http://flora.com/role/OptionsDetails2", "shortName": "OPTIONS (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfFairValueOfStockOptions", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "INF", "lang": null, "name": "flora:CurrentStockPrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - BASIS OF PRESENTATION", "role": "http://flora.com/role/BasisOfPresentation", "shortName": "BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:ExpenseRelatedToOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000070 - Disclosure - OPTIONS (Details Narrative)", "role": "http://flora.com/role/OptionsDetailsNarrative", "shortName": "OPTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:ExpenseRelatedToOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory", "flora:ScheduleOfWarrantsOutstanding", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "flora:WarrantsOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000071 - Disclosure - WARRANTS (Details)", "role": "http://flora.com/role/WarrantsDetails", "shortName": "WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory", "flora:ScheduleOfWarrantsOutstanding", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30_flora_WarrantsMember", "decimals": "-3", "lang": null, "name": "flora:NumberOfWarrantsExercised", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory", "flora:ScheduleOfWarrantsOutstanding", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "flora:GrantDateFairValueVestedAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000072 - Disclosure - WARRANTS (Details 1)", "role": "http://flora.com/role/WarrantsDetails1", "shortName": "WARRANTS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory", "flora:ScheduleOfWarrantsOutstanding", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "flora:GrantDateFairValueVestedAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfProvisionsAndContingentLiabilities", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30_flora_SalesTaxMember", "decimals": "-3", "first": true, "lang": null, "name": "flora:AcquiredThroughBusinessCombinations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000073 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Details)", "role": "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails", "shortName": "PROVISIONS COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfProvisionsAndContingentLiabilities", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30_flora_SalesTaxMember", "decimals": "-3", "first": true, "lang": null, "name": "flora:AcquiredThroughBusinessCombinations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:NumberSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000074 - Disclosure - PROVISIONS COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetailsNarrative", "shortName": "PROVISIONS COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:NumberSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfComputationOfDilutedSharesOutstanding", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000075 - Disclosure - LOSS PER SHARE (Details)", "role": "http://flora.com/role/LossPerShareDetails", "shortName": "LOSS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfComputationOfDilutedSharesOutstanding", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfKeyManagementPersonnelCompensation", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000076 - Disclosure - RELATED PARTY DISCLOSURES (Details)", "role": "http://flora.com/role/RelatedPartyDisclosuresDetails", "shortName": "RELATED PARTY DISCLOSURES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfKeyManagementPersonnelCompensation", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:RentAndPromotionServicesExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000077 - Disclosure - RELATED PARTY DISCLOSURES (Details Narrative)", "role": "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative", "shortName": "RELATED PARTY DISCLOSURES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "flora:RentAndPromotionServicesExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:DisclosureOfTradeAndOtherPayblesTableTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:TradeReceivables", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000078 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details )", "role": "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details )", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:ScheduleOfAssetsAndLiabilitiesDenominatedInForeignCurrencies", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30_flora_CADMember", "decimals": "0", "lang": null, "name": "ifrs-full:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000079 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative)", "role": "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-5", "first": true, "lang": null, "name": "ifrs-full:FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - TRADE AND AMOUNTS RECEIVABLE", "role": "http://flora.com/role/TradeAndAmountsReceivable", "shortName": "TRADE AND AMOUNTS RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "p", "flora:DisclosureOfFinancialRiskCapitalManagementExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-16", "decimals": "-6", "first": true, "lang": null, "name": "flora:MaximumNumberOfSharesRepurchaseAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000080 - Disclosure - CAPITAL MANAGEMENT (Details Narrative)", "role": "http://flora.com/role/CapitalManagementDetailsNarrative", "shortName": "CAPITAL MANAGEMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "flora:DisclosureOfFinancialRiskCapitalManagementExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-16", "decimals": "-6", "first": true, "lang": null, "name": "flora:MaximumNumberOfSharesRepurchaseAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000081 - Disclosure - SEGMENTED INFORMATION (Details)", "role": "http://flora.com/role/SegmentedInformationDetails", "shortName": "SEGMENTED INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "flora:DisclosureOfDetailedInformationAboutGeographicalInformationTableTextBlock", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30_flora_TotalMember", "decimals": "-3", "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Liabilities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000082 - Disclosure - SEGMENTED INFORMATION (Details 1)", "role": "http://flora.com/role/SegmentedInformationDetails1", "shortName": "SEGMENTED INFORMATION (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30_flora_ColombiaMember", "decimals": "-3", "lang": null, "name": "ifrs-full:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "flora:ConsolidatedRevenue", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000083 - Disclosure - SEGMENTED INFORMATION (Details Narrative)", "role": "http://flora.com/role/SegmentedInformationDetailsNarrative", "shortName": "SEGMENTED INFORMATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "flora:ConsolidatedRevenue", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "p", "flora:SubsequentEvents", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-07-05", "decimals": "-6", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000084 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "role": "http://flora.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "flora:SubsequentEvents", "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "AsOf2022-06-30_flora_SubsegmentsAxisMember", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - BIOLOGICAL ASSETS", "role": "http://flora.com/role/BiologicalAssets", "shortName": "BIOLOGICAL ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "flora_ex991.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 104, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://flora.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "flora_AccumulatedAmortization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Accumulated Amortization, Balance Beginning]", "periodEndLabel": "Accumulated Amortization, Balance Ending", "periodStartLabel": "Accumulated Amortization, Balance Beginning" } } }, "localname": "AccumulatedAmortization", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "flora_AccumulatedDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Accumulated Depreciation, Balance Beginning]", "periodEndLabel": "Accumulated Depreciation, Balance Ending", "periodStartLabel": "Accumulated Depreciation, Balance Beginning" } } }, "localname": "AccumulatedDepreciation", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "flora_AccumulatedDepreciationDisposals": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accumulated Depreciation, Disposals" } } }, "localname": "AccumulatedDepreciationDisposals", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "flora_AccumulatedDepreciationForeignExchangeTranslation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accumulated Depreciation, Foreign Exchange Translation" } } }, "localname": "AccumulatedDepreciationForeignExchangeTranslation", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "flora_AccumulatedOtherComprehensiveLossIncome1": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 27.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveLossIncome1", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "flora_AcquiredThroughBusinessCombinations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Acquired Through Business Combinations (note 8)", "verboseLabel": "Acquired through business combinations" } } }, "localname": "AcquiredThroughBusinessCombinations", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "flora_AcquisitionOfNoncontrollingInterestAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Acquisition of noncontrolling interest (Note 8), amount" } } }, "localname": "AcquisitionOfNoncontrollingInterestAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_AcquisitionOfNoncontrollingInterestShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of noncontrolling interest (Note 8), shares" } } }, "localname": "AcquisitionOfNoncontrollingInterestShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "flora_AcquisitionOfNoncontrollingInterestsBreezeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition Of Noncontrolling Interests Breeze" } } }, "localname": "AcquisitionOfNoncontrollingInterestsBreezeMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_AcquisitionOfNoncontrollingInterestsFloraBeautyLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition Of Noncontrolling Interests Flora Beauty LLC" } } }, "localname": "AcquisitionOfNoncontrollingInterestsFloraBeautyLLCMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_AdditionalExpectedCreditLosses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional Expected Credit Losses" } } }, "localname": "AdditionalExpectedCreditLosses", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_AdditionalProvision": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional Provisions" } } }, "localname": "AdditionalProvision", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "flora_AdditionalProvision15": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional Provisions15" } } }, "localname": "AdditionalProvision15", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "flora_AdjustmentsToNetLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to net loss:" } } }, "localname": "AdjustmentsToNetLossAbstract", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "flora_AllowanceForExpectedCreditLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Allowance For Expected Credit Losses" } } }, "localname": "AllowanceForExpectedCreditLosses", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "flora_AmountOwedToRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Amount Owed To Related Parties" } } }, "localname": "AmountOwedToRelatedParties", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_AmountsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Amounts Receivable]", "verboseLabel": "Amounts Receivable" } } }, "localname": "AmountsReceivable", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "flora_AssetAcquisitionsAndBusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSET ACQUISITIONS AND BUSINESS COMBINATIONS" } } }, "localname": "AssetAcquisitionsAndBusinessCombinationsAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_BadDebtExpense": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 }, "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 8.0, "parentTag": "flora_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Bad debt expense (Note 3)", "verboseLabel": "Bad debt expense" } } }, "localname": "BadDebtExpense", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_BeverageandfoodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Beverage and food" } } }, "localname": "BeverageandfoodMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails" ], "xbrltype": "domainItemType" }, "flora_BiologicalAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BIOLOGICAL ASSETS (Details)" } } }, "localname": "BiologicalAssetsAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_BuildingsAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Buildings" } } }, "localname": "BuildingsAndEquipmentMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails", "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "flora_BusinessAcquisitionCommonStockValueOfSharesIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Acquisition, Common Stock, Value of Shares Issued" } } }, "localname": "BusinessAcquisitionCommonStockValueOfSharesIssued", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_BusinessAndAssetAcquisitionsNetOfCashAcquired": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 23.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business and asset acquisitions, net of cash acquired" } } }, "localname": "BusinessAndAssetAcquisitionsNetOfCashAcquired", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details Narrative)" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_CADMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAD" } } }, "localname": "CADMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "flora_CHFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHF" } } }, "localname": "CHFMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "flora_COPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COP" } } }, "localname": "COPMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "flora_CanadaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Canada" } } }, "localname": "CanadaMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "domainItemType" }, "flora_CannabisGrowthandDerivativeProductionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cannabis Growth and Derivative Production Member" } } }, "localname": "CannabisGrowthandDerivativeProductionMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails" ], "xbrltype": "domainItemType" }, "flora_CapitalStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAPITAL STOCK" } } }, "localname": "CapitalStockAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_CapitalStockDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAPITAL STOCK (Details Narrative)" } } }, "localname": "CapitalStockDisclosuresAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_CarryingAmountOfRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total Carrying Amount Of Right Of Use Assets" } } }, "localname": "CarryingAmountOfRightOfUseAssets", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "flora_CashFlowsFromFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "CashFlowsFromFinancingActivitiesAbstract", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "flora_CashFlowsFromInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "CashFlowsFromInvestingActivitiesAbstract", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "flora_ChangeInSharePricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change In Share Price" } } }, "localname": "ChangeInSharePricePercentage", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_ColombiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Colombia" } } }, "localname": "ColombiaMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "domainItemType" }, "flora_CommonShareExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Share Exercisable" } } }, "localname": "CommonShareExercisable", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_CommonSharesDeliveredToTheSellers": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common shares delivered to the sellers" } } }, "localname": "CommonSharesDeliveredToTheSellers", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_CommonSharesIssuedForBusinessCombinationsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common shares issued for business combinations (Notes 8 and 12), amount" } } }, "localname": "CommonSharesIssuedForBusinessCombinationsAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_CommonSharesIssuedForBusinessCombinationsNotes8": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common shares issued for business combinations (Notes 8)" } } }, "localname": "CommonSharesIssuedForBusinessCombinationsNotes8", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_CommonSharesIssuedForBusinessCombinationsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common shares issued for business combinations (Notes 8 and 12), shares" } } }, "localname": "CommonSharesIssuedForBusinessCombinationsShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "flora_CommonSharesIssuedForOtherAgreementsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common shares issued for other agreements (Note 12), amount" } } }, "localname": "CommonSharesIssuedForOtherAgreementsAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_CommonSharesIssuedForOtherAgreementsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common shares issued for other agreements (Note 12), shares" } } }, "localname": "CommonSharesIssuedForOtherAgreementsShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "flora_CommonSharesRepurchased": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 18.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common shares repurchased" } } }, "localname": "CommonSharesRepurchased", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_CommonSharesResultsChangespercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares Results" } } }, "localname": "CommonSharesResultsChangespercentage", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Common Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_CommonStockSharesIssuedDuringPeriodInExchangeForOfStockOptionsAndWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Issued During Period In Exchange Of Stock Options And Warrants Exercised" } } }, "localname": "CommonStockSharesIssuedDuringPeriodInExchangeForOfStockOptionsAndWarrantsExercised", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_CompanyGrantedCommonSharesToFloraBeautyLlc": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Company Granted Common Shares To Flora Beauty LLC" } } }, "localname": "CompanyGrantedCommonSharesToFloraBeautyLlc", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_CompanyGrantedCommonSharesToMrBreeze": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Company Granted Common Shares To Mr Breeze" } } }, "localname": "CompanyGrantedCommonSharesToMrBreeze", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_CompanyGrantedCommonSharesToRelatedParty": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Company Granted Common Shares" } } }, "localname": "CompanyGrantedCommonSharesToRelatedParty", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_CompanysRegisteredOffice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Company's Registered Office" } } }, "localname": "CompanysRegisteredOffice", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/NatureOfOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_ConsolidatedRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "consolidated revenue" } } }, "localname": "ConsolidatedRevenue", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_ConstructionsInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Construction in Progress [Member]" } } }, "localname": "ConstructionsInProgressMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "flora_ConsultingAndManagementFees": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 16.0, "parentTag": "flora_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Consulting and management fees" } } }, "localname": "ConsultingAndManagementFees", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_ConsumerProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consumer Products" } } }, "localname": "ConsumerProductsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails" ], "xbrltype": "domainItemType" }, "flora_ContingentPurchaseConsideration": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Purchase Consideration" } } }, "localname": "ContingentPurchaseConsideration", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SignificantAccountingPoliciesAndCriticalJudgmentsAndEstimationUncertaintiesPolicies" ], "xbrltype": "textBlockItemType" }, "flora_CorporateandEliminationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Corporate and Eliminations" } } }, "localname": "CorporateandEliminationsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails" ], "xbrltype": "domainItemType" }, "flora_CreditRisksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit risk" } } }, "localname": "CreditRisksMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_CurrentStockPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Stock Price" } } }, "localname": "CurrentStockPrice", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails2" ], "xbrltype": "perShareItemType" }, "flora_CustomersRelationshipsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]" } } }, "localname": "CustomersRelationshipsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "domainItemType" }, "flora_DateOfExpiry": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Date of expiry" } } }, "localname": "DateOfExpiry", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "stringItemType" }, "flora_DateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year of incorporation" } } }, "localname": "DateOfIncorporation", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/NatureOfOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_DerivativeFinancialLiabilitiesUndiscounted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total Undiscounted Cash Flows" } } }, "localname": "DerivativeFinancialLiabilitiesUndiscounted", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "flora_DescriptionOfAmortization": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Description Of Amortization]", "verboseLabel": "Description Of Amortization" } } }, "localname": "DescriptionOfAmortization", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_DescriptionOfAmortizations": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description Of Amortization" } } }, "localname": "DescriptionOfAmortizations", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_DescriptionOfExchangeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description Of Exchange Rate" } } }, "localname": "DescriptionOfExchangeRate", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_DescriptionOfLease": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of lease" } } }, "localname": "DescriptionOfLease", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_DescriptionOfValuation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description Of Valuation" } } }, "localname": "DescriptionOfValuation", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_DescriptionToSensitivityAssessmentToRecoverableAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description to sensitivity assessment to recoverable amount" } } }, "localname": "DescriptionToSensitivityAssessmentToRecoverableAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_DisclosureOfDetailedInformationAboutGeographicalInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Geographical Information Of Company's Non-current Assets" } } }, "localname": "DisclosureOfDetailedInformationAboutGeographicalInformationTableTextBlock", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentDisclosuresTables" ], "xbrltype": "textBlockItemType" }, "flora_DisclosureOfFinanceLeaseAndOperatingLeaseByLessorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Carrying Amount Of Right Of Use Asset By Class Of Underlying Asset" } } }, "localname": "DisclosureOfFinanceLeaseAndOperatingLeaseByLessorAbstract", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "flora_DisclosureOfFinancialInstrumentsAndRiskExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments And Risk Management" } } }, "localname": "DisclosureOfFinancialInstrumentsAndRiskExplanatory", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagement" ], "xbrltype": "textBlockItemType" }, "flora_DisclosureOfFinancialRiskCapitalManagementExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Management" } } }, "localname": "DisclosureOfFinancialRiskCapitalManagementExplanatory", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalManagement" ], "xbrltype": "textBlockItemType" }, "flora_DisclosureOfMarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVENTORY (Details)" } } }, "localname": "DisclosureOfMarketableSecuritiesAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_DisclosureOfOptionsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Options]", "verboseLabel": "Options" } } }, "localname": "DisclosureOfOptionsExplanatory", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OPTIONS" ], "xbrltype": "textBlockItemType" }, "flora_DisclosureOfProvisionsCommitmentsAndContingenciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PROVISIONS COMMITMENTS AND CONTINGENCIES (Details)" } } }, "localname": "DisclosureOfProvisionsCommitmentsAndContingenciesAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_DisclosureOfSegmentedInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAPITAL MANAGEMENT (Details Narrative)" } } }, "localname": "DisclosureOfSegmentedInformationAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_DisclosureOfSubsidiariesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiaries" } } }, "localname": "DisclosureOfSubsidiariesTableTextBlock", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationTables" ], "xbrltype": "textBlockItemType" }, "flora_DisclosureOfTradeAndOtherPayblesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade And Other Paybles" } } }, "localname": "DisclosureOfTradeAndOtherPayblesTableTextBlock", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "flora_DriedCannabisCost": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dried Cannabis Per Gram" } } }, "localname": "DriedCannabisCost", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BiologicalAssetsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_EURMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EUR" } } }, "localname": "EURMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "flora_EstimatedRecoverableAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Estimated Recoverable Amount" } } }, "localname": "EstimatedRecoverableAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_ExchangeBaseFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Exchange For Base Fees" } } }, "localname": "ExchangeBaseFees", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_ExchangeOfCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exchange Common Shares" } } }, "localname": "ExchangeOfCommonShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_ExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "localname": "ExerciseOfWarrants", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails" ], "xbrltype": "perShareItemType" }, "flora_ExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise price" } } }, "localname": "ExercisePrice", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_ExpectedOptionLifeInYears": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expected Life (years)" } } }, "localname": "ExpectedOptionLifeInYears", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails2" ], "xbrltype": "durationItemType" }, "flora_ExpectedReimbursementContingentLiabilitiesInBusinessCombinationEnding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Balance End as at June 30, 2022" } } }, "localname": "ExpectedReimbursementContingentLiabilitiesInBusinessCombinationEnding", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "flora_ExpectedReimbursementContingentLiabilitiesInBusinessCombinations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Balance ending as at June 30, 2022" } } }, "localname": "ExpectedReimbursementContingentLiabilitiesInBusinessCombinations", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "flora_ExpectedReimbursementContingentLiabilitiesInBusinessEndingCombination": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Balance Ending as at June 30, 2022" } } }, "localname": "ExpectedReimbursementContingentLiabilitiesInBusinessEndingCombination", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "flora_ExpectedTermInYears": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expected term in years" } } }, "localname": "ExpectedTermInYears", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails" ], "xbrltype": "durationItemType" }, "flora_ExpenseRelatedToOptionsGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Expense Related To Options Granted" } } }, "localname": "ExpenseRelatedToOptionsGranted", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_ExpensesForConsulting": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Expenses For Consulting" } } }, "localname": "ExpensesForConsulting", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_FairValueCalculationsChangesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Calculations" } } }, "localname": "FairValueCalculationsChangesPercentage", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_FairValueDiscount": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Fair Value Discount]", "verboseLabel": "Fair Value Discount" } } }, "localname": "FairValueDiscount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_FairValueDiscountPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Discount" } } }, "localname": "FairValueDiscountPercentage", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_FairValueOfCommonSharesIssued": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 22.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common shares issued" } } }, "localname": "FairValueOfCommonSharesIssued", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_FairValueOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value" } } }, "localname": "FairValueOfWarrants", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails" ], "xbrltype": "perShareItemType" }, "flora_FairValueOfcommonshares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Common Share" } } }, "localname": "FairValueOfcommonshares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_FairValueOfcommonsharesforthefirsttranche": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Common Shares" } } }, "localname": "FairValueOfcommonsharesforthefirsttranche", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_FairValueOfcommonsharesforthesecondtranche": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Common Shares Second Tranch" } } }, "localname": "FairValueOfcommonsharesforthesecondtranche", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_FairValuePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact On The Fair Value" } } }, "localname": "FairValuePercentage", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BiologicalAssetsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_FairValueSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price" } } }, "localname": "FairValueSharePrice", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails" ], "xbrltype": "perShareItemType" }, "flora_FairValueWarrant": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair Value Warrant" } } }, "localname": "FairValueWarrant", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "flora_FinancingCashFlowsFromLeasesInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financing Cash Flows From Leases (interest)" } } }, "localname": "FinancingCashFlowsFromLeasesInterest", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "flora_FinancingCashFlowsFromLeasesPrincipal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financing Cash Flows From Leases (principal)" } } }, "localname": "FinancingCashFlowsFromLeasesPrincipal", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "flora_FloraBeautyLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Flora Beauty LLC" } } }, "localname": "FloraBeautyLLCMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_FloraGrowthCorp": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Flora Growth Corp." } } }, "localname": "FloraGrowthCorp", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_ForbesAndManhattanIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Forbes and Manhattan Inc." } } }, "localname": "ForbesAndManhattanIncMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_FunctionalCurrencyOfSubsidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Functional Currency Of Subsidiary" } } }, "localname": "FunctionalCurrencyOfSubsidiary", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "stringItemType" }, "flora_GBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GBP" } } }, "localname": "GBPMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "flora_GoodwillImpairmentNotes9And10": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 7.0, "parentTag": "flora_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Goodwill impairment (Notes 9 and 10)" } } }, "localname": "GoodwillImpairmentNotes9And10", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_GoodwillsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill [Member]" } } }, "localname": "GoodwillsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "flora_GrantDateFairValueVestedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Grant Date Fair Value Vested Amount" } } }, "localname": "GrantDateFairValueVestedAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "monetaryItemType" }, "flora_GrantDateFairValueVestedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Grant date fair value vested amount" } } }, "localname": "GrantDateFairValueVestedAmount1", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "monetaryItemType" }, "flora_HarvestedCannabis": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Harvested Cannabis" } } }, "localname": "HarvestedCannabis", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "flora_INVENTORYAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVENTORY" } } }, "localname": "INVENTORYAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_ImpairmentOfAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IMPAIRMENT OF ASSETS" } } }, "localname": "ImpairmentOfAssetsAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_ImpairmentOfCgu": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Impairment Of CGU" } } }, "localname": "ImpairmentOfCgu", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_IncomeTaxBenefit": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Income tax benefit" } } }, "localname": "IncomeTaxBenefit", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_IncomeTaxPaidReceived": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income tax (paid) received" } } }, "localname": "IncomeTaxPaidReceived", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_IncomeTaxesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME TAXES" } } }, "localname": "IncomeTaxesAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_IncorporationCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Country of incorporation" } } }, "localname": "IncorporationCountry", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/NatureOfOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_IncreaseInCombinedRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Increase in combined Revenue" } } }, "localname": "IncreaseInCombinedRevenue", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_IncreaseInNetLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Increase in net loss]", "terseLabel": "Increase in net loss" } } }, "localname": "IncreaseInNetLoss", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_InitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Initial public offering" } } }, "localname": "InitialPublicOffering", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_InitialPublicOfferingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Initial public offering, amount" } } }, "localname": "InitialPublicOfferingAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_InitialPublicOfferingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial public offering, shares" } } }, "localname": "InitialPublicOfferingShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "flora_IntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Intangible Assets]", "verboseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssets", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_IntangibleAssetsAcuired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Intangible Assets" } } }, "localname": "IntangibleAssetsAcuired", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "flora_IntangibleAssetsAndGoodwillAtCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Balance, Beginning 1]", "periodEndLabel": "Balance, Ending", "periodStartLabel": "Balance, Beginning" } } }, "localname": "IntangibleAssetsAndGoodwillAtCost", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "flora_IntangibleAssetsAndGoodwillCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Balance, Beginning]", "periodEndLabel": "Balance, Ending", "periodStartLabel": "Balance, Beginning" } } }, "localname": "IntangibleAssetsAndGoodwillCost", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "flora_IntangibleAssetsAndGoodwillOne": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Intangible Assets And Goodwill]", "verboseLabel": "Intangible Assets And Goodwill" } } }, "localname": "IntangibleAssetsAndGoodwillOne", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_IntangibleAssetsAndGoodwillTwo": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Intangible Assets And Goodwill 1]", "verboseLabel": "Intangible Assets And Goodwill" } } }, "localname": "IntangibleAssetsAndGoodwillTwo", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_InterestExpenses": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Interest expense]", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpenses", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_Inventories1": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Inventory" } } }, "localname": "Inventories1", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_InvesteeCommonShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investee common share [member]" } } }, "localname": "InvesteeCommonShareMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails1" ], "xbrltype": "domainItemType" }, "flora_JustCBDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "JustCBD [Member]", "verboseLabel": "Just CBD [Member]" } } }, "localname": "JustCBDMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1", "http://flora.com/role/LossPerShareDetails" ], "xbrltype": "domainItemType" }, "flora_LEASESAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LEASES" } } }, "localname": "LEASESAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_LandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Land" } } }, "localname": "LandsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails", "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "flora_LaterThanFiveYearsAndNotLaterThanSixYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2027" } } }, "localname": "LaterThanFiveYearsAndNotLaterThanSixYearsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "domainItemType" }, "flora_LaterThanFourYearAndNotLaterThanFiveYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2025" } } }, "localname": "LaterThanFourYearAndNotLaterThanFiveYearsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "domainItemType" }, "flora_LaterThanFourYearAndNotLaterThanSixYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2026" } } }, "localname": "LaterThanFourYearAndNotLaterThanSixYearsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "domainItemType" }, "flora_LaterThanSixYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Thereafter" } } }, "localname": "LaterThanSixYearsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "domainItemType" }, "flora_LaterThanThreeYearAndNotLaterThanFourYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2024" } } }, "localname": "LaterThanThreeYearAndNotLaterThanFourYearsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "domainItemType" }, "flora_LaterThanTwoYearAndNotLaterThanThreeYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2023" } } }, "localname": "LaterThanTwoYearAndNotLaterThanThreeYearsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "domainItemType" }, "flora_LeaseExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total Lease Expense" } } }, "localname": "LeaseExpense", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "flora_LeaseLiabilitiesTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total Lease Liabilities" } } }, "localname": "LeaseLiabilitiesTotal", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "flora_LegalDisputesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legal Disputes" } } }, "localname": "LegalDisputesMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "flora_LessPresentValueDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Less: Present Value Discount" } } }, "localname": "LessPresentValueDiscount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "flora_LicenceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Licences [member]" } } }, "localname": "LicenceMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "domainItemType" }, "flora_LoanRepaymentsReceived": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 26.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loan repayments received" } } }, "localname": "LoanRepaymentsReceived", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_LoansProvided": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 27.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loans provided" } } }, "localname": "LoansProvided", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_LongTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONGTERM INVESTMENTS" } } }, "localname": "LongTermInvestmentsAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_LossOnChangesInFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loss On Changes In Fair Value" } } }, "localname": "LossOnChangesInFairValue", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails1" ], "xbrltype": "monetaryItemType" }, "flora_MachineryAndOfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Machinery and Office Equipment [Member]" } } }, "localname": "MachineryAndOfficeEquipmentMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "flora_MaximumNumberOfSharesRepurchaseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Maximum number of shares repurchase, amount" } } }, "localname": "MaximumNumberOfSharesRepurchaseAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalManagementDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_MonteCarloSimulationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Monte Carlo simulation" } } }, "localname": "MonteCarloSimulationMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_NatureOfOperationsAndGoingConcernAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NATURE OF OPERATIONS" } } }, "localname": "NatureOfOperationsAndGoingConcernAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_NatureOfOperationsDetailsNarrativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NATURE OF OPERATIONS (Details Narrative)" } } }, "localname": "NatureOfOperationsDetailsNarrativeAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_NetAssetsAcquiredPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Assets Acquired" } } }, "localname": "NetAssetsAcquiredPercentage", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_NetCarryingValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net Carrying Value" } } }, "localname": "NetCarryingValue", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "flora_NetLossAttributableToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss attributable to:" } } }, "localname": "NetLossAttributableToAbstract", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "stringItemType" }, "flora_NonCompeteAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-compete agreements [Member]" } } }, "localname": "NonCompeteAgreementsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "domainItemType" }, "flora_NonControllingInterests": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Non-controlling interests" } } }, "localname": "NonControllingInterests", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_NonCurrentInvestments": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 15.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Investments (Note 7)" } } }, "localname": "NonCurrentInvestments", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "flora_NonCurrentLeaseLiability": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 22.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Non-current lease liability (Note 11)" } } }, "localname": "NonCurrentLeaseLiability", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "flora_NoncompeteAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncompete Agreement [member]" } } }, "localname": "NoncompeteAgreementMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_NoncontrollingInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "domainItemType" }, "flora_NumberOfOptionsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Exercisable" } } }, "localname": "NumberOfOptionsExercisable", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "sharesItemType" }, "flora_NumberOfShareOptionsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Granted" } } }, "localname": "NumberOfShareOptionsGranted", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails" ], "xbrltype": "sharesItemType" }, "flora_NumberOfWarrantsCancelledExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number Of Warrants, Cancelled/expired" } } }, "localname": "NumberOfWarrantsCancelledExpired", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/WarrantsDetails" ], "xbrltype": "sharesItemType" }, "flora_NumberOfWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number Of Warrants, Exercised" } } }, "localname": "NumberOfWarrantsExercised", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/WarrantsDetails" ], "xbrltype": "sharesItemType" }, "flora_NumberSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issued Common Shares" } } }, "localname": "NumberSharesIssued", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_NumberSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Outstanding" } } }, "localname": "NumberSharesOutstanding", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "sharesItemType" }, "flora_OfficeSpaceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Office Space" } } }, "localname": "OfficeSpaceMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "domainItemType" }, "flora_OntarioCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ontario Corp." } } }, "localname": "OntarioCorpMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_OntarioIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ontario Inc." } } }, "localname": "OntarioIncMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_OperatingCashFlowsForShortTermAndLowValueAssetLeases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Cash Flows For Short Term And Low Value Asset Leases" } } }, "localname": "OperatingCashFlowsForShortTermAndLowValueAssetLeases", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "flora_OperatingExpenses": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 18.0, "parentTag": "flora_OperatingLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Total operating expenses]", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "stringItemType" }, "flora_OperatingLoss": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Operating Loss]", "totalLabel": "Operating Loss" } } }, "localname": "OperatingLoss", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_Options": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 29.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Options (Note 13)" } } }, "localname": "Options", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "flora_OptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPTIONS (Details)" } } }, "localname": "OptionsAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_OptionsExercisedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Options exercised (Note 13), amount" } } }, "localname": "OptionsExercisedAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_OptionsExercisedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options exercised (Note 13), shares" } } }, "localname": "OptionsExercisedShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "flora_OptionsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Options issued" } } }, "localname": "OptionsIssued", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_OptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options" } } }, "localname": "OptionsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "domainItemType" }, "flora_OtherComprehensiveLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveLossAbstract", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "stringItemType" }, "flora_OtherComprehensiveLossExchangeDifferencesOnForeignOperations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other comprehensive loss - exchange differences on foreign operations" } } }, "localname": "OtherComprehensiveLossExchangeDifferencesOnForeignOperations", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_OtherExpenseByNature1": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 17.0, "parentTag": "flora_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other expenses (income), net" } } }, "localname": "OtherExpenseByNature1", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_OtherLongLivedAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Long-lived Assets" } } }, "localname": "OtherLongLivedAssets", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_OtherNoncurrentAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Noncurrent Assets" } } }, "localname": "OtherNoncurrentAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "flora_OtherOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Offering" } } }, "localname": "OtherOfferingMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_OthercurrentAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Current Assets" } } }, "localname": "OthercurrentAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "flora_OwnershipOfInvesteeIncludingExercisableWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership" } } }, "localname": "OwnershipOfInvesteeIncludingExercisableWarrants", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_OwnershipofdilutedBasisIncludingexercisablewarrants6f": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership Of Diluted Basis" } } }, "localname": "OwnershipofdilutedBasisIncludingexercisablewarrants6f", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_PatentsAndGoodwillsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Patents [Member]" } } }, "localname": "PatentsAndGoodwillsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "domainItemType" }, "flora_PharmaceuticalsAndNutraceuticalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pharmaceuticals and Nutraceuticals" } } }, "localname": "PharmaceuticalsAndNutraceuticalsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "flora_PharmaceuticalsandNutraceuticalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Pharmaceuticals and Nutraceuticals]", "verboseLabel": "Pharmaceuticals and Nutraceuticals" } } }, "localname": "PharmaceuticalsandNutraceuticalsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails" ], "xbrltype": "domainItemType" }, "flora_PlanAssetsAtFairValue27": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Change in Fair Value, warrants" } } }, "localname": "PlanAssetsAtFairValue27", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_PostHarvestCost": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Post Harvest Cost Per Gram" } } }, "localname": "PostHarvestCost", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BiologicalAssetsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_PrepaidExpensesAndOtherAssets": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpensesAndOtherAssets", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_PriceToBookValueOfcommonsharesvalue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares Price" } } }, "localname": "PriceToBookValueOfcommonsharesvalue", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_PromissoryNoteReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONGTERM INVESTMENTS (Details Narrative)" } } }, "localname": "PromissoryNoteReceivableAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_PropertyPlantAndEquipmentCarryingValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Property, plant and equipment, Carrying Value" } } }, "localname": "PropertyPlantAndEquipmentCarryingValue", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "flora_ProportionOfOwnershipInterestInSubsidiarya1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest In Flora Beauty Llc" } } }, "localname": "ProportionOfOwnershipInterestInSubsidiarya1", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_ProvisionForSalesTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Provision for sales tax" } } }, "localname": "ProvisionForSalesTax", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "flora_ProvisionsCommitmentsAndContingenciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PROVISIONS COMMITMENTS AND CONTINGENCIES" } } }, "localname": "ProvisionsCommitmentsAndContingenciesAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_PurchaseConsiderationComprisedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchase Consideration Comprised" } } }, "localname": "PurchaseConsiderationComprisedAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_PurchaseconsiderationcomprisedCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase Consideration Comprised Share" } } }, "localname": "PurchaseconsiderationcomprisedCommonShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_PurchaseconsiderationcomprisedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Purchase Consideration Comprised Share]", "verboseLabel": "Purchase Consideration Comprised Share" } } }, "localname": "PurchaseconsiderationcomprisedShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_PurchasedCommonShareOfTheInvesteeForTheFirstTranche": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchased Common Share Of The Investee" } } }, "localname": "PurchasedCommonShareOfTheInvesteeForTheFirstTranche", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_PurchaseofCommonShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Purchased Common Shares" } } }, "localname": "PurchaseofCommonShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_PurchaseofcommonsharesForTheSecondTranche": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchased Common Share Of The Investee Second Tranche" } } }, "localname": "PurchaseofcommonsharesForTheSecondTranche", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_PurchasesOfPropertyPlantAndEquipmentAndOtherAssets": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 25.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchases of property, plant and equipment and other assets" } } }, "localname": "PurchasesOfPropertyPlantAndEquipmentAndOtherAssets", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_QuantityOwnedwarrant": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Quantity Owned" } } }, "localname": "QuantityOwnedwarrant", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price One" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions1Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Two" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions2Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Three" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions3Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Four" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions4Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Five" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions5Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Six" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions6Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Seven" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions7Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions8Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Eight" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions8Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptions9Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Nine" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptions9Member", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptionsElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Eleven" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsElevenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptionsFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Fifteen" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsFifteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptionsFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Fourteen" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsFourteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptionsSixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Sixteen" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsSixteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptionsTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Ten" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsTenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptionsThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Thirteen" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsThirteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RangesOfExercisePricesForOutstandingShareOptionsTwelveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Twelve" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsTwelveMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_RealizedFairValueAmountsIncludedInInventorySoldNote4": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 4.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Realized fair value amounts included in inventory sold (Note 4)" } } }, "localname": "RealizedFairValueAmountsIncludedInInventorySoldNote4", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_RegulationAAndOtherOfferingsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Regulation A and Other Offerings, amount" } } }, "localname": "RegulationAAndOtherOfferingsAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_RegulationAAndOtherOfferingsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Regulation A and Other Offerings, shares" } } }, "localname": "RegulationAAndOtherOfferingsShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "flora_RelatedPartyDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY DISCLOSURES" } } }, "localname": "RelatedPartyDisclosuresAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_RemainingContractualLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants, weighted average remaining contractual life" } } }, "localname": "RemainingContractualLife", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "durationItemType" }, "flora_RentAndPromotionServicesExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Rent And Promotion Services Expenses" } } }, "localname": "RentAndPromotionServicesExpenses", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_RepaymentLeaseliabilities": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 19.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Repayments of lease liability" } } }, "localname": "RepaymentLeaseliabilities", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_RightOfUseAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Right Of Use Assets" } } }, "localname": "RightOfUseAssetsAcquired", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "flora_RightOfUseAssetsAndLeaseLiabilitiesAcquiredNote11": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Right of use assets and lease liabilities acquired (Note 11)" } } }, "localname": "RightOfUseAssetsAndLeaseLiabilitiesAcquiredNote11", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_RightOfUseAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right Of Use Assets [Member]" } } }, "localname": "RightOfUseAssetsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "flora_SalesTaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sales Tax Member" } } }, "localname": "SalesTaxMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "flora_ScheduleOfAssetsAndLiabilitiesDenominatedInForeignCurrencies": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Assets And Liabilities Denominated In Foreign Currencies" } } }, "localname": "ScheduleOfAssetsAndLiabilitiesDenominatedInForeignCurrencies", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfBalancesOfLeaseLiability": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Balances Of Lease Liability" } } }, "localname": "ScheduleOfBalancesOfLeaseLiability", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfCarryingValueOfBiologicalAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Carrying Value Of Biological Assets Table Text Block" } } }, "localname": "ScheduleOfCarryingValueOfBiologicalAssetsTableTextBlock", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BiologicalAssetsTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfComputationOfDilutedSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Computation Of Diluted Shares Outstanding" } } }, "localname": "ScheduleOfComputationOfDilutedSharesOutstanding", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LossPerShareTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfFairValueOfStockOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of Stock Options" } } }, "localname": "ScheduleOfFairValueOfStockOptions", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfFairValueOfTheWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of The Warrants" } } }, "localname": "ScheduleOfFairValueOfTheWarrants", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfGoodwill": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Goodwill" } } }, "localname": "ScheduleOfGoodwill", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfIntangibleAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssets", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfInventory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Inventory" } } }, "localname": "ScheduleOfInventory", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfKeyManagementPersonnelCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Key Management Personnel Compensation" } } }, "localname": "ScheduleOfKeyManagementPersonnelCompensation", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfLeases": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Leases" } } }, "localname": "ScheduleOfLeases", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfLongTermInvestmentsActivity": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Long-term Investments Activity" } } }, "localname": "ScheduleOfLongTermInvestmentsActivity", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfMajorClassOfAssetsAcquiredAndLiabilities": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Major Class Of Assets Acquired And Liabilities" } } }, "localname": "ScheduleOfMajorClassOfAssetsAcquiredAndLiabilities", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfPropertyPlantAndEquipment": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Property Plant And Equipment" } } }, "localname": "ScheduleOfPropertyPlantAndEquipment", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfProvisionsAndContingentLiabilities": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Provisions And Contingent Liabilities" } } }, "localname": "ScheduleOfProvisionsAndContingentLiabilities", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfShareOptionsOutstandingAndExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Share Options Outstanding And Exercisable" } } }, "localname": "ScheduleOfShareOptionsOutstandingAndExercisable", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfTradeAccountsReceivableAllowanceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Trade Accounts Receivable Allowance Table Text Block" } } }, "localname": "ScheduleOfTradeAccountsReceivableAllowanceTableTextBlock", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "flora_ScheduleOfWarrantsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Outstanding" } } }, "localname": "ScheduleOfWarrantsOutstanding", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "flora_ShareAcquiredFromMinorityInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Acquired From Minority Interest" } } }, "localname": "ShareAcquiredFromMinorityInterest", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_ShareBasedPaymentsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Payments" } } }, "localname": "ShareBasedPaymentsShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_ShareIssuanceCostsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Share issuance costs" } } }, "localname": "ShareIssuanceCostsAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_ShareRepurchase": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Share repurchase (Note 12)" } } }, "localname": "ShareRepurchase", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_ShareRepurchased": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share Repurchased" } } }, "localname": "ShareRepurchased", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_ShortTermAndLowValueAssetsLeaseExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Short-term And Low Value Assets Lease Expense" } } }, "localname": "ShortTermAndLowValueAssetsLeaseExpense", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "flora_SignificantAccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies and Critical Judgments and Estimation Uncertainties (Policies)" } } }, "localname": "SignificantAccountingPoliciesAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/BasisOfPresentationDetails", "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative", "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1", "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/LeasesDetails", "http://flora.com/role/LeasesDetails1", "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/LongtermInvestmentsDetails1", "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/OptionsDetails", "http://flora.com/role/OptionsDetails1", "http://flora.com/role/PropertyPlantAndEquipmentDetails", "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails", "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative", "http://flora.com/role/SegmentedInformationDetails", "http://flora.com/role/SegmentedInformationDetails1", "http://flora.com/role/SubsequentEventsDetailsNarrative", "http://flora.com/role/WarrantsDetails", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "stringItemType" }, "flora_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/BasisOfPresentationDetails", "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative", "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1", "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/LeasesDetails", "http://flora.com/role/LeasesDetails1", "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/LongtermInvestmentsDetails1", "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/OptionsDetails", "http://flora.com/role/OptionsDetails1", "http://flora.com/role/PropertyPlantAndEquipmentDetails", "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails", "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative", "http://flora.com/role/SegmentedInformationDetails", "http://flora.com/role/SegmentedInformationDetails1", "http://flora.com/role/SubsequentEventsDetailsNarrative", "http://flora.com/role/WarrantsDetails", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "stringItemType" }, "flora_StockIssuedSharesForConsultingServices": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued For Consulting Services Performed, Shares" } } }, "localname": "StockIssuedSharesForConsultingServices", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_StockIssuedValueForConsultingServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued For Consulting Services Performed, Amount" } } }, "localname": "StockIssuedValueForConsultingServices", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_StockOptionsExercisedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Options Exercised During Period, Shares" } } }, "localname": "StockOptionsExercisedDuringPeriodShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock options" } } }, "localname": "StockOptionsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/OptionsDetails", "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "flora_StockOptionsOutstandingAndExercisableUnderlyingSharesExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercised" } } }, "localname": "StockOptionsOutstandingAndExercisableUnderlyingSharesExercised", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails" ], "xbrltype": "sharesItemType" }, "flora_SubsegmentsAxisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsegments Axis" } } }, "localname": "SubsegmentsAxisMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_SubsequentEvents": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEvents", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "flora_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_SubsidiaryEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 8 [member]" } } }, "localname": "SubsidiaryEightMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 18 [member]" } } }, "localname": "SubsidiaryEighteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 11 [member]" } } }, "localname": "SubsidiaryElevenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 15 [member]" } } }, "localname": "SubsidiaryFifteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 5 [member]" } } }, "localname": "SubsidiaryFiveMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 4 [member]" } } }, "localname": "SubsidiaryFourMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 14 [member]" } } }, "localname": "SubsidiaryFourteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 9 [member]" } } }, "localname": "SubsidiaryNineMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 19 [member]" } } }, "localname": "SubsidiaryNineteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 1 [member]" } } }, "localname": "SubsidiaryOneMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiarySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 7 [member]" } } }, "localname": "SubsidiarySevenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiarySeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 17 [member]" } } }, "localname": "SubsidiarySeventeenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiarySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 6 [member]" } } }, "localname": "SubsidiarySixMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiarySixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 16 [member]" } } }, "localname": "SubsidiarySixteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 10 [member]" } } }, "localname": "SubsidiaryTenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 13 [member]" } } }, "localname": "SubsidiaryThirteenMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 3 [member]" } } }, "localname": "SubsidiaryThreeMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryTwelveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 12 [member]" } } }, "localname": "SubsidiaryTwelveMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 20 [member]" } } }, "localname": "SubsidiaryTwentyMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubsidiaryTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsidiary 2 [member]" } } }, "localname": "SubsidiaryTwoMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "flora_SubtotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subtotal [Member]" } } }, "localname": "SubtotalMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "flora_SupplementalDisclosureOfNonCashActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash activities" } } }, "localname": "SupplementalDisclosureOfNonCashActivitiesAbstract", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "flora_TangibleBookValueOfCommonSharesValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares Value" } } }, "localname": "TangibleBookValueOfCommonSharesValue", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "flora_TerminationBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Termination Benefits" } } }, "localname": "TerminationBenefitsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "flora_TerminationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Termination description" } } }, "localname": "TerminationDescription", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "stringItemType" }, "flora_TotalAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total Assets" } } }, "localname": "TotalAssetsAcquired", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "flora_TotalCarryingValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total Carrying Value" } } }, "localname": "TotalCarryingValue", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_TotalComprehensiveLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total comprehensive loss for the period" } } }, "localname": "TotalComprehensiveLoss", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_TotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total [Member]" } } }, "localname": "TotalMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails", "http://flora.com/role/SegmentedInformationDetails", "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "domainItemType" }, "flora_TotalPurchaseConsideration": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total purchase consideration" } } }, "localname": "TotalPurchaseConsideration", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_TradeAndAmountsReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TRADE AND AMOUNTS RECEIVABLE" } } }, "localname": "TradeAndAmountsReceivableAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_TradeAndOtherReceivablesOne": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Trade and other receivables" } } }, "localname": "TradeAndOtherReceivablesOne", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "flora_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Trade Receivables" } } }, "localname": "TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "flora_TradeReceivablesNintyOneToOneEightyDays": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "91-180 Days" } } }, "localname": "TradeReceivablesNintyOneToOneEightyDays", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "flora_TradeReceivablesOneEightyDays": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "180+ Days" } } }, "localname": "TradeReceivablesOneEightyDays", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "flora_TradeReceivablesOnetoThirtyDays": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "1-30 Days" } } }, "localname": "TradeReceivablesOnetoThirtyDays", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "flora_TradeReceivablesSIxtyOneToNintyDays": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "61-90 Days" } } }, "localname": "TradeReceivablesSIxtyOneToNintyDays", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "flora_TradeReceivablesThirtyOneToSixtyDays": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "31-60 Days" } } }, "localname": "TradeReceivablesThirtyOneToSixtyDays", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "flora_TrademarksAndBrandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks and brands [Member]" } } }, "localname": "TrademarksAndBrandsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "domainItemType" }, "flora_TradenameMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tradename [member]" } } }, "localname": "TradenameMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_TradenamesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tradenames [member]" } } }, "localname": "TradenamesMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_UnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United Kingdom [Member]" } } }, "localname": "UnitedKingdomMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "domainItemType" }, "flora_UnitedStatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United States" } } }, "localname": "UnitedStatesMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "domainItemType" }, "flora_UnrealizedGainOnChangesInFairValueOfBiologicalAssetsNote4": { "auth_ref": [], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 5.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrealized gain on changes in fair value of biological assets (Note 4)" } } }, "localname": "UnrealizedGainOnChangesInFairValueOfBiologicalAssetsNote4", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "flora_ValueOfCompany": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Company Valued" } } }, "localname": "ValueOfCompany", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "flora_VehicleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vehicles [Member]" } } }, "localname": "VehicleMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "flora_VendorsOwnershipInterestInSubsidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Interests Own" } } }, "localname": "VendorsOwnershipInterestInSubsidiary", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_VesselMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vessel [Member]" } } }, "localname": "VesselMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "flora_VesselsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Vessel [Member]]", "verboseLabel": "Vessel [Member]" } } }, "localname": "VesselsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "flora_Volatility": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Volatility]", "verboseLabel": "Volatility" } } }, "localname": "Volatility", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_WarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WARRANTS (Details)" } } }, "localname": "WarrantsAbstract", "nsuri": "http://flora.com/20220630", "xbrltype": "stringItemType" }, "flora_WarrantsCADOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantsCAD One [member]" } } }, "localname": "WarrantsCADOneMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/LongtermInvestmentsDetails1" ], "xbrltype": "domainItemType" }, "flora_WarrantsCADThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantsCAD Thirty [member]" } } }, "localname": "WarrantsCADThirtyMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/LongtermInvestmentsDetails1" ], "xbrltype": "domainItemType" }, "flora_WarrantsExercisedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Warrants exercised, amount" } } }, "localname": "WarrantsExercisedAmount", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_WarrantsExercisedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Exercised During Period, Shares" } } }, "localname": "WarrantsExercisedDuringPeriodShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "flora_WarrantsExercisedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants exercised, shares" } } }, "localname": "WarrantsExercisedShares", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "flora_WarrantsExpiredCancelled": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Warrants expired/cancelled (Note 14)" } } }, "localname": "WarrantsExpiredCancelled", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_WarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Warrants issued" } } }, "localname": "WarrantsIssued", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "flora_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/WarrantsDetails" ], "xbrltype": "domainItemType" }, "flora_WarrantsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number Of Warrants Balance, ending]", "periodEndLabel": "Number Of Warrants Balance, ending", "periodStartLabel": "Number Of Warrants Balance, Beginning", "verboseLabel": "Warrants Outstanding" } } }, "localname": "WarrantsOutstanding", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/WarrantsDetails", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "sharesItemType" }, "flora_WeightedAverageRemainingContractualLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options Outstanding, Weighted Average Remaining Contractual Life" } } }, "localname": "WeightedAverageRemainingContractualLife", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/OptionsDetails1" ], "xbrltype": "durationItemType" }, "flora_WeightedAverageStageOfGrowth": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Stage of Growth" } } }, "localname": "WeightedAverageStageOfGrowth", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BiologicalAssetsDetailsNarrative" ], "xbrltype": "percentItemType" }, "flora_WeightedAverageYieldPerGram": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Yield" } } }, "localname": "WeightedAverageYieldPerGram", "nsuri": "http://flora.com/20220630", "presentation": [ "http://flora.com/role/BiologicalAssetsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "ifrs-full_AccountingEstimatesAxis": { "auth_ref": [ "r127" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Accounting estimates [axis]" } } }, "localname": "AccountingEstimatesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_AccountingEstimatesMember": { "auth_ref": [ "r127" ], "lang": { "en": { "role": { "documentation": "This member stands for an asset, a liability or a periodic consumption of an asset, subject to adjustments that result from the assessment of the present status of, and expected future benefits and obligations associated with, assets and liabilities. It also represents the standard value for the 'Accounting estimates' axis if no other member is used." } } }, "localname": "AccountingEstimatesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "domainItemType" }, "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": { "auth_ref": [ "r101" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]" } }, "en-us": { "role": { "label": "[Acquisitions through business combinations, intangible assets and goodwill]", "terseLabel": "Acquired Through Business Combinations (note 8)", "verboseLabel": "Acquired Through Business Combinations (note 8)" } } }, "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r54" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Business Combinations (note 8)" } } }, "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": { "auth_ref": [ "r66" ], "lang": { "en": { "role": { "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Vessels One [Member]" } } }, "localname": "ActuarialAssumptionOfDiscountRatesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_AdditionalInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Information" } } }, "localname": "AdditionalInformationAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_AdditionalPaidinCapital": { "auth_ref": [ "r24" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } }, "en-us": { "role": { "label": "Additional common shares" } } }, "localname": "AdditionalPaidinCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r101" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "[Additions other than through business combinations, intangible assets other than goodwill]", "verboseLabel": "Additions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r53" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Additions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsToRightofuseAssets": { "auth_ref": [ "r167" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Additions To Right Of Use Assets" } } }, "localname": "AdditionsToRightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets": { "auth_ref": [ "r119" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "Adjustments for gains (losses) on changes in the fair value less costs to sell of biological assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Biological assets; Profit (loss)]" } }, "en-us": { "role": { "label": "Changes In Fair Value Less Cost To Sell Due To Biological Transformation" } } }, "localname": "AdjustmentsForGainsLossesOnChangeInFairValueLessCostsToSellBiologicalAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BiologicalAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "auth_ref": [ "r118" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "[Adjustments for increase (decrease) in trade accounts payable]", "verboseLabel": "Trade payables and accrued liabilities" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdvertisingExpense": { "auth_ref": [ "r10" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 13.0, "parentTag": "flora_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from advertising." } }, "en-us": { "role": { "label": "Promotion and communication" } } }, "localname": "AdvertisingExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AggregatedTimeBandsMember": { "auth_ref": [ "r26", "r67", "r161", "r170", "r171", "r194", "r203", "r205", "r221", "r222", "r224", "r227" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "localname": "AggregatedTimeBandsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_AmortisationExpense": { "auth_ref": [ "r10" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives." } }, "en-us": { "role": { "label": "Total Amortization Expense" } } }, "localname": "AmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Accumulated Amortization, Additions" } } }, "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r24", "r152", "r153", "r154", "r210", "r213" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "[Assets]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "auth_ref": [ "r3", "r10" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Attribution of expenses by nature to their function [axis]" } } }, "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BalancesWithBanks": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash balances held at banks." } }, "en-us": { "role": { "label": "Cash Held Amount" } } }, "localname": "BalancesWithBanks", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BasicEarningsLossPerShare": { "auth_ref": [ "r89", "r90" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } }, "en-us": { "role": { "label": "Basic and diluted loss per share attributable to Flora Growth Corp." } } }, "localname": "BasicEarningsLossPerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "ifrs-full_BiologicalAssets": { "auth_ref": [ "r17", "r110", "r111" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of living animals or plants recognised as assets." } }, "en-us": { "role": { "label": "Biological assets (Note 4)", "periodEndLabel": "Balance, Ending", "periodStartLabel": "Balance, Beginning" } } }, "localname": "BiologicalAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BiologicalAssetsDetails", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BottomOfRangeMember": { "auth_ref": [ "r156", "r157", "r158", "r179", "r202", "r224" ], "lang": { "en": { "role": { "documentation": "This member stands for the bottom of a range." } }, "en-us": { "role": { "label": "Bottom [Member]" } } }, "localname": "BottomOfRangeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_BusinessCombinationsAxis": { "auth_ref": [ "r185" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Business combinations [axis]" } } }, "localname": "BusinessCombinationsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_Cash": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } }, "en-us": { "role": { "label": "[Cash]", "terseLabel": "Cash", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r20", "r124", "r146" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 8.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r112", "r125" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 30.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "[Cash flows from (used in) financing activities]", "totalLabel": "Net cash (used) provided by financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r112", "r125" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 29.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "[Cash flows from (used in) investing activities]", "totalLabel": "Net cash used in investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "auth_ref": [ "r112", "r125" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 31.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } }, "en-us": { "role": { "label": "[Cash flows from (used in) operating activities]", "totalLabel": "Net cash used in operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": { "auth_ref": [ "r119", "r126" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital." } }, "en-us": { "role": { "label": "[Cash flows from (used in) operations before changes in working capital]", "verboseLabel": "Total" } } }, "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashOutflowForLeases": { "auth_ref": [ "r166" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for leases." } }, "en-us": { "role": { "label": "Total Cash Outflows From Leases" } } }, "localname": "CashOutflowForLeases", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashTransferred": { "auth_ref": [ "r181" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "[Cash transferred]", "verboseLabel": "Cash" } } }, "localname": "CashTransferred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of related parties [axis]" } } }, "localname": "CategoriesOfRelatedPartiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ChangesInReimbursementRightsAtFairValue": { "auth_ref": [ "r65" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the fair value of reimbursement rights related to defined benefit obligation. [Refer: At fair value [member]; Reimbursement rights related to defined benefit obligation, at fair value]" } }, "en-us": { "role": { "label": "Volatality change, fair value" } } }, "localname": "ChangesInReimbursementRightsAtFairValue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ClassesOfAssetsAxis": { "auth_ref": [ "r93", "r96", "r155", "r169" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of assets [axis]" } } }, "localname": "ClassesOfAssetsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/LongtermInvestmentsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfAssetsMember": { "auth_ref": [ "r93", "r155", "r169" ], "lang": { "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } } }, "localname": "ClassesOfAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/LongtermInvestmentsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_ClassesOfCashPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net change in non-cash working capital:" } } }, "localname": "ClassesOfCashPaymentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "auth_ref": [ "r196", "r197", "r198", "r199" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of financial instruments [axis]" } } }, "localname": "ClassesOfFinancialInstrumentsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails", "http://flora.com/role/SegmentedInformationDetails", "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfFinancialInstrumentsMember": { "auth_ref": [ "r196", "r197", "r198", "r199" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "localname": "ClassesOfFinancialInstrumentsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails", "http://flora.com/role/SegmentedInformationDetails", "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } } }, "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "auth_ref": [ "r58" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } } }, "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails", "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative", "http://flora.com/role/WarrantsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncome": { "auth_ref": [ "r4", "r37", "r129", "r132", "r140", "r144" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } }, "en-us": { "role": { "label": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "auth_ref": [ "r4", "r38" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } }, "en-us": { "role": { "label": "Comprehensive loss attributable to: Non-controlling interests" } } }, "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "auth_ref": [ "r4", "r39" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } }, "en-us": { "role": { "label": "Comprehensive loss attributable to: Flora Growth Corp." } } }, "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ConcentrationsOfRiskAxis": { "auth_ref": [ "r226" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Concentrations of risk [axis]" } } }, "localname": "ConcentrationsOfRiskAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ConcentrationsOfRiskMember": { "auth_ref": [ "r226" ], "lang": { "en": { "role": { "documentation": "This member stands for the concentrations of risk. It also represents the standard value for the 'Concentrations of risk' axis if no other member is used." } } }, "localname": "ConcentrationsOfRiskMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_ConsiderationPaidReceived": { "auth_ref": [ "r123" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Consideration", "verboseLabel": "Cash Paid" } } }, "localname": "ConsiderationPaidReceived", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContinuingInvolvementInDerecognisedFinancialAssetsByTypeOfInstrumentAxis": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Continuing involvement in derecognised financial assets by type of instrument [axis]" } } }, "localname": "ContinuingInvolvementInDerecognisedFinancialAssetsByTypeOfInstrumentAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/OptionsDetails", "http://flora.com/role/OptionsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_CostOfSales": { "auth_ref": [ "r2", "r45" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 2.0, "parentTag": "ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } }, "en-us": { "role": { "label": "[Cost of sales]", "negatedLabel": "Cost of sales" } } }, "localname": "CostOfSales", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "auth_ref": [ "r82", "r86", "r135", "r138" ], "lang": { "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Country Of Incorporation" } } }, "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [ "r24" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]" } }, "en-us": { "role": { "label": "Accrued Liabilities" } } }, "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r27", "r140", "r141" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 14.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "[Current assets]", "totalLabel": "Total current assets" } } }, "localname": "CurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r164" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Current lease liabilities" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r29", "r140", "r143" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 20.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "[Current liabilities]", "totalLabel": "Total current liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities [abstract]", "verboseLabel": "Current" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentPortionOfLongtermBorrowings": { "auth_ref": [ "r24" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 18.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Current portion of long term debt" } } }, "localname": "CurrentPortionOfLongtermBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPrepaidExpenses": { "auth_ref": [ "r10" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } }, "en-us": { "role": { "label": "Prepaid expenses" } } }, "localname": "CurrentPrepaidExpenses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies": { "auth_ref": [ "r71" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of current raw materials and current production supplies. [Refer: Current production supplies; Current raw materials]" } }, "en-us": { "role": { "label": "Raw Materials And Supplies" } } }, "localname": "CurrentRawMaterialsAndCurrentProductionSupplies", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTradeReceivables": { "auth_ref": [ "r28", "r31" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "[Current trade receivables]", "verboseLabel": "Current" } } }, "localname": "CurrentTradeReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxLiabilities": { "auth_ref": [ "r22", "r25", "r50" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 23.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } }, "en-us": { "role": { "label": "Deferred tax (Note 16)", "verboseLabel": "Deferred Tax" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationAndAmortisationExpense": { "auth_ref": [ "r1", "r3", "r45", "r147", "r208", "r215" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 14.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } }, "en-us": { "role": { "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "auth_ref": [ "r55", "r59" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 9.0, "parentTag": "flora_OperatingExpenses", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Depreciation and amortization (Notes 6 and 9)", "verboseLabel": "Accumulated Depreciation, Depreciation" } } }, "localname": "DepreciationPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss", "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares." } }, "en-us": { "role": { "label": "Warrants" } } }, "localname": "DescriptionOfAccountingPolicyForWarrantsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/WARRANTS" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } }, "en-us": { "role": { "label": "Volatility", "verboseLabel": "Expected Annualized Volatility" } } }, "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/OptionsDetails2" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities": { "auth_ref": [ "r13" ], "lang": { "en": { "role": { "documentation": "The description of the nature of the entity's operations and principal activities." } }, "en-us": { "role": { "label": "Principal Activity" } } }, "localname": "DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/NatureOfOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } }, "en-us": { "role": { "label": "Risk Free Interest Rate", "verboseLabel": "Risk-free Annual Interest Rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/OptionsDetails2" ], "xbrltype": "percentItemType" }, "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": { "auth_ref": [ "r91" ], "lang": { "en": { "role": { "documentation": "The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options." } }, "en-us": { "role": { "label": "Total Anti-dilutive" } } }, "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LossPerShareDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_DisclosureOfAdditionalInformationRepresentativeOfRiskExposureArisingFromContractsWithinScopeOfIFRS17DuringPeriodExplanatory": { "auth_ref": [ "r225" ], "lang": { "en": { "role": { "documentation": "The disclosure of additional information that is representative of the entity's risk exposure arising from contracts within the scope of IFRS 17 during the period, if the information disclosed about the entity\u2019s exposure to risk at the end of the reporting period is not representative." } }, "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details )" } } }, "localname": "DisclosureOfAdditionalInformationRepresentativeOfRiskExposureArisingFromContractsWithinScopeOfIFRS17DuringPeriodExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for consolidation." } }, "en-us": { "role": { "label": "BASIS OF PRESENTATION" } } }, "localname": "DisclosureOfBasisOfConsolidationExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } }, "en-us": { "role": { "label": "Basis Of Presentation" } } }, "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": { "auth_ref": [ "r190" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for business combinations." } }, "en-us": { "role": { "label": "Asset Acquisitions And Business Combinations" } } }, "localname": "DisclosureOfBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinations" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]" } }, "en-us": { "role": { "label": "Provisions, Commitments And Contingencies" } } }, "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BIOLOGICAL ASSETS" } } }, "localname": "DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory": { "auth_ref": [ "r110" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about biological assets. [Refer: Biological assets]" } }, "en-us": { "role": { "label": "Biological Assets" } } }, "localname": "DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BiologicalAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": { "auth_ref": [ "r191" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "ASSET ACQUISITIONS AND BUSINESS COMBINATIONS (Details)" } } }, "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "auth_ref": [ "r92" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for earnings per share." } }, "en-us": { "role": { "label": "Loss Per Share" } } }, "localname": "DisclosureOfEarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LossPerShare" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } }, "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT" } } }, "localname": "DisclosureOfFinancialRiskManagementExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfGoingConcernExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the entity's ability to continue as a going concern." } }, "en-us": { "role": { "label": "Nature Of Operations" } } }, "localname": "DisclosureOfGoingConcernExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/NatureOfOperations" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": { "auth_ref": [ "r73" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for government grants." } }, "en-us": { "role": { "label": "WARRANTS" } } }, "localname": "DisclosureOfGovernmentGrantsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory": { "auth_ref": [ "r99" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for the impairment of assets." } }, "en-us": { "role": { "label": "Impairment Of Assets" } } }, "localname": "DisclosureOfImpairmentOfAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ImpairmentOfAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for income taxes." } }, "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "DisclosureOfIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } }, "en-us": { "role": { "label": "Intangible Assets And Goodwill" } } }, "localname": "DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwill" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "auth_ref": [ "r72" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for inventories." } }, "en-us": { "role": { "label": "Disclosure of inventories [text block]", "verboseLabel": "Inventory" } } }, "localname": "DisclosureOfInventoriesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/INVENTORY" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInvestmentPropertyExplanatory": { "auth_ref": [ "r109" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for investment property." } }, "en-us": { "role": { "label": "Long-term Investments" } } }, "localname": "DisclosureOfInvestmentPropertyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIssuedCapitalExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of issued capital. [Refer: Issued capital]" } }, "en-us": { "role": { "label": "Capital Stock" } } }, "localname": "DisclosureOfIssuedCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/CapitalStock" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfJointOperationsExplanatory": { "auth_ref": [ "r151" ], "lang": { "en": { "role": { "documentation": "The disclosure of joint operations. [Refer: Joint operations [member]]" } }, "en-us": { "role": { "label": "OPTIONS" } } }, "localname": "DisclosureOfJointOperationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfLeasesExplanatory": { "auth_ref": [ "r172", "r173" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for leases." } }, "en-us": { "role": { "label": "Leases" } } }, "localname": "DisclosureOfLeasesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS (Details Narrative)" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEGMENTED INFORMATION" } } }, "localname": "DisclosureOfOperatingSegmentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "auth_ref": [ "r210" ], "lang": { "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } }, "en-us": { "role": { "label": "Segmented Information" } } }, "localname": "DisclosureOfOperatingSegmentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/SegmentedInformation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r61" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } }, "en-us": { "role": { "label": "Property, Plant And Equipment" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortization Expense By Class Of Underlying Asset" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "auth_ref": [ "r79" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for related parties." } }, "en-us": { "role": { "label": "Related Party Disclosures" } } }, "localname": "DisclosureOfRelatedPartyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/RelatedPartyDisclosures" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } }, "en-us": { "role": { "label": "Trade And Amounts Receivable" } } }, "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivable" ], "xbrltype": "textBlockItemType" }, "ifrs-full_EarningsPerShareExplanatory": { "auth_ref": [ "r89" ], "lang": { "en": { "role": { "documentation": "The disclosure of earnings per share." } }, "en-us": { "role": { "label": "LOSS PER SHARE" } } }, "localname": "EarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "auth_ref": [ "r120", "r121" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 28.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Effect of exchange rate on changes on cash" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "auth_ref": [ "r185", "r188" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "localname": "EntitysTotalForBusinessCombinationsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "localname": "EntitysTotalForRelatedPartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": { "auth_ref": [ "r216" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used." } } }, "localname": "EntitysTotalForSegmentConsolidationItemsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "auth_ref": [ "r84", "r88", "r150" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "localname": "EntitysTotalForSubsidiariesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r24", "r33", "r128", "r131", "r152", "r153", "r154" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 31.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "[Equity]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "Total shareholders' equity" } } }, "localname": "Equity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS' EQUITY" } } }, "localname": "EquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r24" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "[Equity and liabilities]", "totalLabel": "Total liabilities and shareholders' equity" } } }, "localname": "EquityAndLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "localname": "EquityAndLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "localname": "EquityMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative", "http://flora.com/role/WarrantsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "auth_ref": [ "r179" ], "lang": { "en": { "role": { "documentation": "The exercise price of outstanding share options." } }, "en-us": { "role": { "label": "[Exercise price of outstanding share options]", "terseLabel": "Exercise Price", "verboseLabel": "Exercise Price" } } }, "localname": "ExercisePriceOfOutstandingShareOptions2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/OptionsDetails1", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "The exercise price of share options granted." } }, "en-us": { "role": { "label": "[Exercise price, share options granted]", "terseLabel": "Exercise Price", "verboseLabel": "Exercise price" } } }, "localname": "ExercisePriceShareOptionsGranted2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/OptionsDetails2" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } }, "en-us": { "role": { "label": "Dividend Yield", "verboseLabel": "Expected Annual Dividend Yield" } } }, "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails", "http://flora.com/role/OptionsDetails2" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpectedReimbursementContingentLiabilitiesInBusinessCombination": { "auth_ref": [ "r184", "r186" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount expected to be reimbursed by another party on expenditures to settle contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]" } }, "en-us": { "role": { "label": "[Expected reimbursement, contingent liabilities in business combination]", "periodStartLabel": "Beginning Balance, Amount" } } }, "localname": "ExpectedReimbursementContingentLiabilitiesInBusinessCombination", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "auth_ref": [ "r10" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 13.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } }, "en-us": { "role": { "label": "Stock-based compensation" } } }, "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities": { "auth_ref": [ "r193" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Contingent liabilities [member]; Financial assets]" } }, "en-us": { "role": { "label": "Financial Assets And Liabilities" } } }, "localname": "FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsWhichDoNotQualifyForDerecognitionAxis": { "auth_ref": [ "r200" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Transferred financial assets that are not derecognised in their entirety [axis]" } } }, "localname": "FinancialAssetsWhichDoNotQualifyForDerecognitionAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_FinancialAssetsWhichDoNotQualifyForDerecognitionMember": { "auth_ref": [ "r200" ], "lang": { "en": { "role": { "documentation": "This member stands for transferred financial assets that are not derecognised in their entirety. It also represents the standard value for the 'Transferred financial assets that are not derecognised in their entirety' axis if no other member is used. [Refer: Financial assets]" } } }, "localname": "FinancialAssetsWhichDoNotQualifyForDerecognitionMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinishedGoods": { "auth_ref": [ "r32", "r71" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Finished Goods" } } }, "localname": "FinishedGoods", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis": { "auth_ref": [ "r64" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Funding arrangements of defined benefit plans [axis]" } } }, "localname": "FundingArrangementsOfDefinedBenefitPlansAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_FundingArrangementsOfDefinedBenefitPlansMember": { "auth_ref": [ "r64" ], "lang": { "en": { "role": { "documentation": "This member stands for all defined benefit plans when disaggregated by funding arrangements of defined benefits plans. It also represents the standard value for the 'Funding arrangements of defined benefits plans' axis if no other member is used." } } }, "localname": "FundingArrangementsOfDefinedBenefitPlansMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "auth_ref": [ "r14", "r74" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Foreign exchange loss (gain)" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty": { "auth_ref": [ "r108" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 6.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "lang": { "en": { "role": { "documentation": "The gains (losses) from changes in the fair value of investment property. [Refer: Investment property]" } }, "en-us": { "role": { "label": "[Gains (losses) on fair value adjustment, investment property]", "totalLabel": "Gross profit before fair value adjustments" } } }, "localname": "GainsLossesOnFairValueAdjustmentInvestmentProperty", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnLoansAndReceivables": { "auth_ref": [ "r231" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) on loans and receivables. [Refer: Loans and receivables]" } }, "en-us": { "role": { "label": "Trade receivables" } } }, "localname": "GainsLossesOnLoansAndReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsOnLitigationSettlements": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gain on settlements of litigation." } }, "en-us": { "role": { "label": "Payment settlements" } } }, "localname": "GainsOnLitigationSettlements", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeographicalAreasAxis": { "auth_ref": [ "r62", "r163", "r219", "r228" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Geographical areas [axis]" } } }, "localname": "GeographicalAreasAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1", "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_GeographicalAreasMember": { "auth_ref": [ "r62", "r163", "r219", "r228" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "localname": "GeographicalAreasMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1", "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_Goodwill": { "auth_ref": [ "r16", "r97", "r98", "r187" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 10.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Goodwill (Note 9)", "periodEndLabel": "Goodwill, Balance ending", "periodStartLabel": "Goodwill, Balance Beginning" } } }, "localname": "Goodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r185", "r189" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]" } }, "en-us": { "role": { "label": "Goodwill" } } }, "localname": "GoodwillRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GrossProfit": { "auth_ref": [ "r2" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 19.0, "parentTag": "flora_OperatingLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } }, "en-us": { "role": { "label": "[Gross profit]", "terseLabel": "Gross Profit", "totalLabel": "Gross Profit", "verboseLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss", "http://flora.com/role/SegmentedInformationDetails", "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": { "auth_ref": [ "r183", "r189" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Total Net Assets Acquired" } } }, "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLoss": { "auth_ref": [ "r95", "r96" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 12.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]" } }, "en-us": { "role": { "label": "Impairments" } } }, "localname": "ImpairmentLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill": { "auth_ref": [ "r102" ], "lang": { "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]" } }, "en-us": { "role": { "label": "Impairment", "verboseLabel": "Impairment" } } }, "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interim Condensed Consolidated Statements of Loss on Comprehensive Loss" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "auth_ref": [ "r41", "r47", "r48", "r49", "r80", "r149", "r209" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Income tax benefit (Note 16)" } } }, "localname": "IncomeTaxExpenseContinuingOperations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "auth_ref": [ "r124" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "[Increase (decrease) in cash and cash equivalents after effect of exchange rate changes]", "totalLabel": "Change in cash during the period" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInFairValueMeasurementAssets": { "auth_ref": [ "r154" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the fair value measurement of assets. [Refer: At fair value [member]]" } }, "en-us": { "role": { "label": "Unrealized loss on fair value of investments (Note 7)" } } }, "localname": "IncreaseDecreaseInFairValueMeasurementAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": { "auth_ref": [ "r7" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 20.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants." } }, "en-us": { "role": { "label": "Exercise of warrants and options" } } }, "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r104" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Foreign Currency Translation" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "auth_ref": [ "r56" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Foreign Exchange Translation" } } }, "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "auth_ref": [ "r6" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 11.0, "parentTag": "flora_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } }, "en-us": { "role": { "label": "Share based compensation (Note 13)" } } }, "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughTransferToStatutoryReserve": { "auth_ref": [ "r7" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from transfers to a statutory reserve. [Refer: Statutory reserve]" } }, "en-us": { "role": { "label": "Transferred To Harvested Cannabis Inventory Upon Harvest" } } }, "localname": "IncreaseDecreaseThroughTransferToStatutoryReserve", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BiologicalAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsAndGoodwill": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "[Intangible assets and goodwill]", "periodEndLabel": "Intangible Assets And Goodwill", "verboseLabel": "Goodwill And Identified Intangible Assets" } } }, "localname": "IntangibleAssetsAndGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsAndGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS AND GOODWILL" } } }, "localname": "IntangibleAssetsAndGoodwillAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r16", "r105" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 11.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Intangible assets (Note 9)", "verboseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "auth_ref": [ "r94", "r106", "r169" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } } }, "localname": "IntangibleAssetsOtherThanGoodwillMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails", "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_InterestExpense": { "auth_ref": [ "r148", "r207", "r215" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from interest." } }, "en-us": { "role": { "label": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "auth_ref": [ "r165" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Interest On Lease Liabilities" } } }, "localname": "InterestExpenseOnLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestPaidClassifiedAsOperatingActivities": { "auth_ref": [ "r122" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 17.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for interest paid, classified as operating activities." } }, "en-us": { "role": { "label": "Interest paid" } } }, "localname": "InterestPaidClassifiedAsOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Inventories": { "auth_ref": [ "r18", "r28", "r70" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Inventory (Note 5)", "verboseLabel": "Total" } } }, "localname": "Inventories", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://flora.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InventoryRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r183", "r189" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]" } }, "en-us": { "role": { "label": "[Inventory recognised as of acquisition date]", "verboseLabel": "Inventory" } } }, "localname": "InventoryRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapital": { "auth_ref": [ "r33" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 30.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital issued." } }, "en-us": { "role": { "label": "Share capital (Note 12)" } } }, "localname": "IssuedCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalOrdinaryShares": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]" } }, "en-us": { "role": { "label": "Shares Issued" } } }, "localname": "IssuedCapitalOrdinaryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensation": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "[Key management personnel compensation]", "verboseLabel": "Total" } } }, "localname": "KeyManagementPersonnelCompensation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "auth_ref": [ "r76" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Share-based Payments" } } }, "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Directors' And Officers' Compensation" } } }, "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/RelatedPartyDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LeaseLiabilities": { "auth_ref": [ "r164" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } }, "en-us": { "role": { "label": "Lease Liability", "verboseLabel": "Lease Liabilities" } } }, "localname": "LeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LEASES (Details)" } } }, "localname": "LeaseLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r24", "r152", "r153", "r154", "r210", "r214" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 32.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "[Liabilities]", "totalLabel": "Total liabilities", "verboseLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONGTERM INVESTMENTS (Details)" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_LiabilitiesIncurred": { "auth_ref": [ "r182" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of liabilities incurred (for example, a liability for contingent consideration) as consideration transferred in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Total Liabilities" } } }, "localname": "LiabilitiesIncurred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LineItemsByFunctionMember": { "auth_ref": [ "r3", "r10" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used." } } }, "localname": "LineItemsByFunctionMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LoansAndAdvancesToBanks": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of loans and advances the entity has made to banks." } }, "en-us": { "role": { "label": "Loans Receivable" } } }, "localname": "LoansAndAdvancesToBanks", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LoansAndReceivables": { "auth_ref": [ "r232" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]" } }, "en-us": { "role": { "label": "Loans receivable and advances" } } }, "localname": "LoansAndReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LongtermDeposits": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of long-term deposits held by the entity." } }, "en-us": { "role": { "label": "Long Term Debt" } } }, "localname": "LongtermDeposits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LossesOnChangeInFairValueOfDerivatives": { "auth_ref": [ "r42" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 11.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } }, "en-us": { "role": { "label": "Changes in fair value of investments and biological assets" } } }, "localname": "LossesOnChangeInFairValueOfDerivatives", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_MaturityAxis": { "auth_ref": [ "r26", "r67", "r161", "r170", "r171", "r194", "r201", "r203", "r221", "r222", "r224", "r227" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Maturity [axis]" } } }, "localname": "MaturityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_NameOfSubsidiary": { "auth_ref": [ "r81", "r85", "r134", "r137" ], "lang": { "en": { "role": { "documentation": "The name of a subsidiary. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Name Of Subsidiary" } } }, "localname": "NameOfSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncontrollingInterests": { "auth_ref": [ "r23", "r133", "r136" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 25.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Non-controlling interest" } } }, "localname": "NoncontrollingInterests", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentAssets": { "auth_ref": [ "r27", "r140", "r142" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } }, "en-us": { "role": { "label": "Non-current Assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current" } } }, "localname": "NoncurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentDebtInstrumentsIssued": { "auth_ref": [ "r24" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 21.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current debt instruments issued. [Refer: Debt instruments issued]" } }, "en-us": { "role": { "label": "Non-current debt" } } }, "localname": "NoncurrentDebtInstrumentsIssued", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentFinancialAssets": { "auth_ref": [ "r195" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current financial assets. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "[Non-current financial assets]", "periodEndLabel": "Balance, Ending", "periodStartLabel": "Balance, Beginning" } } }, "localname": "NoncurrentFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r164" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 17.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Current portion of lease liability (Note 11)" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current liabilities [abstract]", "verboseLabel": "Non-current" } } }, "localname": "NoncurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NumberOfSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity." } }, "en-us": { "role": { "label": "[Number of shares issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares", "terseLabel": "Common Shares" } } }, "localname": "NumberOfSharesIssued", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative", "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r35" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "[Number of shares outstanding]", "periodEndLabel": "Outstanding Balance, Ending", "periodStartLabel": "Outstanding Balance, Beginning", "verboseLabel": "Options Outstanding" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/OptionsDetails", "http://flora.com/role/OptionsDetails1" ], "xbrltype": "sharesItemType" }, "ifrs-full_OtherAssets": { "auth_ref": [ "r24" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 9.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other Assets" } } }, "localname": "OtherAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "auth_ref": [ "r30", "r43" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Exchange differences on foreign operations" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentLiabilities": { "auth_ref": [ "r24" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]" } }, "en-us": { "role": { "label": "Other current liabilities" } } }, "localname": "OtherCurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherLiabilities": { "auth_ref": [ "r24" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 16.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other accrued liabilities" } } }, "localname": "OtherLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherNoncurrentLiabilities": { "auth_ref": [ "r24" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 24.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]" } }, "en-us": { "role": { "label": "Other long term liabilities (Note 8)" } } }, "localname": "OtherNoncurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherReceivables": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other Receivables" } } }, "localname": "OtherReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ParValuePerShare": { "auth_ref": [ "r34" ], "lang": { "en": { "role": { "documentation": "The nominal value per share." } }, "en-us": { "role": { "label": "[Par value per share]", "verboseLabel": "Issued Common Shares" } } }, "localname": "ParValuePerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "ifrs-full_PaymentsForDebtIssueCosts": { "auth_ref": [ "r116" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 21.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for debt issue costs." } }, "en-us": { "role": { "label": "Equity issue costs" } } }, "localname": "PaymentsForDebtIssueCosts", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PlanAssetsAtFairValue": { "auth_ref": [ "r69" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]" } }, "en-us": { "role": { "label": "[Plan assets, at fair value]", "verboseLabel": "Fair Value" } } }, "localname": "PlanAssetsAtFairValue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LongtermInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PrincipalPlaceOfBusiness": { "auth_ref": [ "r12" ], "lang": { "en": { "role": { "documentation": "The place where an entity principally conducts operations." } }, "en-us": { "role": { "label": "Principal Place Of Business" } } }, "localname": "PrincipalPlaceOfBusiness", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/NatureOfOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ProceedsFromIssuingShares": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from issuing shares." } }, "en-us": { "role": { "label": "Gross Proceeds" } } }, "localname": "ProceedsFromIssuingShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/CapitalStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProductsAndServicesAxis": { "auth_ref": [ "r162", "r217" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Products and services [axis]" } } }, "localname": "ProductsAndServicesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_ProductsAndServicesMember": { "auth_ref": [ "r162", "r217" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "localname": "ProductsAndServicesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_ProfessionalFeesExpense": { "auth_ref": [ "r10" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 15.0, "parentTag": "flora_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } }, "en-us": { "role": { "label": "Professional fees" } } }, "localname": "ProfessionalFeesExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r5", "r36", "r117", "r129", "r132", "r140", "r210", "r212", "r223", "r230" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 15.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Net loss for the period", "terseLabel": "Net loss", "verboseLabel": "Current year net loss attributable to Flora" } } }, "localname": "ProfitLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows", "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss", "http://flora.com/role/SegmentedInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossBeforeTax": { "auth_ref": [ "r1", "r2", "r192", "r210", "r212" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Net loss before income taxes" } } }, "localname": "ProfitLossBeforeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r15", "r57" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 13.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Property, plant and equipment (Note 6)", "periodEndLabel": "Property Plant And Equipment" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PROPERTY PLANT AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The gross carrying amount of fully depreciated property, plant and equipment that is still in use. [Refer: Gross carrying amount [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "[Property, plant and equipment, gross carrying amount of fully depreciated assets still in use]", "periodEndLabel": "Balance, Ending", "periodStartLabel": "Balance, Beginning" } } }, "localname": "PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipmentMember": { "auth_ref": [ "r58", "r94", "r169" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails", "http://flora.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r183", "r189" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]" } }, "en-us": { "role": { "label": "[Property, plant and equipment recognised as of acquisition date]", "verboseLabel": "Property, Plant And Equipment" } } }, "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "auth_ref": [ "r83", "r87", "r139" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Ownership Of Subsidiary", "verboseLabel": "Non-controlling Interest" } } }, "localname": "ProportionOfOwnershipInterestInSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r113" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 24.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of investments" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RangeAxis": { "auth_ref": [ "r156", "r157", "r158", "r179", "r202", "r224" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Range [axis]" } } }, "localname": "RangeAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesMember": { "auth_ref": [ "r156", "r157", "r158", "r179", "r202", "r224" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "localname": "RangesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "auth_ref": [ "r179" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/OptionsDetails1", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "auth_ref": [ "r179" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/OptionsDetails1", "http://flora.com/role/WarrantsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_ReconciliationOfUndiscountedLeasePaymentsToNetInvestmentInFinanceLeaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities" } } }, "localname": "ReconciliationOfUndiscountedLeasePaymentsToNetInvestmentInFinanceLeaseAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RedesignatedMember": { "auth_ref": [ "r130" ], "lang": { "en": { "role": { "documentation": "This member stands for financial instruments redesignated during the transition to IFRSs. It also represents the standard value for the 'Redesignation' axis if no other member is used." } } }, "localname": "RedesignatedMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_RedesignationAxis": { "auth_ref": [ "r130" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Redesignation [axis]" } } }, "localname": "RedesignationAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ImpairmentOfAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ReductionOfIssuedCapital": { "auth_ref": [ "r7" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]" } }, "en-us": { "role": { "label": "Options Issued (Note 13)" } } }, "localname": "ReductionOfIssuedCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [ "r115" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows": { "order": 16.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Loan borrowing (repayments)" } } }, "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r107" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 10.0, "parentTag": "flora_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments": { "auth_ref": [ "r24" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 28.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing components of convertible instruments classified as equity." } }, "en-us": { "role": { "label": "Warrants (Note 14)" } } }, "localname": "ReserveOfEquityComponentOfConvertibleInstruments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r24" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 7.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Restricted cash", "verboseLabel": "Restricted Cash" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetailsNarrative", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarnings": { "auth_ref": [ "r33", "r46" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 26.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Deficit" } } }, "localname": "RetainedEarnings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r8", "r9" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "domainItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r1", "r2", "r40", "r140", "r145", "r192", "r206", "r211", "r217", "r218", "r220" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 3.0, "parentTag": "ifrs-full_GainsLossesOnFairValueAdjustmentInvestmentProperty", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "[Revenue]", "negatedLabel": "Revenue (Note 21)", "terseLabel": "Revenue", "verboseLabel": "Revenue" } } }, "localname": "Revenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative", "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss", "http://flora.com/role/SegmentedInformationDetails", "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssets": { "auth_ref": [ "r168" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 12.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } }, "en-us": { "role": { "label": "Right of use assets (Note 11)" } } }, "localname": "RightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SegmentConsolidationItemsAxis": { "auth_ref": [ "r210" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Segment consolidation items [axis]" } } }, "localname": "SegmentConsolidationItemsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/SegmentedInformationDetails1" ], "xbrltype": "stringItemType" }, "ifrs-full_SegmentsAxis": { "auth_ref": [ "r63", "r96", "r159", "r210", "r229" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Segments [axis]" } } }, "localname": "SegmentsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_SegmentsMember": { "auth_ref": [ "r63", "r96", "r159", "r216", "r229" ], "lang": { "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "localname": "SegmentsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 14.0, "parentTag": "flora_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } }, "en-us": { "role": { "label": "General and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareIssueRelatedCost": { "auth_ref": [ "r7" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cost related to the issuance of shares." } }, "en-us": { "role": { "label": "[Share issue related cost]", "verboseLabel": "Share issuance costs" } } }, "localname": "ShareIssueRelatedCost", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementOfShareholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "auth_ref": [ "r84", "r88", "r150" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Subsidiaries [axis]" } } }, "localname": "SignificantInvestmentsInSubsidiariesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/BasisOfPresentationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interim Condensed Consolidated Statement of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interim Condensed Consolidated Statement of Shareholders' Equity (Deficiency)" } } }, "localname": "StatementOfChangesInEquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interim Condensed Consolidated Statements of Financial Position" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TerminationBenefitsExpense": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense in relation to termination benefits. Termination benefits are employee benefits provided in exchange for the termination of an employee's employment as a result of either: (a) an entity's decision to terminate an employee's employment before the normal retirement date; or (b) an employee's decision to accept an offer of benefits in exchange for the termination of employment. [Refer: Employee benefits expense]" } }, "en-us": { "role": { "label": "Payment For Termination" } } }, "localname": "TerminationBenefitsExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TopOfRangeMember": { "auth_ref": [ "r156", "r157", "r158", "r179", "r202", "r224" ], "lang": { "en": { "role": { "documentation": "This member stands for top of a range." } }, "en-us": { "role": { "label": "Top [Member]" } } }, "localname": "TopOfRangeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r21" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 19.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Trade payables and accrued liabilities", "verboseLabel": "Trade And Other Payables" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://flora.com/role/RelatedPartyDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentReceivables": { "auth_ref": [ "r19", "r31" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } }, "en-us": { "role": { "label": "Trade and amounts receivable (Note 3)" } } }, "localname": "TradeAndOtherCurrentReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayables": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } }, "en-us": { "role": { "label": "Trade Payables" } } }, "localname": "TradeAndOtherPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r183" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]" } }, "en-us": { "role": { "label": "Trade Payables And Accrued Liabilities" } } }, "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherReceivables": { "auth_ref": [ "r19", "r31" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]" } }, "en-us": { "role": { "label": "[Trade and other receivables]", "verboseLabel": "Total" } } }, "localname": "TradeAndOtherReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TRADE AND AMOUNTS RECEIVABLE (Details)" } } }, "localname": "TradeAndOtherReceivablesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of receivables due from related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Hst Receivable" } } }, "localname": "TradeAndOtherReceivablesDueFromRelatedParties", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/TradeAndAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeReceivables": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount due from customers for goods and services sold." } }, "en-us": { "role": { "label": "Trade Accounts Receivable", "terseLabel": "Amounts Receivable", "verboseLabel": "Total Trade Receivables" } } }, "localname": "TradeReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://flora.com/role/TradeAndAmountsReceivableDetails", "http://flora.com/role/TradeAndAmountsReceivableDetails1" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": { "auth_ref": [ "r160" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]" } }, "en-us": { "role": { "label": "Total Contracts Payment" } } }, "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/ProvisionsCommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TravelExpense": { "auth_ref": [ "r10" ], "calculation": { "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss": { "order": 12.0, "parentTag": "flora_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from travel." } }, "en-us": { "role": { "label": "Travel expenses" } } }, "localname": "TravelExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TypesOfInstrumentMember": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of financial instruments. It also represents the standard value for the 'Continuing involvement in derecognised financial assets by type of instrument' axis if no other member is used." } } }, "localname": "TypesOfInstrumentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/LossPerShareDetails", "http://flora.com/role/OptionsDetails", "http://flora.com/role/OptionsDetails1" ], "xbrltype": "domainItemType" }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r100" ], "lang": { "en": { "role": { "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Useful Lives" } } }, "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "durationItemType" }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": { "auth_ref": [ "r52" ], "lang": { "en": { "role": { "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "[Useful life measured as period of time, property, plant and equipment]", "verboseLabel": "Useful Lives" } } }, "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/AssetAcquisitionsAndBusinessCombinationsDetailsNarrative" ], "xbrltype": "durationItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r176" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised", "verboseLabel": "Weighted Average Exercise Price, Exercised" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/OptionsDetails", "http://flora.com/role/WarrantsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r177" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, Cancelled/expired" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/WarrantsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r175" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/OptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r174", "r178" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "[Weighted average exercise price of share options outstanding in share-based payment arrangement]", "periodEndLabel": "Weighted Average Exercise Price Outstanding Balance, Ending", "periodStartLabel": "Weighted Average Exercise Price Outstanding Balance, Beginning" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/OptionsDetails", "http://flora.com/role/WarrantsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageShares": { "auth_ref": [ "r91" ], "lang": { "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } }, "en-us": { "role": { "label": "Weighted average number of common shares outstanding - basic and diluted (Note 17)" } } }, "localname": "WeightedAverageShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InterimCondensedConsolidatedStatementsOfLossOnComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "ifrs-full_WorkInProgress": { "auth_ref": [ "r32", "r71" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]" } }, "en-us": { "role": { "label": "Work In Progress" } } }, "localname": "WorkInProgress", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://flora.com/role/InventoryDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2021-03-24" }, "r1": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard", "URIDate": "2021-03-24" }, "r10": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2021-03-24" }, "r100": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_a&doctype=Standard", "URIDate": "2021-03-24" }, "r101": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r102": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r103": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r104": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r105": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2021-03-24" }, "r106": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard", "URIDate": "2021-03-24" }, "r107": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard", "URIDate": "2021-03-24" }, "r108": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "76", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76_d&doctype=Standard", "URIDate": "2021-03-24" }, "r109": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS40_g74-79_TI", "URIDate": "2021-03-24" }, "r11": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard", "URIDate": "2021-03-24" }, "r110": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "43", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_43&doctype=Standard", "URIDate": "2021-03-24" }, "r111": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "50", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard", "URIDate": "2021-03-24" }, "r112": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard", "URIDate": "2021-03-24" }, "r113": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2021-03-24" }, "r114": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2021-03-24" }, "r115": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2021-03-24" }, "r116": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r117": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2021-03-24" }, "r118": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2021-03-24" }, "r119": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard", "URIDate": "2021-03-24" }, "r12": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "138", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2021-03-24" }, "r120": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "25", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard", "URIDate": "2021-03-24" }, "r121": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "28", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard", "URIDate": "2021-03-24" }, "r122": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "31", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard", "URIDate": "2021-03-24" }, "r123": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "40", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2021-03-24" }, "r124": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r125": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2021-03-24" }, "r126": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI", "URIDate": "2021-03-24" }, "r127": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "8", "Paragraph": "39", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard", "URIDate": "2021-03-24" }, "r128": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2021-03-24" }, "r129": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2021-03-24" }, "r13": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "138", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_138_b&doctype=Standard", "URIDate": "2021-03-24" }, "r130": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "29", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_29&doctype=Standard", "URIDate": "2021-03-24" }, "r131": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r132": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r133": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "10", "Paragraph": "22", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22&doctype=Standard", "URIDate": "2021-03-24" }, "r134": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_a&doctype=Standard", "URIDate": "2021-03-24" }, "r135": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2021-03-24" }, "r136": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2021-03-24" }, "r137": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_a&doctype=Standard", "URIDate": "2021-03-24" }, "r138": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2021-03-24" }, "r139": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2021-03-24" }, "r14": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard", "URIDate": "2021-03-24" }, "r140": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r141": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r142": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r143": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r144": { "Clause": "ix", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r145": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r146": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r147": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r148": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r149": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r15": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2021-03-24" }, "r150": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r151": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_c&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r152": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2021-03-24" }, "r153": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2021-03-24" }, "r154": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2021-03-24" }, "r155": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard", "URIDate": "2021-03-24" }, "r156": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "B6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r157": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "IE63", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r158": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "14", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2021-03-24" }, "r159": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "115", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_115&doctype=Standard", "URIDate": "2021-03-24" }, "r16": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2021-03-24" }, "r160": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "120", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_a&doctype=Standard", "URIDate": "2021-03-24" }, "r161": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "120", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r162": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r163": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r164": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2021-03-24" }, "r165": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2021-03-24" }, "r166": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_g&doctype=Standard", "URIDate": "2021-03-24" }, "r167": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2021-03-24" }, "r168": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "j", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2021-03-24" }, "r169": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard", "URIDate": "2021-03-24" }, "r17": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2021-03-24" }, "r170": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "94", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard", "URIDate": "2021-03-24" }, "r171": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "97", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard", "URIDate": "2021-03-24" }, "r172": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2021-03-24" }, "r173": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Section": "Presentation", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2021-03-24" }, "r174": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r175": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r176": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r177": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2021-03-24" }, "r178": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r179": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2021-03-24" }, "r18": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2021-03-24" }, "r180": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r181": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r182": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_iii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r183": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r184": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "j", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_j&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r185": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r186": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r187": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r188": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r189": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "IE72", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_IE72&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r19": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2021-03-24" }, "r190": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI", "URIDate": "2021-03-24" }, "r191": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures application of paragraphs 59 and 61", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67_TI", "URIDate": "2021-03-24" }, "r192": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r193": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "14", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_14_a&doctype=Standard", "URIDate": "2021-03-24" }, "r194": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "23B", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2021-03-24" }, "r195": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "25", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard", "URIDate": "2021-03-24" }, "r196": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35H", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2021-03-24" }, "r197": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35K", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2021-03-24" }, "r198": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35M", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2021-03-24" }, "r199": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "36", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_36&doctype=Standard", "URIDate": "2021-03-24" }, "r2": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard", "URIDate": "2021-03-24" }, "r20": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2021-03-24" }, "r200": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "42D", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42D&doctype=Standard", "URIDate": "2021-03-24" }, "r201": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "42E", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2021-03-24" }, "r202": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r203": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B11", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r204": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B33&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r205": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r206": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2021-03-24" }, "r207": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2021-03-24" }, "r208": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2021-03-24" }, "r209": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2021-03-24" }, "r21": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2021-03-24" }, "r210": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard", "URIDate": "2021-03-24" }, "r211": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2021-03-24" }, "r212": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2021-03-24" }, "r213": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2021-03-24" }, "r214": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2021-03-24" }, "r215": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2021-03-24" }, "r216": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard", "URIDate": "2021-03-24" }, "r217": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard", "URIDate": "2021-03-24" }, "r218": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2021-03-24" }, "r219": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard", "URIDate": "2021-03-24" }, "r22": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "o", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2021-03-24" }, "r220": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r221": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard", "URIDate": "2021-03-24" }, "r222": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2021-03-24" }, "r223": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2021-03-24" }, "r224": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "120", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard", "URIDate": "2021-03-24" }, "r225": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "123", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_123&doctype=Standard", "URIDate": "2021-03-24" }, "r226": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r227": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "132", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2021-03-24" }, "r228": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2021-03-24" }, "r229": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2021-03-24" }, "r23": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "q", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_q&doctype=Standard", "URIDate": "2021-03-24" }, "r230": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2021-03-24" }, "r231": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_a_iv&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r232": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "8", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_c&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r233": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r24": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard", "URIDate": "2021-03-24" }, "r25": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "56", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard", "URIDate": "2021-03-24" }, "r26": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "61", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard", "URIDate": "2021-03-24" }, "r27": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r28": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "68", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard", "URIDate": "2021-03-24" }, "r29": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard", "URIDate": "2021-03-24" }, "r3": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "104", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_104&doctype=Standard", "URIDate": "2021-03-24" }, "r30": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r31": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2021-03-24" }, "r32": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_c&doctype=Standard", "URIDate": "2021-03-24" }, "r33": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2021-03-24" }, "r34": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r35": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r36": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2021-03-24" }, "r37": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2021-03-24" }, "r38": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r39": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r4": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2021-03-24" }, "r40": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2021-03-24" }, "r41": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2021-03-24" }, "r42": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard", "URIDate": "2021-03-24" }, "r43": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2021-03-24" }, "r44": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "98", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_f&doctype=Standard", "URIDate": "2021-03-24" }, "r45": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "99", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard", "URIDate": "2021-03-24" }, "r46": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r47": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "79", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard", "URIDate": "2021-03-24" }, "r48": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2021-03-24" }, "r49": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r5": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2021-03-24" }, "r50": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2021-03-24" }, "r51": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2021-03-24" }, "r52": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2021-03-24" }, "r53": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r54": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r55": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r56": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2021-03-24" }, "r57": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2021-03-24" }, "r58": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard", "URIDate": "2021-03-24" }, "r59": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2021-03-24" }, "r6": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r60": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "79", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_79_b&doctype=Standard", "URIDate": "2021-03-24" }, "r61": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2021-03-24" }, "r62": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2021-03-24" }, "r63": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2021-03-24" }, "r64": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_e&doctype=Standard", "URIDate": "2021-03-24" }, "r65": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141&doctype=Standard", "URIDate": "2021-03-24" }, "r66": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "145", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145&doctype=Standard", "URIDate": "2021-03-24" }, "r67": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "147", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2021-03-24" }, "r68": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "171", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_171&doctype=Standard", "URIDate": "2021-03-24" }, "r69": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "57", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_57_a&doctype=Standard", "URIDate": "2021-03-24" }, "r7": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2021-03-24" }, "r70": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2021-03-24" }, "r71": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "37", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard", "URIDate": "2021-03-24" }, "r72": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI", "URIDate": "2021-03-24" }, "r73": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "20", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI", "URIDate": "2021-03-24" }, "r74": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "21", "Paragraph": "52", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2021-03-24" }, "r75": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2021-03-24" }, "r76": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2021-03-24" }, "r77": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r78": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard", "URIDate": "2021-03-24" }, "r79": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2021-03-24" }, "r8": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard", "URIDate": "2021-03-24" }, "r80": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2021-03-24" }, "r81": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r82": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r83": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r84": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2021-03-24" }, "r85": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r86": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r87": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r88": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2021-03-24" }, "r89": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r9": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard", "URIDate": "2021-03-24" }, "r90": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "67", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard", "URIDate": "2021-03-24" }, "r91": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2021-03-24" }, "r92": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2021-03-24" }, "r93": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "126", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard", "URIDate": "2021-03-24" }, "r94": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r95": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_b&doctype=Standard", "URIDate": "2021-03-24" }, "r96": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r97": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2021-03-24" }, "r98": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "135", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2021-03-24" }, "r99": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS36_g126-137_TI", "URIDate": "2021-03-24" } }, "version": "2.1" } ZIP 100 0001477932-22-007013-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-22-007013-xbrl.zip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ஶ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